https://lungcancerclinicaltrials.org 2026-08-30T05:32:45.548Z daily 1 https://lungcancerclinicaltrials.org/about 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/methodology 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/trial-basics 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/for-sites 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/privacy 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/terms 2026-08-30T05:32:45.548Z monthly 0.5 https://lungcancerclinicaltrials.org/trials/type/nsclc 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/type/sclc 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/type/mesothelioma 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/disease-setting/early-resectable 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/disease-setting/locally-advanced 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/disease-setting/metastatic 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/disease-setting/recurrent 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/disease-setting/resistant-refractory 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/egfr 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/alk 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/ros1 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/kras 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/met 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/ret 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/braf 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/her2 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/ntrk 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/biomarker/pd-l1 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/immunotherapy 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/targeted-therapy 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/chemotherapy 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/radiation 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/surgery 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/cell-gene-therapy 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/treatment/supportive-behavioral 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/treatment 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/prevention 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/screening 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/diagnostic 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/supportive-care 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/basic-science 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/purpose/health-services-research 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/early-phase-1 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-1 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-1-phase-2 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-2 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-2-phase-3 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-3 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/phase-4 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/phase/not-applicable 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/design/interventional 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/design/observational 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/design/expanded-access 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/topic/brain-metastases 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/topic/before-surgery 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/topic/after-surgery 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/topic/after-prior-treatment 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/topic/survivorship-quality-of-life 2026-08-30T05:32:45.548Z weekly 0.7 https://lungcancerclinicaltrials.org/trials/nct07793253/phase-2-study-of-daraxonrasib-in-recurrent-kras-mutant-biliary-tract-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07554339/a-clinical-trial-of-calderasib-mk-1084-and-durvalumab-in-people-with-non-small-cell-lung 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06475937/a-study-of-dm001-in-patients-with-advanced-solid-tumors 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07365241/a-study-to-evaluate-adverse-events-and-change-in-disease-activity-of-intravenous-abbv-70 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06780137/a-study-to-evaluate-the-safety-and-efficacy-of-gocatamig-mk-6070-and-ifinatamab-deruxtec 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02595944/nivolumab-after-surgery-and-chemotherapy-in-treating-patients-with-stage-ib-iiia-non-sma 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04267848/testing-the-addition-of-a-type-of-drug-called-immunotherapy-to-the-usual-chemotherapy-tr 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07190248/a-clinical-study-of-calderasib-mk-1084-and-other-treatments-for-participants-with-non-sm 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05498428/a-study-of-amivantamab-in-participants-with-advanced-or-metastatic-solid-tumors-includin 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04387656/nci-covid-19-in-cancer-patients-nccaps-study 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07586202/a-study-of-neoadjuvant-amivantamab-with-either-lazertinib-or-chemotherapy-in-participant 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07639242/olomorasib-pembrolizumab-kras-g12c-mutant-pd-l1-tps-1-49-locally-advanced-or-metastatic 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01441089/collection-of-blood-from-patients-with-cancer-other-tumors-or-tumor-predisposition-syndr 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07792824/witness-project-lung 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001620/screening-for-hematology-branch-protocols 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02146170/tissue-procurement-and-natural-history-study-of-people-with-non-small-cell-lung-cancer-s 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05777603/study-of-aerosolized-antibiotics-and-pembrolizumab-in-advanced-non-small-cell-lung-cance 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06116786/a-study-of-jnj-86974680-in-participants-with-advanced-non-small-cell-lung-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04487080/a-study-of-amivantamab-and-lazertinib-combination-therapy-versus-osimertinib-in-locally 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05298423/study-of-pembrolizumab-vibostolimab-mk-7684a-in-combination-with-concurrent-chemoradioth 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04450927/data-collection-of-standard-care-and-evaluation-of-nhlbi-patients-and-donors 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001465/study-of-the-disease-process-of-lymphangioleiomyomatosis 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06120140/enhanced-dermatological-care-to-reduce-rash-and-paronychia-in-epidermal-growth-factor-re 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227025/a-study-of-amivantamab-and-olomorasib-combination-therapy-in-participants-with-metastati 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07005297/clinical-genetics-branch-eligibility-screening-survey 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02609776/study-of-amivantamab-a-human-bispecific-egfr-and-cmet-antibody-in-participants-with-adva 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05211895/a-global-study-to-assess-the-effects-of-durvalumab-domvanalimab-following-concurrent-che 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00034216/collection-of-blood-from-patients-with-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05488314/a-study-of-amivantamab-and-capmatinib-combination-therapy-in-unresectable-metastatic-non 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06236438/study-to-evaluate-adverse-events-optimal-dose-and-change-in-disease-activity-with-livmon 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07783477/a-study-of-armored-car-t-cells-in-people-with-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04449874/a-study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-6036-alone-or-in-com 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06694454/neoadjuvant-inhaled-azacytidine-with-platinum-based-chemotherapy-and-durvalumab-medi4736 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07781852/evaluation-of-the-distribution-of-64cu-68ga-labeled-cm500-in-healthy-volunteers-and-pati 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07217171/a-study-evaluating-the-safety-efficacy-and-pharmacokinetics-pk-of-evolve104-in-participa 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07038343/aventine-1-study-of-avzo-1418-as-a-single-agent-and-in-combination-therapy-in-patients-w 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05642195/evaluation-of-a-cancer-lysate-vaccine-and-montanide-registered-trademark-isa-51-vg-with 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07388524/testing-the-impact-of-an-anti-cancer-drug-atezolizumab-after-surgery-to-prevent-early-st 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06096844/chemotherapy-combined-with-immunotherapy-versus-immunotherapy-alone-for-older-adults-wit 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07509034/autologous-b7-h3-chimeric-antigen-receptor-t-cells-in-previously-treated-extensive-stage 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00339495/prostate-lung-colorectal-and-ovarian-plco-cancer-screening-trial 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06667076/a-study-of-amivantamab-in-combination-with-lazertinib-or-amivantamab-in-combination-with 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06636721/lung-cancer-and-aging-improving-well-being-for-older-adults-with-lung-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02465060/targeted-therapy-directed-by-genetic-testing-in-treating-patients-with-advanced-refracto 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07057791/phase-ii-study-of-platinum-etoposide-plus-ivonescimab-for-extensive-stage-small-cell-lun 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03793179/testing-the-timing-of-pembrolizumab-alone-or-with-chemotherapy-as-first-line-treatment-a 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07659782/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-non-small-cell-lung-cancer 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06667908/a-study-of-jnj-90301900-in-combination-with-chemoradiation-followed-by-consolidation-imm 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02194738/genetic-testing-in-screening-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that 2026-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06726148/study-of-eci830-single-agent-or-in-combination-in-patients-with-advanced-hr-her2-breast 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227168/a-study-of-stro-004-in-adults-with-refractory-recurrent-metastatic-cancer 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05500092/an-open-label-randomized-study-of-neoadjuvant-nivolumab-and-chemotherapy-with-or-without 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00242723/evaluation-of-cell-changes-in-blood-and-tissue-in-cancers-of-the-lung-esophagus-and-lung 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05338970/herthena-lung02-a-study-of-patritumab-deruxtecan-versus-platinum-based-chemotherapy-in-m 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07602842/a-study-of-idp-001-in-advanced-or-metastatic-solid-tumors 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06582017/safety-pk-and-efficacy-of-qxl138am-in-patients-with-solid-tumors-and-multiple-myeloma 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02133196/t-cell-receptor-immunotherapy-for-patients-with-metastatic-non-small-cell-lung-cancer 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05150691/a-phase-1-2a-study-of-db-1303-bnt323-in-advanced-metastatic-solid-tumors 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07322341/sx-682-and-atezolizumab-for-the-treatment-of-advanced-or-metastatic-recurrent-non-small 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01064466/pharmacogenomics-anda-snp-clinical-study-etoposide-and-single-nucleotide-polymorphisms 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05920356/a-study-evaluating-sotorasib-platinum-doublet-combination-versus-pembrolizumab-platinum 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05479812/dose-escalation-and-expansion-study-of-wtx-124-as-monotherapy-and-in-combination-with-pe 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07660055/study-of-177lu-lu-dwj155-and-68ga-ga-dwj155-in-patients-with-solid-tumors 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06881784/study-of-daraxonrasib-rmc-6236-in-patients-with-ras-mutated-nsclc-rasolve-301 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07012031/sotorasib-in-combination-with-trastuzumab-deruxtecan-for-the-treatment-of-locally-advanc 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03975829/pediatric-long-term-follow-up-and-rollover-study 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02682667/biospecimen-procurement-for-center-for-immuno-oncology-immunotherapy-protocols 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07789912/brain-avoidant-proton-craniospinal-irradiation-for-leptomeningeal-metastases-from-solid 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06623422/a-study-of-pembrolizumab-mk-3475-with-or-without-intismeran-autogene-v940-in-participant 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00068003/harvesting-cells-for-experimental-cancer-treatments 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03811002/testing-the-addition-of-a-new-immunotherapy-drug-atezolizumab-mpdl3280a-to-the-usual-che 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05132075/study-of-jdq443-in-comparison-with-docetaxel-in-participants-with-locally-advanced-or-me 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06170788/sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-versus-pembrolizumab-a 2026-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06892548/a-clinical-study-to-investigate-the-efficacy-and-safety-of-an-investigational-combinatio 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04209595/plx038-pegylated-sn38-and-rucaparib-in-solid-tumors-and-small-cell-cancers 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06577987/safety-efficacy-study-of-cid-078-in-patients-with-advanced-solid-tumor-malignancies 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00334815/combination-chemotherapy-radiation-therapy-and-bevacizumab-in-treating-patients-with-new 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06995898/the-vanguard-study-testing-a-new-way-to-screen-for-cancer 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07718672/hotspot-stereotactic-ablative-radiotherapy-versus-traditional-stereotactic-ablative-radi 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07254650/combination-versus-alone-liposomal-bupivacaine-blocks-in-minimally-invasive-thoracic-sur 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07288177/study-to-assess-the-efficacy-and-safety-of-rina-s-in-participants-with-non-small-cell-lu 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05144997/lorlatinib-continuation-study 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06885697/anti-mesothelin-tnaive-scm-hyp218-tnhyp218-car-t-cells-in-participants-with-mesothelin-e 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06383988/a-web-based-program-to-help-caregivers-of-lung-patients-learn-about-available-supportive 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07513376/a-clinical-trial-of-adjuvant-intismeran-v940-with-or-without-pembrolizumab-coformulated 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05722015/a-study-of-subcutaneous-sc-pembrolizumab-coformulated-with-berahyaluronidase-alfa-mk-347 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07128199/a-study-to-assess-zipalertinib-versus-placebo-in-participants-with-early-stage-nsclc-wit 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06863233/a-study-of-cd8-t-cell-imaging-during-treatment-in-people-with-non-small-cell-lung-cancer 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06745882/prospective-trial-assessing-real-world-outcomes-response-to-pembro-in-black-patients-w-n 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01950572/tissue-procurement-and-natural-history-study-of-patients-with-malignant-mesothelioma 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06350097/phase-iii-open-label-study-of-first-line-osimertinib-with-or-without-datopotamab-deruxte 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06482073/molecular-analysis-of-suspected-or-high-risk-lung-cancer-to-drive-individualized-care-in 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05587439/investigating-hereditary-risk-in-thoracic-cancers-inherit 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04025879/a-study-of-neoadjuvant-chemotherapy-plus-nivolumab-versus-neoadjuvant-chemotherapy-plus 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04656652/study-of-ds-1062a-versus-docetaxel-in-previously-treated-advanced-or-metastatic-non-smal 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07169617/testing-the-survaxm-vaccine-for-lung-cancer-prevention 2026-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04670445/improving-patient-and-caregiver-understanding-of-risks-and-benefits-of-immunotherapy-for 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04181060/osimertinib-with-or-without-bevacizumab-as-initial-treatment-for-patients-with-egfr-muta 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04613596/phase-2-trial-of-adagrasib-monotherapy-and-in-combination-with-pembrolizumab-and-a-phase 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06765109/neladalkib-nvl-655-for-tki-naive-patients-with-advanced-alk-positive-nsclc 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07154290/a-study-to-investigate-ubamatamab-with-and-without-marlotamig-regn7075-in-adult-particip 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05120869/healthcare-provider-human-papillomavirus-education-and-professional-skills-intervention 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07488923/a-first-in-human-fih-phase-1-study-of-ml261-an-autologous-potency-enhanced-anti-dll3-car 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06780098/substudy-01i-a-study-of-investigational-agents-in-participants-with-previously-treated-s 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07600801/legacy-lung-cancer-screening-in-individuals-with-a-lung-cancer-family-history-protocol-b 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07155174/a-study-to-evaluate-the-optimal-dose-adverse-events-and-change-in-disease-activity-of-in 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07784959/study-of-nxp900-with-lorlatinib-in-alk-lung-cancer 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06188702/s095035-as-a-single-agent-and-in-combination-in-adult-participants-with-advanced-or-meta 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06987890/practical-geriatric-assessment-in-older-adults-with-non-small-cell-lung-cancer-undergoin 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06676956/the-sequence-trial 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07176000/tailored-patient-navigation-to-improve-the-uptake-of-lung-cancer-screening-in-tribal-com 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07492680/a-study-of-bms-986504-monotherapy-and-in-combination-with-other-agents-in-participants-w 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05997056/trial-of-nab-sirolimus-in-patients-with-well-differentiated-neuroendocrine-tumors-nets-o 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05483491/kk-lc-1-tcr-t-cell-therapy-for-gastric-breast-cervical-and-lung-cancer 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02568267/basket-study-of-entrectinib-rxdx-101-for-the-treatment-of-patients-with-solid-tumors-har 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07063745/a-study-to-compare-the-combination-of-navlimetostat-bms-986504-with-pembrolizumab-and-ch 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05041140/hyperpolarized-129-xenon-imaging-in-adult-hematopoietic-cell-transplant-recipients-with 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03007030/brentuximab-vedotin-in-treating-patients-with-cd30-malignant-mesothelioma-that-cannot-be 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06070870/health-education-approach-to-lung-screening 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165070/keymaker-u01-substudy-01a-efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-wit 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03340506/dabrafenib-and-or-trametinib-rollover-study 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07250477/risk-adapted-proteomic-guided-systemic-therapy-for-previously-untreated-advanced-non-sma 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165798/keymaker-u01-umbrella-master-study-studies-of-investigational-agents-with-either-pembrol 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06909201/hyperpolarized-xenon-129-magnetic-resonance-imaging-in-lung-cancer-patients-receiving-ra 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07100080/study-of-izalontamab-brengitecan-bms-986507-versus-platinum-pemetrexed-for-egfr-mutated 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06780085/a-study-of-investigational-agents-in-participants-with-previously-treated-stage-iv-nonsq 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02715284/study-of-tsr-042-an-anti-programmed-cell-death-1-receptor-pd-1-monoclonal-antibody-in-pa 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05235165/thoracotomy-versus-thoracoscopic-management-of-pulmonary-metastases-in-patients-with-ost 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07124000/destiny-pantumour04 2026-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001823/evaluation-for-nci-surgery-branch-clinical-research-protocols 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07566052/a-study-to-compare-setidegrasib-asp3082-with-docetaxel-in-people-with-non-small-cell-lun 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06904365/ovarian-sparing-adaptive-radiotherapy-in-young-adult-women 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06890598/study-of-olomorasib-ly3537982-in-combination-with-standard-of-care-in-participants-with 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06119581/a-study-of-first-line-olomorasib-ly3537982-and-pembrolizumab-with-or-without-chemotherap 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05517811/pre-and-post-operative-teg-indices-in-patients-with-or-without-adenocarcinoma-undergoing 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06465329/a-study-of-cemiplimab-plus-chemotherapy-versus-cemiplimab-plus-chemotherapy-plus-other-c 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07782359/impact-of-using-a-glp1-on-treatment-related-side-effects-of-lung-cancer-patients-receivi 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06218914/phase-1-study-to-investigate-tcrts-kras-mutation-in-unresectable-advanced-and-or-metasta 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03412877/administration-of-autologous-t-cells-genetically-engineered-to-express-t-cell-receptors 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05899608/clinical-study-of-ivonescimab-for-first-line-treatment-of-metastatic-nsclc-patients 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06586515/moonray-01-a-study-of-ly3962673-in-participants-with-kras-g12d-mutant-solid-tumors 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07680790/study-of-izalontamab-brengitecan-bms-986507-in-combination-with-osimertinib-versus-osime 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07629960/a-first-in-human-trial-of-blu-924-sar449336-in-advanced-solid-tumors-harboring-kras-muta 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06385262/top-2301-neoadjuvant-chemo-for-nsclc 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01352962/gemcitabine-carboplatin-and-lenalidomide-for-treatment-of-advanced-metastatic-urothelial 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04402788/testing-the-addition-of-radiation-therapy-to-the-usual-immune-therapy-treatment-atezoliz 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04310020/study-of-radiation-therapy-followed-by-atezolizumab-in-stage-ii-or-iii-non-small-cell-lu 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07488676/a-study-of-asp546c-in-adults-with-gastroesophageal-cancer-pancreatic-cancer-or-other-sol 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07002034/re104-safety-and-efficacy-study-in-adjustment-disorder-in-cancer-and-other-medical-illne 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06465069/a-study-of-ly4052031-in-participants-with-advanced-or-metastatic-urothelial-cancer-or-ot 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03460977/a-study-of-mevrometostat-for-treatment-of-relapsed-refractory-sclc-castration-resistant 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04073745/single-fraction-stereotactic-body-radiation-therapy-after-surgery-in-treating-patients-w 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05987956/pharmacogenomics-ind-snp-clinical-trial-alectinib-and-single-nucleotide-polymorphisms 2026-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07553819/home-based-respiratory-muscle-training-and-aerobic-exercise-programs-to-improve-lung-hea 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06312137/a-study-to-assess-efficacy-and-safety-of-pembrolizumab-with-or-without-sacituzumab-tirum 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04579380/basket-study-of-tucatinib-and-trastuzumab-in-solid-tumors-with-her2-alterations 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227597/a-clinical-study-of-gocatamig-mk-6070-and-infinatamab-deruxtecan-mk-2400-in-people-with 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04447222/impact-of-the-covid-19-pandemic-and-hrqol-in-cancer-patients-and-survivors 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07109726/a-phase-1-2-trial-of-ter-2013-in-patients-with-solid-tumors-harboring-akt-pi3k-pten-path 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05241834/a-study-of-loxo-260-in-cancer-patients-with-a-change-in-a-particular-gene-ret-that-has-n 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06774963/a-phase-1-study-of-lncb74-in-advanced-solid-tumors 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03965234/pulmonary-suffusion-in-controlling-minimal-residual-disease-in-patients-with-sarcoma-or 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04699123/the-study-of-nc318-alone-or-in-combination-with-pembrolizumab-in-patients-with-advanced 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06077760/a-study-of-intismeran-autogene-v940-plus-pembrolizumab-mk-3475-versus-placebo-plus-pembr 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06179069/a-study-of-zl-1310-in-subjects-with-small-cell-lung-cancer 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07778316/phase-3-trial-of-tarlatamab-sc-vs-iv-in-extensive-stage-small-cell-lung-cancer-after-pla 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07705035/dbc-664-in-adult-patients-with-solid-tumors 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03940703/a-study-of-tepotinib-plus-osimertinib-in-osimertinib-relapsed-met-amplified-nsclc-insigh 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06384417/using-an-end-of-life-conversation-game-to-engage-patients-with-cancer-in-advance-care-pl 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07168629/a-community-health-worker-intervention-to-improve-lung-cancer-screening-uptake-in-commun 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04147494/experimental-pet-imaging-scans-before-cancer-surgery-to-study-the-amount-of-pet-tracer-a 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06498635/immunotherapy-after-surgery-for-people-who-have-no-remaining-cancer-cells-after-standard 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07195695/beamion-lung-3-adjuvant-zongertinib-vs-standard-treatment-in-people-with-completely-rese 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06172478/a-study-of-her3-dxd-in-subjects-with-locally-advanced-or-metastatic-solid-tumors 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05797168/phase-i-iia-study-of-azd5335-as-monotherapy-and-combination-therapy-in-participants-with 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06632327/comparing-impact-of-treatment-before-or-after-surgery-in-patients-with-stage-ii-iiib-res 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07531095/study-of-tarlatamab-zl-1310-anti-programmed-death-ligand-1-anti-pd-l1-in-small-cell-lung 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04429087/a-study-to-test-different-doses-of-obrixtamig-in-patients-with-small-cell-lung-cancer-an 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07221474/a-study-of-intismeran-autogene-v940-placebo-pembrolizumab-and-chemotherapy-in-metastatic 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05061550/neoadjuvant-and-adjuvant-treatment-in-resectable-non-small-cell-lung-cancer 2026-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04410302/patient-derived-xenografts-to-reduce-cancer-health-disparities 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04988295/a-study-of-amivantamab-and-lazertinib-in-combination-with-platinum-based-chemotherapy-co 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07770100/concurrent-immunotherapy-and-systemic-therapy-with-stereotactic-body-radiation-therapy-s 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06122064/a-tool-for-improving-the-shared-decision-making-process-in-patients-with-non-small-cell 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05064150/neuroendocrine-tumors-patient-reported-outcomes 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07133425/a-phase-2-platform-study-of-immunomodulatory-compounds-in-ici-refractory-non-small-cell 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07777822/study-of-pembrolizumab-pemetrexed-platinum-chemotherapy-with-or-without-zoldonrasib-as-f 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04933903/bruog-397-neo-rad-low-neoadjuvant-low-dose-stereotactic-body-radiotherapy-ipilimumab-and 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04557449/study-to-test-the-safety-and-tolerability-of-pf-07220060-in-participants-with-advance-so 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04886804/beamion-lung-1-a-study-to-test-different-doses-of-zongertinib-in-people-with-different-t 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04902872/study-of-cbx-12-in-subjects-with-advanced-or-metastatic-refractory-solid-tumors 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04667234/expanded-access-of-sotorasib 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06202066/temozolomide-and-survivin-long-peptide-vaccine-survaxm-for-the-treatment-of-patients-wit 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06422143/pembrolizumab-with-or-without-maintenance-sacituzumab-tirumotecan-sac-tmt-mk-2870-in-met 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04665739/testing-lutetium-lu-177-dotatate-in-patients-with-somatostatin-receptor-positive-advance 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06151574/beamion-lung-2-a-study-to-test-whether-zongertinib-bi-1810631-helps-people-with-advanced 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07410117/regn7508-in-adult-participants-for-prevention-of-cancer-associated-thrombosis 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07776353/understanding-new-cachexia-subtypes-through-observational-epidemiological-research 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07354074/study-to-determine-the-efficacy-and-safety-of-asciminib-in-pediatric-patients-with-ph-cm 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05269381/personalized-neoantigen-peptide-based-vaccine-in-combination-with-pembrolizumab-for-trea 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227077/dosing-physical-activity-among-older-cancer-survivors-who-experience-chronic-pain-a-micr 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00897117/collecting-and-analyzing-tissue-samples-from-patients-undergoing-surgery-for-non-small-c 2026-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05317858/blood-brain-barrier-bbb-opening-using-exablate-focused-ultrasound-with-standard-of-care 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04104776/a-study-of-tulmimetostat-dzr123-cpi-0209-in-patients-with-advanced-solid-tumors-and-lymp 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07241039/a-study-to-assess-the-adverse-events-change-in-disease-activity-and-how-oral-abbv-711-ta 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07499674/evaluation-of-the-safety-and-efficacy-of-abenacianine-vgt-309-to-identify-cancer-in-subj 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04644068/study-of-azd5305-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-patients-w 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07472517/dareon-lung-1-a-study-in-people-with-advanced-small-cell-lung-cancer-to-compare-obrixtam 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04819997/a-nurse-led-intervention-for-fear-of-progression-in-advanced-cancer 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04092283/testing-the-addition-of-an-antibody-to-standard-chemoradiation-followed-by-the-antibody 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05787834/home-based-respiratory-muscle-training-for-minimizing-side-effects-in-patients-undergoin 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07115043/a-study-to-investigate-safety-of-azd6750-in-adult-participants-with-select-advanced-or-m 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06767514/clinical-study-of-ivonescimab-for-first-line-treatment-of-metastatic-nsclc-patients-with 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04683250/study-of-ret-inhibitor-tas0953-hm06-in-patients-with-advanced-solid-tumors-with-ret-gene 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07636785/a-phase-1-and-2-study-of-vmd-102-in-hepatocellular-carcinoma-and-other-solid-tumors 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05827614/study-of-the-chk1-inhibitor-bbi-355-an-ecdna-directed-therapy-ecdtx-and-the-rnr-inhibito 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06922539/phase-1-trial-of-st-001-nanofenretinide-in-relapsed-refractory-small-cell-lung-cancer 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05142696/a-study-of-177lu-lu-dota-tate-in-newly-diagnosed-es-sclc-patients-in-combination-with-ca 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06452277/a-study-to-learn-more-about-how-well-sevabertinib-works-and-how-safe-it-is-compared-with 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07023731/a-study-to-evaluate-arv-806-in-adults-with-advanced-cancer-that-has-the-kras-g12d-mutati 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05215340/study-of-dato-dxd-plus-pembrolizumab-vs-pembrolizumab-alone-in-the-first-line-treatment 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07246863/trial-investigating-visugromab-and-nivolumab-with-or-without-docetaxel-in-2l-treatment-o 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04505267/nbtxr3-and-radiation-therapy-for-the-treatment-of-inoperable-recurrent-non-small-cell-lu 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07017829/gt103-in-combination-with-pembrolizumab-for-the-treatment-of-advanced-or-metastatic-stk1 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07493304/treatment-and-secondary-prevention-of-venous-thromboembolism-vte-in-adult-participants-w 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07707895/dareon-36-a-study-to-test-obrixtamig-in-combination-with-zl-1310-in-people-with-advanced 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06194448/to-evaluate-the-efficacy-safety-of-osimertinib-prior-to-crt-and-maintenance-of-it-with-s 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07768046/multiparametric-lung-mri-with-diffusion-weighted-imaging-in-lung-rads-4-lesion-character 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03025256/intravenous-and-intrathecal-nivolumab-in-treating-patients-with-leptomeningeal-disease 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07772895/pemefolacianine-for-imi-of-lung-cancer 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07365319/a-safety-and-efficacy-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherap 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04949464/impact-of-behavior-modification-interventions-and-lung-cancer-screening-on-smoking-cessa 2026-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07160335/a-phase-i-clinical-study-to-evaluate-the-pk-profile-efficacy-safety-and-immunogenicity-o 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06564844/a-phase-iii-randomised-study-of-adjuvant-dato-dxd-in-combination-with-rilvegostomig-or-r 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06731907/a-study-of-pembrolizumab-with-or-without-chemotherapy-in-combination-with-additional-tre 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04929041/testing-the-addition-of-radiation-therapy-to-the-usual-treatment-immunotherapy-with-or-w 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05393154/pilot-study-of-biopsy-scanner-for-evaluation-of-bronchoscopic-small-biopsy-specimens-to 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00033137/genetic-analysis-of-birt-hogg-dube-syndrome-and-characterization-of-predisposition-to-ki 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03728361/nivolumab-and-temozolomide-in-treating-patients-with-recurrent-or-refractory-small-cell 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06479811/212pb-vmt-alpha-net-in-metastatic-or-inoperable-somatostatin-receptor-positive-gastroint 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06618287/a-study-to-evaluate-the-safety-tolerability-drug-levels-and-preliminary-efficacy-of-bms 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06593106/cryodevitalization-for-the-treatment-of-early-stage-lung-cancer-crystal-trial 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07224152/nbtxr3-with-radiation-therapy-alone-for-locally-advanced-non-small-cell-lung-cancer 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07325136/a-study-to-assess-the-safety-and-tolerability-of-bms-986525-alone-and-in-combination-the 2026-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07218146/a-study-of-zl-1310-versus-investigator-s-choice-of-therapy-in-participants-with-relapsed 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07519655/phase-1-study-of-pf-08046033-in-advanced-solid-tumors 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07476287/symbiotic-lung-14-a-study-to-learn-about-the-study-medicine-called-pf08634404-in-combina 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07139990/personalized-radiotherapy-for-individualized-treatment-strategies-and-monitoring-prism 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06792552/a-phase-i-study-of-sim0505-in-participants-with-advanced-solid-tumors 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06146920/use-of-serial-plasma-ngs-as-a-new-efficacy-metric-to-guide-immunotherapy-treatment-disco 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07144280/a-study-to-learn-about-the-study-medicine-called-pf-08046054-sgn-pdl1v-versus-docetaxel 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02484404/phase-i-ii-study-of-the-anti-programmed-death-ligand-1-durvalumab-antibody-medi4736-in-c 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06303505/fih-study-to-investigate-safety-pk-and-efficacy-of-the-napi2b-adc-tub-040-in-patients-wi 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05463796/inadvance-surveillance-prevention-and-interception-in-a-population-at-risk-for-cancer 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06095505/a-study-of-alisertib-in-patients-with-extensive-stage-small-cell-lung-cancer 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06773910/bms-986489-atigotatug-nivolumab-vs-durvalumab-in-limited-stage-small-cell-lung-cancer-ti 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07102212/telemedicine-mhealth-symptom-cluster-intervention-for-advanced-cancer-patients-finding-o 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00720785/natural-killer-cells-and-bortezomib-to-treat-cancer 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02955940/an-open-label-study-to-enable-continued-treatment-access-for-subjects-previously-enrolle 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04465214/mobile-sensor-technologies-to-assess-general-symptomology-of-people-with-cancer 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04895709/a-study-of-bms-986340-as-monotherapy-and-as-combination-therapy-in-participants-with-adv 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07140016/a-study-of-gilteritinib-in-adults-with-advanced-alk-positive-non-small-cell-lung-cancer 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06500481/testing-proton-craniospinal-radiation-therapy-versus-the-usual-radiation-therapy-for-lep 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05624996/testing-the-addition-of-high-dose-targeted-radiation-to-the-usual-treatment-for-locally 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06616766/a-phase-1-2-open-label-multicenter-fih-study-to-evaluate-safety-tolerability-pk-and-anti 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06561386/a-study-to-compare-the-efficacy-of-nivolumab-and-relatlimab-plus-chemotherapy-vs-pembrol 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06745323/a-phase-2-open-label-randomized-multicenter-study-of-tarlatamab-dosing-regimens-in-subje 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04804644/testing-if-high-dose-radiation-only-to-the-sites-of-brain-cancer-compared-to-whole-brain 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06500455/testing-longer-duration-radiation-therapy-versus-the-usual-radiation-therapy-in-patients 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07226999/symbiotic-lung-04-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combin 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07222566/symbiotic-lung-01-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combin 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07489066/symbiotic-lung-10-a-study-to-learn-about-pf-08634404-alone-or-in-combination-in-early-st 2026-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06875310/a-study-of-adagrasib-plus-pembrolizumab-plus-chemotherapy-vs-placebo-plus-pembrolizumab 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01606826/severe-asthma-research-program 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06627647/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-plus-chemotherapy-for-first-l 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06772623/study-to-evaluate-adverse-events-and-efficacy-of-intravenous-iv-telisotuzumab-adizutecan 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06253520/autologous-t-cells-genetically-engineered-to-express-receptors-reactive-against-kras-mut 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06646276/a-study-to-compare-the-efficacy-and-safety-of-bms-986489-bms-986012-nivolumab-fixed-dose 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07701733/a-study-of-lung-cancer-risk 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06074588/sacituzumab-tirumotecan-mk-2870-versus-chemotherapy-in-previously-treated-advanced-or-me 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06120803/esomeprazole-and-radiation-induced-esophagitis 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06568939/a-study-to-assess-adverse-events-and-how-intravenously-iv-infused-telisotuzumab-vedotin 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05853575/trial-of-two-adagrasib-dosing-regimens-in-nsclc-with-kras-g12c-mutation-krystal-21 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05538130/a-study-to-learn-about-the-study-medicine-called-pf-07799544-as-monotherapy-or-in-combin 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06518057/hippocampal-avoidance-in-craniospinal-irradiation-for-the-treatment-of-leptomeningeal-me 2026-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06228066/lurbinectedin-with-or-without-avelumab-in-small-cell-carcinoma-of-the-bladder-laser 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07111936/evaluating-the-impact-of-connect-in-a-multilingual-population 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05198830/testing-the-addition-of-an-anti-cancer-drug-trc102-to-the-usual-chemotherapy-treatment-p 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05671510/onc-392-versus-docetaxel-in-metastatic-nsclc-that-progressed-on-pd-1-pd-l1-inhibitors 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06120075/a-study-of-ab801-monotherapy-and-combination-therapy-in-participants-with-advanced-malig 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02971501/osimertinib-with-or-without-bevacizumab-in-treating-patients-with-egfr-positive-non-smal 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06692738/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-plus-chemotherapy-for-first-l 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02769962/trial-of-ep0057-a-nanoparticle-camptothecin-with-olaparib-in-people-with-relapsed-refrac 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07353957/study-to-investigate-petosemtamab-in-adults-with-metastatic-non-small-cell-lung-cancer 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05572684/a-safety-tolerability-and-efficacy-study-of-nc410-plus-pembrolizumab-in-participants-wit 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04924101/efficacy-and-safety-of-pembrolizumab-plus-investigational-agents-in-combination-with-che 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03987555/paclitaxel-therapeutic-drug-monitoring-in-cancer-patients 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06712316/safety-efficacy-and-pharmacokinetics-of-bnt327-in-combination-with-chemotherapy-and-othe 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05985655/study-to-assess-gtaexs617-in-participants-with-advanced-solid-tumors 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06007937/a-study-of-lorlatinib-in-combination-with-ramucirumab-in-people-with-lung-cancer 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04780568/osimertinib-and-tegavivint-as-first-line-therapy-for-the-treatment-of-metastatic-egfr-mu 2026-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05099172/first-in-human-study-of-bay2927088-in-participants-who-have-advanced-non-small-cell-lung 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07490860/a-restorative-justice-based-lung-cancer-screening-decision-making-support-intervention-t 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04044859/adp-a2m4cd8-as-monotherapy-or-in-combination-with-either-nivolumab-or-pembrolizumab-in-h 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06526819/smp-3124lp-in-adults-with-advanced-solid-tumors 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04017819/biodistribution-pharmacokinetic-of-position-emission-tomography-pet-radiopharmaceutical 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06801834/study-of-sacituzumab-govitecan-versus-standard-of-care-in-participants-with-previously-t 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06357533/phase-iii-open-label-study-of-first-line-dato-dxd-in-combination-with-rilvegostomig-for 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07761910/prospective-study-on-radiation-induced-cardiotoxicity-assessed-by-pet-ct-for-locally-adv 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04410796/osimertinib-alone-or-with-chemotherapy-for-egfr-mutant-lung-cancers 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04354246/com902-a-tigit-inhibitor-in-subjects-with-advanced-malignancies 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05123482/a-phase-i-iia-study-of-azd8205-given-alone-or-combined-in-participants-with-advanced-met 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04199741/pet-ct-imaging-of-small-cell-lung-cancer-using-89zr-dfo-sc16-56 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07535008/dental-cleaning-to-prevent-chronic-graft-versus-host-disease 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07619599/a-pet-imaging-agent-64cu-dota-pembrolizumab-for-determining-treatment-response-among-pat 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07146568/evaluating-the-implementation-and-effectiveness-of-the-pink-and-pearl-campaign-on-lung-c 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07155200/small-cell-lung-cancer-irinotecan-and-cdc2-like-kinase-inhibition-trial-slick-trial 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06898333/implementation-and-effectiveness-of-the-bjc-pink-and-pearl-project-on-lung-cancer-screen 2026-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03600701/atezolizumab-and-cobimetinib-in-treating-patients-with-metastatic-recurrent-or-refractor 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05592626/a-study-of-a-selective-t-cell-receptor-tcr-targeting-bifunctional-antibody-fusion-molecu 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06242470/a-study-of-mgc026-in-participants-with-advanced-solid-tumors 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04913311/predictive-biomarkers-for-pneumonitis-after-chemoradiotherapy-and-immunotherapy-in-patie 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05858164/a-first-in-human-study-to-learn-how-safe-the-study-treatment-bay2862789-is-to-find-the-b 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06807632/a-study-of-valemetostat-in-combination-with-atezolizumab-in-people-with-lung-cancer 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06162572/phase-1b-2-platform-study-of-select-immunotherapy-combinations-in-participants-with-adva 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07166601/m0324-as-monotherapy-and-in-combination-with-pembrolizumab-or-chemotherapy-in-participan 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06389981/co-design-and-pilot-testing-of-peer-led-community-outreach-to-improve-equity-veteran-cen 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04085315/alisertib-in-combination-with-osimertinib-in-metastatic-egfr-mutant-lung-cancer 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06131398/a-study-of-amg-355-alone-and-in-combination-with-pembrolizumab-in-participants-with-adva 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07382726/phase-1-study-of-izalontamab-brengitecan-adagrasib-in-nsclc-the-iza-a-trial 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04302025/a-study-of-multiple-therapies-in-biomarker-selected-participants-with-resectable-stages 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04685135/phase-3-study-of-mrtx849-adagrasib-vs-docetaxel-in-patients-with-advanced-non-small-cell 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03392246/a-phase-2-study-of-osimertinib-in-combination-with-selumetinib-in-egfr-inhibitor-nai-ve 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03422302/continuous-positive-airway-pressure-device-or-deep-inspiration-breath-hold-in-reducing-t 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06732401/testing-the-addition-of-azd6738-ceralasertib-to-immunotherapy-to-increase-time-without-c 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04837716/ensartinib-carboplatin-pemetrexed-and-bevacizumab-for-the-treatment-of-stage-iiic-or-iv 2026-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06026111/preliminary-efficacy-of-different-exercise-training-during-immunotherapy-in-patients-wit 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07098988/trial-investigating-visugromab-in-combination-with-immunochemotherapy-in-1l-treatment-of 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06567704/cancer-related-fatigue-during-maintenance-immunotherapy-for-non-small-cell-lung-cancer-n 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07705334/a-study-of-shy-onc6-a-novel-proteasome-inhibitor-in-adults-with-advanced-or-metastatic-s 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07174388/an-external-control-arm-study-in-non-small-cell-lung-cancer 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04197934/wsd0922-fu-for-treatment-of-glioblastoma-anaplastic-astrocytoma-or-non-small-cell-lung-c 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07361497/a-study-to-evaluate-pumitamig-versus-durvalumab-following-concurrent-chemoradiation-ther 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04892953/local-consolidative-therapy-and-durvalumab-for-oligoprogressive-and-polyprogressive-stag 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07361510/a-study-to-evaluate-the-efficacy-of-pumitamig-versus-pembrolizumab-in-participants-with 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02955290/cimavax-vaccine-nivolumab-and-pembrolizumab-in-treating-patients-with-advanced-non-small 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05022446/the-impact-of-covid-19-on-pulmonary-procedures 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04585750/the-evaluation-of-pc14586-in-patients-with-advanced-solid-tumors-harboring-a-tp53-y220c 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05153239/clinical-trial-of-lurbinectedin-as-single-agent-or-in-combination-with-irinotecan-versus 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05262556/np-101-tq-formula-with-nivolumab-and-ipilimumab-in-advanced-or-metastatic-extra-pulmonar 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04106973/mesothelioma-early-detection-by-vocs 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07541170/a-study-to-evaluate-the-efficacy-and-safety-of-divarasib-compared-with-investigator-s-ch 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06251310/sw-682-in-advanced-solid-tumors 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06448754/volrustomig-priming-regimens-exploratory-phase-ii-platform-study 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06161441/a-trial-to-learn-if-the-combination-of-fianlimab-cemiplimab-and-chemotherapy-is-safe-and 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05789082/a-study-evaluating-the-safety-activity-and-pharmacokinetics-of-divarasib-as-a-single-age 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06237881/a-phase-1-2-study-of-ksq-001ex-autologous-tumor-infiltrating-lymphocytes-engineered-to-i 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04253964/pilot-study-of-performance-status-2-vs-performance-status-0-1-non-small-cell-lung-cancer 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07718737/global-multicenter-study-of-amt-116-versus-investigator-s-choice-in-participants-with-ad 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05057676/autoimmune-intervention-mastery-course-study 2026-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01143480/study-of-the-effect-of-innate-on-the-inflammatory-response-to-endotoxin 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07517692/facilitation-of-information-exchange-for-shared-decision-making-for-lung-cancer-screenin 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06561685/a-study-of-ly4050784-in-participants-with-advanced-or-metastatic-solid-tumors 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07535359/medical-access-program-for-ifinatamab-deruxtecan-in-3l-pretreated-extensive-stage-small 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06424327/a-registry-for-people-with-lung-cancer 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06515990/a-study-of-dm005-in-patients-with-advanced-solid-tumors 2026-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05785845/computed-tomography-guided-stereotactic-adaptive-radiotherapy-ct-star-for-the-treatment 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02453282/phase-iii-open-label-first-line-therapy-study-of-medi-4736-durvalumab-with-or-without-tr 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05627674/precision-prevention-strategy-to-increase-uptake-and-engagement-in-lung-cancer-screening 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06834074/expanded-access-program-of-neladalkib-nvl-655-for-patients-with-advanced-alk-nsclc-or-ot 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07749586/a-study-to-evaluate-arv-6723-alone-and-with-pembrolizumab-in-participants-with-advanced 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04151940/pet-ct-changes-during-chemoimmunotherapy-and-radiation-therapy-in-patients-with-stage-iv 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05879211/goal-concordant-care-learning-laboratory 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07127874/a-study-of-phn-012-in-patients-with-advanced-solid-tumors 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05028621/molecular-basis-of-langerhans-and-non-langerhans-cell-histiocytic-neoplasms-and-castlema 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07286149/a-clinical-study-of-mk-1084-with-other-treatments-for-non-small-cell-lung-cancer-mk-3475 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07751042/phase-1-2-study-of-intravenous-injection-of-stx-003-in-advanced-solid-tumors-as-monother 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07594067/tcr1188-abc-cells-in-kras-mutated-cancers 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05877599/a-study-of-nt-175-in-adult-participants-with-advanced-malignancies-that-are-positive-for 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06203210/a-study-of-ifinatamab-deruxtecan-versus-treatment-of-physician-s-choice-in-subjects-with 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03776253/conquer-fear-support-intervention-in-supporting-patients-with-stage-iii-iv-lung-or-gynec 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02542293/study-of-durvalumab-with-tremelimumab-versus-soc-as-1st-line-therapy-in-metastatic-non-s 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06287775/testing-the-combination-of-an-anti-cancer-drug-iadademstat-with-other-anti-cancer-drugs 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05600933/prospective-procurement-of-tumor-tissue-to-identify-novel-therapeutic-targets-and-study 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07408531/lung-07-advancing-precision-based-lung-cancer-screening-implementation-ai-guided-risk-st 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06941480/a-study-of-177lu-dtpa-sc16-56-in-people-with-neuroendocrine-carcinomas-of-the-lung-and-p 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05401110/study-of-osimertinib-with-carotuximab-in-advanced-egfr-mutated-non-small-cell-lung-cance 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05261399/savolitinib-plus-osimertinib-versus-platinum-based-doublet-chemotherapy-in-participants 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05995821/immunobiology-blood-and-tissue-collection-of-upper-aerodigestive-malignancies 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06793215/a-study-evaluating-the-efficacy-and-safety-of-divarasib-and-pembrolizumab-versus-pembrol 2026-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05176483/study-of-zanzalintinib-in-combination-with-immuno-oncology-or-other-agents-in-participan 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07059884/distance-based-exercise-to-preserve-function-and-prevent-disability 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07444814/study-evaluating-the-safety-and-efficacy-of-hwk-007-a-ptk7-directed-antibody-drug-conjug 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03220477/pembrolizumab-immunotherapy-drug-in-combination-with-guadecitabine-and-mocetinostat-epig 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06910657/idov-immune-for-advanced-solid-tumors 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03999710/determining-whether-durvalumab-in-combination-with-radiation-therapy-can-prevent-the-pro 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06014827/biologically-guided-radiation-therapy-bgrt-and-stereotactic-body-radiation-therapy-sbrt 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07357597/an-open-label-single-arm-study-of-prophylaxis-for-datopotamab-deruxtecan-dato-dxd-relate 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07277413/a-study-of-ide892-as-monotherapy-and-combination-in-mtap-deleted-advanced-solid-tumors 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05144542/risk-and-benefits-of-electronic-cigarettes-to-older-smokers-at-high-risk-for-lung-cancer 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06449313/neoadjuvant-chemo-immunotherapy-and-surgical-resection-in-locally-advanced-non-small-cel 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07111520/a-clinical-trial-to-test-if-an-investigational-combination-therapy-with-bnt326-and-bnt32 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05334069/collecting-blood-samples-from-patients-with-and-without-cancer-to-evaluate-tests-for-ear 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07412041/precise-exercise-regimen-for-cancer-care-percc-a-pilot-study 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05170204/a-study-evaluating-the-efficacy-and-safety-of-multiple-therapies-in-cohorts-of-participa 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07293247/a-study-of-targeted-post-surgery-radiation-therapy-for-non-small-cell-lung-cancer-with-r 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06706076/a-study-of-bh-30643-in-subjects-with-locally-advanced-or-metastatic-nsclc-harboring-egfr 2026-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06486428/small-cell-lung-cancer-community-engagement-to-eliminate-research-discepancies 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07545954/dsp-0390-in-combination-with-atezolizumab-for-small-cell-lung-cancer 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05990738/dareontm-9-a-study-to-test-how-well-different-doses-of-bi-764532-are-tolerated-by-people 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01386385/veliparib-with-or-without-radiation-therapy-carboplatin-and-paclitaxel-in-patients-with 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03375320/testing-cabozantinib-in-patients-with-advanced-pancreatic-neuroendocrine-and-carcinoid-t 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07217301/a-study-comparing-tak-928-with-docetaxel-in-adults-with-non-small-cell-lung-cancer 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03228537/atezolizumab-pemetrexed-disodium-cisplatin-and-surgery-with-or-without-radiation-therapy 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05579366/rinatabart-sesutecan-rina-s-pro1184-gen1184-for-advanced-solid-tumors-gct1184-01-pro1184 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07075627/a-study-to-evaluate-the-incidence-of-clinically-suspicious-lambert-eaton-myasthenic-synd 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04640259/epidemiology-of-young-lung-cancer-survey 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06635824/trial-to-evaluate-acasunlimab-and-pembrolizumab-combination-superiority-over-standard-of 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01064648/pemetrexed-disodium-and-cisplatin-with-or-without-cediranib-maleate-in-treating-patients 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03521154/a-global-study-to-assess-the-effects-of-osimertinib-following-chemoradiation-in-patients 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02642042/trametinib-and-docetaxel-in-treating-patients-with-recurrent-or-stage-iv-kras-mutation-p 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01639508/cabozantinib-in-patients-with-ret-fusion-positive-advanced-non-small-cell-lung-cancer-an 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03191149/testing-osimertinib-as-a-treatment-for-lung-cancers-with-an-egfr-exon-20-change 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04083599/gen1042-safety-trial-and-anti-tumor-activity-in-participants-with-malignant-solid-tumors 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04310007/testing-the-addition-of-the-pill-chemotherapy-cabozantinib-to-the-standard-immune-therap 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07192900/fast-tils-to-treat-metastatic-cancer-patients-with-pleural-disease 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06199570/support-for-cancer-patients-awaiting-news 2026-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03662074/subsequent-line-gemcitabine-and-nivolumab-in-treating-participants-with-metastatic-small 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04320888/selpercatinib-for-the-treatment-of-advanced-solid-tumors-lymphomas-or-histiocytic-disord 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06066138/a-study-of-therapeutic-drug-monitoring-based-atezolizumab-dosing 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03861091/prophylactic-risedronate-for-patients-with-peripheral-lung-tumors-treated-with-sbrt 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07397338/study-of-ras-on-inhibitors-in-combination-with-ivonescimab-in-patients-with-solid-tumors 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03337399/stepped-palliative-care-versus-early-integrated-palliative-care-in-patients-with-advance 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06868277/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-monotherapy-for-first-line-tr 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07234799/feasibility-testing-of-a-dyadic-exercise-program-for-patients-undergoing-thoracic-radiot 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06270706/a-phase-1-study-of-pln-101095-in-adults-with-advanced-or-metastatic-solid-tumors 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06128551/study-of-elironrasib-and-daraxonrasib-as-monotherapies-and-combination-therapy-in-partic 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05526755/a-study-of-5-years-of-adjuvant-osimertinib-in-completely-resected-epidermal-growth-facto 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05369611/covid-19-experiences-in-the-self-cohort 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07185997/study-to-evaluate-efficacy-and-safety-of-firmonertinib-compared-with-investigator-s-choi 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06305754/sacituzumab-tirumotecan-mk-2870-versus-pemetrexed-and-carboplatin-combination-therapy-in 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05433142/study-of-xmab-819-in-subjects-with-advanced-clear-cell-renal-cell-carcinoma 2026-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04093167/study-of-ctdna-response-adaptive-immuno-chemotherapy-in-lung-cancer 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02595931/m6620-and-irinotecan-hydrochloride-in-treating-patients-with-solid-tumors-that-are-metas 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05355701/a-study-to-learn-about-the-study-medicine-called-pf-07799933-in-people-with-advanced-sol 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04491942/testing-the-addition-of-an-anti-cancer-drug-bay-1895344-to-the-usual-chemotherapy-treatm 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01366144/veliparib-paclitaxel-and-carboplatin-in-treating-patients-with-solid-tumors-that-are-met 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05663866/premedication-to-reduce-amivantamab-associated-infusion-related-reactions 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04216316/testing-the-addition-of-an-anti-cancer-drug-berzosertib-m6620-vx-970-to-the-usual-treatm 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04079712/testing-the-combination-of-xl184-cabozantinib-nivolumab-and-ipilimumab-for-poorly-differ 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03896503/randomized-trial-of-topotecan-with-m6620-an-atr-kinase-inhibitor-in-small-cell-lung-canc 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02496663/osimertinib-and-necitumumab-in-treating-patients-with-egfr-mutant-stage-iv-or-recurrent 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02888743/durvalumab-and-tremelimumab-with-or-without-high-or-low-dose-radiation-therapy-in-treati 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06532032/a-study-of-combination-therapy-with-amivantamab-and-docetaxel-in-participants-with-metas 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02905591/a-phase-2-study-adding-ascorbate-to-chemotherapy-and-radiation-therapy-for-nsclc 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05715255/adaptive-symptom-self-management-immunotherapy-study 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07646847/a-study-of-a-side-effects-and-resource-navigation-program-for-people-with-cancer 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06983743/a-study-of-eras-0015-in-patients-with-advanced-or-metastatic-solid-tumors 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03831932/telaglenastat-hydrochloride-and-osimertinib-in-treating-patients-with-egfr-mutated-stage 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03394365/a-phase-3-study-of-tabelecleucel-for-participants-with-epstein-barr-virus-associated-pos 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04514497/testing-the-addition-of-an-anti-cancer-drug-bay-1895344-to-usual-chemotherapy-for-advanc 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05388669/a-study-of-lazertinib-with-subcutaneous-amivantamab-compared-with-intravenous-amivantama 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01804686/a-long-term-extension-study-of-pci-32765-ibrutinib 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02535312/methoxyamine-cisplatin-and-pemetrexed-disodium-in-treating-patients-with-advanced-solid 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03300817/muc1-vaccine-in-preventing-lung-cancer-in-current-and-former-smokers-at-high-risk-for-lu 2026-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06410300/cardiopulmonary-monitoring-in-lung-cancer-patients-receiving-combined-thoracic-radiother 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07285044/the-cancer-connected-access-and-remote-expertise-beyond-walls-program-to-provide-in-home 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05327023/donor-lymphocyte-infusion-after-allogeneic-hematopoietic-cell-transplantation-for-high-r 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07252739/keymaker-u01-substudy-01j-a-study-of-pembrolizumab-plus-mk-1084-in-participants-with-non 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05891171/study-of-ab598-monotherapy-and-combination-therapy-in-participants-with-advanced-cancers 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02718066/study-of-hbi-8000-with-nivolumab-in-melanoma-renal-cell-carcinoma-and-non-small-cell-lun 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04340882/phase-2-docerampem-for-patients-with-metastatic-or-recurrent-nsclc-who-progressed-on-pla 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05039632/phase-i-ii-randomized-study-of-nbtxr3-activated-by-abscopal-or-radscopal-radiation-in-co 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04606771/a-study-comparing-savolitinib-plus-osimertinib-vs-savolitinib-plus-placebo-in-patients-w 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05267626/study-of-au-007-a-monoclonal-antibody-that-binds-to-il-2-and-inhibits-il-2r-binding-in-p 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06710132/study-of-anti-ceacam5-adc-m9140-in-participants-with-advanced-solid-tumors-proceade-pant 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05973773/rezilient3-researching-zipalertinib-in-egfr-non-small-cell-lung-cancer-tumors 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07094113/amg-410-alone-and-in-combination-with-other-agents-in-participants-with-kras-altered-adv 2026-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07298096/a-prospective-single-center-single-arm-single-institution-registry-that-aims-to-assess-t 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02486718/study-to-assess-safety-and-efficacy-of-atezolizumab-mpdl3280a-compared-to-best-supportiv 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07728773/a-stepped-intervention-for-coping-with-dyspnea-in-patients-with-lung-cancer-phase-a-open 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03425643/efficacy-and-safety-of-pembrolizumab-mk-3475-with-platinum-doublet-chemotherapy-as-neoad 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04198766/study-of-inbrx-106-and-inbrx-106-in-combination-with-pembrolizumab-keytruda-in-subjects 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02306161/combination-chemotherapy-with-or-without-ganitumab-in-treating-patients-with-newly-diagn 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07733141/mindfulness-intervention-to-reduce-patient-reported-symptoms-in-patients-with-chronic-gr 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07008664/signature-development-and-validation-protocol-for-an-epigenetic-assay-in-diagnosing-lung 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07723495/symptom-management-to-improve-completion-of-patient-reported-outcome-measures 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06764771/a-study-of-bms-986488-as-monotherapy-and-combination-therapy-in-participants-with-advanc 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06427941/a-phase-1-study-of-bgb-b2033-alone-or-in-combination-with-tislelizumab-with-or-without-b 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07732686/analysis-of-breath-volatile-organic-compounds-using-mass-spectrometry 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02178163/comprehensive-genomic-analysis-in-tissue-samples-from-patients-with-recurrent-or-stage-i 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05632809/restoring-lymphocytes-using-nktr-255-after-chemoradiotherapy-in-solid-tumors-rescue 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04736173/study-evaluating-effectiveness-and-safety-of-zimberelimab-and-domvanalimab-in-lung-cance 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06562192/phase-i-study-of-177lu-lu-nns309-in-patients-with-pancreatic-lung-breast-and-colorectal 2026-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05950139/peptide-vaccine-to-prevent-acquired-resistance-in-patients-with-advanced-alk-nsclc 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03141359/use-of-high-dose-radiation-followed-by-chemotherapy-and-radiation-to-treat-locally-advan 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04928846/a-study-to-assess-disease-activity-and-adverse-events-of-intravenous-iv-telisotuzumab-ve 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07339059/study-of-sacituzumab-govitecan-with-atezolizumab-durvalumab-as-maintenance-therapy-for-e 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05984277/a-global-study-of-volrustomig-medi5752-plus-chemotherapy-versus-pembrolizumab-plus-chemo 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06396065/phase-iii-study-of-ak112-for-nsclc-patients 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03581487/durvalumab-tremelimumab-and-selumetinib-in-treating-participants-with-recurrent-or-stage 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07140315/dk222-study-at-hopkins 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06644768/a-study-of-valemetostat-tosylate-plus-pembrolizumab-versus-pembrolizumab-alone-in-first 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06150664/a-phase-1-of-ctx-8371-in-patients-with-advanced-malignancies 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05227326/aoh1996-for-the-treatment-of-refractory-solid-tumors 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07006727/phase-i-study-of-225ac-ac-etn029-in-patients-with-advanced-dll3-expressing-solid-tumors 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06097728/medi5752-in-combination-with-carboplatin-plus-pemetrexed-in-unresectable-pleural-mesothe 2026-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05242965/a-multiple-antigen-vaccine-stemvac-for-the-treatment-of-patients-with-stage-iv-non-small 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06745908/clinical-trial-of-n-803-plus-tislelizumab-or-prior-failed-immune-checkpoint-inhibitor-an 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07339176/intratumoral-n17350-in-advanced-solid-tumors 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05616624/adi-peg-20-in-combination-with-gemcitabine-and-docetaxel-after-progression-on-frontline 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05250037/the-longitudinal-impact-of-respiratory-viruses-on-bronchiolitis-obliterans-syndrome-afte 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07491497/a-phase-1-2-study-of-tri-611-in-alk-positive-nsclc 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07630168/effects-of-infusion-timing-on-treatment-response-in-solid-tumors 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01843374/randomized-double-blind-study-comparing-tremelimumab-to-placebo-in-subjects-with-unresec 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06781983/safety-and-tolerability-of-iph4502-in-patients-with-advanced-solid-tumors 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04612751/phase-1b-study-of-dato-dxd-in-combination-with-immunotherapy-with-or-without-carboplatin 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04577326/mesothelin-targeted-car-t-cell-therapy-in-patients-with-mesothelioma 2026-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01696994/screening-for-ovarian-cancer-in-older-patients-plco-screening-trial 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002540/screening-for-prostate-cancer-in-older-patients-plco-screening-trial 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01696968/screening-for-lung-cancer-in-older-patients-plco-screening-trial 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07282444/a-new-way-to-share-radiation-therapy-plans-between-doctors-correct-trial 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01696981/screening-for-colorectal-cancer-in-older-patients-plco-screening-trial 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03155620/targeted-therapy-directed-by-genetic-testing-in-treating-pediatric-patients-with-relapse 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05378763/a-study-of-poziotinib-in-previously-treated-participants-with-locally-advanced-or-metast 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06712355/safety-and-efficacy-of-bnt327-an-investigational-therapy-in-combination-with-chemotherap 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06931626/study-of-nms-03305293-in-adult-patient-with-relapsed-small-cell-lung-cancer 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02264678/ascending-doses-of-ceralasertib-in-combination-with-chemotherapy-and-or-novel-anti-cance 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07680764/a-study-to-assess-the-safety-tolerability-and-efficacy-of-imzokitug-in-combination-with 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03693014/a-study-of-several-radiation-doses-for-patients-with-progression-on-immunotherapy-checkp 2026-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05456841/empathic-communication-skills-ecs-training 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06472245/trial-of-therapeutic-cancer-vaccine-ose2101-in-patients-with-non-small-cell-lung-cancer 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06008483/a-dose-finding-study-to-treat-bone-tumor-s 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05180474/gen1047-for-solid-tumors-first-in-human-fih-trial 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05882058/dareontm-5-a-study-to-test-whether-different-doses-of-bi-764532-help-people-with-small-c 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06012435/a-study-of-sgn-b6a-versus-docetaxel-in-previously-treated-non-small-cell-lung-cancer 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02523040/lenalidomide-for-adult-histiocyte-disorders 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07042243/the-florida-ascent-study 2026-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04491292/assessment-of-the-psychosocial-impact-of-the-covid-19-pandemic-on-the-md-anderson-cancer 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05832008/increasing-adherence-to-lung-cancer-screening 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05208762/a-study-of-pf-08046054-sgn-pdl1v-in-advanced-solid-tumors 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02546986/safety-and-efficacy-study-of-cc-486-with-mk-3475-to-treat-locally-advanced-or-metastatic 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02414269/malignant-pleural-disease-treated-with-autologous-t-cells-genetically-engineered-to-targ 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06447662/a-study-to-learn-about-the-study-medicine-pf-07934040-when-given-alone-or-with-other-ant 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04303780/study-to-compare-amg-510-proposed-inn-sotorasib-with-docetaxel-in-non-small-cell-lung-ca 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07720141/dissemination-of-lung-cancer-screening-education-through-tobacco-quitlines 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05060016/a-phase-2-study-of-tarlatamab-in-patients-with-small-cell-lung-cancer-sclc 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227298/symbiotic-lung-20-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combin 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07070232/a-clinical-study-to-test-if-an-investigational-treatment-called-bnt326-is-safe-and-poten 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04166487/plasma-adapted-first-line-pembro-in-nsclc 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06179160/a-study-to-evaluate-incb161734-in-participants-with-advanced-or-metastatic-solid-tumors 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03485209/efficacy-and-safety-study-of-tisotumab-vedotin-for-patients-with-solid-tumors 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06131840/a-study-of-sgn-ceacam5c-in-adults-with-advanced-solid-tumors 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04163432/staggered-chemo-immunotherapy-with-durvalumab-medi4736-pemetrexed-carboplatin-pc-for-met 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07720167/cemiplimab-for-clinical-stage-i-2-3-9cm-non-small-cell-lung-cancer 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07720102/patient-reported-outcomes-following-percutaneous-lung-ablation 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06902272/ctdna-to-predict-response-to-chemo-immunotherapy-and-detect-minimal-residual-disease-in 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06003231/a-study-of-disitamab-vedotin-in-previously-treated-solid-tumors-that-express-her2 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07090499/a-study-to-learn-about-the-study-medicine-called-pf-08046876-in-people-with-advanced-sol 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05142189/clinical-trial-evaluating-the-safety-tolerability-and-preliminary-efficacy-of-bnt116-alo 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05098210/personalized-neo-antigen-peptide-vaccine-for-the-treatment-of-stage-iiic-iv-melanoma-hor 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06758401/this-is-a-study-to-learn-about-how-the-combination-of-the-study-medicines-sigvotatug-ved 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07711691/empowering-patients-lung-cancer-screening-uptake-empower-lcs-call 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05256290/phase-1-2-study-of-silevertinib-bdtx-1535-in-patients-with-glioblastoma-or-non-small-cel 2026-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06458712/study-to-assess-safety-tolerability-and-activity-of-dsb2455-in-participants-with-advance 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06472076/a-study-of-belrestotug-plus-dostarlimab-compared-with-placebo-plus-pembrolizumab-in-prev 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04826341/a-phase-i-ii-study-of-sacituzumab-govitecan-plus-berzosertib-in-small-cell-lung-cancer-e 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07716280/digital-health-implementation-strategies-to-improve-lung-cancer-screening-among-safety-n 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06996782/a-platform-study-in-non-small-cell-lung-cancer-nsclc 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06033248/using-urine-samples-to-identify-lung-cancer 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06088771/neoadjuvant-dupilumab-and-cemiplimab-in-patients-with-early-stage-resectable-nsclc 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05512377/brightline-2-a-study-to-test-whether-brigimadlin-bi-907828-helps-people-with-cancer-in-t 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05013450/dupilumab-metastatic-nsclc 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06057935/a-study-of-additional-chemotherapy-after-surgery-for-people-with-malignant-peritoneal-me 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06698042/a-clinical-study-of-pembrolizumab-berahyaluronidase-alfa-mk-3475a-to-treat-newly-diagnos 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07716527/pilot-testing-a-web-based-prototype-of-a-lung-cancer-screening-digital-health-tool 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05098132/study-of-stk-012-alone-and-with-other-treatments-in-patients-with-advanced-lung-cancer-a 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06899126/study-of-trastuzumab-deruxtecan-pembrolizumab-and-platinum-based-chemotherapy-in-first-l 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01933932/assess-efficacy-safety-of-selumetinib-in-combination-with-docetaxel-in-patients-receivin 2026-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06607185/a-study-of-the-pan-kras-inhibitor-ly4066434-in-participants-with-kras-mutant-solid-tumor 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06814496/radiation-combined-with-bispecific-t-cell-engager-in-dll3-expressing-tumors 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07713875/extended-prophylactic-anticoagulation-following-spinal-surgery-for-metastatic-disease 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06476808/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-escalating-doses-of-bms-9864 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04919369/all-trans-retinoic-acid-atra-and-atezolizumab-for-the-treatment-of-recurrent-or-metastat 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05775289/a-study-of-tobemstomig-plus-platinum-based-chemotherapy-vs-pembrolizumab-plus-platinum-b 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03833154/durvalumab-with-stereotactic-body-radiation-therapy-sbrt-vs-placebo-with-sbrt-in-early-s 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02143466/azd9291-in-combination-with-ascending-doses-of-novel-therapeutics 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06293898/open-label-study-to-evaluate-bl-m07d1-in-her2-expressing-malignant-solid-tumors 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07459634/a-study-of-lurbinectedin-in-combination-with-durvalumab-for-the-treatment-of-participant 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03706027/study-comparing-two-different-schedules-of-radiation-for-early-stage-lung-cancer 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07080242/evaluating-bl-m14d1-in-subjects-with-locally-advanced-or-metastatic-small-cell-lung-canc 2026-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03804255/assessment-of-current-biomarker-testing-practices-for-common-solid-cancers-in-precision 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03938324/peer-i-coaching-for-activated-self-management-optimization-in-adolescents-and-young-adul 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00508443/evaluation-of-a-novel-ct-on-rails-or-trilogy-stereotactic-spine-radiotherapy-system-ssrs 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04285671/necitumumab-and-trastuzumab-in-combination-with-osimertinib-for-the-treatment-of-refract 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06385483/testing-afatinib-as-potentially-targeted-treatment-in-cancers-with-egfr-genetic-changes 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04619004/herthena-lung01-patritumab-deruxtecan-in-subjects-with-metastatic-or-locally-advanced-eg 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05692635/reducing-the-incidence-of-symptomatic-brain-metastases-with-mri-surveillance 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05334329/genetically-engineered-natural-killer-nk-cells-with-or-without-atezolizumab-for-the-trea 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001532/role-of-genetic-factors-in-the-development-of-lung-disease 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06529822/personalized-cancer-vaccine-pcv-strategy-in-patients-with-solid-tumors-and-molecular-res 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05799274/safety-of-rad301-in-healthy-human-volunteers-and-patients-with-pancreatic-cancer-or-othe 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07064018/trial-of-single-protein-encapsulated-doxorubicin-spedox-6-in-advanced-malignancies 2026-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06060613/safety-and-efficacy-of-obx-115-in-advanced-solid-tumors 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03425331/biomarkers-of-response-to-ipilimumab-and-nivolumab-in-first-line-nsclc 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05053867/a-randomized-controlled-trial-of-inhaled-tranexamic-acid-for-the-treatment-of-pulmonary 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06364696/a-study-to-find-a-suitable-dose-of-asp4396-in-adults-with-solid-tumors 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07168993/evaluate-the-clinical-performance-of-the-flow-cytometry-flowpath-lung-test-as-a-sensitiv 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04500600/well-being-and-health-related-quality-of-life-in-cancer-patients-and-survivors-during-th 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05228275/evaluation-of-immunologic-response-following-covid-19-vaccination-in-children-adolescent 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03148327/astra-zeneca-immuno-stereotactic-ablative-body-radiotherapy-isabr-study-randomized-phase 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07028489/prospective-external-control-cohort-in-patients-with-newly-diagnosed-advanced-or-metasta 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06047379/safety-and-efficacy-of-neo212-in-patients-with-astrocytoma-idh-mutant-glioblastoma-idh-w 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03599752/chemotherapy-and-or-metastasectomy-in-treating-patients-with-metastatic-colorectal-adeno 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03043872/durvalumab-tremelimumab-in-combination-with-platinum-based-chemotherapy-in-untreated-ext 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05705492/olanzapine-for-the-management-of-cancer-associated-appetite-loss-in-patients-with-advanc 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03225664/trametinib-and-pembrolizumab-in-treating-patients-with-recurrent-non-small-cell-lung-can 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07005128/a-study-comparing-tarlatamab-durvalumab-carboplatin-and-etoposide-versus-durvalumab-carb 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02525757/mpdl3280a-with-chemoradiation-for-lung-cancer 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00499330/comparison-of-different-types-of-surgery-in-treating-patients-with-stage-ia-non-small-ce 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04607590/yoga-program-for-improving-the-quality-of-life-in-couples-coping-with-cancer 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00618553/effect-of-pulmonary-rehabilitation-on-surgical-outcomes-in-the-cancer-setting 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02282969/pcori-cer-1306-03385-lung-cancer-screening-decision-aid-development-and-testing 2026-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04374877/study-of-chs-388-formerly-known-as-srf388-in-patients-with-advanced-solid-tumors 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07450183/perioperative-cemiplimab-for-resectable-non-small-cell-lung-cancer-with-high-pd-l1 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03819296/role-of-gut-microbiome-and-fecal-transplant-on-medication-induced-gi-complications-in-pa 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05800015/a-trial-to-learn-how-the-combination-of-fianlimab-with-cemiplimab-and-chemotherapy-works 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07405190/ivonescimab-alone-and-with-carboplatin-pemetrexed-for-nsclc 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06228209/tier-palliative-care-for-patients-with-advanced-heart-failure-or-cancer 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04038619/fecal-microbiota-transplantation-in-treating-immune-checkpoint-inhibitor-induced-diarrhe 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04284774/tipifarnib-for-the-treatment-of-advanced-solid-tumors-lymphoma-or-histiocytic-disorders 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03456076/a-study-comparing-adjuvant-alectinib-versus-adjuvant-platinum-based-chemotherapy-in-pati 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05951777/autologous-adipose-derived-mesenchymal-stem-cells-for-chronic-traumatic-brain-injury 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06716580/equal-egfr-ctdna-quantative-assessment-for-lung-cancer-screening-in-asian-and-latinx-pop 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05652686/a-study-of-peluntamig-pt217-in-patients-with-neuroendocrine-carcinomas-expressing-dll3-t 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03093909/study-of-aerosol-gemcitabine-in-patients-with-solid-tumors-and-pulmonary-metastases 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04407247/infliximab-or-vedolizumab-in-treating-immune-checkpoint-inhibitor-related-colitis-in-pat 2026-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06420206/goals-of-care-discussion-for-patients-with-advanced-lung-and-gastrointestinal-cancer-in 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05889546/rapid-autopsy-protocol-for-patients-with-small-cell-lung-cancer 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04995523/a-study-of-azd2936-anti-tigit-anti-pd-1-bispecific-antibody-in-participants-with-advance 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06896162/progress-precision-oncology-using-genomic-reflexive-evaluations-for-study-selection-and 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02864992/tepotinib-phase-ii-in-nsclc-harboring-met-alterations-vision 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06580002/repurposing-riluzole-for-cancer-related-cognitive-impairment-a-pilot-trial 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07543172/cimavax-egf-with-kras-g12c-inhibitor-for-the-treatment-of-advanced-kras-g12c-mutated-non 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03391362/stereotactic-radiation-in-patients-with-small-cell-lung-cancer-and-1-10-brain-metastases 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06686771/radiotherapy-to-block-oligoprogression-in-metastatic-non-small-cell-lung-cancer 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02734004/a-phase-i-ii-study-of-medi4736-in-combination-with-olaparib-in-patients-with-advanced-so 2026-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04577599/lung-b-a-s-e-s-4-life-mobile-low-dose-computed-tomography-ldct-screening-ages-40-54 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04933695/a-study-of-sotorasib-amg-510-in-participants-with-stage-iv-nsclc-whose-tumors-harbor-a-k 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05787587/a-study-of-parg-inhibitor-ide161-in-participants-with-advanced-solid-tumors 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05451849/a-phase-1-2-trial-of-tc-510-in-patients-with-advanced-mesothelin-expressing-cancer 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02186847/chemotherapy-and-radiation-therapy-with-or-without-metformin-hydrochloride-in-treating-p 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05450692/a-phase-iii-study-of-ceralasertib-plus-durvalumab-versus-docetaxel-in-patients-with-non 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06037954/a-study-of-mental-health-care-in-people-with-cancer 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04158141/testing-the-addition-of-targeted-radiation-therapy-to-surgery-and-the-usual-chemotherapy 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07535437/a-study-of-ivonescimab-in-combination-with-dato-dxd-or-osimertinib-in-people-with-non-sm 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04060927/pilot-study-of-sgrt-alone-vs-sgrt-with-fiducials-for-breath-hold-sbrt-tx-of-the-lung 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06427954/mobile-application-to-improve-health-related-outcomes-in-patients-with-advanced-lung-can 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04130516/study-assessing-mtd-safety-tolerability-pk-and-anti-tumor-effects-of-lns8801alone-and-wi 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03381274/oleclumab-medi9447-epidermal-growth-factor-receptor-mutant-egfrm-non-small-cell-lung-can 2026-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02635009/whole-brain-radiation-therapy-with-or-without-hippocampal-avoidance-in-limited-stage-or 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07096024/a-study-to-understand-about-the-study-medicine-palbociclib-in-breast-cancer-patients-aft 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06791057/multi-site-trial-of-a-brief-behavioral-intervention-for-dyspnea-in-patients-with-advance 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07020117/a-study-of-225ac-ac-aky-1189-in-patients-with-solid-tumors 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03213652/ensartinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-ho 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05048797/a-study-to-investigate-the-efficacy-and-safety-of-trastuzumab-deruxtecan-as-the-first-tr 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07452224/ilkn421h-plus-pembrolizumab-in-advanced-non-small-cell-lung-cancer 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05181826/collection-of-blood-from-healthy-patients-patients-with-benign-disease-and-patients-with 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04699838/chemo-immunotherapy-followed-by-durvalumab-and-ceralasertib-in-treatment-nai-ve-patients 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02364557/testing-whether-treating-breast-cancer-metastases-with-surgery-or-high-dose-radiation-im 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06695845/a-phase-2-study-of-zanidatamab-in-patients-with-her2-expressing-tumors 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07355205/first-line-ipilimumab-plus-nivolumab-and-nogapendekin-alfa-inbakicept-n-803-in-patients 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07349537/study-of-rmc-5127-in-patients-with-advanced-kras-g12v-mutant-solid-tumors 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05286814/pds01adc-in-combination-with-hepatic-artery-infusion-pump-haip-and-systemic-therapy-for 2026-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02009449/a-phase-1-study-of-pegilodecakin-ly3500518-in-participants-with-advanced-solid-tumors 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07315113/study-of-nxp900-with-osimertinib-in-subjects-with-advanced-egfr-mutated-non-small-cell-l 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07155187/a-study-to-assess-adverse-events-and-change-in-disease-activity-of-intravenous-iv-teliso 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07174583/a-study-of-ide849-in-patients-with-dll3-expressing-tumors-including-small-cell-lung-canc 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07578571/a-phase-1-study-of-im-1617-in-participants-with-advanced-cancer 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05873686/a-phase-1-clinical-study-of-nxp900-in-subjects-with-advanced-cancers 2026-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04905316/a-study-of-canakinumab-with-chemotherapy-radiation-therapy-and-durvalumab-in-people-with 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07690917/a-study-of-a-new-pet-scanner-in-people-with-cancer 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06103682/locally-ablative-therapy-for-oligoprogressive-lung-and-thoracic-malignancies-obliterate 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06585488/a-first-in-human-study-of-bgb-53038-a-pan-kras-inhibitor-alone-or-in-combinations-in-par 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06139627/evaluation-of-geriatric-assessment-and-management-for-older-adults-with-non-small-cell-l 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07296887/care-tool-study-aim-3 2026-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06077500/dareontm-8-a-study-to-test-how-well-different-doses-of-bi-764532-in-addition-to-standard 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06147037/a-phase-1-dose-escalation-study-of-225ac-fpi-2068-in-adult-patients-with-advanced-solid 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05537740/a-first-in-human-study-to-learn-how-safe-the-study-drug-bay3375968-an-anti-ccr8-antibody 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06825715/multilevel-intervention-for-precision-oncology 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06403436/a-study-evaluating-the-safety-tolerability-pharmacokinetics-and-efficacy-of-tt125-802-in 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06038526/evaluation-of-canakinumab-in-high-risk-former-smokers 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03345563/project-hero-health-empowerment-recovery-outcomes 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06466187/a-study-of-sgn-mesoc2-in-advanced-solid-tumors 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04585477/adjuvant-ctdna-adapted-personalized-treatment-in-early-stage-nsclc-adapt-e 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05424029/extracellular-vesicles-and-particles-evp-as-biomarkers-of-recurrence-in-non-small-cell-l 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04906746/ruxolitinib-for-cancer-cachexia 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04765059/a-study-to-evaluate-chemotherapy-plus-osimertinib-against-chemotherapy-plus-placebo-in-p 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05614102/a-first-in-human-study-to-learn-how-safe-the-study-drug-bay2965501-is-find-the-best-dose 2026-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04389632/a-study-of-sigvotatug-vedotin-in-advanced-solid-tumors 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03976323/study-of-pembrolizumab-with-maintenance-olaparib-or-maintenance-pemetrexed-in-first-line 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02843568/improving-pulmonary-function-following-radiation-therapy 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05117840/screening-for-high-frequency-malignant-disease 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07685938/pharmacologic-therapies-to-mitigate-radiation-associated-heart-disease 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04478318/comparison-of-imaging-characteristics-of-uexplorer-and-conventional-pet-ct-in-patients-w 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07682597/statewide-optimization-of-lung-cancer-screening-utilizing-the-quilstm-system-in-nevada-a 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07682610/kentucky-quality-improvement-implementation-lung-cancer-screening-quilstm-health-service 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05908734/a-study-of-combination-therapy-with-amivantamab-and-cetrelimab-in-participants-with-meta 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07538804/a-study-to-investigate-ans02-in-participants-with-egfr-mutation-positive-non-small-cell 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04077463/a-study-of-lazertinib-as-monotherapy-or-in-combination-with-amivantamab-in-participants 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05696782/quick-start-durvalumab-following-chemoradiation-for-stage-iii-nonsmall-cell-lung-cancer 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04609566/brentuximab-vedotin-with-pembrolizumab-in-metastatic-solid-tumors 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04205812/platinum-based-chemotherapy-with-without-incmga00012-an-anti-pd-1-antibody-in-non-small 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07423585/tarlatamab-for-the-treatment-of-extensive-stage-small-cell-lung-cancer 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05120349/a-global-study-to-assess-the-effects-of-osimertinib-in-participants-with-egfrm-stage-ia2 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03567642/a-study-of-the-combination-of-osimertinib-platinum-and-etoposide-for-patients-with-metas 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07300150/a-study-of-pt0511-in-participants-with-kras-mutated-or-amplified-advanced-solid-tumors 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05887492/study-of-tng260-and-an-anti-pd-antibody-in-stk11-mutated-solid-tumors 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07462377/a-phase-1-study-of-epi-326-in-egfr-mutant-nsclc-and-hnscc 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04745689/study-of-azd2811-durvalumab-in-es-sclc 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07685028/legacy-lung-cancer-screening-in-individuals-with-a-lung-cancer-family-history-protocol-a 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04538664/a-study-of-combination-amivantamab-and-carboplatin-pemetrexed-therapy-compared-with-carb 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07220356/c-raven-a-virtual-tobacco-cessation-intervention-in-residency-clinics 2026-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03603002/pathologic-and-immunologic-response-after-ablative-radiation-in-lung-cancer 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05445843/study-of-efficacy-and-safety-of-jdq443-single-agent-as-first-line-treatment-for-patients 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07064395/bright-light-therapy-on-sleep-health-in-lung-cancer-patients 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07169734/a-study-to-investigate-ale-p03-as-monotherapy-in-adult-patients-with-selected-advanced-o 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05785767/a-study-to-learn-if-a-combination-of-fianlimab-and-cemiplimab-versus-cemiplimab-alone-is 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06008093/a-study-to-investigate-the-efficacy-of-durvalumab-plus-tremelimumab-in-combination-with 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05375994/study-of-avutometinib-vs-6766-adagrasib-in-kras-g12c-nsclc-patients 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06730750/a-study-of-bms-986490-with-or-without-bevacizumab-in-advanced-solid-tumors 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01708954/erlotinib-hydrochloride-and-cabozantinib-s-malate-alone-or-in-combination-as-second-or-t 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07176559/pilot-randomized-clinical-trial-of-informational-support-versus-spiritual-care 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07118176/determining-the-biodistribution-of-an-imaging-tracer-68ga-fapi-46-in-patients-with-solid 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02193282/erlotinib-hydrochloride-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-canc 2026-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05118854/a-phase-ii-study-of-neoadjuvant-sotorasib-in-combination-with-cisplatin-or-carboplatin-a 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03655223/early-check-expanded-screening-in-newborns 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07098338/a-study-of-novel-combinations-in-non-small-cell-lung-cancer-nsclc 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07186296/exopert-emerald-clinical-study 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04195555/ivosidenib-in-treating-patients-with-advanced-solid-tumors-lymphoma-or-histiocytic-disor 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04116970/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-with-suction-in-obtaini 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04548830/safety-of-lung-cryobiopsy-in-people-with-cancer 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05967533/the-immune-effects-of-fermented-wheat-germ-nutritional-supplementation-in-patients-with 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04655976/efficacy-comparison-of-cobolimab-dostarlimab-docetaxel-to-dostarlimab-docetaxel-to-docet 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05571839/a-study-of-pf-08046049-sgn-bb228-in-advanced-melanoma-and-other-solid-tumors 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02576431/a-study-to-test-the-effect-of-the-drug-larotrectinib-in-adults-and-children-with-ntrk-fu 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07639255/kentucky-quality-improvement-implementation-lung-cancer-screening-quilstm-implementation 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07675876/inhaled-cromolyn-sodium-in-patients-with-locally-advanced-lung-cancer 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00568490/identification-of-secreted-markers-for-tumor-hypoxia-in-patients-with-head-and-neck-or-l 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04227028/brigatinib-and-bevacizumab-for-the-treatment-of-alk-rearranged-locally-advanced-metastat 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07291037/phase-iii-study-of-datopotamab-deruxtecan-versus-docetaxel-in-previously-treated-trop2-p 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07679607/gcc-2545-improving-post-radiotherapy-respiratory-function-through-sparing-serial-and-par 2026-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05136846/papaverine-in-combination-with-chemoradiation-for-the-treatment-of-stage-ii-iii-non-smal 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006344/radiation-therapy-in-preventing-brain-metastases-in-patients-with-small-cell-lung-cancer 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05925530/study-to-assess-neoadjuvant-durvalumab-d-and-platinum-based-chemotherapy-ct-followed-by 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07675967/clonal-hematopoiesis-chemotherapy-and-radiation-effects-study 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06015724/anti-cd38-antibody-with-kras-vaccine-and-anti-pd-1-antibody-in-subjects-with-pancreatic 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06162221/study-of-ras-on-inhibitors-in-patients-with-advanced-ras-mutated-nsclc 2026-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05283564/study-to-evaluate-percussive-ventilation-breathhold-to-improve-lung-stereotactic-ablativ 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07458347/a-phase-1-dose-escalation-trial-of-kst-6051-in-participants-with-advanced-solid-tumors-w 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06712745/feasibility-study-of-personalized-ultra-fractionated-stereotactic-ablative-radiotherapy 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05478538/observational-lung-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05164757/female-asian-nonsmoker-screening-study 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06747585/a-study-to-investigate-ale-p02-as-monotherapy-in-adult-patients-with-selected-cldn1-soli 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05520099/observational-basket-trial-to-collect-tissue-to-develop-and-train-a-live-tumor-diagnosti 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07327489/predicting-response-to-immunotherapy-from-analysis-of-live-tumor-biopsies-elephas-05 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03815643/avelumab-program-rollover-study 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02012699/integrated-cancer-repository-for-cancer-research 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05091567/a-phase-iii-open-label-study-of-maintenance-lurbinectedin-in-combination-with-atezolizum 2026-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165096/keymaker-u01-substudy-3-efficacy-and-safety-study-of-pembrolizumab-mk-3475-when-used-wit 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04738487/coformulation-of-pembrolizumab-vibostolimab-mk-7684a-versus-pembrolizumab-mk-3475-monoth 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06598306/subcutaneous-tarlatamab-in-participants-with-extensive-stage-small-cell-lung-cancer-dell 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06914128/a-study-of-prmt5-inhibitor-bay-3713372-in-participants-with-mtap-deleted-solid-tumors 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04614103/autologous-ln-145-in-patients-with-metastatic-non-small-cell-lung-cancer 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06538636/prediction-augmented-screening-initiative 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07398209/gcc-2546-motion-management 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05967689/a-study-of-zipalertinib-in-patients-with-advanced-non-small-cell-lung-cancer-with-epider 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07661966/bright-light-therapy-in-patients-with-melanoma-or-non-small-cell-lung-cancer-nsclc-who-a 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07149363/adjuvant-chemotherapy-and-immunotherapy-for-completely-resected-small-cell-lung-cancer 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06788912/pembrolizumab-mk-3475-plus-investigational-agents-in-resectable-non-small-cell-lung-canc 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06225427/gilteritinib-for-the-treatment-of-alk-nsclc 2026-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05277051/first-time-in-human-study-of-gsk4381562-in-participants-with-advanced-solid-tumors 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05407168/improving-decision-making-encounters-in-lung-cancer-using-a-low-literacy-conversation-to 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06227546/mgc018-in-patients-with-relapsed-or-refractory-extensive-stage-small-cell-lung-cancer 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00899405/studying-tumor-tissue-samples-and-blood-samples-to-learn-more-about-dna-changes-in-patie 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02206334/stereotactic-body-radiation-therapy-in-treating-patients-with-metastatic-breast-cancer-n 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06216301/lunar-2-ttfields-with-pembrolizumab-platinum-based-chemotherapy-for-metastatic-nsclc 2026-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05568680/synkir-110-for-mesothelin-expressing-ovarian-cancer-cholangiocarcinoma-or-mesothelioma 2026-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07664579/investigating-the-feasibility-and-acceptability-of-an-innovative-interdisciplinary-suppo 2026-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01642251/cisplatin-and-etoposide-with-or-without-veliparib-in-treating-patients-with-extensive-st 2026-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00887159/a-randomized-phase-ii-study-of-cisplatin-and-etoposide-in-combination-with-either-hedgeh 2026-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07564401/a-study-to-evaluate-dji136-a-dll3-targeted-car-t-therapy 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06625775/open-label-study-of-bbo-10203-in-subjects-with-advanced-solid-tumors 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04678648/a-trial-of-rsc-1255-for-treatment-of-patients-with-advanced-malignancies 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05555732/datopotamab-deruxtecan-dato-dxd-and-pembrolizumab-with-or-without-platinum-chemotherapy 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05609578/combination-therapies-with-adagrasib-in-patients-with-advanced-nsclc-with-kras-g12c-muta 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06983899/exercise-training-for-the-improvement-of-immune-activity-and-treatment-outcomes-during-i 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05005403/study-to-assess-adverse-events-and-pharmacokinetics-in-adult-participants-with-non-small 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00693992/sunitinib-malate-as-maintenance-therapy-in-treating-patients-with-stage-iii-or-stage-iv 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00324805/chemotherapy-with-or-without-bevacizumab-in-treating-patients-with-stage-ib-stage-ii-or 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07046923/a-study-of-ly4175408-in-participants-with-advanced-cancer 2026-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03110978/stereotactic-body-radiation-therapy-with-or-without-nivolumab-in-treating-patients-with 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05325866/a-study-evaluating-bemarituzumab-in-solid-tumors-with-fibroblast-growth-factor-receptor 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06545331/study-of-xb010-in-subjects-with-solid-tumors 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03476681/study-of-neo-201-in-solid-tumors-expansion-cohorts 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07660094/aglatimagene-besadenovec-prodrug-and-pembrolizumab-vs-docetaxel-for-stage-iv-non-squamou 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05017025/aurora-kinase-inhibitor-ly3295668-in-combination-with-osimertinib-for-the-treatment-of-a 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06943664/photoimmunotherapy-with-asp-1929-and-cemiplimab-for-the-treatment-of-refractory-inoperab 2026-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06400472/a-study-of-ly4170156-in-participants-with-selected-advanced-solid-tumors 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07116057/mov19-bbz-car-t-cells-in-fra-cancers 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05867121/a-study-to-evaluate-safety-pharmacokinetics-activity-of-ro7496353-in-combination-with-a 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04623775/a-study-of-relatlimab-plus-nivolumab-in-combination-with-chemotherapy-vs-nivolumab-in-co 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06257264/a-study-to-examine-the-safety-of-different-doses-of-bg-68501-given-to-participants-with 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04475939/placebo-controlled-study-comparing-niraparib-plus-pembrolizumab-versus-placebo-plus-pemb 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05130255/gd2-sada-177lu-dota-complex-in-patients-with-solid-tumors-known-to-express-gd2 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05514717/a-study-of-xmt-2056-in-advanced-recurrent-solid-tumors-that-express-her2 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05708950/a-clinical-trial-of-kva12123-tbs-2025-treatment-alone-and-in-combination-with-pembrolizu 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07153055/lurbinectedin-with-osimertinib-in-transformed-small-cell-lung-cancer 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07503808/a-study-of-ide034-in-adult-participants-with-locally-advanced-metastatic-solid-tumors-ty 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06497556/a-study-evaluating-the-efficacy-and-safety-of-divarasib-versus-sotorasib-or-adagrasib-in 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06075524/evaluation-of-anti-pd-1-therapy-by-monitoring-t-cell-responses-in-melanoma-lung-and-othe 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05221840/a-global-study-to-assess-the-effects-of-durvalumab-with-oleclumab-or-durvalumab-with-mon 2026-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05742607/iph5201-and-durvalumab-in-patients-with-resectable-non-small-cell-lung-cancer-matisse 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02498613/a-phase-2-study-of-cediranib-in-combination-with-olaparib-in-advanced-solid-tumors 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05786924/phase-1-2-trial-of-s241656-in-selected-ras-mapk-mutation-positive-malignancies 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06963970/using-community-health-workers-to-support-rural-care-partners-of-seriously-ill-older-vet 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03210714/erdafitinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-h 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04899908/stereotactic-brain-directed-radiation-with-or-without-aguix-gadolinium-based-nanoparticl 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05930418/cardiovascular-magnetic-resonance-prognosticators-in-pediatric-oncology-patients-with-se 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04077099/a-study-of-regn5093-in-adult-patients-with-mesenchymal-epithelial-transition-factor-met 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04036682/a-phase-1-2-trial-of-cln-081-in-patients-with-non-small-cell-lung-cancer 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05570825/sx-682-with-pembrolizumab-for-the-treatment-of-metastatic-or-recurrent-stage-iiic-or-iv 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03213704/larotrectinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02834013/nivolumab-and-ipilimumab-in-treating-patients-with-rare-tumors 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03631199/study-of-efficacy-and-safety-of-pembrolizumab-plus-platinum-based-doublet-chemotherapy-w 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04702880/a-study-of-bms-986012-in-combination-with-carboplatin-etoposide-and-nivolumab-as-first-l 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06741085/a-study-of-stereotactic-radiosurgery-srs-and-standard-treatment-in-people-with-lung-canc 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03698994/ulixertinib-in-treating-patients-with-advanced-solid-tumors-non-hodgkin-lymphoma-or-hist 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01638546/temozolomide-with-or-without-veliparib-in-treating-patients-with-relapsed-or-refractory 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07473128/effect-of-trilaciclib-in-the-prevention-of-myelosupression-in-subjects-with-limited-stag 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04210492/dose-deescalated-3-fraction-stereotactic-body-radiotherapy-for-centrally-located-lung-ca 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03199651/beating-lung-cancer-in-ohio-protocol-in-improving-survival-in-patients-with-stage-iv-non 2026-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07603856/a-study-evaluating-the-combination-of-immunotherapy-with-radiotherapy-in-non-small-cell 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07540572/a-study-to-investigate-the-safety-pharmacokinetics-and-preliminary-efficacy-of-ide574-th 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07650357/a-study-of-clsp-5282-in-hla-a-03-01-positive-adult-patients-with-solid-tumors-sentinel-1 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00453154/cisplatin-or-carboplatin-and-etoposide-with-or-without-sunitinib-malate-in-treating-pati 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05984680/copd-care-pathway-among-patients-with-cancer 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07572773/champ-lung-cancer-screening-program 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04225117/a-study-to-evaluate-enfortumab-vedotin-in-subjects-with-locally-advanced-or-metastatic-m 2026-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06345729/a-study-of-calderasib-mk-1084-plus-pembrolizumab-mk-3475-in-participants-with-kras-g12c 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05257551/tempus-small-cell-lung-cancer-observational-study-sculptor 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07407933/a-study-of-yl201-in-combination-with-other-anti-cancer-therapies-in-patients-with-advanc 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06213532/connecting-to-lungcare 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05358249/platform-study-of-jdq443-in-combinations-in-patients-with-advanced-solid-tumors-harborin 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05589818/pembrolizumab-for-advanced-nsclc-and-ps-2-3 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04262856/study-to-evaluate-monotherapy-and-combination-immunotherapies-in-participants-with-pd-l1 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06364917/discern-dual-versus-single-icb-in-pdl-1-negative-nsclc 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05565378/a-platform-study-of-novel-immunotherapy-combinations-in-participants-with-previously-unt 2026-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00991094/data-collection-for-the-assessment-of-acute-and-late-normal-tissue-in-patients-treated-w 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07284186/first-in-human-study-of-plx-61639-in-locally-advanced-or-metastatic-solid-tumors 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04439292/testing-trametinib-and-dabrafenib-as-a-potential-targeted-treatment-in-cancers-with-braf 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03318939/phase-2-study-of-poziotinib-in-participants-with-nsclc-having-egfr-or-her2-exon-20-inser 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05915208/histiocytic-disorder-follow-up-study 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04789681/canakinumab-for-the-prevention-of-lung-cancer-the-can-prevent-lung-trial 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06756035/ct-95-in-advanced-cancers-associated-with-mesothelin-expression 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07303816/statins-to-prevent-cancer-associated-blood-clots 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06957314/a-study-of-hospital-at-home-for-people-receiving-tarlatamab 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06051695/a-study-to-evaluate-the-safety-and-efficacy-of-mesothelin-targeting-logic-gated-car-t-in 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06840288/bronchoscopic-lung-ablation-of-small-thoracic-tumors-the-blastt-registry 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07405086/morning-versus-afternoon-administration-of-immunotherapy-for-the-treatment-of-advanced-o 2026-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04959175/phase-i-ii-study-to-reduce-post-transplantation-cyclophosphamide-dosing-for-older-or-unf 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05076760/mem-288-oncolytic-virus-alone-and-in-combination-with-standard-of-care-therapy-in-advanc 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05647122/first-in-human-study-of-azd9592-in-solid-tumors 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07619339/a-study-of-tepotinib-and-ivonescimab-in-people-with-non-small-cell-lung-cancer 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03609580/post-operative-urinary-retention-pour-following-thoracic-surgery 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02393625/study-of-safety-and-efficacy-of-ceritinib-in-combination-with-nivolumab-in-patients-with 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03040973/study-to-allow-patients-previously-participating-in-a-novartis-sponsored-trial-to-contin 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06789172/a-phase-1-first-in-human-study-of-okn4395-and-pembrolizumab-in-patients-with-solid-tumor 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00597636/genetic-susceptibility-to-lung-cancer-in-never-smokers 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03194893/a-rollover-study-of-alectinib-in-patients-with-anaplastic-lymphoma-kinase-alk-positive-o 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04984811/nt-i7-in-combination-with-atezolizumab-in-previously-untreated-pd-l1-expressing-locally 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04155034/s1827-maverick-testing-whether-the-use-of-brain-scans-alone-instead-of-brain-scans-plus 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04728230/olaparib-and-durvalumab-with-carboplatin-etoposide-and-or-radiation-therapy-for-the-trea 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04214262/testing-the-addition-of-the-drug-atezolizumab-to-the-usual-radiation-treatment-for-patie 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04771520/avapritinib-for-the-treatment-of-ckit-or-pdgfra-mutation-positive-locally-advanced-or-me 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05283330/safety-and-tolerability-of-212pb-dotam-grpr1-in-adult-subjects-with-recurrent-or-metasta 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04751747/adaptive-radiation-planning-for-the-reduction-of-radiation-induced-toxicity-in-patients 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03003962/study-of-durvalumab-alone-or-chemotherapy-for-patients-with-advanced-non-small-cell-lung 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02503722/testing-the-combination-of-mln0128-tak-228-and-azd9291-in-advanced-egfr-epidermal-growth 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07218003/a-phase-1-1b-of-rndo-564-single-agent-or-in-combination-with-pembrolizumab-in-bladder-ca 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05361174/a-study-to-investigate-the-efficacy-and-safety-of-an-infusion-of-iov-4001-in-adult-parti 2026-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04332367/carboplatin-taxane-and-ramucirumab-for-patients-with-nsclc-after-pemetrexed-or-pembroliz 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03305341/proof-of-concept-clinical-pharmacology-trial-for-covid-19-antigen-presentation-therapeut 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07287995/a-study-of-asp2998-given-by-itself-and-given-with-standard-therapies-in-people-with-soli 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07517198/dose-determining-study-of-exs74539-rec-4539-in-participants-with-select-solid-tumors 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06835569/a-study-to-learn-about-study-medicine-alta3263-in-adults-with-advanced-solid-tumors-with 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05419076/a-study-of-stereotactic-radiosurgery-srs-for-people-with-lung-cancer-that-has-spread-to 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06855771/a-study-of-navlimetostat-bms-986504-in-participants-with-pre-treated-advanced-or-metasta 2026-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03306992/precision-exercise-prescription-for-lung-cancer-patients-undergoing-surgery-the-pep-stud 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04916002/a-trial-to-find-out-if-vidutolimod-together-with-cemiplimab-is-safe-and-if-it-works-in-a 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07636200/the-ease-study-randomized-trial-of-a-novel-approach-to-addressing-fear-of-progression-in 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07146230/the-selective-personalized-radio-immunotherapy-for-locally-advanced-non-small-cell-lung 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06265285/comparison-of-in-home-versus-in-clinic-administration-of-subcutaneous-nivolumab-through 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02785952/lung-map-nivolumab-with-or-without-ipilimumab-as-second-line-therapy-in-treating-patient 2026-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04791839/safety-and-efficacy-of-zimberelimab-ab122-in-combination-with-domvanalimab-ab154-and-etr 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03137771/maintenance-chemotherapy-with-or-without-local-consolidative-therapy-in-treating-patient 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03289962/a-study-of-autogene-cevumeran-ro7198457-as-a-single-agent-and-in-combination-with-atezol 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07005102/a-study-to-assess-adverse-events-change-in-disease-activity-of-intravenous-telisotuzumab 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03516981/a-study-of-biomarker-directed-pembrolizumab-mk-3475-based-combination-therapy-for-advanc 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01993810/comparing-photon-therapy-to-proton-therapy-to-treat-patients-with-lung-cancer 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06026410/ko-2806-monotherapy-and-combination-therapies-in-advanced-solid-tumors 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03939481/treatment-effects-on-development-of-chemotherapy-induced-peripheral-neuropathy-in-patien 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05789069/a-study-of-hfb200603-as-a-single-agent-and-in-combination-with-tislelizumab-in-adult-pat 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07631299/nebulized-aer101-in-pre-op-nsclc 2026-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07564960/social-optimization-study 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04351555/a-study-of-osimertinib-with-or-without-chemotherapy-versus-chemotherapy-alone-as-neoadju 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03178552/a-study-to-evaluate-the-efficacy-and-safety-of-multiple-targeted-therapies-as-treatments 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04748419/safety-efficacy-of-consolidative-hypofractionated-radiation-therapy-for-boosting-residua 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00451022/follow-up-study-of-subjects-previously-enrolled-in-poxviral-vector-gene-transfer-studies 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05960773/decitabine-cedazuridine-inqovi-an-oral-dna-demethylating-agent-in-subjects-with-bap1-can 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04334941/testing-maintenance-therapy-for-small-cell-lung-cancer-in-patients-with-slfn11-positive 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07579221/ph1-2-trial-of-navlimetostat-with-pumitamig-in-mtap-deficient-advanced-non-small-cell-lu 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04574518/teachable-moment-to-opt-out-of-tobacco-interactive-voice-response-quit-line-for-veteran 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06235125/safety-and-feasibility-of-intraoperative-visualization-with-cytalux-in-children 2026-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00238628/a-phase-i-ii-study-of-bexarotene-in-combination-with-zd1839-iressa-in-the-treatment-of-n 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03132922/mage-a4c1o32t-for-multi-tumor 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04458259/study-of-pf-07265807-in-participants-with-metastatic-solid-tumors 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04777994/study-with-abbv-cls-484-in-participants-with-locally-advanced-or-metastatic-tumors 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04189614/an-efficacy-and-safety-study-of-cofetuzumab-pelidotin-in-participants-with-ptk7-expressi 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04297605/study-of-pembrolizumab-and-single-agent-chemotherapy-as-first-line-treatment-for-patient 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04800822/pf-07284892-in-participants-with-advanced-solid-tumors 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04566393/expanded-access-to-ulixertinib-bvd-523-in-patients-with-advanced-mapk-pathway-altered-ma 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06463665/efficacy-safety-of-olvimulogene-nanivacirepvec-platinum-doublet-physician-s-choice-of-im 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04300556/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-morab-202-herein-referred-to 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06253871/a-phase-1-1b-study-of-iam1363-in-her2-cancers 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03774758/biomarkers-for-risk-stratification-in-lung-cancer 2026-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05062980/quaratusugene-ozeplasmid-reqorsa-in-combination-with-pembrolizumab-in-previously-treated 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06040541/study-of-rmc-9805-in-participants-with-kras-g12d-mutant-solid-tumors 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06559059/evaluating-the-implementation-of-a-comprehensive-multilevel-virtual-oncology-program-amo 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01451853/spi-1005-for-prevention-and-treatment-of-chemotherapy-induced-hearing-loss 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05490251/translational-research-center-in-lung-cancer-disparities-tracer-project-2 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05546476/study-of-the-efficacy-and-safety-of-ponsegromab-in-patients-with-cancer-cachexia-and-ele 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04619797/a-study-of-tiragolumab-in-combination-with-atezolizumab-plus-pemetrexed-and-carboplatin 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04513925/a-study-of-atezolizumab-and-tiragolumab-compared-with-durvalumab-in-participants-with-lo 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03958565/response-of-bony-metastasis-to-tyrosine-kinase-inhibitors-in-non-small-cell-lung-cancers 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03881098/the-lung-pca-a-multi-dimensional-atlas-of-pulmonary-premalignancy 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05642572/comparing-combinations-of-targeted-drugs-for-advanced-non-small-cell-lung-cancer-that-ha 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05703971/quaratusugene-ozeplasmid-reqorsa-and-atezolizumab-maintenance-therapy-in-es-sclc-patient 2026-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04881045/study-to-test-the-safety-and-tolerability-of-pf-07257876-in-participants-with-selected-a 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06731413/reduced-ct-anti-pd-1-as-first-line-tx-in-vulnerable-older-adults-w-adv-50-pd-l1-non-smal 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04981119/solid-tumor-analysis-for-hla-loss-of-heterozygosity-loh-and-apheresis-for-car-t-cell-man 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05968898/assessment-of-a-radiomics-based-computer-aided-diagnosis-tool-for-pulmonary-nodules 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07454642/ava6103-in-subjects-with-locally-advanced-or-metastatic-selected-solid-tumors 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04551378/the-effect-of-covid-19-pandemic-on-adolescent-and-young-adult-cancer-patients-and-surviv 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06917079/bbo-11818-in-adult-subjects-with-kras-mutant-cancer 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06492954/atezolizumab-in-combination-with-stereotactic-body-radiation-therapy-sbrt-and-surgery-fo 2026-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04938817/safety-and-efficacy-study-of-investigational-agents-as-monotherapy-or-in-combination-wit 2026-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05676931/study-with-various-immunotherapy-treatments-in-participants-with-lung-cancer 2026-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05783622/study-of-janx008-in-subjects-with-advanced-or-metastatic-solid-tumor-malignancies 2026-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06171789/pro1107-in-patients-with-advanced-solid-tumors 2026-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05633667/study-of-novel-treatment-combinations-in-patients-with-lung-cancer 2026-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07037758/a-study-of-tarlatamab-in-combination-with-ab248-in-participants-with-extensive-stage-sma 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03402880/alcmi-005-pembrolizumab-and-epacadostat-in-treating-patients-with-extensive-stage-small 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02597738/a-feasibility-study-to-further-the-development-of-lung-cancer-based-precision-medicine 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07073183/safety-and-tolerability-of-cvhnlc-plus-pembrolizumab-in-patients-with-squamous-non-small 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06682013/virtual-agent-feasibility-in-oncology-patients-ntt-data 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02075840/a-study-comparing-alectinib-with-crizotinib-in-treatment-naive-anaplastic-lymphoma-kinas 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04956640/study-of-ly3537982-in-cancer-patients-with-a-specific-genetic-mutation-kras-g12c 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06638554/integrating-telehealth-to-advance-lung-cancer-screening 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07615764/an-educational-intervention-lung-toolkit-for-improving-knowledge-about-lung-cancer-and-s 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05679349/support-and-outreach-to-increase-screening-for-lung-cancer-in-patients-with-a-history-of 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05802186/stereotactic-body-radiation-therapy-planning-with-artificial-intelligence-directed-dose 2026-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05764954/a-study-of-tumor-treating-fields-ttfields-in-people-with-lung-adenocarcinoma 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06566443/honokiol-in-early-stage-resectable-non-small-cell-lung-cancer 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06593522/a-phase-2-study-of-anvumetostat-in-participants-with-mtap-deleted-advanced-nsclc-mtapest 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06869447/new-york-better-breathing-study 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04514484/testing-the-combination-of-the-anti-cancer-drugs-xl184-cabozantinib-and-nivolumab-in-pat 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05094336/a-study-of-anvumetostat-in-participants-with-advanced-mtap-null-solid-tumors-mtapestry-1 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06333951/anvumetostat-alone-or-in-combination-with-other-therapies-in-subjects-with-advanced-thor 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07223047/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-bms-986523-alone-and-in-comb 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05882734/tuvusertib-m1774-in-combination-with-cemiplimab-in-participants-with-non-squamous-nsclc 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06477419/a-study-of-sacituzumab-govitecan-in-people-with-mesothelioma 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07102147/telehealth-collaborative-care-model-cocm-in-lung-cancer 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06246110/a-phase-2-study-of-eik1001-in-combo-with-pembrolizumab-and-chemotherapy-in-patients-with 2026-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03237377/neoadjuvant-immunoradiation-for-resectable-non-small-cell-lung-cancer 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07599943/population-health-management-increase-lung-cancer-screening-in-community-health-centers 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04183218/characterizing-chemo-radiotherapy-treatment-related-cardiac-changes 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00600496/a-phase-i-open-label-multi-center-study-to-assess-the-safety-tolerability-and-pharmacoki 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02959463/pembrolizumab-after-radiation-therapy-in-treating-patients-with-pleural-malignant-mesoth 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03093116/a-study-of-repotrectinib-tpx-0005-in-patients-with-advanced-solid-tumors-harboring-alk-r 2026-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06745258/icare-lcs-queri-partnered-evaluation-initiative-integrating-comprehensive-tobacco-treatm 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07249372/drp-104-in-patients-with-nfe2l2-keap1-altered-non-small-cell-lung-cancer 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03520686/nogapendekin-alfa-inbakicept-for-advanced-non-small-cell-lung-cancer 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06496659/segmentectomy-after-induction-therapy-saint 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06974370/avoiding-radiation-therapy-due-to-intracranial-response-to-chemotherapy-targeted-therapy 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04250545/testing-of-the-anti-cancer-drugs-cb-839-hcl-telaglenastat-and-mln0128-sapanisertib-in-ad 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07584239/prehabilitation-physical-therapy-and-relaxation-intervention-program-to-promote-resilien 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05668988/a-study-of-dzd9008-versus-platinum-based-doublet-chemotherapy-in-local-advanced-or-metas 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06337552/high-fermented-food-intervention-among-locally-advanced-rectal-cancer-patients-the-feed 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04624204/placebo-controlled-study-of-concurrent-chemoradiation-therapy-with-pembrolizumab-followe 2026-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05800587/dose-attenuated-chemotherapy-in-compromised-patients-with-lung-cancer 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06567015/study-of-fih-of-stx-241-in-locally-advanced-or-metastatic-nsclc-resistant-to-egfr-tkis 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06043817/first-in-human-study-of-stx-721-pfl-721-in-participants-with-locally-advanced-or-metasta 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07278479/study-of-212pb-pb-dotam-mam279-212pb-pb-mp0712-in-patients-with-small-cell-lung-cancer-a 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03527108/nivolumab-plus-ramucirumab-in-patients-with-recurrent-advanced-metastatic-nsclc 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06685718/a-study-investigating-bg-60366-in-adults-with-epidermal-growth-factor-receptor-egfr-muta 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03786692/phase-ii-randomized-trial-of-carboplatin-pemetrexed-bevacizumab-atezolizumab-in-stage-iv 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06704724/a-study-to-learn-about-the-study-medicine-pf-07985045-when-given-alone-or-with-other-ant 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06271616/ibrutinib-for-the-prevention-of-chronic-graft-versus-host-disease-in-patients-undergoing 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06238479/a-study-of-ly4101174-in-participants-with-recurrent-advanced-or-metastatic-solid-tumors 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06953089/db-1311-in-combination-with-bnt327-or-db-1305-in-advanced-metastatic-solid-tumors 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05726383/iscador-p-mistletoe-immunotherapy-for-recurrent-resectable-osteogenic-sarcoma 2026-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02321501/ceritinib-and-everolimus-in-treating-patients-with-locally-advanced-or-metastatic-solid 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06037837/improving-surgeon-performance-measures-for-robot-assisted-surgery 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04123379/neoadjuvant-nivolumab-with-ccr2-5-inhibitor-or-anti-il-8-for-non-small-cell-lung-cancer 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05672355/a-vaccine-booster-geo-cm04s1-for-the-prevention-of-covid-19-in-patients-with-chronic-lym 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04588246/comparing-whole-brain-radiotherapy-using-a-technique-that-avoids-the-hippocampus-to-ster 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06885424/a-long-term-follow-up-study-of-participants-treated-with-a2-biotherapeutics-a2-bio-gene 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04565665/study-of-cord-blood-derived-mesenchymal-stem-cells-for-treatment-of-moderate-severe-or-c 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06898957/study-of-tarlatamab-in-combination-with-yl201-with-or-without-anti-programmed-death-liga 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02696993/nivolumab-and-radiation-therapy-with-or-without-ipilimumab-in-treating-patients-with-bra 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05102656/patient-perceptions-of-the-relational-empathy-of-healthcare-practitioners-from-the-depar 2026-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06503146/18f-fibroblast-activation-protein-inhibitor-18f-fapi-74-pet-imaging-for-cancer-detection 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02504489/docetaxel-plinabulin-compared-to-docetaxel-placebo-in-patients-with-advanced-nsclc 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05431270/dose-escalation-expansion-study-of-mavrostobart-pt199-an-anti-cd73-mab-administered-alon 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07154706/phase-3-study-of-taletrectinib-vs-placebo-as-an-adjuvant-therapy-in-ros1-positive-nsclc 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06713564/a-single-dose-open-label-dose-escalation-study-of-the-safety-and-imaging-characteristics 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04141644/safety-and-efficacy-of-combination-osimertinib-and-ipilimumab-in-patients-w-egfr-mutated 2026-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03851445/lung-map-a-master-screening-protocol-for-previously-treated-non-small-cell-lung-cancer 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05885698/mylung-consortium-part-3-observational-study 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05096663/testing-the-use-of-combination-immunotherapy-treatment-n-803-alt-803-plus-pembrolizumab 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02438722/s1403-afatinib-dimaleate-with-or-without-cetuximab-in-treating-patients-with-newly-diagn 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04067830/respiratory-muscle-training-before-surgery-in-preventing-lung-complications-in-patients 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04154956/sar408701-versus-docetaxel-in-previously-treated-carcinoembryonic-antigen-related-cell-a 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05831787/covid19-outcomes-in-myeloma-and-the-impact-of-vaccines 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03409614/combinations-of-cemiplimab-anti-pd-1-antibody-and-platinum-based-doublet-chemotherapy-in 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04032418/pembrolizumab-every-12-weeks-versus-every-3-weeks-in-treating-patients-with-non-small-ce 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07094204/a-study-to-find-a-suitable-dose-of-asp5834-in-adults-with-solid-tumors 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07594522/a-study-of-ivonescimab-in-people-with-non-small-cell-lung-cancer 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06324110/evaluating-the-impact-of-centralized-interventions-on-lung-cancer-screening-adherence-in 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05644808/mylung-consortium-study-protocol-2 2026-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03645928/study-of-autologous-tumor-infiltrating-lymphocytes-in-patients-with-solid-tumors 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07460440/sparc-screening-for-lung-cancer-with-platelets-via-an-ai-enabled-rna-based-classifier 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03611738/ceritinib-plus-docetaxel-in-alk-negative-egfr-wt-advanced-nsclc 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05462717/dose-escalation-and-dose-expansion-study-of-rmc-6291-monotherapy-in-subjects-with-advanc 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04380636/study-of-pembrolizumab-with-concurrent-chemoradiation-therapy-followed-by-pembrolizumab 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02444741/pembrolizumab-and-stereotactic-body-radiation-therapy-or-non-stereotactic-wide-field-rad 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05379985/study-of-rmc-6236-in-patients-with-advanced-solid-tumors-harboring-specific-mutations-in 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05653752/a-study-of-yl202-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-can 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05599321/piloting-a-virtual-navigation-vn-system-for-bronchoscopic-lung-nodule-sampling 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04526691/datopotamab-deruxtecan-dato-dxd-in-combination-with-pembrolizumab-with-or-without-platin 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07224464/the-sarah-nanotechnology-system-for-treatment-of-advanced-metastatic-solid-tumors-using 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04977453/gi-101-gi-101a-as-a-single-agent-or-in-combination-with-pembrolizumab-or-lenvatinib-in-a 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07591389/promoting-radon-testing-among-mothers-of-young-children 2026-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04789486/nano-smart-nanoparticles-with-mr-guided-sbrt-in-centrally-located-lung-tumors-and-pancre 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03735095/endobronchial-ultrasound-guided-interstitial-photodynamic-therapy-in-treating-patients-w 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06922591/study-to-evaluate-the-safety-tolerability-efficacy-of-tng462-in-combination-in-pdac-nscl 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06417814/a-study-to-investigate-the-efficacy-and-safety-of-dato-dxd-with-or-without-osimertinib-c 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01937039/johns-hopkins-breast-cancer-program-longitudinal-repository 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06946797/a-study-to-evaluate-two-dosing-regimens-of-subcutaneous-nivolumab-in-combination-with-in 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07216404/psilocybin-assisted-therapy-for-the-treatment-of-major-depressive-disorder-in-patients-w 2026-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05231278/confocal-laser-endomicroscopy-nodule-localization-by-robotic-bronchoscopy 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05353439/testing-of-tazemetostat-in-combination-with-topotecan-and-pembrolizumab-in-patients-with 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06145048/phase-2b-safety-and-efficacy-study-of-vgt-309-in-subjects-with-cancer-in-the-lung 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06673329/brodalumab-in-the-treatment-of-immune-related-adverse-events 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04314401/national-cancer-institute-cancer-moonshot-biobank 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05208944/thio-sequenced-with-cemiplimab-in-advanced-nsclc 2026-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07567352/a-study-to-learn-about-patients-with-non-small-cell-lung-cancer-nsclc-who-took-lorlatini 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01624220/a-prospective-study-using-implanted-fiducial-markers-to-assess-treatment-accuracy-and-es 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04010357/targeted-therapy-with-cdk4-6-inhibitors-in-chemo-refractory-rb-wild-type-extensive-sclc 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04746924/a-study-of-ociperlimab-with-tislelizumab-compared-to-pembrolizumab-in-participants-with 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03337698/a-study-of-multiple-immunotherapy-based-treatment-combinations-in-participants-with-meta 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07581379/advancing-precision-lung-cancer-surveillance-and-outcomes-in-diverse-populations 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07085091/a-first-in-human-study-of-alx2004-with-advanced-or-metastatic-selected-solid-tumors 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07485179/emulation-of-the-keynote-042-nct02220894-trial-using-specialty-oncology-electronic-healt 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03819465/a-study-of-novel-anti-cancer-agents-in-patients-with-previously-untreated-nsclc 2026-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07576595/multilevel-intervention-for-ldct-lung-cancer-screening-and-smoking-cessation-among-afric 2026-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04716946/treating-early-stage-non-small-cell-lung-cancer-with-durvalumab-and-radiation-therapy 2026-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04152499/phase-i-ii-fih-trop2-adc-advanced-unresectable-metastatic-solid-tumors-refractory-to-sta 2026-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06910956/deep-learning-using-chest-x-rays-to-identify-high-risk-patients-for-lung-cancer-screenin 2026-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04878952/testing-the-addition-of-activity-monitoring-with-a-wearable-electronic-device-to-improve 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03202940/a-phase-ib-ii-study-of-alectinib-combined-with-cobimetinib-in-advanced-alk-rearranged-al 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06870487/a-study-to-learn-about-the-study-medicine-called-pf-08046032-in-people-with-advanced-can 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05655494/a-multilevel-approach-to-connecting-underrepresented-populations-to-clinical-trials 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06351085/enhancing-lung-cancer-screening-through-human-centered-intervention 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06047301/pathways-a-hope-intervention-to-support-personal-goal-pursuit-mental-health-and-quality 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00301119/lung-cancer-biomarkers-and-screening 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02399371/pembrolizumab-in-treating-patients-with-malignant-mesothelioma 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07164404/nicotine-replacement-therapy-prescribing-and-lung-cancer-screening-in-hospitalized-patie 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07485166/emulation-of-the-checkmate-017-057-nct01642004-and-nct01673867-trials-using-specialty-on 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05363280/phase-2-study-for-the-patient-who-has-diagnosed-with-small-cell-lung-cancer-sclc-or-non 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06269133/evaluation-of-cemiplimab-in-combination-with-platinum-doublet-chemotherapy-in-first-line 2026-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04439266/testing-crizotinib-as-a-potential-targeted-treatment-in-cancers-with-alk-genetic-changes 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05089734/study-of-sacituzumab-govitecan-sg-versus-docetaxel-in-participants-with-advanced-or-meta 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07164313/a-study-of-zw251-in-participants-with-advanced-solid-tumors 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05599984/study-to-evaluate-adverse-events-change-in-disease-activity-and-how-abbv-706-moves-throu 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03552718/quilt-2-025-nant-neoepitope-yeast-vaccine-ye-neo-001-adjuvant-immunotherapy-using-a-pers 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04668833/ali-post-radiation-therapy-in-patients-with-lung-and-esophageal-canter 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05657873/a-study-of-targeted-radiation-therapy-in-people-with-non-small-cell-lung-cancer-nsclc 2026-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06800339/a-study-evaluating-neoadjuvant-chemoimmunotherapy-with-immunosensitizing-radiation-for-b 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04657042/4d-mri-for-precision-medicine 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04553133/pf-07104091-as-a-single-agent-and-in-combination-therapy 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03295279/wtc-chest-ct-imaging-archive 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02434809/respiratory-motion-corrected-cone-beam-ct-and-intratreatment-gating-based-on-electromagn 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04848961/a-study-to-develop-a-strategy-to-increase-lung-cancer-screening-in-women-who-may-be-at-r 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07555210/pilot-study-of-bone-mineral-density-changes-during-anti-pd-1-immunotherapy 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04734145/using-e-nose-technology-to-identify-early-lung-cancer 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06239194/dose-escalation-and-dose-expansion-study-of-mdx2001-in-patients-with-advanced-solid-tumo 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05354570/a-study-of-intensity-modulated-pleural-radiation-therapy-imprint-in-people-with-thymic-c 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06116682/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-has-increased-copies-of 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06311721/a-study-to-compare-abp-234-and-keytruda-pembrolizumab-in-participants-with-advanced-or-m 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05557591/a-trial-to-learn-how-the-cancer-vaccine-bnt116-in-combination-with-cemiplimab-works-and 2026-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05144529/a-randomized-pilot-study-of-evolocumab-plus-nivolumab-ipilimumab-in-treatment-nai-ve-pat 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07415005/lorlatinib-plus-local-consolidation-therapy-in-alk-positive-advanced-non-small-cell-lung 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07354919/axelopran-for-advanced-cancer-in-patients-receiving-opioids 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05812274/apricity-care-to-improve-ici-outcomes-of-ethnic-racial-minority-nsclc-patients 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06616584/adding-the-immunotherapy-drug-cemiplimab-to-usual-treatment-for-people-with-advanced-non 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06343402/open-label-study-of-bbo-8520-in-adult-subjects-with-krasg12c-non-small-cell-lung-cancer 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01851395/rapid-autopsy-and-procurement-of-cancer-tissue 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04786093/durvalumab-and-stereotactic-radiotherapy-for-advanced-nsclc 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05983133/a-study-of-pf-08046052-sgn-egfrd2-in-advanced-solid-tumors 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04317534/adjuvant-pembrolizumab-vs-observation-following-curative-resection-for-stage-i-non-small 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05138900/a-pilot-study-of-single-fraction-stereotactic-body-radiation-therapy-sbrt-in-central-non 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04430725/microwave-ablation-or-wedge-resection-for-the-treatment-of-lung-sarcoma-and-colorectal-l 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06031688/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-has-a-met-exon-14-skippi 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03181256/early-detection-of-lung-cancer 2026-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03563716/a-study-of-tiragolumab-in-combination-with-atezolizumab-in-chemotherapy-nai-ve-patients 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07287085/increasing-lung-cancer-screening-uptake-among-emergency-department-patients 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07563738/a-2-part-phase-1-2-open-label-trial-on-odm-212 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06192004/study-of-non-small-cell-lung-cancer-patients-in-the-us-receiving-standard-of-care-and-in 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04169542/impact-of-covid-19-pandemic-on-out-of-pocket-costs-lost-wages-and-unemployment-in-patien 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05456256/a-study-of-lp-300-with-carboplatin-and-pemetrexed-in-never-smokers-with-advanced-lung-ad 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05815160/debio-0123-in-combination-with-carboplatin-and-etoposide-in-adult-participants-with-smal 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05337735/a-phase-ii-clinical-trial-to-evaluate-safety-and-efficacy-of-xmab20717-in-advanced-rare 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04585490/personalized-escalation-of-consolidation-treatment-following-chemoradiotherapy-and-immun 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06934343/machine-learning-approaches-to-personalized-therapy-for-advanced-non-small-cell-lung-can 2026-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03775486/study-of-durvalumab-olaparib-or-durvalumab-after-treatment-with-durvalumab-and-chemother 2026-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02095808/metabolic-biomarkers-in-thoracic-cancers 2026-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02838836/tumor-cell-and-dna-detection-in-the-blood-urine-and-bone-marrow-of-patients-with-solid-c 2026-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06236516/one-fraction-simulation-free-treatment-with-ct-guided-stereotactic-adaptive-radiotherapy 2026-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05358548/atatch-alternating-treatment-plans-for-advanced-cancer 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05297734/comparative-effectiveness-trial-of-two-supportive-cancer-care-delivery-models-for-adults 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04902040/plinabulin-in-combination-with-radiation-immunotherapy-in-patients-with-select-advanced 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01625234/phase-1-2-study-of-x-396-an-oral-alk-inhibitor-in-patients-with-alk-positive-non-small-c 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04084067/indocyanine-green-icg-guided-tumor-resection 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05117242/safety-and-efficacy-study-of-gen1046-as-a-single-agent-or-in-combination-with-pembrolizu 2026-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03586453/osimertinib-in-egfr-mutant-lung-cancer 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05903092/monalizumab-in-combination-with-durvalumab-medi4736-for-trreatment-of-small-cell-lung-ca 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02495896/recombinant-ephb4-hsa-fusion-protein-with-standard-chemotherapy-regimens-in-treating-pat 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02589522/testing-the-safety-of-m6620-vx-970-when-given-with-standard-whole-brain-radiation-therap 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06743308/novel-input-screening-tool-to-improve-illness-understanding-in-patients-with-metastatic 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04439253/testing-crizotinib-as-a-potential-targeted-treatment-in-cancers-with-ros1-genetic-change 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06117774/study-evaluating-tarlatamab-after-chemoradiotherapy-in-limited-stage-small-cell-lung-can 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03122717/osimertinib-and-gefitinib-in-egfr-inhibitor-nai-ve-advanced-egfr-mutant-lung-cancer 2026-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07328490/bispecific-t-cell-engager-tarlatamab-and-trop2-targeted-antibody-drug-conjugate-sacituzu 2026-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05168566/study-to-evaluate-sutetinib-maleate-capsule-in-locally-advanced-or-metastatic-non-small 2026-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02839265/flt3-ligand-immunotherapy-and-stereotactic-radiotherapy-for-advanced-non-small-cell-lung 2026-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06124508/promoting-lung-cancer-screening-awareness-and-implementation-in-hispanics-latinx-head-an 2026-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00898313/molecular-predictors-of-cancer-in-patients-at-high-risk-of-lung-cancer 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04913285/a-study-to-evaluate-kin-2787-in-participants-with-braf-and-or-nras-mutation-positive-sol 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06513663/exercise-as-maintenance-therapy-in-advanced-lung-cancer 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07439094/a-first-in-human-study-of-ckd-703-in-advanced-solid-tumors-and-non-small-cell-lung-cance 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07551635/smarca4-2-inhibitor-for-pou2f3-positive-sclc 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04330521/impact-of-the-coronavirus-covid-19-on-patients-with-cancer 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04650178/well-being-in-cancer-patients-with-neuropathy-during-covid-19-who-participated-in-prior 2026-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02630615/circulating-tumor-cells-ctc-in-lung-cancer 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06084078/rural-illinois-lung-cancer-screening-initiative 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06004440/real-world-registry-for-use-of-the-ion-endoluminal-system 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06385925/a-study-of-tsn1611-treating-patients-with-advanced-solid-tumors-harboring-kras-g12d-muta 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06010329/a-study-to-evaluate-the-efficacy-and-safety-of-sutetinib-maleate-capsule-in-locally-adva 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06841055/safety-and-preliminary-efficacy-of-pumitamig-bnt327-an-investigational-therapy-for-patie 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06736418/study-of-225ac-abd147-to-establish-optimal-dose-in-patients-with-sclc-and-lcnec-of-the-l 2026-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02333604/cancer-experience-registry-cer-for-cancer-patients-and-caregivers 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06974734/a-clinical-trial-of-pf-08046037-alone-or-with-sasanlimab-in-patients-with-advanced-or-me 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04266730/trial-of-a-personalized-and-adaptive-neoantigen-dose-adjusted-vaccine-concurrently-with 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03737994/targeted-treatment-for-alk-positive-patients-who-have-previously-been-treated-for-non-sq 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05893888/a-study-evaluating-the-safety-and-efficacy-of-prv111-prv211-and-prv131-in-subjects-with 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03778229/osimertinib-plus-savolitinib-in-egfrm-met-nsclc-following-prior-osimertinib 2026-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03563976/multiparametric-image-analysis-and-correlation-with-outcomes-in-lung-cancer-screening-an 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05975073/a-phase-1-2-study-of-anvumetostat-in-combination-with-ide397-in-participants-with-advanc 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05415358/immune-signature-analysis-of-disease-progression-in-post-immunotherapy-lung-cancer-patie 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03625323/combination-study-with-soluble-lag-3-fusion-protein-eftilagimod-alpha-imp321-and-pembrol 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03481114/patient-reported-outcomes-following-chemoradiotherapy-for-locally-advanced-non-small-cel 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07020221/a-phase-1-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-solid-tumors 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04701307/niraparib-and-dostarlimab-for-the-treatment-of-small-cell-lung-cancer-and-other-high-gra 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05687266/phase-iii-open-label-first-line-study-of-dato-dxd-in-combination-with-durvalumab-and-car 2026-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02296125/azd9291-versus-gefitinib-or-erlotinib-in-patients-with-locally-advanced-or-metastatic-no 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06187103/evaluation-of-improved-onboard-patient-imaging 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07216209/the-impact-of-exercise-on-the-tumor-microenvironment-in-patients-with-lung-cancer 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06623656/preoperative-radioimmunotherapy-versus-chemoimmunotherapy-in-nsclc 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03710876/efficacy-safety-of-rad-ifn-administered-with-celecoxib-gemcitabine-in-patients-with-mali 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01590069/aerosolized-aldesleukin-in-treating-patients-with-lung-metastases 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02257619/study-of-itacitinib-in-combination-with-docetaxel-in-subjects-with-non-small-cell-lung-c 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01507428/positron-emission-tomography-and-computed-tomography-in-guiding-radiation-therapy-for-st 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03213678/samotolisib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-h 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03568019/pet-avidity-in-cachexia-inducing-lung-and-gastrointestinal-tumors 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06586957/a-study-with-nkt3964-for-adults-with-advanced-metastatic-solid-tumors 2026-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03655015/patient-derived-organoid-model-and-circulating-tumor-cells-for-treatment-response-of-lun 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05969860/at-home-cancer-directed-therapy-versus-in-clinic-for-the-treatment-of-patients-with-adva 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02298153/a-study-of-atezolizumab-in-combination-with-epacadostat-in-subjects-with-previously-trea 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01802632/azd9291-first-time-in-patients-ascending-dose-study 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07276789/efficacy-and-safety-of-a-single-dose-of-ls301-it-for-fluorescence-intraoperative-molecul 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07323641/telisotuzumab-vedotin-and-osimertinib-for-the-treatment-of-progressive-incurable-non-sma 2026-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06544655/a-study-of-bms-986484-alone-and-combination-therapy-in-participants-with-advanced-solid 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06449209/safety-preliminary-effectiveness-of-bnt327-an-investigational-therapy-for-patients-with 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03909334/study-of-osimertinib-with-and-without-ramucirumab-in-locally-advanced-or-metastatic-non 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02713269/thermal-ablation-and-spine-stereotactic-radiosurgery-in-treating-patients-with-spine-met 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171075/a-study-comparing-abelacimab-to-dalteparin-in-the-treatment-of-gastrointestinal-genitour 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06286592/lungevity-lung-cancer-stigma-community-based-participatory-research 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03881488/study-of-ctx-471-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-patients-post 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05633602/ramucirumab-plus-pembrolizumab-vs-usual-care-for-treatment-of-stage-iv-or-recurrent-non 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07535463/a-study-of-ivonescimab-chemotherapy-and-stereotactic-radiosurgery-for-people-with-non-sm 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06777316/a-study-of-an-fgfr2-3-inhibitor-cgt4859-in-patients-with-cholangiocarcinoma-and-other-ad 2026-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02468024/jolt-ca-sublobar-resection-sr-versus-stereotactic-ablative-radiotherapy-sabr-for-lung-ca 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04783168/walking-after-surgery-to-improve-recovery-and-outcomes-after-surgery-airtech-study 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04479306/osimertinib-in-combination-with-alisertib-or-sapanisertib-for-the-treatment-of-osimertin 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07220096/registry-trial-and-needs-assessment-of-patients-with-young-onset-lung-cancer-impact-of-a 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07229313/a-study-of-kivu-107-in-participants-with-locally-advanced-or-metastatic-solid-tumors 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04474301/well-being-and-health-related-quality-of-life-in-melanoma-patients-during-covid-19-pande 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04701476/tate-and-pembrolizumab-mk3475-in-mcrc-and-nsclc 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02816697/implementation-of-a-system-level-tobacco-treatment-intervention 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03634241/pembrolizumab-in-preventing-lung-cancer-in-patients-with-stage-i-ii-non-small-cell-lung 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04595422/educating-smokers-about-lung-cancer-screening-using-tobacco-quitlines 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03157128/a-study-of-selpercatinib-loxo-292-in-participants-with-advanced-solid-tumors-ret-fusion 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07223424/patient-preference-for-subcutaneous-vs-intravenous-immune-therapy 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04606446/study-of-pf-07248144-in-advanced-or-metastatic-solid-tumors 2026-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06688422/incentive-spirometry-to-improve-outcomes-in-lung-cancer-patients-undergoing-concurrent-c 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02596490/couple-based-meditation-for-metastatic-lung-cancer-patients-and-their-partners 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03059940/smoking-cessation-intervention-during-low-dose-ct-ldct-screening-for-lung-cancer 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01630733/a-multinational-randomized-open-label-study-of-custirsen-in-patients-with-advanced-or-me 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05635708/a-study-of-tislelizumab-in-combination-with-investigational-agents-in-participants-with 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06886516/apixaban-in-thrombocytopenia 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07288034/immunotherapy-biomarkers-to-predict-first-line-pd-l-1-based-immunotherapy-response-and-s 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05397093/itil-306-in-advanced-solid-tumors 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05704634/a-phase-ib-study-to-evaluate-the-safety-and-preliminary-efficacy-of-il6-receptor-antibod 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03637816/anamorelin-hydrochloride-in-reducing-anorexia-in-patients-with-advanced-non-small-cell-l 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03731585/online-psychosocial-intervention-in-improving-social-well-being-and-support-in-women-wit 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03948100/dyadic-yoga-intervention-in-improving-physical-performance-and-quality-of-life-in-patien 2026-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280189/study-of-outcomes-of-radiofrequency-ablation-of-lung-tumors 2026-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07073898/ug3-pilot-clinical-trial 2026-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03213665/tazemetostat-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03102229/real-time-activity-monitoring-to-prevent-admissions-during-radiotherapy 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05595460/study-of-ryz101-in-combination-with-soc-in-subjects-with-sstr-es-sclc 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05215769/a-video-intervention-to-improve-patient-understanding-of-tumor-genomic-testing-in-patien 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06660407/grid-radiation-therapy-for-the-treatment-of-stage-iv-non-small-cell-lung-cancer 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06865339/thoracic-radiotherapy-and-inhibition-of-pd-1-and-lag-3-for-locally-advanced-non-small-ce 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05461430/mass-response-of-tumor-cells-as-a-biomarker-for-rapid-therapy-guidance-traverartgx 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06362369/a-study-of-oral-7hp349-alintegimod-in-combination-with-ipilimumab-followed-by-nivolumab 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06342284/patient-generated-health-data-collection-during-chemoradiotherapy-for-lung-cancer 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03115398/a-simple-walking-program-to-enhance-concurrent-chemoradiotherapy-delivery 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02259218/metabolomic-and-epigenetic-profiling-of-bodyfluids-from-lung-and-brain-cancer-receiving 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06816121/identification-and-validation-of-blood-based-biomarkers-for-early-detection-of-asymptoma 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05106374/risk-of-chemotherapy-toxicity-in-older-patients-with-blood-cancer-or-non-small-cell-lung 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02649569/continuous-activity-monitoring-during-fractionated-radiotherapy-in-patients-with-head-an 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06191939/adapting-and-testing-a-novel-self-compassion-intervention-to-reduce-lung-cancer-stigma 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07104630/pulmonary-rehabilitation-in-advanced-lung-cancer-survivors 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04686305/phase-ib-study-of-the-safety-of-t-dxd-and-immunotherapy-agents-with-and-without-chemothe 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05553834/pcsk9-inhibitor-and-pd-1-inhibitor-in-patients-with-metastatic-refractory-to-prior-anti 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03965689/testing-the-combination-of-mln4924-pevonedistat-carboplatin-and-paclitaxel-in-patients-w 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06810544/safety-and-tolerability-of-tng456-alone-and-in-combination-with-abemaciclib-in-patients 2026-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03523702/the-selective-personalized-radio-immunotherapy-for-locally-advanced-nsclc-trial 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03236935/phase-ib-of-l-nmma-and-pembrolizumab 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05952778/reminder-messages-for-lung-cancer-screening 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06130254/phase-ib-trial-of-the-kras-g12c-inhibitor-adagrasib-mrtx849-in-combination-with-the-parp 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06159790/a-study-to-compare-efficacy-safety-and-immunogenicity-of-gme751-and-eu-authorized-keytru 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04794699/study-of-ide397-in-participants-with-solid-tumors-harboring-mtap-deletion 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06810375/erector-spinae-versus-intercostal-nerve-blocks-with-liposomal-bupivacaine-for-analgesia 2026-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05077709/io102-io103-in-combination-with-pembrolizumab-as-first-line-treatment-for-patients-with 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06248606/adagrasib-srs-for-patients-with-metastatic-kras-g12c-mutated-nsclc-with-untreated-brain 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06973161/esperanza-external-control-arm-study-for-t-dxd-for-patients-with-her2-ihc3-solid-tumors 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04919382/temozolomide-and-atezolizumab-for-subsequent-line-for-the-treatment-of-metastatic-or-rec 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05281237/avecure-flexible-microwave-ablation-probe-for-lung-nodules 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04892017/study-of-inlexisertib-dcc-3116-in-participants-with-ras-mapk-pathway-mutant-solid-tumors 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04081779/survivorship-care-plans-and-telehealth-education-for-the-improvement-of-access-to-cancer 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06099782/a-study-of-participant-reported-preference-for-subcutaneous-pembrolizumab-coformulated-w 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06816979/lumbar-punctures-for-the-detection-of-ctdna-in-the-cerebrospinal-fluid-of-patients-with 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05987644/delayed-or-upfront-brain-radiotherapy-in-treatment-nai-ve-lung-cancer-patients-with-asym 2026-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06080061/personalized-accelerated-chemoradiation-pacer-for-lung-cancer 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07443020/fast-tils-to-treat-metastatic-pleural-effusions-from-epithelial-or-mesothelial-primary-t 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03937154/study-of-romiplostim-for-chemotherapy-induced-thrombocytopenia-in-adult-subjects-with-no 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06079970/confocal-laser-endomicroscopy-verification 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07424547/phase-i-study-of-sys6043-in-patients-with-advanced-metastatic-solid-tumors 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06444815/a-study-of-vet3-tgi-in-patients-with-solid-tumors 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00579514/germline-alterations-of-tumor-susceptibility-genes-in-new-york-cancer-patients 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07216105/ft836-with-or-without-chemotherapy-and-or-monoclonal-antibodies-in-participants-with-adv 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05183932/surgery-versus-stereotactic-body-radiation-therapy-for-stage-i-non-small-cell-lung-cance 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04560972/lb-100-carboplatin-etoposide-and-atezolizumab-for-the-treatment-of-untreated-extensive-s 2026-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03158129/nivolumab-with-or-without-ipilimumab-or-chemotherapy-in-treating-patients-with-previousl 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05362318/project-heals-helping-and-empowering-patients-for-living-a-life-smoke-free 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07458425/the-sentinl-1-study-evaluating-patient-reported-outcomes-of-ai-inferred-lung-cancer-risk 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05785741/a-study-of-db-1310-in-advanced-metastatic-solid-tumors 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02087423/a-global-study-to-assess-the-effects-of-medi4736-durvalumab-in-patients-with-locally-adv 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03916627/neoadjuvant-cemiplimab-for-the-treatment-of-resectable-nsclc-hcc-and-hnscc-in-adult-pati 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03410043/osimertinib-surgery-and-radiation-therapy-in-treating-patients-with-stage-iiib-or-iv-non 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06495125/defactinib-avutometinib-and-nivolumab-for-the-treatment-of-anti-pd1-refractory-lkb1-muta 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05703269/comparing-single-vs-multiple-dose-radiation-for-cancer-patients-with-brain-metastasis-an 2026-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03526250/palbociclib-in-treating-patients-with-relapsed-or-refractory-rb-positive-advanced-solid 2026-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03678883/9-ing-41-in-patients-with-advanced-cancers 2026-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04931823/dose-escalation-and-dose-expansion-study-of-cpo-100-in-patients-with-advanced-solid-tumo 2026-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04256421/a-study-of-atezolizumab-plus-carboplatin-and-etoposide-with-or-without-tiragolumab-in-pa 2026-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06249282/carfilzomib-in-combination-with-sotorasib-for-the-treatment-of-patients-with-kras-g12c-m 2026-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05746325/tumor-treating-fields-for-the-treatment-of-leptomeningeal-metastases-of-the-spine-in-pat 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06451497/this-is-a-phase-1-trial-of-zm008-an-anti-llt1-antibody-used-as-single-agent-followed-by 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05765734/a-study-of-tas3351-in-nsclc-patients-with-egfrmt 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03348748/stereotactic-body-radiation-therapy-followed-by-surgery-in-treating-patients-with-stage 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03589547/durvalumab-and-consolidation-sbrt-following-chemoradiation-for-locally-advanced-stage-ii 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03377023/phase-i-ii-study-of-nivolumab-and-ipilimumab-combined-with-nintedanib-in-non-small-cell 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07186699/qualitative-study-on-detection-tx-of-nsclc-in-pts-w-a-history-of-alcohol-or-sud 2026-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02504697/decamp-2-screening-of-patients-with-early-stage-lung-cancer-or-at-high-risk-for-developi 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05873439/genomically-guided-radiation-dose-personalization-in-locally-advanced-nsclc 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07505797/atusa-ultrasound-diagnostic-imaging-for-breast-lesions-evaluation-audible 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165564/decamp-1-plus-prediction-of-lung-cancer-using-noninvasive-biomarkers 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04948060/tribally-engaged-approaches-to-lung-screening-teals 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03923270/radiotherapy-and-durvalumab-durvalumab-combo-tremelimumab-olaparid-for-small-cell-lung-c 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05318027/chatbot-and-activity-monitoring-in-patients-undergoing-chemoradiotherapy 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03126630/pembrolizumab-with-or-without-anetumab-ravtansine-in-treating-patients-with-mesothelin-p 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05665504/using-biomarkers-for-diagnosis-risk-stratification-of-post-treatment-recurrence-and-long 2026-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04607954/durvalumab-and-lurbinectedin-for-the-treatment-of-relapsed-or-refractory-small-cell-lung 2026-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04762199/mrx-2843-and-osimertinib-for-the-treatment-of-advanced-egfr-mutant-non-small-cell-lung-c 2026-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05681780/clinical-trial-of-cd40l-augmented-til-for-patients-with-egfr-alk-ros1-or-her2-driven-nsc 2026-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06769126/using-biomarker-tests-to-select-and-test-new-personalized-treatments-for-extensive-stage 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03860272/fc-engineered-anti-ctla-4-monoclonal-antibody-in-advanced-cancer 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02511106/azd9291-versus-placebo-in-patients-with-stage-ib-iiia-non-small-cell-lung-carcinoma-foll 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06424067/phase-2-study-of-fingolimod-in-lung-cancers 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05087251/the-transitions-project-efficacy-trial 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03433469/osimertinib-in-treating-participants-with-stage-i-iiia-egfr-mutant-non-small-cell-lung-c 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06225414/empowering-hispanic-patients-lung-cancer-screening-uptake-empower-latinx 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04881916/immune-and-genomic-markers-in-alk-nsclc 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04129502/tak-788-as-first-line-treatment-versus-platinum-based-chemotherapy-for-non-small-cell-lu 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05837767/a-study-of-radiation-therapy-to-treat-solid-tumor-cancer-that-has-spread-to-soft-tissue 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05254184/kras-targeted-vaccine-with-chemoimmunotherapy-nivolumab-and-ipilimumab-for-patients-with 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05578326/study-of-trilaciclib-and-lurbinectidin 2026-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07189871/177lu-betabart-in-patients-with-relapsed-refractory-locally-advanced-inoperable-or-metas 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06538038/prospective-non-interventional-study-comparing-osimertinib-chemotherapy-for-egfr-mutated 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06338592/the-mylunghealth-study-protocol-engaging-patients-to-enable-interoperable-lung-cancer-de 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07113691/iadademstat-sbrt-with-atezo-in-es-sclc 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03678350/light-dosimetry-for-photodynamic-therapy-with-porfimer-sodium-in-treating-participants-w 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04234113/study-of-nanrilkefusp-alfa-alone-and-with-pembrolizumab-in-adult-patients-with-advanced 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05142033/avera-cancer-sequencing-and-analytics-protocol-asap 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06638398/biomarker-platform-virtual-nodule-clinic-for-the-management-of-indeterminate-pulmonary-n 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04450043/the-transitions-project-supporting-adults-during-the-shift-from-cancer-treatment-to-surv 2026-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07322367/a-mobile-patient-health-technology-intervention-for-improving-lung-cancer-screening-rate 2026-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06858813/a-study-to-assess-adverse-events-and-change-in-disease-activity-of-intravenously-iv-infu 2026-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04432207/a-study-of-imu-201-pd1-vaxx-a-b-cell-immunotherapy-in-adults-with-non-small-cell-lung-ca 2026-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07482475/university-of-michigan-copd-identification-through-lung-cancer-screening-cohort-study-ma 2026-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06582771/a-study-of-sotorasib-in-people-with-non-small-cell-lung-cancer 2026-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06628167/community-support-program-for-lung-cancer-screening-volume-ii 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04484142/study-of-ds-1062a-in-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable-g 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03915951/an-open-label-study-of-encorafenib-binimetinib-in-patients-with-brafv600-mutant-non-smal 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04911166/phase-i-trial-of-atezolizumab-and-interleukin-12-gene-therapy-in-metastatic-non-small-ce 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05362344/colorectal-cancer-screening-in-cystic-fibrosis 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05680922/dll3-directed-chimeric-antigen-receptor-t-cells-in-subjects-with-extensive-stage-small-c 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04905082/hope-genomics-intervention-for-the-improvement-of-cancer-patient-knowledge-of-genomics 2026-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06432972/accelerated-pulmonary-rehabilitation-in-the-preoperative-period 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06580938/a-study-to-learn-about-pf-07921585-alone-or-with-other-anti-cancer-medicines-in-people-w 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03391869/nivolumab-and-ipilimumab-with-or-without-local-consolidation-therapy-in-treating-patient 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07218601/using-e-nose-technology-to-track-treatment-response-in-people-with-non-small-cell-lung-c 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05669846/study-of-healthy-donor-fmt-hdfmt-and-pembrolizumab-in-relapsed-refractory-r-r-pd-l1-posi 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04268550/targeted-treatment-for-ret-fusion-positive-advanced-non-small-cell-lung-cancer-a-lung-ma 2026-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05948865/a-phase-1-study-of-cpo301-in-adult-patients-with-advanced-or-metastatic-solid-tumors 2026-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03420963/donor-natural-killer-cells-cyclophosphamide-and-etoposide-in-treating-children-and-young 2026-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07130786/prophylactic-anti-seizure-medication-vs-no-anti-seizure-medication-for-patients-with-pri 2026-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07132190/stereotactic-radiation-for-growing-changing-brain-metastases-with-same-day-radiation-pla 2026-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05306288/cascade-lung-cancer-screening-assay-using-delfi-a-clinical-validation-study-in-lung 2026-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227623/a-digital-health-intervention-to-improve-physical-function-and-wellness-of-lung-cancer-s 2026-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04789668/bintrafusp-alfa-and-pimasertib-for-the-treatment-of-patients-with-brain-metastases 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04007744/sonidegib-and-pembrolizumab-in-treating-patients-with-advanced-solid-tumors 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06108479/study-of-df6215-in-patients-with-advanced-solid-tumors 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06328621/lung-cancer-risk-assessment-and-etiology 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06244771/a-study-evaluating-fmc-376-in-participants-with-kras-g12c-mutated-solid-tumors 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04699188/study-of-jdq443-in-patients-with-advanced-solid-tumors-harboring-the-kras-g12c-mutation 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04423029/a-study-of-df6002-alone-and-in-combination-with-nivolumab 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04143711/study-of-df1001-in-patients-with-advanced-solid-tumors 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06726265/study-of-eftilagimod-alfa-efti-in-combination-with-pembrolizumab-and-chemotherapy-versus 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06599502/a-phase-i-iia-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-efficacy 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05962606/safety-and-efficacy-of-aon-d21-in-severe-community-acquired-pneumonia 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02973789/effect-of-tumor-treating-fields-ttfields-150-khz-concurrent-with-standard-of-care-therap 2026-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04802174/lurbinectedin-with-berzosertib-an-atr-kinase-inhibitor-in-small-cell-cancers-and-high-gr 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04119024/gene-modified-immune-cells-after-conditioning-regimen-for-the-treatment-of-stage-iiic-or 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04298606/a-vaccine-cimavax-egf-for-the-prevention-of-lung-cancer-development-or-recurrence 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06654050/alrizomadlin-apg-115-in-subjects-with-bap1-cancer-syndrome-and-early-stage-mesothelioma 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02818920/neoadjuvant-pembrolizumab 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06418204/assessing-benefits-and-harms-of-cannabis-cannabinoid-use-among-cancer-patients-treated-i 2026-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07339254/experiences-w-attitudes-towards-immune-chckpt-inhibitors-in-nsclc-patients-single-center 2026-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06894771/a-study-of-mk-4700-alone-or-with-pembrolizumab-in-participants-with-advanced-or-metastat 2026-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06555588/engage-psychosocial-intervention-for-cancer-symptoms 2026-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04499053/durvalumab-and-tremelimumab-in-combination-with-chemotherapy-in-hiv-infected-patients-wi 2026-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06083454/ascorbate-with-durvalumab-in-non-small-cell-lung-cancer-nsclc 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05209880/advance-care-planning-in-the-emergency-department 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05364073/study-of-furmonertinib-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cance 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07225452/an-exosomal-mirna-based-liquid-biopsy-for-icc-detection 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06173505/study-of-vudalimab-or-pembrolizumab-in-combination-with-chemotherapy-as-first-line-treat 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07224737/liquid-biopsy-using-exosomal-mirna-enables-risk-stratification-of-potential-metastasis-i 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06945120/act-lung-health-intervention-phase-two 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03164616/study-of-durvalumab-tremelimumab-with-chemotherapy-or-durvalumab-with-chemotherapy-or-ch 2026-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06349642/immune-checkpoint-inhibitor-response-in-solid-tumors-using-a-live-tumor-diagnostic-platf 2026-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04897022/a-study-of-pembrolizumab-and-radiation-therapy-in-people-with-mesothelioma 2026-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06439914/first-in-human-study-of-interferon-y-pet-imaging-to-assess-response-to-immunotherapy 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05010109/cardiovascular-injury-and-cardiac-fitness-in-locally-advanced-non-small-cell-lung-cancer 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06052449/assessing-social-determinants-of-health-to-increase-cancer-screening 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06681220/biomarker-directed-trial-of-temozolomide-and-stenoparib-in-relapsed-sclc 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03074513/atezolizumab-and-bevacizumab-in-treating-patients-with-rare-solid-tumors 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05853887/liquid-biopsy-based-ngs-in-newly-diagnosed-nsclc 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07132918/hearts-trial-for-thoracic-cancers 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03313804/priming-immunotherapy-in-advanced-disease-with-radiation 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04832854/a-study-evaluating-the-safety-and-efficacy-of-neoadjuvant-and-adjuvant-tiragolumab-plus 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05607108/a-study-of-zen003694-in-people-with-squamous-cell-lung-cancer 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06083857/phi-ii-study-of-amivantamab-and-tepotinib-combo-in-met-altered-non-small-cell-lung-cance 2026-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05807048/daratumumab-in-stk11-mutated-nsclc 2026-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07461662/evaluation-of-endobronchial-ultrasound-needle-cleaning-techniques-and-their-impact-on-sp 2026-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02402920/pembrolizumab-and-concurrent-chemoradiotherapy-or-radiation-therapy-in-treating-patients 2026-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04332653/nt-i7-efineptakin-alfa-in-combination-with-pembrolizumab-in-participants-with-advanced-s 2026-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02858869/pembrolizumab-and-stereotactic-radiosurgery-for-melanoma-or-non-small-cell-lung-cancer-b 2026-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01629498/image-guided-intensity-modulated-photon-or-proton-beam-radiation-therapy-in-treating-pat 2026-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05660408/rna-lipid-particles-targeting-pediatric-recurrent-intracranial-malignancies-and-other-sy 2026-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06219174/targeting-odc-as-an-immunotherapeutic-target-in-stk11-lkb1-pathway-deficient-nsclc-dfmo 2026-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06171750/phase-i-study-of-tolododekin-alfa-ank-101-in-advanced-solid-tumors 2026-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05254795/precision-medicine-randomized-clinical-trial-comparing-molecular-tumor-board-assisted-ca 2026-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06693336/an-adjuvant-study-to-evaluate-sms001-paclitaxel-in-non-small-cell-lung-cancer 2026-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04940299/tocilizumab-ipilimumab-and-nivolumab-for-the-treatment-of-advanced-melanoma-non-small-ce 2026-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06196008/telephone-based-physical-activity-coaching-or-self-monitored-physical-activity-to-improv 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05166616/minnelide-and-osimertinib-for-the-treatment-of-advanced-egfr-mutated-non-small-cell-lung 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04013542/ipilimumab-and-nivolumab-in-combination-with-radiation-therapy-in-treating-patients-with 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05672108/phase-ii-trial-of-lung-chemoemobolization 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06287463/study-of-dcc-3084-in-participants-with-advanced-malignancies-driven-by-the-mitogen-activ 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05199584/a-study-evaluating-the-safety-and-efficacy-of-env-101-taladegib-in-patients-with-advance 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04075305/the-momentum-study-the-multiple-outcome-evaluation-of-radiation-therapy-using-the-mr-lin 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03260491/u3-1402-in-metastatic-or-unresectable-non-small-cell-lung-cancer 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06252129/maximizing-lymph-node-dissection-on-fresh-and-fixed-lung-cancer-resection-specimens 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04516070/stereotactic-radiosurgery-for-the-treatment-of-patients-with-small-cell-lung-cancer-brai 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04644952/the-rise-in-robotic-atypical-segmentectomies 2026-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06955468/evaluating-a-bidirectional-priming-intervention-for-goals-of-care-communication-in-oncol 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03223155/concurrent-or-sequential-immunotherapy-and-radiation-therapy-in-patients-with-metastatic 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05068232/durvalumab-and-ablative-radiation-in-small-cell-lung-cancer-dares 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04091295/blessed-expanded-access-for-dng64-car-v-for-advanced-pancreatic-cancer-sarcoma-and-carci 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03992183/utility-of-caml-as-diagnostic-for-early-stage-lung-cancer 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04819100/a-study-of-selpercatinib-after-surgery-or-radiation-in-participants-with-non-small-cell 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02675829/trial-of-ado-trastuzumab-emtansine-for-patients-with-her2-amplified-or-mutant-cancers 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04347161/implementation-strategies-for-monitoring-adherence-in-real-time 2026-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04785287/anti-ctla4-nf-mab-bms986218-nivolumab-and-stereotactic-body-radiation-therapy-for-the-tr 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05361395/first-line-tarlatamab-in-combination-with-carboplatin-etoposide-and-pd-l1-inhibitor-in-s 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06315296/an-interactive-time-restricted-diet-intervention-txt4fasting-for-reducing-neurocognitive 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07219251/engagement-of-veterans-with-lung-cancer 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06974981/leveraging-lung-cancer-screening-to-optimize-screening-outcomes-and-copd-management-copd 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07323732/a-study-of-bio-300-and-thoracic-radiation-therapy-in-people-with-non-small-cell-lung-can 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05546268/study-of-oral-mrt-2359-in-selected-cancer-patients 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07447050/riluzole-for-preventing-cognitive-dysfunction-in-ca-pts-receiving-chemo-refocus-pilot-tr 2026-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02574728/sirolimus-in-combination-with-metronomic-chemotherapy-in-children-with-recurrent-and-or 2026-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06275360/repositioning-immunotherapy-in-vetarans-with-lung-cancer 2026-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06956690/a-phase-1-2-clinical-trial-to-assess-the-safety-tolerability-pharmacokinetics-and-prelim 2026-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03535545/preliminary-evaluation-of-68ga-cbp8-in-healthy-individuals-lung-cancer-and-idiopathic-pu 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03164486/first-in-human-positron-emission-tomography-study-using-the-18f-v-6-binding-peptide 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03598309/phase-ii-trial-to-modulate-intermediate-endpoint-biomarkers-in-former-and-current-smoker 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03808337/investigating-the-effectiveness-of-stereotactic-body-radiotherapy-sbrt-in-addition-to-st 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04485286/evaluation-of-pet-probe-68ga-cbp8-in-the-detection-of-radiation-induced-tissue-injury 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06228482/molecularly-targeted-radionuclide-therapy-via-the-integrin-alphavbeta6 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05452005/fluorine-18-alphavbeta6-binding-peptide-positron-emission-tomography-in-metastatic-non-s 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07225036/promoting-immunotherapy-efficacy-with-low-dose-liver-rt 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02738398/fdg-pet-ct-in-lung-cancer-staging 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04894591/to-assess-the-effectiveness-and-safety-of-zepzelca-in-adult-patients-with-extensive-stag 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06616623/vismodegib-and-atezolizumab-for-the-treatment-of-recurrent-or-metastatic-non-small-cell 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05907304/a-study-to-assess-naporafenib-eras-254-administered-with-trametinib-in-patients-with-ras 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06905197/a-multinational-study-assessing-an-oral-egfr-inhibitor-dzd6008-in-patients-who-have-adva 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07361562/a-study-of-a-selective-erbb2-inhibitor-cgt4255-in-patients-with-advanced-solid-tumors 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03830320/positron-emission-tomography-pet-imaging-of-thrombosis 2026-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04798664/comparing-smoking-cessation-interventions-among-underserved-patients-referred-for-lung-c 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02716116/a-study-of-tak-788-in-adults-with-non-small-cell-lung-cancer 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03976362/a-study-of-pembrolizumab-mk-3475-with-or-without-maintenance-olaparib-in-first-line-meta 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05280470/ifinatamab-deruxtecan-i-dxd-in-subjects-with-pretreated-extensive-stage-small-cell-lung 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05521789/erector-spinae-block-for-thoracic-surgery 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01345851/image-guided-hypofractionated-radiation-therapy-with-stereotactic-body-radiation-therapy 2026-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05081609/a-study-to-investigate-safety-and-tolerability-of-transcon-il-2-alone-or-in-combination 2026-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06918132/cemiplimab-and-fianlimab-before-surgery-for-the-treatment-of-stage-ib-iiib-non-small-cel 2026-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03724331/understanding-the-post-surgical-non-small-cell-lung-cancer-patient-s-symptom-experience 2026-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04471727/a-study-in-participants-with-advanced-cancers-associated-with-expression-of-dll3-mk-6070 2026-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04428905/self-management-survivorship-care-in-stage-i-iii-non-small-cell-lung-cancer-or-colorecta 2026-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06546553/a-study-to-learn-about-how-different-amounts-of-the-study-medicine-pf-07826390-act-in-th 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05753722/a-first-in-human-study-of-prth-101-monotherapy-pembrolizumab-in-subjects-with-advanced-m 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05974150/real-world-treatment-experience-of-patients-with-breast-lung-ovarian-multiple-myeloma-or 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05587972/real-world-treatment-experience-of-patients-with-breast-lung-or-gi-cancer-or-multiple-my 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06552000/pre-operative-tumor-treating-fields-in-patients-with-resectable-lung-cancer 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05566223/cish-inactivated-tils-in-the-treatment-of-nsclc 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171049/a-study-comparing-abelacimab-to-apixaban-in-the-treatment-of-cancer-associated-vte 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05898594/lung-cancer-screening-in-high-risk-black-individuals 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07428044/a-study-of-trastuzumab-deruxtecan-in-people-with-non-small-cell-lung-cancer 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05857995/precision-lung-cancer-survivorship-care-intervention 2026-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03066206/poziotinib-in-egfr-exon-20-mutant-advanced-nsclc 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03523546/oncology-episode-payment-model-in-hawaii 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04258813/onco-primary-care-networking-to-support-team-based-care 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03042221/early-rebiopsy-to-identify-biomarkers-of-tumor-cell-survival-following-egfr-alk-ros1-or 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06000683/empowering-patients-lung-cancer-screening-uptake 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03366766/nivolumab-plus-cisplatin-pemetrexed-or-cisplatin-gemcitabine-as-induction-in-resectable 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04354064/circulating-tumor-dna-ctdna-for-early-treatment-response-assessment-of-solid-tumors 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03686007/multimedia-self-management-intervention-for-lung-cancer-surgery-family-caregivers-and-pa 2026-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05403723/adaptive-sbrt-plus-chemoimmunotherapy-for-es-sclc 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03829332/efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e7 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02513563/azd1775-plus-carboplatin-paclitaxel-in-squamous-cell-lung-cancer 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07235280/testing-the-safety-of-dapagliflozin-prior-to-surgery-for-the-treatment-of-patients-with 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07227480/advancing-lung-cancer-screening-one-text-at-a-time 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04868877/phase-1-2-study-evaluating-mcla-129-a-human-anti-egfr-anti-c-met-bispecific-antibody-in 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05233436/pf-07265028-as-single-agent-and-in-combination-with-sasanlimab-in-advanced-or-metastatic 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05578092/a-phase-1-study-of-mrtx0902-in-solid-tumors-with-mutations-in-the-kras-mapk-pathway 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02984761/veterans-affairs-lung-cancer-surgery-or-stereotactic-radiotherapy 2026-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02422381/mk-3475-and-gemcitabine-in-non-small-cell-lung-cancer-nsclc 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01580982/molecular-analysis-of-oncogenes-and-resistance-mechanisms-in-lung-cancer 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05081882/reducing-tobacco-associated-lung-cancer-risk-a-randomized-clinical-trial-of-ab-free-kava 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07030257/study-of-cp-383-in-patients-with-advanced-or-metastatic-solid-tumors 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03621813/exercise-rehabilitation-in-veteran-cancer-survivors 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05715229/immune-profile-selection-by-fraction-of-ctdna-in-patients-with-advanced-nsclc-treated-wi 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04485013/ttx-080-hla-g-antagonist-in-subjects-with-advanced-cancers 2026-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02523469/alt-803-plus-nivolumab-in-patients-with-pretreated-advanced-or-metastatic-non-small-cell 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06566079/study-of-ism6331-in-participants-with-advanced-metastatic-malignant-mesothelioma-or-othe 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06290869/tobacco-education-and-lung-health-study-teal 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07126509/partial-pleurectomy-surgery-for-unresectable-pleural-mesothelioma 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06010355/culturally-tailored-educational-video-to-promote-lung-cancer-screening-in-vulnerable-com 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02738606/liver-surgery-and-chemotherapy-in-treating-patients-with-colorectal-cancer-with-liver-me 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05462873/a-study-to-investigate-the-safety-and-tolerability-of-intravenous-qeq278-in-patients-wit 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04515004/leucoselect-phytosome-for-neoadjuvant-treatment-of-early-stage-lung-cancer 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07145255/phase-1-2-dose-finding-safety-and-pk-study-in-advanced-refractory-solid-tumors 2026-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02226276/copper-cu-64-dota-trastuzumab-pet-in-predicting-response-to-treatment-with-ado-trastuzum 2026-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03065062/study-of-the-cdk4-6-inhibitor-palbociclib-pd-0332991-in-combination-with-the-pi3k-mtor-i 2026-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06445192/evaluating-the-impact-of-a-virtually-supervised-exercise-intervention-and-group-counseli 2026-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03767348/study-of-rp1-monotherapy-and-rp1-in-combination-with-nivolumab-ignyte 2026-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06778863/a-study-of-clsp-1025-in-adult-patients-with-solid-tumors-that-harbor-the-p53-r175h-mutat 2026-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05493566/low-dose-interleukin-2-and-pembrolizumab-for-the-treatment-of-stage-iv-non-small-cell-lu 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06464562/livewell-adapted-dbt-skills-training-for-metastatic-lung-cancer 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03170206/study-of-palbociclib-in-combination-with-binimetinib-for-patients-with-advanced-kras-mut 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03559049/rucaparib-and-pembrolizumab-for-maintenance-therapy-in-stage-iv-non-squamous-non-small-c 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06731270/diclofenac-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-on-s 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03830918/niraparib-temozolomide-and-atezolizumab-in-treating-patients-with-advanced-solid-tumors 2026-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06575933/a-study-of-calderasib-mk-1084-with-midazolam-and-digoxin-in-healthy-participants-mk-1084 2026-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05186974/study-of-sacituzumab-govitecan-combinations-in-first-line-treatment-of-participants-with 2026-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04977024/sars-cov-2-vaccine-geo-cm04s1-versus-mrna-sars-cov-2-vaccine-in-patients-with-blood-canc 2026-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05863052/analyzing-clinical-outcomes-and-genomic-data-of-american-indian-patient-population 2026-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03582124/panitumumab-irdye800-in-detecting-cancer-in-participants-with-lung-cancer-during-surgery 2026-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06605534/leveraging-the-emergency-department-lead-study 2026-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07401797/specimens-for-lung-cancer-panel-design 2026-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05775939/pet-ct-imaging-to-evaluate-cardiac-radiation-damage-in-patients-with-lung-or-esophageal 2026-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06332131/effects-of-immune-checkpoint-inhibitors-on-coronary-microvasculature 2026-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05551117/a-study-of-vobramitamab-duocarmazine-in-participants-with-metastatic-castration-resistan 2026-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04384146/radiation-therapy-to-relieve-symptoms-in-patients-with-advanced-non-small-cell-lung-canc 2026-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02917993/an-open-label-phase-1-2-study-of-itacitinib-in-combination-with-osimertinib-in-subjects 2026-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05239143/p-muc1c-allo1-allogeneic-car-t-cells-in-the-treatment-of-subjects-with-advanced-or-metas 2026-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03879694/survivin-long-peptide-vaccine-in-treating-patients-with-metastatic-neuroendocrine-tumors 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02152631/a-study-of-abemaciclib-ly2835219-in-participants-with-previously-treated-kras-mutated-lu 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03740256/binary-oncolytic-adenovirus-in-combination-with-her2-specific-autologous-car-vst-advance 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06362252/a-study-of-i-dxd-in-combination-with-atezolizumab-with-or-without-carboplatin-as-first-l 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04809103/intratumoral-cisplatin-for-resectable-nsclc 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04357574/assessing-the-system-for-high-intensity-evaluation-during-radiotherapy-during-changes-in 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05443971/durvalumab-and-grid-therapy-for-non-small-cell-lung-cancer-in-progression-during-or-afte 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05234307/pbf-1129-and-nivolumab-for-the-treatment-of-recurrent-or-metastatic-non-small-cell-lung 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07391956/tier-palliative-care-for-patients-with-advanced-heart-failure-or-cancer 2026-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05226598/study-of-pembrolizumab-vibostolimab-coformulation-mk-7684a-in-combination-with-chemother 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05488626/daily-adaptive-radiation-therapy-an-individualized-approach-for-stage-iii-lung-cancer 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06939036/study-of-225ac-ss0110-in-subjects-with-es-sclc-or-mcc-santana-225 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03829319/safety-and-efficacy-study-of-pemetrexed-platinum-chemotherapy-pembrolizumab-mk-3475-with 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04916990/improving-care-for-rural-patients-with-solid-tumors 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02732834/clinician-patient-communication-in-lung-cancer-care 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06221800/assess-diversity-of-gut-microbiome-in-met-nsclc-in-correlation-to-tx-adverse-effects 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05119855/safety-and-immunogenicity-of-9-valent-human-papillomavirus-9vhpv-vaccine-coadministered 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04081688/atezolizumab-and-varlilumab-in-combination-with-radiation-therapy-for-nsclc 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05620342/autologous-car-t-cells-targeting-the-gd2-antigen-for-lung-cancer 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05236114/gemini-nsclc-nsclc-biomarker-study 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07229339/zipalertinib-with-carboplatin-and-pemetrexed-for-the-treatment-of-resectable-stage-ii-ii 2026-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06563388/stereotactic-ablative-radiotherapy-sabr-for-the-treatment-of-patients-with-metastatic-ca 2026-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03707574/genetic-analysis-of-blood-and-tissue-samples-from-patients-with-advanced-cancer-moonshot 2026-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04836429/photodynamic-therapy-to-amplify-the-response-to-immunotherapy-in-patients-with-non-small 2026-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06472804/insomnia-in-patients-with-metastatic-lung-cancer 2026-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03808662/randomized-study-of-stereotactic-body-radiation-therapy-sbrt-in-patients-with-oligoprogr 2026-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07382557/adaptation-and-pilot-testing-of-a-lung-cancer-screening-decision-aid-for-patients-from-a 2026-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06945484/pilot-for-the-precision-exercise-regimen-for-cancer-care-percc-study 2026-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06105801/ebus-tbna-vs-transbronchial-mediastinal-cryobiopsy-for-adequacy-of-next-generation-seque 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05142358/a-prospective-study-to-evaluate-continuous-positive-airway-pressure-devices-to-reduce-pu 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05061823/bintrafusp-alfa-program-rollover-study 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06861088/the-effect-of-kinisoquintm-on-thromboembolic-events-in-patients-with-metastatic-or-local 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06560645/a-study-of-prt7732-an-oral-smarca2-degrader-in-patients-with-advanced-or-metastatic-soli 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04752215/a-study-evaluating-different-doses-of-bi-765049-when-given-alone-and-when-given-with-eza 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06682806/a-study-of-prt3789-in-combination-with-pembrolizumab-in-patients-with-advanced-or-metast 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06545669/c-raven-a-virtual-tobacco-cessation-intervention-in-the-community 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05429320/a-study-of-local-ablative-therapy-lat-in-people-with-non-small-cell-lung-cancer-nsclc 2026-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06675695/emulation-of-the-flaura-nct02296125-trial-using-specialty-oncology-electronic-health-rec 2026-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05833334/healthy-homes-study 2026-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06654245/assessing-and-addressing-follow-up-care-needs-that-will-facilitate-care-transitions-for 2026-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04294810/a-study-of-tiragolumab-in-combination-with-atezolizumab-compared-with-placebo-in-combina 2026-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05502237/zimberelimab-and-domvanalimab-in-combination-with-chemotherapy-versus-pembrolizumab-with 2026-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07148128/phase-1-2a-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-effi 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06333678/a-study-comparing-sotorasib-with-durvalumab-in-people-with-non-small-cell-lung-cancer-ns 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05340309/subcutaneous-atezolizumab-for-the-treatment-of-non-small-cell-lung-cancer 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06457997/a-study-of-phn-010-in-patients-with-advanced-solid-tumors 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03474497/ucdcc-272-il-2-radiotherapy-and-pembrolizumab-in-patients-refractory-to-checkpoint-block 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05997225/tobacco-cessation-at-fdny 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05983432/evaluate-bl-b01d1-in-patients-with-metastatic-or-unresectable-non-small-cell-lung-cancer 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03974022/assessing-an-oral-egfr-inhibitor-sunvozertinib-in-patients-who-have-advanced-non-small-c 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01585675/specimen-banking-from-patients-with-lung-cancer 2026-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06266299/a-study-of-kk2269-in-adult-participants-with-solid-tumors 2026-01-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02432963/vaccine-therapy-and-pembrolizumab-in-treating-patients-with-solid-tumors-that-have-faile 2026-01-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03824327/papaverine-and-stereotactic-body-radiotherapy-sbrt-for-non-small-cell-lung-cancer-nsclc 2026-01-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04467723/combination-of-atezolizumab-and-pirfenidone-in-second-line-and-beyond-nsclc 2026-01-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05467748/ezh2-inhibitor-tulmimetostat-and-pd-1-blockade-for-treatment-of-advanced-non-small-cell 2026-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05179408/targeted-telerehabilitation-following-curative-intent-therapy-of-lung-cancer 2026-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03156114/this-study-tests-the-new-medicine-bi-754111-alone-or-in-combination-with-another-new-sub 2026-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06674811/biomarkers-of-resiliency-in-childhood-cancer-surgery 2026-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04341012/breath-analysis-based-disease-biomarkers 2026-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04958811/tiragolumab-with-atezolizumab-plus-bevacizumab-in-previously-treated-advanced-non-squamo 2026-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02779751/a-study-of-abemaciclib-ly2835219-in-participants-with-non-small-cell-lung-cancer-or-brea 2026-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05443321/advancing-health-information-exchange-hie-during-inter-hospital-transfer-iht-to-improve 2026-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06717334/a-study-of-lung-cancer-screening-in-people-with-unexplained-weight-loss 2026-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04294641/front-line-ibrutinib-without-corticosteroids-for-newly-diagnosed-chronic-graft-versus-ho 2026-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06284408/centralized-screening-unit-csu-at-montefiore-einstein 2026-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05502523/the-impact-of-surgical-technique-on-circulating-tumor-dna-in-stage-i-iii-non-small-cell 2026-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04334759/durvalumab-with-chemotherapy-as-first-line-treatment-in-advanced-pleural-mesothelioma 2026-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05070247/a-study-of-tak-500-with-or-without-pembrolizumab-in-adults-with-select-locally-advanced 2026-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03456063/a-study-of-neoadjuvant-atezolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-i 2026-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05746481/tiragolumab-and-atezolizumab-in-patients-with-non-squamous-non-small-cell-lung-cancer-ns 2026-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04806620/unhide-project-a-digital-health-platform-to-collect-lifestyle-data-for-brain-inflammatio 2026-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03891953/study-of-safety-and-efficacy-of-dky709-alone-or-in-combination-with-pdr001-in-patients-w 2026-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02408861/nivolumab-and-ipilimumab-in-treating-patients-with-hiv-associated-relapsed-or-refractory 2026-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04673175/ceftolozane-tazobactam-for-directed-treatment-of-pseudomonas-aeruginosa-bacteremia-and-p 2026-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07291414/a-self-monitoring-platform-for-tracking-medication-safety-and-concerns-in-cancer-patient 2026-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04486833/quaratusugene-ozeplasmid-reqorsa-and-osimertinib-in-patients-with-advanced-lung-cancer-w 2026-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03003468/pembrolizumab-imprime-pgg-for-metastatic-non-small-cell-lung-cancer-after-progression-on 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05366881/cfdna-assay-prospective-observational-validation-for-early-cancer-detection-and-minimal 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05302817/functional-lung-avoidance-radiation-therapy-using-hyperpolarized-xenon-129-mri 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03285321/unresectable-stage-iiia-iiib-non-small-cell-lung-cancer-nsclc 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03575793/a-phase-i-ii-study-of-nivolumab-ipilimumab-and-plinabulin-in-patients-with-recurrent-sma 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04743505/safety-and-efficacy-of-combining-apl-101-with-frontline-osimertinib-in-patients-with-egf 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06576635/lung-05-investigating-chemotherapy-effectiveness-for-non-small-cell-lung-cancer-nsclc-me 2026-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02411448/a-study-of-ramucirumab-ly3009806-in-combination-with-erlotinib-in-previously-untreated-p 2026-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06472869/assessing-e-cigarettes-for-tobacco-harm-reduction-in-the-context-of-lung-cancer-screenin 2026-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04118660/thoracic-specimen-registry 2026-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04063215/a-clinical-trial-to-determine-the-safety-and-efficacy-of-hope-biosciences-autologous-mes 2026-01-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07318051/sample-collection-for-ongoing-research-and-product-evaluation-study 2026-01-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04763824/kansurvive-testing-a-model-for-improving-cancer-survivorship-care-in-rural-practice 2026-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05845671/amivantamab-with-tyrosine-kinase-inhibitors-tki-for-advanced-nsclc-with-alk-ros1-or-ret 2026-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03228667/quilt-3-055-a-study-of-combination-immunotherapies-in-patients-who-have-previously-recei 2026-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03546829/safety-trial-of-antimicrobial-therapy-and-precision-radiation-therapy-in-patients-with-o 2026-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05651022/study-of-decoy20-with-or-without-tislelizumab-in-patients-with-advanced-solid-tumors 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05002270/jab-21822-activity-in-adult-patients-with-advanced-solid-tumors-harboring-kras-g12c-muta 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00596648/a-study-of-xl184-cabozantinib-with-or-without-erlotinib-in-subjects-with-non-small-cell 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05854563/cough-capture-as-a-portal-into-the-lung 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05353257/a-study-to-evaluate-the-efficacy-and-safety-of-serplulimab-in-combination-with-chemother 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07219576/retifanlimab-and-ruxolitinib-in-solid-malignancies 2026-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05074810/phase-1-2-study-of-avutometinib-vs-6766-sotorasib-with-or-without-defactinib-in-kras-g12 2026-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07181473/a-study-to-evaluate-the-safety-pharmacokinetics-and-efficacy-of-tj101-in-patients-with-a 2026-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06073431/lotus-cc-an-observational-research-study-to-uncover-subtypes-of-cancer-cachexia 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05194072/a-study-of-felmetatug-vedotin-sgn-b7h4v-in-advanced-solid-tumors 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06919874/dyadic-yoga-program-for-patients-undergoing-thoracic-radiotherapy-and-their-family-careg 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02988960/a-study-of-abbv-927-and-abbv-181-an-immunotherapy-in-participants-with-advanced-solid-tu 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04585815/study-of-immunotherapy-sasanlimab-in-combination-with-targeted-therapies-in-people-with 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04697927/a-study-of-risk-factors-for-the-covid-19-virus-infection 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05490472/jab-2485-activity-in-adult-patients-with-advanced-solid-tumors 2026-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05021133/tele-navigation-of-lung-cancer-screening-tele-navi-lcs 2026-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05902520/adoptive-cell-therapy-using-cancer-specific-cd8-tumor-infiltrating-lymphocytes-in-adult 2026-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05613413/a-pilot-phase-ii-study-of-maintenance-cabozantinib-plus-pembrolizumab-for-patients-with 2026-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04306939/genomic-resources-for-enhancing-available-therapies-great1-0-study 2026-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06999187/a-study-of-dr-0202-in-patients-with-locally-advanced-or-metastatic-relapsed-or-refractor 2026-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04691817/tocilizumab-and-atezolizumab-in-adults-with-locally-advanced-or-metastatic-non-small-cel 2026-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04919811/taletrectinib-phase-2-global-study-in-ros1-positive-nsclc 2026-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05054725/combination-study-of-rmc-4630-and-sotorasib-for-nsclc-subjects-with-krasg12c-mutation-af 2026-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03899792/a-study-of-oral-loxo-292-selpercatinib-in-pediatric-participants-with-advanced-solid-or 2026-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02998528/a-neoadjuvant-study-of-nivolumab-plus-ipilimumab-or-nivolumab-plus-chemotherapy-versus-c 2026-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04872738/patient-experiences-with-the-covid-19-vaccination-after-breast-cancer-treatment 2026-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05544929/a-study-of-safety-and-efficacy-of-kfa115-alone-and-in-combo-with-pembrolizumab-in-patien 2026-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05676749/c-til051-in-non-small-cell-lung-cancer 2026-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05830058/positron-emission-tomography-pet-guided-stereotactic-body-radiation-therapy-for-the-trea 2026-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05740566/study-comparing-tarlatamab-with-standard-of-care-chemotherapy-in-relapsed-small-cell-lun 2026-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05717998/imaging-and-blood-based-biomarkers-for-the-evaluation-of-early-signs-of-myocardial-injur 2026-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04367311/adjuvant-treatment-with-cisplatin-based-chemotherapy-plus-concomitant-atezolizumab-in-pa 2026-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06925295/using-xe-mri-to-guide-radiation-therapy-for-lung-cancer 2026-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05815173/ladarixin-with-sotorasib-in-advanced-nsclc 2025-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07307157/head-to-head-evaluation-of-the-cancer-ontology-supervised-multimodal-orchestration-cosmo 2025-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04045496/a-first-in-human-phase-1-study-of-jab-3312-in-adult-patients-with-advanced-solid-tumors 2025-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01385722/molecular-analysis-of-thoracic-malignancies 2025-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06646016/epic-extracorporeal-photopheresis-ecp-for-immune-related-colitis 2025-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05747443/multilevel-interventions-to-increase-adherence-to-lung-cancer-screening 2025-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05141357/a-study-of-hbi-8000-tucidinostat-with-pembrolizumab-in-non-small-cell-lung-cancer 2025-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05609968/study-of-pembrolizumab-mk-3475-monotherapy-versus-sacituzumab-govitecan-in-combination-w 2025-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06125197/oncolytic-adenovirus-tilt-123-with-pembrolizumab-as-treatment-for-refractory-non-small-c 2025-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03810807/study-of-dacomitinib-and-osimertinib-for-patients-with-advanced-egfr-mutant-lung-cancer 2025-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05305365/study-assessing-qbs72s-for-treating-brain-metastases 2025-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05150210/sp-thoracic-ide-study 2025-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02638090/pembro-and-vorinostat-for-patients-with-stage-iv-non-small-cell-lung-cancer-nsclc 2025-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04471428/study-of-atezolizumab-in-combination-with-cabozantinib-versus-docetaxel-in-patients-with 2025-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06327074/testing-the-engaged-approach-to-lung-cancer-screening 2025-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04447118/phase-3-study-of-pyrotinib-versus-docetaxel-in-patients-with-advanced-non-squamous-nsclc 2025-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04691297/digitally-enhanced-smoking-cessation-for-high-risk-smokers 2025-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02201992/crizotinib-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-b 2025-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04965090/a-study-of-amivantamab-and-lazertinib-in-people-with-non-small-cell-lung-cancer-nsclc 2025-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05860296/testing-experimental-anti-cancer-drug-slc-391-with-an-approved-immunotherapy-drug-pembro 2025-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04395495/rasopathy-biorepository 2025-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02611037/transarterial-chemoperfusion-cisplatin-methotrexate-gemcitabine-for-unresectable-pleural 2025-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06397651/a-randomised-controlled-trial-to-evaluate-the-impact-of-complement-theory-s-live-coactiv 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06211036/study-comparing-tarlatamab-and-durvalumab-versus-durvalumab-alone-in-first-line-extensiv 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03215706/a-study-of-nivolumab-and-ipilimumab-combined-with-chemotherapy-compared-to-chemotherapy 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04349267/study-of-bms-986315-alone-and-in-combination-with-nivolumab-or-cetuximab-in-participants 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171478/full-field-optical-coherence-tomography-ffoct-for-evaluation-of-bronchoscopic-small-biop 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05856981/phase-1-study-evaluating-the-safety-and-pk-of-adu-1805-in-advanced-solid-tumors 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04945317/rose-for-improved-molecular-marker-testing-via-ebus 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05450965/study-of-plk1-inhibitor-onvansertib-in-relapsed-small-cell-lung-cancer 2025-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05652868/clinical-study-of-antibody-drug-conjugate-mytx-011-in-subjects-with-non-small-cell-lung 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02621398/pembrolizumab-paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-with-sta 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02314364/a-trial-of-integrating-sbrt-with-targeted-therapy-in-stage-iv-oncogene-driven-nsclc 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05001347/a-clinical-study-of-tj004309-with-atezolizumab-tecentriq-in-patients-with-ovarian-cancer 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05313009/tarlox-and-sotorasib-in-patients-with-kras-g12c-mutations 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07285148/a-study-to-evaluate-ans014004-in-combination-with-egfr-tki-in-non-small-cell-lung-cancer 2025-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04696575/lamivudine-in-combination-with-chemoimmunotherapy-for-the-treatment-of-extensive-stage-s 2025-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03347838/nivolumab-for-the-reversal-of-squamous-dysplasia-in-high-risk-current-and-former-smokers 2025-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06943521/a-study-of-mt-4561-in-patients-with-various-advanced-solid-tumors 2025-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03924869/efficacy-and-safety-study-of-stereotactic-body-radiotherapy-sbrt-with-or-without-pembrol 2025-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03556228/vmd-928-monotherapy-and-in-combination-with-pembrolizumab-to-treat-trka-overexpression-d 2025-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171777/a-study-to-evaluate-participant-and-healthcare-professional-reported-preference-for-subc 2025-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03449901/adi-peg-20-in-combination-with-gemcitabine-and-docetaxel-for-the-treatment-of-soft-tissu 2025-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07216144/centralized-lung-cancer-screening-engagement-in-at-risk-populations 2025-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03595059/a-study-with-abbv-155-alone-and-in-combination-with-taxane-therapy-in-adults-with-relaps 2025-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02592577/mage-a10c796t-for-advanced-nsclc 2025-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07224971/impact-of-circadian-rhythm-on-immunotherapy 2025-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05491213/telescope-telehealth-shared-decision-making-coaching 2025-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06910761/photon-craniospinal-irradiation-for-the-treatment-of-leptomeningeal-disease-secondary-to 2025-12-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05120271/boxr1030-t-cells-in-subjects-with-advanced-gpc3-positive-solid-tumors 2025-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04625647/testing-the-use-of-targeted-treatment-amg-510-for-kras-g12c-mutated-advanced-non-squamou 2025-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05245500/phase-1-study-of-mrtx1719-in-solid-tumors-with-mtap-deletion 2025-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03177291/pirfenidone-combined-with-standard-first-line-chemotherapy-in-advanced-stage-lung-nsclc 2025-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04844073/a-study-of-tak-186-also-known-as-mvc-101-in-adults-with-advanced-or-metastatic-cancer 2025-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06530615/investigation-of-mp-pollution-in-the-human-respiratory-system-and-its-relationship-to-lu 2025-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03760575/pembrolizumab-in-combination-with-chemotherapy-and-image-guided-surgery-for-malignant-pl 2025-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04021043/bms-986156-ipilimumab-and-nivolumab-with-or-without-stereotactic-body-radiation-therapy 2025-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02259621/neoadjuvant-nivolumab-or-nivolumab-in-combination-with-ipilimumab-in-resectable-nsclc 2025-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04063501/longitudinal-evaluation-of-microbial-and-host-signatures-during-immunotherapy-for-lung-c 2025-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05035407/t-cell-receptor-gene-therapy-targeting-kk-lc-1-for-gastric-breast-cervical-lung-and-othe 2025-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07165691/telehealth-shared-decision-making-coaching-for-lung-cancer-screening-in-primary-care-tel 2025-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07175077/7t-brain-mri-scan-for-micro-brain-metastasis-microbm-detection-for-patients-with-small-c 2025-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04830046/covid-19-vaccine-responsiveness-in-mm-and-waldenstrom 2025-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165083/keymaker-u01-substudy-2-efficacy-and-safety-study-of-pembrolizumab-mk-3475-when-used-wit 2025-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05346380/near-infrared-perfusion-during-minimally-invasive-thoracic-surgery-download 2025-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05795595/a-safety-and-efficacy-study-evaluating-ctx131-in-adult-subjects-with-relapsed-or-refract 2025-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02639026/trial-of-hypofractionated-radiotherapy-in-combination-with-medi4736-and-tremelimumab-for 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03307785/study-of-niraparib-tsr-022-bevacizumab-and-platinum-based-doublet-chemotherapy-in-combin 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05370469/real-time-monitoring-of-symptoms-in-lung-cancer-patients-receiving-oral-targeted-therapi 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01147965/quilt-3-038-active-immunotherapy-cea-vaccine-in-patients-with-malignancies-expressing-ce 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03132532/platinum-doublet-chemotherapy-and-proton-beam-radiation-therapy-in-treating-patients-wit 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03052608/a-study-of-lorlatinib-versus-crizotinib-in-first-line-treatment-of-patients-with-alk-pos 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01754025/inherit-egfr-studying-germline-egfr-mutations 2025-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03315910/implementing-tobacco-treatment-in-low-dose-ct-lung-cancer-screening-sites 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06145750/implementing-fragmentomics-into-real-world-screening-interventions-to-evaluate-clinical 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05299606/power-study-prospective-transbronchial-microwave-robotic-assisted-bronchoscopy 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06332755/study-to-evaluate-lb-lr1109-administered-alone-for-the-treatment-of-solid-tumor-and-in-c 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04614129/lung-cancer-risk-and-early-detection-in-firefighters 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04900935/patient-centered-optimal-integration-of-survivorship-and-palliative-care 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05025774/fitness-and-lung-function-among-survivors-of-heart-transplant-leukemia-and-infant-bpd-th 2025-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05339022/supportive-care-intervention-roar-lct-for-patients-with-stage-iiia-iiib-and-iv-lung-canc 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02914899/informing-the-adaptation-of-a-chw-model-to-facilitate-lung-cancer-screening-for-the-chin 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05824273/the-inspire-lung-study 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04644237/trastuzumab-deruxtecan-in-participants-with-her2-mutated-metastatic-non-small-cell-lung 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05914116/a-phase-1-2a-study-of-db-1311-bnt324-in-advanced-metastatic-solid-tumors 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03703297/study-of-durvalumab-tremelimumab-durvalumab-and-placebo-in-limited-stage-small-cell-lung 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06140836/a-study-of-repotrectinib-versus-crizotinib-in-participants-with-locally-advanced-or-meta 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05238883/a-study-of-hfb200301-as-a-single-agent-and-in-combination-with-tislelizumab-in-adult-pat 2025-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01946100/treatment-of-multifocal-lung-adenocarcinoma 2025-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02197234/study-to-assess-the-effect-of-azd9291-on-the-blood-levels-of-simvastatin-in-patients-wit 2025-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03319940/study-evaluating-safety-tolerability-and-pharmacokinetics-pk-of-tarlatamab-in-adults-wit 2025-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02157883/study-to-assess-the-effect-of-itraconazole-a-cyp3a4-inhibitor-on-the-pharmacokinetics-of 2025-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01221077/study-of-erlotinib-tarceva-in-combination-with-osi-906-in-patients-with-advanced-non-sma 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07027514/a-study-of-tolododekin-alfa-ank-101-in-combination-with-an-anti-pd-1-pd-l1-antibody-in-p 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04042701/ds8201a-and-pembrolizumab-in-participants-with-locally-advanced-metastatic-breast-or-non 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01186861/phase-2-study-of-maintenance-osi-906-plus-erlotinib-tarceva-or-placebo-plus-erlotinib-in 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04895579/lung-cancer-with-copanlisib-and-durvalumab 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01847209/percutaneous-image-guided-video-assisted-thoracic-surgery-vats-resection-of-lung-lesions 2025-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04180371/study-bt5528-100-in-patients-with-advanced-solid-tumors-associated-with-epha2-expression 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05812027/a-screening-study-to-collect-samples-for-taa-hla-hla-loss-of-heterozygosity-in-patients 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04396535/docetaxel-with-or-without-bintrafusp-alfa-for-the-treatment-of-advanced-non-small-cell-l 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05256381/a-study-of-sot101-in-combination-with-pembrolizumab-to-evaluate-the-efficacy-and-safety 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06052852/study-of-bdc-3042-as-single-agent-and-in-combination-with-cemiplimab-in-patients-with-ad 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05588388/study-of-bevacizumab-in-combination-with-chemoimmunotherapy-and-atezolizumab-in-patients 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07231159/building-on-trust-navigating-preventive-lung-breast-and-prostate-cancer-screenings-at-co 2025-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02293954/copper-cu-64-anti-cea-monoclonal-antibody-m5a-pet-in-diagnosing-patients-with-cea-positi 2025-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04106492/phase-1-2a-study-of-sq3370-in-patients-with-advanced-solid-tumors 2025-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04561362/study-bt8009-100-in-subjects-with-nectin-4-expressing-advanced-malignancies 2025-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04115254/stereotactic-magnetic-resonance-guided-radiation-therapy 2025-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05954871/study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-1971-in-combination-wi 2025-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05562895/a-multicenter-study-to-evaluate-the-cios-spin-and-the-ion-endoluminal-system-for-pulmona 2025-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03623958/image-guided-vats-vs-vats-resection 2025-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02812667/nivolumab-in-combination-with-plinabulin-in-patients-with-metastatic-non-small-cell-lung 2025-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03916419/magnetic-resonance-guided-hypofractionated-adaptive-radiation-therapy-with-concurrent-ch 2025-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05558904/an-investigational-scan-me-4fdg-pet-ct-for-the-detection-of-sodium-glucose-transport-for 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03672773/talazoparib-and-low-dose-temozolomide-in-treating-participants-with-relapsed-or-refracto 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06671613/evaluating-a-fasting-mimicking-diet-in-combination-with-immunotherapy-in-patients-with-n 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04504916/a-study-of-zilovertamab-vedotin-mk-2140-vls-101-in-participants-with-solid-tumors-mk-214 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03468426/a-study-to-test-different-doses-of-bi-836880-combined-with-ezabenlimab-in-patients-with 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05194735/phase-i-ii-study-of-autologous-t-cells-to-express-t-cell-receptors-tcrs-in-subjects-with 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06630429/a-pilot-study-of-blood-based-biomarkers-for-response-to-immune-checkpoint-inhibitors 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02823990/tg4010-and-nivolumab-in-patients-with-lung-cancer 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05609331/feasibility-safety-and-efficacy-of-stereotactic-mri-guided-adaptive-radiation-therapy-sm 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05275868/study-of-mgy825-in-patients-with-advanced-non-small-cell-lung-cancer 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06008730/proton-beam-radiation-therapy-after-treatment-for-resected-n2-non-small-cell-lung-cancer 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05978128/utilizing-advocates-and-supporters-to-increase-lung-cancer-screening-rates-in-eligible-p 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00264602/real-time-image-guided-lymphatic-mapping-and-nodal-targeting-in-lung-cancer 2025-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04074967/study-of-arry-614-plus-either-nivolumab-or-nivolumab-ipilimumab 2025-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02316002/phase-ii-study-of-pembrolizumab-after-curative-intent-treatment-for-oligometastatic-non 2025-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03396445/study-of-boserolimab-mk-5890-as-monotherapy-and-in-combination-with-pembrolizumab-mk-347 2025-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03176173/radical-radiotherapy-and-immunotherapy-for-metastatic-cancer-of-the-lung-rradical 2025-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03539536/study-of-telisotuzumab-vedotin-abbv-399-in-participants-with-previously-treated-c-met-no 2025-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06714617/evaluate-bl-m17d1-in-patients-w-her2-expressing-mutant-advanced-or-metastatic-solid-tumo 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05902988/a-phase-i-ii-study-of-vls-1488-in-subjects-with-advanced-cancer 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02712905/an-open-label-dose-escalation-dose-expansion-safety-study-of-incb059872-in-subjects-with 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04042714/tas-102-in-extrapulmonary-neuroendocrine-carcinoma 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04968548/determination-and-validation-of-a-multi-analyte-assay-for-lung-cancer-screening 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06148636/a-safety-study-of-212pb-vmt-alpha-net-in-patients-with-neuroendocrine-tumors 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03667820/study-of-osimertinib-and-stereotactic-ablative-radiation-sabr-in-egfr-mutant-nsclc 2025-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03707938/local-consolidative-therapy-and-brigatinib-in-treating-patients-with-stage-iv-or-recurre 2025-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04982224/study-of-regn5093-m114-metxmet-antibody-drug-conjugate-in-adult-patients-with-mesenchyma 2025-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04373369/vorolanib-atezolizumab-as-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer 2025-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02831959/pivotal-open-label-randomized-study-of-radiosurgery-with-or-without-tumor-treating-field 2025-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04964960/pembro-chemo-in-brain-mets 2025-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05244239/palliative-radiotherapy-with-lurbinectedin-in-patients-with-extensive-stage-small-cell-l 2025-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04311762/phase-1-trial-of-endobronchial-ultrasound-guided-transbronchial-needle-injection-of-cisp 2025-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02477826/an-investigational-immuno-therapy-trial-of-nivolumab-or-nivolumab-plus-ipilimumab-or-niv 2025-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05018208/remote-monitoring-in-cancer-care-a-platform-study 2025-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05416983/developing-a-shared-decision-making-tool-for-patients-with-surgically-removed-non-small 2025-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05597839/study-of-df9001-in-patients-with-advanced-solid-tumors 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04524689/tusamitamab-ravtansine-sar408701-in-combination-with-pembrolizumab-and-tusamitamab-ravta 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05029882/study-to-assess-adverse-events-and-change-in-disease-activity-in-adult-participants-with 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05169437/niraparib-in-the-treatment-of-patients-with-advanced-palb2-mutated-tumors 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05469178/a-clinical-study-of-bemcentinib-with-standard-of-care-chemoimmunotherapy-in-untreated-ad 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06538376/clinical-utility-of-portable-dynamic-chest-x-ray-ddr-in-the-icu 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05265429/biology-of-young-lung-cancer-study-the-young-lung-study 2025-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03452774/synergy-ai-artificial-intelligence-based-precision-oncology-clinical-trial-matching-and 2025-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02817633/a-study-of-tsr-022-in-participants-with-advanced-solid-tumors-amber 2025-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04824443/exercise-therapy-in-cancer-patients-who-are-recovering-from-covid-19 2025-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02599454/atezolizumab-and-stereotactic-body-radiation-therapy-in-treating-patients-with-non-small 2025-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06158958/a-study-to-assess-the-safety-pharmacokinetics-and-efficacy-of-intravenous-iv-abbv-303-as 2025-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03334617/phase-ii-umbrella-study-of-novel-anti-cancer-agents-in-participants-with-nsclc-who-progr 2025-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05513703/a-study-to-assess-disease-activity-of-intravenously-iv-infused-telisotuzumab-vedotin-in 2025-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06228326/a-study-assessing-kb707-for-the-treatment-of-advanced-solid-tumor-malignancies-affecting 2025-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280202/detection-of-genetic-markers-of-lung-cancer 2025-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03589339/nbtxr3-activated-by-radiotherapy-for-patients-with-advanced-cancers-treated-with-an-anti 2025-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06974604/preventing-dato-dxd-associated-stomatitis-with-dexamethasone-mouthwash-tropion-dm 2025-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04543188/a-fih-study-of-pf-07284890-in-participants-with-braf-v600-mutant-solid-tumors-with-and-w 2025-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03049618/recombinant-ephb4-hsa-fusion-protein-and-pembrolizumab-mk-3475 2025-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04397003/personalized-neoantigen-vaccine-in-combination-with-durvalumab-medi4736-in-extensive-sta 2025-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03906071/phase-3-study-of-sitravatinib-plus-nivolumab-vs-docetaxel-in-patients-with-advanced-non 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01720836/study-of-the-immune-response-of-muc1-mucin1-peptide-vaccine-for-non-small-cell-lung-canc 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03401385/first-in-human-study-of-ds-1062a-for-advanced-solid-tumors-tropion-pantumor01 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06523803/a-study-of-zw171-in-participants-with-advanced-or-metastatic-mesothelin-expressing-cance 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02711137/open-label-safety-and-tolerability-study-of-incb057643-in-subjects-with-advanced-maligna 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02959437/azacitidine-combined-with-pembrolizumab-and-epacadostat-in-subjects-with-advanced-solid 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05468489/to-evaluate-efficacy-and-safety-of-serplulimab-chemotherapy-carboplatin-etoposide-in-us 2025-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05846646/study-of-pulsar-ici-imsa101-in-patients-with-oligometastatic-nsclc-and-rcc 2025-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04991025/adding-certolizumab-to-chemotherapy-nivolumab-in-people-who-have-lung-cancer-that-can-be 2025-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05292521/quality-of-life-intervention-to-inform-patient-decision-making-in-early-stage-lung-cance 2025-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05565417/study-of-the-monoclonal-antibody-imt-009-in-patients-with-advanced-solid-tumors-or-lymph 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05620329/unc-pleural-fluid-registry 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05082610/a-study-of-hmbd-002-a-monoclonal-antibody-targeting-vista-as-monotherapy-and-combined-wi 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05639751/prt3789-monotherapy-and-in-combo-w-docetaxel-in-participants-w-advanced-or-metastatic-so 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04926831/phase-ii-of-neoadjuvant-and-adjuvant-capmatinib-in-nsclc 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04272034/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-incb099318-in-participants 2025-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04056247/predicting-responsiveness-in-oncology-patients-based-on-host-response-evaluation-during 2025-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03392064/a-phase-1-study-evaluating-the-safety-tolerability-and-efficacy-of-amg-119-in-subjects-w 2025-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06336148/a-phase-1a-1b-study-of-actm-838-in-patients-with-advanced-solid-tumors 2025-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00977470/erlotinib-with-or-without-hydroxychloroquine-in-chemo-naive-advanced-nsclc-and-egfr-muta 2025-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04982926/a-study-of-tas2940-in-participants-with-locally-advanced-or-metastatic-solid-tumor-cance 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02549638/identification-of-prognostic-biomarkers-for-progression-of-invasive-squamous-cell-carcin 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05784922/health-opportunities-and-promoters-of-equitable-screening-for-lung-cancer 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02767804/exalt3-study-comparing-x-396-ensartinib-to-crizotinib-in-alk-positive-non-small-cell-lun 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07215962/long-term-safety-outcomes-and-first-line-treatment-patterns-in-patients-with-non-small-c 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05640765/bewell360-cg-care-model-health-and-wellness-coaching-to-support-caregivers-of-patients-l 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03573947/phase-ii-clinical-trial-of-nivo-ipi-taxane-in-untreated-metastatic-nsclc 2025-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04035486/a-study-of-osimertinib-with-or-without-chemotherapy-as-1st-line-treatment-in-patients-wi 2025-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05329623/a-phase-1-study-to-evaluate-the-pharmacokinetics-of-jdq443-in-participants-with-hepatic 2025-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04954625/prolonged-air-leak-pal-autologous-blood-patch-intervention-trial 2025-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06784193/phase-1-study-of-op-3136-in-advanced-or-metastatic-solid-tumors 2025-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06712810/q702-for-the-treatment-of-patients-with-hematologic-malignancies 2025-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04931654/a-study-to-assess-the-safety-and-efficacy-of-azd7789-in-participants-with-advanced-or-me 2025-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07214441/evaluating-the-feasibility-and-preliminary-effects-of-be 2025-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03551951/tumor-cell-and-dna-detection-in-the-blood-urine-and-bone-marrow 2025-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05317078/a-phase-1-safety-tolerability-and-pharmacokinetics-study-of-amg-794-with-claudin-6-posit 2025-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06180460/calm-managing-distress-in-malignant-brain-cancer 2025-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04931017/metformin-for-chemoprevention-of-lung-cancer-in-overweight-or-obese-individuals-at-high 2025-10-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05384769/feasibility-of-cell-free-dna-liquid-biopsy-in-screening-high-risk-patients-for-lung-canc 2025-10-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06305715/radiation-prior-to-tki-to-delay-progression-in-advanced-driver-mutated-non-small-cell-lu 2025-10-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07207395/a-study-of-orally-administered-jbi-802-alone-or-in-combination-with-pembrolizumab-for-pa 2025-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04215978/safety-and-preliminary-effectiveness-of-bgb-a445-in-combination-with-tislelizumab-in-par 2025-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04631029/testing-the-addition-of-an-anti-cancer-drug-entinostat-to-the-usual-chemotherapy-and-imm 2025-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04985604/tovorafenib-day101-monotherapy-for-patients-with-melanoma-and-other-solid-tumors 2025-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04305613/cardiotoxicity-in-locally-advanced-lung-cancer-patients-treated-with-chemoradiation-ther 2025-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03833934/study-of-plasma-ngs-for-assessment-characterization-evaluation-of-patients-with-alk-resi 2025-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04914897/a-study-of-sar444245-combined-with-other-anticancer-therapies-for-the-treatment-of-parti 2025-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03993873/study-of-tpx-0022-in-patients-with-advanced-nsclc-gastric-cancer-or-solid-tumors-harbori 2025-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04497584/phase-2-trial-of-afatinib-plus-prednisone-for-advanced-squamous-nsclc 2025-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01172314/effects-of-essential-amino-acid-intake-on-net-protein-synthesis-in-weight-losing-non-sma 2025-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06432985/smoking-cessation-cm-for-veterans-with-or-at-risk-for-cancer 2025-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04000529/phase-ib-study-of-tno155-in-combination-with-spartalizumab-or-ribociclib-in-selected-mal 2025-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04986670/nutricare-plus-a-medically-tailored-meal-intervention-among-patients-with-lung-cancer 2025-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04885998/amg-757-and-amg-404-in-subjects-with-small-cell-lung-cancer-sclc 2025-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02111681/calypso-based-deep-inspiration-breath-hold-dibh-radiation-treatments-of-lung-cancer 2025-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02514447/trilaciclib-g1t28-in-patients-with-previously-treated-extensive-stage-sclc-receiving-top 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06264921/a-study-with-nkt3447-for-adults-with-advanced-metastatic-solid-tumors 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03184571/bemcentinib-bgb324-in-combination-with-pembrolizumab-in-patients-with-advanced-non-small 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03041311/carboplatin-etoposide-and-atezolizumab-with-or-without-trilaciclib-g1t28-a-cdk4-6-inhibi 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04589247/improving-cancer-on-treatment-symptom-management 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04681131/cab-axl-adc-safety-and-efficacy-study-in-adults-with-nsclc 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05203328/prospective-study-to-evaluate-high-flow-nasal-cannula-with-monitored-anesthesia-care-dur 2025-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05485974/a-dose-escalation-study-of-hbi-2438-in-patients-with-solid-tumors-harboring-kras-g12c-mu 2025-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05941507/a-study-to-evaluate-trop2-adc-lcb84-single-agent-and-in-combination-with-an-anti-pd-1-ab 2025-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05163028/a-dose-escalation-study-of-shp2-inhibitor-in-patients-with-solid-tumors-harboring-kras-o 2025-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06805825/a-study-of-the-c-kit-specific-antibody-drug-conjugate-nn3201-for-advanced-and-or-metasta 2025-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03801902/testing-the-safety-of-adding-either-monalizumab-iph2201-or-oleclumab-medi9447-to-durvalu 2025-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02719847/ebus-tbna-after-pet-ct-in-diagnosing-patients-with-stage-i-iia-non-small-cell-lung-cance 2025-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00900419/biomarkers-in-patients-with-respiratory-tract-dysplasia-or-lung-cancer-head-and-neck-can 2025-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06037941/using-e-nose-technology-to-measure-response-to-treatment-in-people-with-malignant-pleura 2025-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03128060/expanding-access-to-home-based-palliative-care 2025-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01218854/a-comparison-of-methods-for-assisting-needle-angle-selection-during-image-guided-tissue 2025-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06270082/study-of-ik-595-in-ras-or-raf-altered-advanced-tumors 2025-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03289780/clinical-effectiveness-assessment-of-veristrat-testing-and-validation-of-immunotherapy-t 2025-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04079179/cobimetinib-in-refractory-langerhans-cell-histiocytosis-lch-and-other-histiocytic-disord 2025-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06008574/a-study-comparing-mindfulness-apps-to-decrease-anxiety-in-people-with-lung-cancer 2025-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05556525/needle-based-confocal-laser-endomicroscopy-for-diagnosis-of-lung-cancer-in-patients-with 2025-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02170181/clinical-registry-for-oligometastic-disease-consolidation-therapy-debulking-prior-to-che 2025-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06285097/a-study-of-pf-07820435-as-a-single-agent-and-in-combination-in-participants-with-advance 2025-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05014815/ociperlimab-with-tislelizumab-and-chemotherapy-in-participants-with-untreated-metastatic 2025-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03647163/ph-i-ii-trial-of-systemic-vsv-ifn-nis-in-combination-with-checkpoint-inhibitor-therapy-i 2025-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05013554/dose-escalation-and-expansion-study-of-sar443216-in-participants-with-relapsed-refractor 2025-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05472623/neoadjuvant-kras-g12c-directed-therapy-with-adagrasib-mrtx849-with-or-without-nivolumab 2025-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04278144/a-first-in-human-study-using-bdc-1001-as-a-single-agent-and-in-combination-with-nivoluma 2025-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04162015/a-study-of-nivolumab-and-chemotherapy-followed-by-surgery-for-mesothelioma 2025-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04344795/phase-1a-1b-study-of-tpst-1495-as-a-single-agent-and-in-combination-with-pembrolizumab-i 2025-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03596866/a-study-of-brigatinib-compared-to-alectinib-in-adults-with-non-small-cell-lung-cancer 2025-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06726590/interprofessional-pharmacogenomics-ipgx-registry-and-repository 2025-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04105270/rmt-in-combination-with-durvalumab-chemo-in-untreated-adenocarcinoma-nsclc-a-randomized 2025-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00532155/a-study-of-aflibercept-versus-placebo-in-patients-with-second-line-docetaxel-for-locally 2025-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06289192/testing-c-raven-a-virtual-tobacco-cessation-intervention-in-the-community 2025-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05653882/a-study-evaluating-ab248-alone-or-in-combination-with-pembrolizumab-in-adult-patients-wi 2025-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05107674/a-study-of-nx-1607-in-adults-with-advanced-malignancies 2025-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04694846/effectiveness-of-an-enhanced-tobacco-intervention-protocol-compared-to-standard-treatmen 2025-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01770418/a-phase-i-ii-study-of-hypofractionated-proton-therapy-for-stage-ii-iii-non-small-cell-lu 2025-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06682793/a-study-to-evaluate-the-safety-and-efficacy-of-a2b395-an-allogeneic-logic-gated-car-t-in 2025-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06262321/thoracic-radiotherapy-for-patients-with-metastatic-stage-iv-non-small-cell-lung-cancer-a 2025-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07145333/pharmacogenomics-anda-snp-clinical-study-topotecan-and-single-nucleotide-polymorphisms 2025-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06868485/a-study-to-assess-the-efficacy-of-wsd0922-fu-in-patients-with-c797s-advanced-non-small-c 2025-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04162678/fluid-biopsy-for-the-diagnosis-of-lung-cancer 2025-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04853017/a-study-of-eli-002-in-subjects-with-kras-mutated-pancreatic-ductal-adenocarcinoma-pdac-a 2025-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06016270/a-study-of-hstc810-in-combination-with-paclitaxel-in-relapsed-or-refractory-extensive-st 2025-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01737502/sirolimus-and-auranofin-in-treating-patients-with-advanced-or-recurrent-non-small-cell-l 2025-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04946279/decision-aid-for-the-improvement-of-decision-making-in-patients-with-non-small-cell-lung 2025-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05577715/a-study-of-morab-202-in-participants-with-previously-treated-metastatic-non-small-cell-l 2025-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05318573/a-study-to-evaluate-safety-efficacy-of-ff-10832-in-combo-with-pembrolizumab-in-urothelia 2025-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04879849/a-study-of-tak-676-with-pembrolizumab-after-radiation-therapy-to-treat-a-number-of-cance 2025-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04047251/a-study-of-ff-10850-topotecan-liposome-injection-in-advanced-solid-tumors-including-merk 2025-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04418167/jsi-1187-01-monotherapy-and-in-combination-with-dabrafenib-for-advanced-solid-tumors-wit 2025-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05585320/a-phase-1-2a-study-of-imm-1-104-in-participants-with-advanced-or-metastatic-solid-tumors 2025-09-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06207435/community-support-program-for-lung-cancer-screening 2025-09-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05245071/tusamitamab-ravtansine-in-nsq-nsclc-participants-with-negative-or-moderate-ceacam5-expre 2025-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04772989/a-study-to-evaluate-ab308-in-combination-with-ab122-in-participants-with-advanced-malign 2025-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03907852/phase-1-2-trial-of-gavo-cel-tc-210-in-patients-with-advanced-mesothelin-expressing-cance 2025-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03977467/atezolizumab-and-tiragolumab-in-patients-with-nsclc-or-advanced-solid-tumors-having-had 2025-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01777802/immune-responses-in-prostate-lung-melanoma-and-breast-cancer-patients-following-stereota 2025-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06582849/enhanced-assistance-during-radiotherapy-for-unmet-essential-needs 2025-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02923349/a-phase-1-2-open-label-dose-escalation-safety-study-of-incagn01949-in-subjects-with-adva 2025-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05935384/sibyl-observation-of-therapy-response-with-liquid-biopsy-evaluation 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03322540/pembrolizumab-plus-epacadostat-vs-pembrolizumab-plus-placebo-in-metastatic-non-small-cel 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02819024/dexamethasone-effects-in-patients-with-refractory-non-small-cell-lung-cancer-using-flt-p 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05059444/oracle-observation-of-residual-cancer-with-liquid-biopsy-evaluation 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04495153/can-2409-plus-prodrug-with-standard-of-care-immune-checkpoint-inhibitor-for-stage-iii-iv 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02735746/novel-lung-imaging-in-adults-undergoing-radiation-therapy-to-assess-for-radiation-pneumo 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06555263/study-to-investigate-luveltamab-tazevibulin-in-adults-with-advanced-or-metastatic-non-sm 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03746392/project-to-improve-communication-about-serious-illness-pilot-study 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04200534/centralized-lung-cancer-early-detection-among-smokers-clear-study 2025-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04926662/understanding-rural-patient-and-provide-preferences-for-mobile-lung-cancer-screening-cli 2025-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05890872/aliyatm-pulsed-electric-fields-pef-for-advanced-cancer 2025-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03708328/a-dose-escalation-and-expansion-study-of-lomvastomig-a-pd-1-tim-3-bispecific-antibody-in 2025-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05259696/glycan-mediated-immune-regulation-with-a-bi-sialidase-fusion-protein-glimmer-01 2025-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04951154/a-study-to-examine-biomarkers-from-lung-and-blood-samples-in-participants-with-suspected 2025-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03170960/study-of-cabozantinib-alone-or-in-combination-with-atezolizumab-to-subjects-with-locally 2025-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06907615/a-phase-ii-clinical-study-to-evaluate-hlx43-in-subjects-with-advanced-non-small-cell-lun 2025-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06685133/prospective-evaluation-of-the-tool-in-lesion-technology-of-the-galaxy-system-in-routine 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04429542/study-of-safety-and-tolerability-of-bca101-monotherapy-and-in-combination-therapy-in-pat 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04725188/pembrolizumab-vibostolimab-coformulation-mk-7684a-or-pembrolizumab-vibostolimab-coformul 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03976375/efficacy-and-safety-of-pembrolizumab-mk-3475-with-lenvatinib-e7080-mk-7902-vs-docetaxel 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05049837/prospect-profiling-of-resistance-patterns-oncogenic-signaling-pathways-in-evaluation-of 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05864144/a-study-of-sns-101-anti-vista-monotherapy-and-in-combination-with-cemiplimab-in-patients 2025-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03126110/phase-1-2-study-exploring-the-safety-tolerability-and-efficacy-of-incagn01876-combined-w 2025-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06605404/pan-tumor-mrd-study 2025-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07121829/tovorafenib-day101-or-in-combination-with-pimasertib-for-participants-with-melanoma-and 2025-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02327078/a-study-of-the-safety-tolerability-and-efficacy-of-epacadostat-administered-in-combinati 2025-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02623712/the-watch-the-spot-trial 2025-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06412172/the-natural-history-and-biological-study-of-pulmonary-recurrent-respiratory-papillomatos 2025-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04761822/covid19-sars-vaccinations-systemic-allergic-reactions-to-sars-cov-2-vaccinations 2025-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03893955/a-study-to-determine-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-o 2025-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02273375/double-blind-placebo-controlled-controlled-study-of-adjuvant-medi4736-in-completely-rese 2025-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02475213/safety-study-of-enoblituzumab-mga271-in-combination-with-pembrolizumab-or-mga012-in-refr 2025-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04825834/dna-evaluation-of-fragments-for-early-interception-lung-cancer-training-study-delfi-l101 2025-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04581824/efficacy-comparison-of-dostarlimab-plus-chemotherapy-versus-pembrolizumab-plus-chemother 2025-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03568656/study-to-evaluate-ccs1477-in-advanced-tumours 2025-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05655546/immunocare-rapid-accurate-covid-testing-to-reduce-hospitalization-of-immunocompromised-i 2025-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02681549/pembrolizumab-plus-bevacizumab-for-treatment-of-brain-metastases-in-metastatic-melanoma 2025-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05585034/phase-1-first-in-human-dose-finding-and-expansion-study-to-evaluate-xmab-808-in-combinat 2025-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05717140/aerosolized-sargramostim-added-to-immunotherapy-for-the-treatment-of-patients-with-metas 2025-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06360822/increasing-equity-in-lung-cancer-screening 2025-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06592638/a-phase-1-dose-escalation-study-of-zg006-in-patients-with-small-cell-lung-cancer 2025-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02903914/arginase-inhibitor-incb001158-as-a-single-agent-and-in-combination-with-immune-checkpoin 2025-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06122077/clinical-validation-of-freenome-multiomics-blood-test-for-lung-cancer-screening 2025-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05253807/study-to-evaluate-the-efficacy-and-safety-of-pemigatinib-in-participants-with-relapsed-o 2025-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05403385/study-of-inupadenant-eos100850-with-chemotherapy-as-second-line-treatment-for-nonsquamou 2025-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06039384/a-study-of-incb099280-in-combination-with-adagrasib-in-adults-with-advanced-solid-tumors 2025-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00243867/taxoprexin-plus-carboplatin-treatment-for-advanced-lung-cancer 2025-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03729596/mgc018-with-or-without-mga012-in-advanced-solid-tumors 2025-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03535740/a-study-of-brigatinib-in-participants-with-anaplastic-lymphoma-kinase-positive-alk-advan 2025-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06451003/intervention-to-improve-utilization-of-extended-venous-thromboembolism-prophylaxis-after 2025-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05617313/study-of-gt103-in-combination-with-pembrolizumab-in-refractory-metastatic-non-small-cell 2025-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05124743/hla-typing-tumor-neoantigen-identification-for-phase-i-ii-study-of-autologous-tcr-t-cell 2025-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05420636/iadademstat-in-combination-with-paclitaxel-in-relapsed-refractory-sclc-and-extrapulmonar 2025-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06105021/phase-i-study-of-autologous-cd8-and-cd4-engineered-t-cell-receptor-t-cells-in-subjects-w 2025-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05292859/long-term-follow-up-study-of-subjects-treated-with-autologous-t-cells-using-the-sleeping 2025-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03862131/proactive-evaluation-of-function-to-avoid-cardiotoxicity 2025-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04702165/image-navigated-resection-of-lung-nodules 2025-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04306900/ttx-030-in-combination-with-immunotherapy-and-or-chemotherapy-in-subjects-with-advanced 2025-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02769832/nab-paclitaxel-with-gemcitabine-for-relapsed-small-cell-cancer 2025-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05691829/immunotherapy-with-non-ablative-radiation-in-previously-untreated-patients-with-stage-iv 2025-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04579679/open-label-surufatinib-in-european-patients-with-net 2025-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06579196/trabedersen-ot-101-with-pembrolizumab-for-newly-diagnosed-advanced-nsclc-and-positive-pd 2025-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04026412/a-study-of-nivolumab-and-ipilimumab-in-untreated-participants-with-stage-3-non-small-cel 2025-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06299163/nm32-2668-in-adult-patients-with-selected-advanced-solid-tumors 2025-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06024174/a-study-of-bms-986466-with-adagrasib-with-or-without-cetuximab-in-participants-with-kirs 2025-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03199586/clinical-trial-of-metastasis-inhibitor-np-g2-044-in-patients-with-advanced-or-metastatic 2025-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02264236/vaccination-of-advanced-stage-lung-cancer-patients 2025-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03670056/ipilimumab-and-nivolumab-in-recurrent-extensive-stage-small-cell-lung-cancer-after-recei 2025-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03087708/naloxegol-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer 2025-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00354393/combination-chemotherapy-with-or-without-surgery-chemoradiotherapy-in-patients-with-mali 2025-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04342429/prospective-study-of-intensity-modulated-proton-therapy-impt-for-small-cell-lung-cancer 2025-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05650879/elvn-002-in-her2-mutant-non-small-cell-lung-cancer 2025-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07062172/lung-cancer-screening-of-family-members-of-patients-with-mutation-driven-lung-cancer 2025-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04242199/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-incb099280-in-participants 2025-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04116320/focused-ultrasound-ablation-and-pd-1-antibody-blockade-in-advanced-solid-tumors 2025-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04580485/incb106385-alone-or-in-combination-with-immunotherapy-in-advanced-solid-tumors 2025-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03131037/intratumoral-gene-mediated-cytotoxic-immunotherapy-in-patients-with-resectable-non-small 2025-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04120454/ramucirumab-and-pembrolizumab-for-the-treatment-of-egfr-mutant-recurrent-or-metastatic-n 2025-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05879484/study-of-front-line-pembrolizumab-and-valemetostat-in-pd-l1-positive-hpv-negative-recurr 2025-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05563272/89zr-girentuximab-for-pet-imaging-of-caix-positive-solid-tumors 2025-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05086692/a-beta-only-il-2-immunotherapy-study 2025-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05557708/a-safety-study-of-212pb-pentixather-radioligand-therapy 2025-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04062708/chio3-trial-chemotherapy-combined-with-immune-checkpoint-inhibitor-for-operable-stage-ii 2025-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05224141/pembrolizumab-vibostolimab-mk-7684a-or-atezolizumab-in-combination-with-chemotherapy-in 2025-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05937074/metabolic-response-to-food-in-lung-cancer 2025-07-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05919147/the-neuroendocrine-effects-of-pioglitazone-in-patients-with-cancer-and-cachexia 2025-07-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06279728/medical-access-program-for-datopotamab-deruxtecan-in-egfrm-nsclc-patients 2025-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06926673/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-sm 2025-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03382561/cisplatin-carboplatin-and-etoposide-with-or-without-nivolumab-in-treating-patients-with 2025-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04721015/study-of-intravenous-iv-abbv-637-alone-or-in-combination-with-iv-docetaxel-osimertinib-t 2025-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04616768/prostep-a-feasibility-trial-using-pros-and-step-data-to-monitor-patients-with-lung-and-g 2025-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00540982/vinorelbine-in-treating-patients-with-advanced-solid-tumors-that-have-not-responded-to-t 2025-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04678440/18f-f-arag-total-body-pet-imaging-and-healthy-subjects-and-lung-cancer-patients 2025-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03884556/ttx-030-single-agent-and-in-combination-with-immunotherapy-or-chemotherapy-for-patients 2025-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06669117/fih-trial-of-vert-002-in-patients-with-locally-advanced-or-metastatic-solid-tumors-with 2025-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05573035/a-study-to-investigate-lyl845-in-adults-with-solid-tumors 2025-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07045103/a-multicenter-study-in-bronchoscopy-combining-stimulated-raman-histology-with-artificial 2025-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05274451/a-study-to-investigate-lyl797-in-adults-with-solid-tumors 2025-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05891197/a-biomarker-screening-protocol-for-participants-with-solid-tumors 2025-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05958199/a-study-of-npx267-for-subjects-with-solid-tumors-known-to-express-hhla2-b7-h7 2025-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03175224/apl-101-study-of-subjects-with-nsclc-with-c-met-exon-14-skip-mutations-and-c-met-dysregu 2025-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04083859/digital-outreach-intervention-for-lung-cancer-screening 2025-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04525859/poly-iclc-hiltonol-vaccine-in-malignant-pleural-mesothelioma 2025-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02299141/nintedanib-in-molecularly-selected-patients-with-advanced-non-small-cell-lung-cancer 2025-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03099174/this-study-in-patients-with-different-types-of-cancer-solid-tumours-aims-to-find-a-safe 2025-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02279433/a-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ds-60 2025-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04283994/project-to-improve-communication-about-serious-illness-hospital-study-comparative-effect 2025-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03267524/walking-for-recovery-from-surgery-in-improving-quality-of-life-in-older-adults-with-lung 2025-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05607550/study-to-compare-furmonertinib-to-platinum-based-chemotherapy-for-patients-with-locally 2025-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04676477/her3-dxd-patritumab-deruxtecan-u3-1402-in-combination-with-osimertinib-in-subjects-with 2025-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00981058/first-line-treatment-of-participants-with-stage-iv-squamous-non-small-cell-lung-cancer-w 2025-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06041906/international-registry-of-congenital-portosystemic-shunt-ircpss 2025-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct07024862/long-term-outcomes-among-patients-with-programmed-death-ligand-1-1-metastatic-non-small 2025-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04314089/phase-ib-first-in-human-dose-escalation-of-gt103-in-refractory-advanced-stage-non-small 2025-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05788484/a-study-of-cdx-585-in-patients-with-advanced-malignancies 2025-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03739710/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-sm 2025-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03867175/immunotherapy-with-or-without-sbrt-in-patients-with-stage-iv-non-small-cell-lung-cancer 2025-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04533451/testing-the-effects-of-mk-3475-pembrolizumab-with-or-without-the-usual-chemotherapy-trea 2025-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01351103/a-study-of-lgk974-in-patients-with-malignancies-dependent-on-wnt-ligands 2025-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05342675/effect-of-rapid-rollover-on-pneumothorax-after-ct-guided-lung-biopsy 2025-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02262325/hypofractionated-boost-before-chemoradiation-for-patients-with-stage-ii-iii-non-small-ce 2025-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04731571/toward-high-fidelity-adaptive-radiotherapy-in-the-thorax 2025-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03800134/a-study-of-neoadjuvant-adjuvant-durvalumab-for-the-treatment-of-patients-with-resectable 2025-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04362072/study-of-lorlatinib-in-people-with-alk-positive-non-small-cell-lung-cancer 2025-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03094169/avid100-in-advanced-epithelial-carcinomas 2025-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05888831/a-study-of-bms-986449-with-and-without-nivolumab-in-participants-with-advanced-solid-tum 2025-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01130285/validation-of-a-multi-gene-test-for-lung-cancer-risk 2025-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03292133/a-study-of-egf816-and-gefitinib-in-tki-nai-ve-egfr-mutant-non-small-cell-lung-cancer 2025-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06099639/medical-access-program-for-patritumab-deruxtecan 2025-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03613363/engineering-evaluation-of-the-helix-ventilator 2025-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04394624/tusamitamab-ravtansine-sar408701-in-combination-with-ramucirumab-or-ramucirumab-and-pemb 2025-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04214015/a-pilot-study-to-explore-the-role-of-gut-flora-in-metastatic-mesothelioma 2025-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06140407/pembrolizumab-after-radiation-therapy-and-chemotherapy-in-limited-stage-small-cell-lung 2025-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06494046/defining-musical-toxicity-and-its-effect-on-patient-well-being 2025-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06790303/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-sm 2025-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02419495/phase-ib-study-to-evaluate-the-safety-of-selinexor-kpt-330-in-combination-with-multiple 2025-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06133816/lung-cancer-screening-eligibility-assessment 2025-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03037385/phase-1-2-study-of-the-highly-selective-ret-inhibitor-pralsetinib-blu-667-in-participant 2025-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03505710/ds-8201a-in-human-epidermal-growth-factor-receptor-2-her2-expressing-or-mutated-non-smal 2025-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03242915/pembrolizumab-plus-chemotherapy-in-nsclc-with-targetable-genetic-alterations-after-progr 2025-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02029729/rta-408-in-the-treatment-of-advanced-solid-tumors-nsclc-melanoma-discover 2025-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04068896/study-of-ngm120-in-subjects-with-advanced-solid-tumors-pancreatic-cancer-and-prostate-ca 2025-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05704985/evaluating-safety-and-biomarkers-using-dk210-egfr-for-locally-advanced-or-metastatic-egf 2025-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04043195/nivolumab-and-ipilimumab-in-combination-with-immunogenic-chemotherapy-for-patients-with 2025-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06208124/a-study-of-imm-6-415-in-ras-raf-mutant-solid-tumors 2025-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04152018/study-of-pf-06940434-in-patients-with-advanced-or-metastatic-solid-tumors 2025-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04441138/chemoradiation-followed-by-durvalumab-in-poor-risk-and-or-elderly-patients-with-stage-ii 2025-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04377659/tocilizumab-for-prevention-of-respiratory-failure-in-patients-with-severe-covid-19-infec 2025-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05722847/risk-stratification-for-patients-with-hospital-diagnosed-advanced-lung-cancer 2025-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04442126/a-study-of-nm21-1480-in-adult-patients-with-advanced-solid-tumors 2025-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03767517/a-culturally-based-palliative-care-tele-consult-program-for-rural-southern-elders 2025-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04314895/trial-of-nanopac-intratumoral-injection-in-lung-cancer 2025-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04140526/safety-pk-and-efficacy-of-onc-392-in-monotherapy-and-in-combination-of-anti-pd-1-in-adva 2025-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04347226/anti-interleukin-8-anti-il-8-for-patients-with-covid-19 2025-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04788264/exercise-training-and-behavioral-modification-for-the-improvement-of-physical-activity-i 2025-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02799095/a-study-of-the-effects-of-alks-4230-nemvaleukin-alfa-on-subjects-with-solid-tumors 2025-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03845296/rucaparib-in-treating-patients-with-genomic-loh-high-and-or-deleterious-brca1-2-mutation 2025-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03299088/pembrolizumab-and-trametinib-in-treating-patients-with-stage-iv-non-small-cell-lung-canc 2025-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04969341/improving-lung-cancer-screening-adherence-by-overcoming-barriers-for-vulnerable-populati 2025-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03929926/proactive-outreach-and-shared-decision-making-in-improving-lung-cancer-screening-rates-i 2025-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06979661/trial-of-ctdna-of-guidance-to-determine-postoperative-radiation-therapy 2025-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03080883/apixaban-in-preventing-secondary-cancer-related-venous-thrombosis-in-cancer-patients-who 2025-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03375489/early-integrated-telehealth-versus-in-person-palliative-care-for-patients-with-lung-canc 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03704688/trial-of-trametinib-and-ponatinib-in-patients-with-kras-mutant-advanced-non-small-cell-l 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02093962/study-of-th-302-or-placebo-in-combination-with-pemetrexed-in-patients-with-non-squamous 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04200417/chemoembolization-for-lung-tumors 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04379492/a-study-of-hydroxycholoroquine-compared-to-placebo-as-treatment-for-people-with-covid-19 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05394831/a-phase-1-2-study-to-evaluate-the-safety-tolerability-and-pk-of-jin-a02-in-patients-with 2025-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03755102/a-pilot-study-of-dacomitinib-with-or-without-osimertinib-for-patients-with-metastatic-eg 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03877250/analysis-of-biopsy-specimens-to-study-responses-to-pd-1-or-pd-l1-therapies 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03340714/automated-device-for-asthma-monitoring-and-management-in-monitoring-adults-with-lung-can 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02245100/circulating-tumor-dna-in-predicting-outcomes-in-patients-with-stage-iv-head-and-neck-can 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04926181/apalutamide-plus-cetrelimab-in-patients-with-treatment-emergent-small-cell-neuroendocrin 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02318771/radiation-therapy-and-mk-3475-for-patients-with-recurrent-metastatic-head-and-neck-cance 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03784378/continued-access-to-rxdx-105 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02745548/bronchial-mapping-gcc-1635 2025-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05144698/rapa-201-therapy-of-solid-tumors 2025-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06165419/definitive-radiation-for-high-risk-spine-metastases 2025-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04567251/survivorship-study-of-cancer-patients-who-received-cranial-radiation-therapy 2025-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05555342/a-novel-method-for-treating-lung-met-w-combo-of-electric-fields-rad-therapy-a-single-arm 2025-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02991651/study-of-irx4204-with-erlotinib-in-previously-treated-advanced-nsclc 2025-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04040231/using-a-targeted-cancer-vaccine-galinpepimut-s-with-immunotherapy-nivolumab-in-mesotheli 2025-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04383938/phase-1-2-study-of-apr-246-in-combination-with-pembrolizumab-in-subjects-with-solid-tumo 2025-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02521051/phase-i-ii-trial-of-alectinib-and-bevacizumab-in-patients-with-advanced-anaplastic-lymph 2025-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05270395/piloting-mpal-a-multilevel-strategy-for-palliative-care-implementation 2025-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04993677/a-study-of-sea-cd40-given-with-other-drugs-in-cancers 2025-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03554473/m7824-and-topotecan-or-temozolomide-in-relapsed-small-cell-lung-cancers 2025-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04579757/surufatinib-in-combination-with-tislelizumab-in-subjects-with-advanced-solid-tumors 2025-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02983578/danvatirsen-and-durvalumab-in-treating-patients-with-advanced-and-refractory-pancreatic 2025-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05179824/tempus-priority-study-a-pan-tumor-observational-study 2025-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06751576/retrospective-clinical-trial-comparing-radiologists-diagnosis-accuracy-in-lung-cancer-sc 2025-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04261439/a-phase-i-ib-study-of-niz985-alone-and-in-combination-with-spartalizumab 2025-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04515836/olaparib-in-patients-with-hrd-malignant-mesothelioma 2025-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01068210/lung-cancer-exercise-training-study 2025-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00328562/zd1839-with-hypofractionated-radiation-therapy-with-an-immobilization-device-for-advance 2025-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05388435/safety-tolerability-pk-pd-preliminary-efficacy-of-skl27969-in-advanced-solid-tumors-pati 2025-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00838929/study-of-the-combination-of-vorinostat-and-radiation-therapy-for-the-treatment-of-patien 2025-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06124131/building-engagement-using-financial-incentives-trial-colorectal-cancer-screening 2025-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00330044/alimta-carboplatin-and-radiation-therapy-for-non-small-cell-lung-cancer 2025-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05374538/vic-1911-monotherapy-in-combination-with-sotorasib-for-the-treatment-of-kras-g12c-mutant 2025-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05757492/study-to-evaluate-safety-and-pk-of-chs-006-in-combination-with-toripalimab-in-patients-w 2025-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02954809/feasibility-of-bright-light-therapy-on-fatigue-sleep-and-circadian-activity-rhythms-in-l 2025-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00983307/a-study-of-erlotinib-plus-radiotherapy-rt-for-patients-with-advanced-or-inoperable-non-s 2025-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02016872/prognostic-value-of-tumor-hypoxia-as-measured-by-18f-fmiso-breath-hold-pet-ct-in-non-sma 2025-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06003075/induction-chemo-nivo-in-unresectable-stage-iii-nsclc 2025-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03054298/car-t-cells-in-mesothelin-expressing-cancers 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04291079/srk-181-alone-or-in-combination-with-anti-pd-l-1-antibody-therapy-in-patients-with-local 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02912949/a-study-of-zenocutuzumab-mcla-128-in-patients-with-solid-tumors-harboring-an-nrg1-fusion 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03944265/genetics-and-shared-decision-making-in-improving-care-for-patients-with-stage-iva-c-non 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03820557/decision-counseling-program-in-increasing-shared-decision-making-and-clinical-trial-part 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04075396/a-study-of-lazertinib-in-participants-with-epidermal-growth-factor-receptor-egfr-mutatio 2025-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04973436/dbt-for-metastatic-lung-cancer 2025-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05840510/adagrasib-in-combination-with-nab-sirolimus-in-patients-with-advanced-solid-tumors-and-n 2025-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05736731/a-study-to-evaluate-the-safety-and-efficacy-of-a2b530-a-logic-gated-car-t-in-participant 2025-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05275673/a-study-of-sapanisertib-in-relapsed-refractory-nfe2l2-mutated-and-wild-type-squamous-non 2025-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04049474/bronchoscopic-cryo-immunotherapy-of-lung-cancer 2025-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04892472/ef-36-keynote-b36-a-pilot-randomized-open-label-study-of-tumor-treating-fields-ttfields 2025-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06046495/a-study-of-the-oral-egfr-inhibitor-plb1004-in-non-small-cell-lung-cancer 2025-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05937399/project-plus-lung-cancer-screening-promotion 2025-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04875806/a-safety-and-tolerability-study-of-nc762-in-subjects-with-advanced-or-metastatic-solid-t 2025-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05790460/telehealth-based-synchronous-navigation-to-improve-molecularly-informed-care-for-patient 2025-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00026754/eligibility-screening-for-the-nih-intramural-research-program-clinical-protocols 2025-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06933758/temple-health-chest-initiative-thci-2-0 2025-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04925986/sitravatinib-plus-pembrolizumab-in-patients-with-advanced-treatment-nai-ve-pd-l1-non-squ 2025-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05123118/lung-and-breast-cancer-prevention-by-an-integrated-intervention-of-maternal-smoking-cess 2025-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04870112/a-study-to-evaluate-subcutaneous-durvalumab-in-patients-with-non-small-cell-lung-cancer 2025-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04209465/a-study-of-bdtx-189-an-orally-available-allosteric-erbb-inhibitor-in-patients-with-advan 2025-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05358691/a-trial-of-an0025-with-chemoradiation-therapy-in-stage-iii-nsclc-participants 2025-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02496585/study-to-evaluate-the-efficacy-and-safety-of-nintedanib-bibf-1120-prednisone-taper-in-pa 2025-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06094296/a-study-of-bms-986315-and-nivolumab-in-combination-with-chemotherapy-in-participants-wit 2025-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04774952/dose-escalation-of-rmc-5552-monotherapy-in-relapsed-refractory-solid-tumors 2025-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04706962/th1902-in-patients-with-advanced-solid-tumors 2025-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06462365/prevention-of-gvhd-in-participants-with-hematological-malignancies-undergoing-hematopoie 2025-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02974725/a-phase-ib-study-of-lxh254-centric-combinations-in-nsclc-or-melanoma 2025-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02487095/trial-of-topotecan-with-vx-970-m6620-an-atr-kinase-inhibitor-in-small-cell-cancers-and-e 2025-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01817192/adjuvant-chemotherapy-in-patients-with-intermediate-or-high-risk-stage-i-or-stage-iia-no 2025-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02119065/pilot-study-to-assess-lung-shunting-of-yttrium-90-microspheres-using-pet-ct 2025-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03824535/18f-fspg-pet-ct-in-diagnosing-early-lung-cancer-in-patients-with-lung-nodules 2025-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04943900/a-study-of-bms-986416-with-and-without-nivolumab-in-select-solid-tumors 2025-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03631706/m7824-versus-pembrolizumab-as-a-first-line-1l-treatment-in-participants-with-programmed 2025-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05737706/study-of-mrtx1133-in-patients-with-advanced-solid-tumors-harboring-a-kras-g12d-mutation 2025-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04364620/ab-16b5-combined-with-docetaxel-in-subjects-with-metastatic-non-small-cell-lung-cancer-e 2025-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03290534/feasibility-study-to-treat-lung-cancer-with-the-permanently-implantable-ldr-civasheet 2025-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04281784/project-to-improve-communication-about-serious-illness-hospital-study-pragmatic-trial-tr 2025-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04330664/adagrasib-in-combination-with-tno155-in-patients-with-cancer-krystal-2 2025-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04925284/study-of-xb002-in-subjects-with-solid-tumors-jewel-101 2025-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04383210/study-of-seribantumab-in-adult-patients-with-nrg1-gene-fusion-positive-advanced-solid-tu 2025-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01394679/a-phase-3-study-of-99mtc-ec-dg-spect-ct-versus-pet-ct-in-lung-cancer 2025-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04969315/tt-10-port-6-and-tt-4-port-7-as-single-agents-and-in-combination-in-subjects-with-advanc 2025-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03894618/sl-279252-pd1-fc-ox40l-in-subjects-with-advanced-solid-tumors-or-lymphomas 2025-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06872723/cprit-patient-adherence-to-lung-cancer-screening 2025-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03829501/a-phase-1-2-open-label-multi-center-study-of-the-safety-and-efficacy-of-alomfilimab-ky10 2025-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04507828/combined-deep-inspiration-breath-hold-dibh-expiration-planning-technique-in-patients-wit 2025-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04735068/binimetinib-and-hydroxychloroquine-in-patients-with-advanced-kras-mutant-non-small-cell 2025-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03035890/hypofractionated-radiation-therapy-to-improve-immunotherapy-response-in-non-small-cell-l 2025-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03457415/collection-of-sputum-and-labeling-for-lung-cancer 2025-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04854980/serologic-response-to-the-sars-cov-2-covid-19-mrna-1273-vaccine-in-select-subsets-of-onc 2025-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02922764/a-study-of-rgx-104-in-patients-with-advanced-lung-endometrial-cancer 2025-03-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05267470/a-study-of-bemarituzumab-monotherapy-and-combination-with-other-anti-cancer-therapy-in-s 2025-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03389399/pulmonary-physiology-and-systemic-inflammatory-in-eo-pulmonary-events-with-brigatinib-us 2025-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03631784/a-trial-of-pembrolizumab-in-combination-with-chemotherapy-and-radiotherapy-in-stage-iii 2025-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04498052/evaluation-of-a-scalable-decision-support-and-shared-decision-making-tool-for-lung-cance 2025-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04003246/phase-ii-concurrent-durvalumab-and-radiotherapy-for-for-stage-iii-non-small-cell-lung-ca 2025-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03195699/oral-stat3-inhibitor-tti-101-in-patients-with-advanced-cancers 2025-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05911308/abequolixron-rgx-104-and-durvalumab-in-lung-cancer 2025-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05137067/a-novel-approach-for-alleviating-the-side-effects-of-chemotherapeutic-agents 2025-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06659458/utilizing-long-read-sequencing-to-investigate-the-egfr-landscape-of-egfr-positive-lung-c 2025-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02437136/ph1b-2-dose-escalation-study-of-entinostat-with-pembrolizumab-in-non-small-cell-lung-can 2025-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06686602/a-study-assessing-risk-factors-for-oral-mucositis-stomatitis-and-ocular-surface-events-i 2025-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06717243/genomic-and-methylation-markers-in-sclc-and-lcnec-for-chemo-immunotherapy-resistance-pre 2025-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04101357/safety-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-trial-of-bnt411 2025-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05543629/a-study-of-bms-986442-with-nivolumab-with-or-without-chemotherapy-in-solid-tumors-and-no 2025-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02489903/rrx-001-in-lung-cancer-ovarian-cancer-and-neuroendocrine-tumors-prior-to-re-administrati 2025-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06876831/inpatient-capture-a-mixed-methods-study-to-develop-an-inpatient-lung-cancer-screening-pr 2025-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04316013/volatile-anaesthesia-and-perioperative-outcomes-related-to-cancer-the-vapor-c-trial 2025-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04510129/a-multicenter-cancer-biospecimen-collection-study 2025-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05386355/improving-pediatric-covid-19-vaccine-uptake-using-an-mhealth-tool 2025-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04032847/atl001-in-patients-with-advanced-unresectable-or-metastatic-nsclc 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04032704/a-study-of-ladiratuzumab-vedotin-in-advanced-solid-tumors 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05576077/a-study-of-tbio-4101-til-and-pembrolizumab-in-patients-with-advanced-solid-tumors 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06064500/tarlatamab-amg-757-expanded-access-protocol-for-advanced-small-cell-lung-cancer 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05619744/a-study-to-evaluate-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminar 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02783300/an-open-label-dose-escalation-study-to-investigate-the-safety-pharmacokinetics-pharmacod 2025-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03761017/mgd019-dart-protein-in-unresectable-metastatic-cancer 2025-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05697198/prospective-registry-of-advanced-stage-cancer-prefer-patients-to-assess-prevalence-of-ac 2025-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06069570/safety-study-for-a-gamma-delta-t-cell-product-used-with-low-dose-radiotherapy-in-patient 2025-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04495894/pre-incisional-ketorolac-for-patients-undergoing-surgery-for-non-small-cell-lung-cancer 2025-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02535338/erlotinib-hydrochloride-and-onalespib-lactate-in-treating-patients-with-recurrent-or-met 2025-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04880863/nap-in-combination-with-docetaxel-following-obinutuzumab-pretreatment-in-subjects-with-c 2025-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04182815/transbronchial-biopsy-assisted-by-robot-guidance-in-the-evaluation-of-tumors-of-the-lung 2025-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06849518/study-of-longitudinal-plasma-pd-l1-testing-with-immunotherapy-in-lung-cancer 2025-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06168825/mind-over-matter-for-black-and-african-american-women-a-single-arm-trial-examining-feasi 2025-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03089125/brief-behavioral-intervention-for-dyspnea-in-patients-with-advanced-lung-cancer 2025-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03058289/a-phase-1-2-safety-study-of-intratumorally-dosed-int230-6 2025-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05131815/the-burnalong-pilot-study-for-adolescent-and-young-adult-cancer-survivors 2025-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02424617/a-study-of-bgb324-bemcentinib-in-combination-with-erlotinib-in-patients-with-non-small-c 2025-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06474611/evaluation-of-a-patient-nudge-on-engagement-in-lung-cancer-screening 2025-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02464007/study-of-rsifn-co-for-patients-with-advanced-solid-tumors 2025-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165330/evaluation-of-al3818-in-combination-with-nivolumab-in-solid-tumors 2025-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03574649/quilt-2-024-phase-2-neoadjuvant-consolidation-and-adjuvant-combination-nant-immunotherap 2025-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03167281/early-intrapleural-tpa-instillation-versus-late 2025-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04213794/heated-intra-peritoneal-chemotherapy-with-doxorubicin-and-cisplatin-for-abdominal-for-pe 2025-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03088813/study-of-irinotecan-liposome-injection-onivyde-in-patients-with-small-cell-lung-cancer 2025-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03190174/nivolumab-opdivo-plus-abi-009-nab-rapamycin-for-advanced-sarcoma-and-certain-cancers 2025-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06272864/bostongene-and-exigent-genomic-insight-study 2025-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05669430/a-study-of-gv20-0251-monotherapy-and-gv20-0251-in-combination-with-pembrolizumab-in-part 2025-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02231164/lume-columbus-nintedanib-plus-docetaxel-in-advanced-non-small-cell-lung-cancer-with-tran 2025-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00708448/early-prediction-of-therapeutic-response-to-targeted-therapy-in-stage-iiib-iv-or-recurre 2025-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05135650/pharmacokinetics-of-sotrovimab-as-pre-exposure-prophylaxis-for-covid-19-in-hematopoietic 2025-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00984321/a-pilot-study-of-geriatric-specific-interventions-for-quality-of-life-in-elderly-patient 2025-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05795959/ensuring-precision-medicine-delivery-for-veterans-with-lung-cancer 2025-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05918783/padeliporfin-vtp-using-robotic-assisted-bronchoscopy-in-peripheral-lung-cancer 2025-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01586104/intensity-modulated-radiation-therapy-in-treating-younger-patients-with-lung-metastases 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00282516/asthma-in-home-monitoring-aim-trial 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04999202/a-study-to-learn-how-safe-the-study-drug-bay-2416964-ahr-inhibitor-in-combination-with-t 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04862780/symphony-phase-1-2-study-targeting-egfr-resistance-mechanisms-in-nsclc 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05241873/concerto-study-of-blu-451-in-advanced-cancers-with-egfr-exon-20-insertion-mutations 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05229900/a-study-of-sgn-alpv-in-advanced-solid-tumors 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04254107/a-safety-study-of-sea-tgt-sgn-tgt-in-advanced-cancer 2025-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01828112/ldk378-versus-chemotherapy-in-alk-rearranged-alk-positive-patients-previously-treated-wi 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03721952/facilitating-communication-study 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04665921/a-study-of-sgn-stnv-in-advanced-solid-tumors 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02349412/early-palliative-care-with-standard-care-or-standard-care-alone-in-improving-quality-of 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05407038/remote-monitoring-with-health-coaching-for-lifestyle-changes-in-patients-with-lung-cance 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05631574/study-of-covalent-menin-inhibitor-bmf-219-in-adult-patients-with-kras-driven-non-small-c 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03532880/a-study-of-olaparib-and-low-dose-radiotherapy-for-small-cell-lung-cancer 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01638533/romidepsin-in-treating-patients-with-lymphoma-chronic-lymphocytic-leukemia-or-solid-tumo 2025-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05403736/cardiac-aggressive-risk-mitigation-in-thoracic-radiotherapy-carma-trial 2025-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04474613/liquid-biopsy-to-reduce-time-to-treatment-for-advanced-nonsquamous-nsclc-diagnosed-at-ou 2025-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03371381/an-efficacy-and-safety-study-of-jnj-64041757-a-live-attenuated-listeria-monocytogenes-im 2025-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04370834/tocilizumab-for-patients-with-cancer-and-covid-19-disease 2025-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02876510/actolog-in-patients-with-solid-cancers 2025-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01703481/a-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-jnj-42756493-in 2025-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02887521/pulmonary-rehabilitation-before-lung-cancer-resection 2025-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02592967/safety-immunogenicity-of-jnj-64041757-live-attenuated-double-deleted-listeria-immunother 2025-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04683744/facilitators-and-barriers-to-cancer-screening-stakeholder-perspectives-on-implementation 2025-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02576574/avelumab-in-first-line-nsclc-javelin-lung-100 2025-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04761107/impact-of-covid-19-on-gu-disease 2025-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03207594/improving-evidence-based-care-for-cancer-patients 2025-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03944772/phase-2-platform-study-in-patients-with-advanced-non-small-lung-cancer-who-progressed-on 2025-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03821233/a-dose-finding-study-of-zw49-in-patients-with-her2-positive-cancers 2025-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04466098/multiple-dosing-of-mesenchymal-stromal-cells-in-patients-with-ards-covid-19 2025-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03948763/a-study-of-mrna-5671-v941-as-monotherapy-and-in-combination-with-pembrolizumab-v941-001 2025-01-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04954885/evaluating-modifiable-biomarkers-for-the-prediction-of-immunotherapy-response-and-toxici 2025-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03220035/vemurafenib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-h 2025-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04538378/olaparib-lynparza-plus-durvalumab-imfinzi-in-egfr-mutated-adenocarcinomas-that-transform 2025-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03674567/dose-escalation-and-expansion-study-of-flx475-monotherapy-and-in-combination-with-pembro 2025-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03154190/health-care-coach-support-in-reducing-acute-care-use-and-cost-in-patients-with-cancer 2025-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01121588/studying-an-investigational-drug-crizotinib-pf-02341066-in-non-non-small-cell-lung-cance 2025-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04350463/a-safety-and-efficacy-study-of-cc-90011-in-combination-with-nivolumab-in-subjects-with-a 2025-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01946789/a-phase-1-study-of-the-clinical-and-immunologic-effects-of-alt-803-in-patients-with-adva 2025-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02240238/combination-therapy-with-nc-6004-and-gemcitabine-in-advanced-solid-tumors-or-non-small-c 2025-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03667716/com701-an-inhibitor-of-pvrig-in-subjects-with-advanced-solid-tumors 2025-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03906331/expanded-access-for-the-treatment-of-cancers-with-rearranged-during-transfection-ret-act 2025-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03504488/cab-ror2-adc-safety-and-efficacy-study-in-patients-with-tnbc-or-head-neck-cancer-ph1-and 2025-01-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03509012/immunotherapy-in-combination-with-chemoradiation-in-patients-with-advanced-solid-tumors 2025-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03069924/gain-framed-messages-and-nrt-for-lung-cancer-screening-patients 2025-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03546361/ccl21-gene-modified-dendritic-cell-vaccine-and-pembrolizumab-in-treating-patients-with-s 2025-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01014286/lung-cancer-mutation-consortium-protocol 2025-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03854227/a-dose-escalation-study-of-pf-06939999-in-participants-with-advanced-or-metastatic-solid 2025-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04739696/developing-a-virtual-stress-management-intervention-for-spousal-partnered-caregivers-of 2025-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03824366/same-session-mr-only-simulation-and-treatment-with-mri-guided-adaptive-palliative-radiot 2025-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04249362/study-of-durvalumab-following-radiation-therapy-in-patients-with-stage-3-unresectable-ns 2025-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00682032/the-effect-of-beta-glucan-in-non-small-cell-lung-cancer 2025-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03982459/national-comprehensive-cancer-network-nccn-decision-support-tool-for-patients-with-nsclc 2025-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03262779/ipilimumab-and-nivolumab-in-patients-with-anti-pd-1-axis-therapy-resistant-advanced-non 2025-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04440735/a-study-of-dsp107-alone-and-in-combination-with-atezolizumab-for-patients-with-advanced 2025-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05688280/intratumoral-injection-of-ip-001-following-thermal-ablation-in-patients-with-crc-nsclc-a 2025-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06090266/a-study-of-or502-a-monoclonal-antibody-targeting-lilrb2-alone-and-in-combination-with-an 2025-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02151981/azd9291-osimertinib-versus-platinum-based-doublet-chemotherapy-in-locally-advanced-or-me 2025-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04856176/a-study-of-sargramostim-plus-pembrolizumab-with-or-without-pemetrexed-in-patients-with-a 2025-01-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00418886/efficacy-study-comparing-zd6474-in-combination-with-pemetrexed-and-pemetrexed-alone-in-2 2024-12-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02765412/prove-queri-project-1 2024-12-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04923776/liver-directed-rt-chemo-immunotherapy-for-es-sclc 2024-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05001009/goals-of-care-conversations-study 2024-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04731467/a-study-of-cm24-in-combination-with-nivolumab-in-adults-with-advanced-solid-tumors 2024-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04675476/a-patient-and-provider-intervention-to-address-health-disparities-in-lung-cancer-screeni 2024-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02432560/safety-and-durability-of-sirolimus-for-treatment-of-lam 2024-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03997968/a-phase-1-2-study-of-cyt-0851-in-b-cell-malignancies-and-advanced-solid-tumors 2024-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05500508/oral-amxt-1501-dicaprate-in-combination-with-iv-dfmo 2024-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04364048/durvalumab-followed-by-chemoradiation-and-consolidation-durvalumab-for-stage-iii-non-sma 2024-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03043599/ipilimumab-nivolumab-w-thoracic-radiotherapy-for-extensive-stage-small-cell-lung-cancer 2024-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03150810/study-to-assess-safety-tolerability-and-clinical-activity-of-bgb-290-in-combination-with 2024-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04078152/durvalumab-long-term-safety-and-efficacy-study 2024-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01463423/individualized-lung-tumor-stereotactic-ablative-radiotherapy-isabr 2024-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06281678/a-study-of-ibi363-in-subjects-with-advanced-solid-malignancies 2024-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04660929/car-macrophages-for-the-treatment-of-her2-overexpressing-solid-tumors 2024-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04028479/the-registry-of-oncology-outcomes-associated-with-testing-and-treatment 2024-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03232138/clinical-trial-of-lung-cancer-chemoprevention-with-sulforaphane-in-former-smokers 2024-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04975256/adagrasib-in-combination-with-bi-1701963-in-patients-with-cancer-krystal-14 2024-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05462795/liquid-biopsy-for-early-non-small-lung-cancer-detection 2024-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03518554/a-first-in-human-dose-escalation-study-of-jab-3068-shp2-inhibitor-in-adult-patients-with 2024-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03549000/a-phase-i-ib-study-of-nzv930-alone-and-in-combination-with-pdr001-and-or-nir178-in-patie 2024-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05094544/pre-operative-immuno-modulatory-sbrt-poims-trial-a-pilot-trial-in-early-stage-nsclc 2024-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05375084/shp2-inhibitor-bbp-398-in-combination-with-nivolumab-in-patients-with-advanced-non-small 2024-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02108964/a-phase-i-ii-multicenter-open-label-study-of-egfrmut-tki-egf816-administered-orally-in-a 2024-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05349227/comprehensive-outcomes-for-after-cancer-health 2024-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03233204/olaparib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodg 2024-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04865133/efficacy-and-safety-of-covid-19-vaccine-in-cancer-patients 2024-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02588261/a-study-of-asp8273-vs-erlotinib-or-gefitinib-in-first-line-treatment-of-patients-with-st 2024-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04273893/lymphocyte-depletion-and-change-in-lymphocyte-functionality 2024-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03846310/a-study-to-evaluate-immunotherapy-combinations-in-participants-with-lung-cancer 2024-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04672434/sym024-monotherapy-and-in-combination-with-sym021-in-patients-with-advanced-solid-tumor 2024-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06557967/study-on-prevalence-and-impact-of-brain-metastases-on-survival-in-lung-cancer-by-line-of 2024-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05831995/safety-and-effectiveness-of-abm-168-in-adults-with-advanced-solid-tumors 2024-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06055972/impact-of-patient-centered-approach-for-communicating-coronary-calcium-on-cardiovascular 2024-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04319757/ace1702-in-subjects-with-advanced-or-metastatic-her2-expressing-solid-tumors 2024-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05049863/chemotherapy-in-patients-with-relapsed-small-cell-lung-cancer-in-combination-with-allopu 2024-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04995172/feasibility-of-mobile-ct-assisted-bronchoscopy-for-the-diagnosis-of-lung-lesion 2024-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04956692/study-of-pembrolizumab-mk-3475-subcutaneous-sc-versus-pembrolizumab-intravenous-iv-admin 2024-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04436120/treatment-resistance-following-anti-cancer-therapies 2024-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05304390/a-tailored-screening-and-smoking-cessation-program-for-the-lgbtq-community-of-seattle 2024-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00471978/dna-analysis-of-blood-and-tissue-from-patients-with-lung-cancer 2024-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03029325/molecular-and-genetic-analysis-of-lung-cancer 2024-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06626243/analysis-of-rats-vats-and-open-lung-resections-after-neoadjuvant-chemo-immunotherapy-in 2024-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02892123/trial-of-zw25-zanidatamab-in-patients-with-advanced-her2-expressing-cancers 2024-11-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04951115/a-trial-with-chemotherapy-immunotherapy-and-radiotherapy-for-patients-with-newly-diagnos 2024-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04526509/master-protocol-to-assess-safety-and-dose-of-first-time-in-human-next-generation-enginee 2024-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04318249/behavioral-relaxation-approaches-for-insomnia-in-lung-cancer-patients 2024-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05128487/a-study-of-ndi-1150-101-in-patients-with-solid-tumors 2024-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03515837/study-of-pemetrexed-platinum-chemotherapy-with-or-without-pembrolizumab-mk-3475-in-adult 2024-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03927989/tobacco-treatment-in-the-context-of-lung-cancer-screening 2024-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03944798/surveillance-after-extremity-tumor-surgery 2024-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04629300/supportive-care-mobile-application-for-patients-with-nsclc 2024-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04994795/predictive-multimodal-signatures-associated-with-response-to-treatment-and-prognosis-of 2024-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00739453/a-phase-1-dose-escalation-study-of-osi-906-and-erlotinib-tarceva 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01553942/afatinib-with-ct-and-rt-for-egfr-mutant-nsclc 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02135679/the-detection-of-circulating-tumor-cells-ctc-in-patients-with-nsclc-undergoing-definitiv 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03082300/a-study-of-asp8273-in-subjects-with-non-small-cell-lung-cancer-nsclc-harboring-epidermal 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00514306/study-of-intermittent-osi-906-dosing 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00514007/study-of-continuous-osi-906-dosing 2024-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03761914/galinpepimut-s-in-combination-with-pembrolizumab-in-patients-with-selected-advanced-canc 2024-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01217411/ro4929097-and-whole-brain-radiation-therapy-or-stereotactic-radiosurgery-in-treating-pat 2024-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03166631/a-trial-to-find-the-safe-dose-for-bi-891065-alone-and-in-combination-with-bi-754091-in-p 2024-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05228015/oral-tead-inhibitor-targeting-the-hippo-pathway-in-subjects-with-advanced-solid-tumors 2024-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04787042/phase-1a-and-phase-2-study-for-safety-preliminary-efficacy-pk-and-pd-of-st-067 2024-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02635672/phase-i-dose-escalation-study-for-vip152-in-patients-with-advanced-cancer 2024-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05712889/phase-1-dose-escalation-study-for-vip236-in-patients-with-advanced-cancer 2024-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05199272/a-phase-1-2a-study-of-23me-00610-in-patients-with-advanced-solid-malignancies 2024-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05671887/dream-double-lung-transplant-registry-aimed-for-lung-limited-malignancies 2024-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03413449/a-prospective-study-frailty-for-esophagectomy-and-lung-resection-in-thoracic-surgery 2024-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02113813/a-dose-escalation-study-of-asp8273-in-subjects-with-non-small-cell-lung-cancer-nsclc-who 2024-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02899754/incorporating-veterans-preferences-into-lung-cancer-screening-decisions 2024-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06539169/flower-following-longitudinal-outcomes-with-epidemiology-for-rare-diseases 2024-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06048705/study-of-gsk3901961-in-previously-treated-advanced-metastatic-or-unresectable-synovial-s 2024-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06426628/clinical-utility-of-management-of-patients-with-pulmonary-nodules-using-the-percepta-nas 2024-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01413750/carboplatin-and-paclitaxel-with-or-without-vorinostat-in-treating-patients-with-advanced 2024-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03285893/oral-cell-dna-adducts-in-smokers 2024-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04183062/bio-11006-for-osteosarcoma-and-ewing-s-sarcoma-lung-metastases 2024-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05048082/a-study-to-evaluate-pegsitacianine-an-intraoperative-fluorescence-imaging-agent-for-the 2024-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02094261/phase-ii-azd9291-open-label-study-in-nsclc-after-previous-egfr-tki-therapy-in-egfr-and-t 2024-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06448364/a-study-in-advanced-metastatic-solid-tumors-with-the-study-medicine-pf-07329640-when-giv 2024-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04702607/functional-lung-imaging-with-dect-and-4dct 2024-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04504669/first-time-in-human-study-of-azd8701-with-or-without-durvalumab-in-participants-with-adv 2024-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04795713/study-of-mt-6402-in-subjects-with-advanced-solid-cancer-that-expresses-pd-l1 2024-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06034860/study-of-mt-8421-as-monotherapy-and-in-combination-with-nivolumab-in-patients-with-selec 2024-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06583395/quest-to-analyze-one-thousand-humans-meditating 2024-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05304793/testing-a-cognitive-behavioral-model-for-reducing-dyspnea-in-patients-with-lung-cancer 2024-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05566041/a-phase-3-controlled-open-label-global-randomized-study-of-rrx-001-with-a-platinum-doubl 2024-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04866017/a-study-to-compare-ociperlimab-plus-tislelizumab-versus-durvalumab-following-concurrent 2024-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05248256/vertebral-marrow-attention-trial-vmat 2024-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00309998/vinorelbine-and-bevacizumab-in-treating-older-patients-with-stage-iii-or-stage-iv-non-sm 2024-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03611881/assessing-the-integration-of-tobacco-cessation-treatment-into-lung-cancer-screening-lcs 2024-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05046067/feasibility-study-of-anatomical-modeling-for-image-guided-thoracic-surgery 2024-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04952597/study-of-ociperlimab-plus-tislelizumab-plus-chemoradiotherapy-in-participants-with-untre 2024-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01766739/intra-pleural-administration-of-gl-onc1-a-genetically-modified-vaccinia-virus-in-patient 2024-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04791215/circulating-tumor-dna-alterations-in-non-small-cell-lung-cancer-patients-treated-with-pe 2024-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04887298/study-of-liposomal-annamycin-for-the-treatment-of-subjects-with-soft-tissue-sarcomas-sts 2024-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01725165/surgery-and-or-radiation-therapy-or-standard-therapy-and-or-clinical-observation-in-trea 2024-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06084806/test-retest-evaluation-of-18f-f-arag-pet 2024-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06107374/imaging-advanced-nsclc-patients-undergoing-pd-1-pd-l1-directed-therapy-using-18f-farag 2024-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03075072/hippocampal-sparing-whole-brain-radiation-versus-stereotactic-radiation-in-patients-with 2024-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04987281/robotic-bronchoscopy-with-cone-ct-and-indocyanine-green-to-aid-removal-of-lung-lesions-i 2024-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03809624/study-of-inbrx-105-and-inbrx-105-with-pembrolizumab-in-patients-with-solid-tumors-includ 2024-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03217071/pembrolizumab-with-and-without-radiotherapy-for-non-small-cell-lung-cancer 2024-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03958045/combination-rucaparib-with-nivolumab-in-small-cell-lung-carcinoma 2024-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03345485/study-of-the-safety-pharmacokinetics-and-efficacy-of-tinostamustine-in-patients-with-adv 2024-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03239340/a-molecular-profiling-study-of-patients-with-egfr-mutation-positive-locally-advanced-or 2024-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05427214/imaging-study-on-halcyon-4-0-system-for-patients-receiving-radiation-therapy 2024-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05012397/milademetan-in-advanced-metastatic-solid-tumors 2024-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05400226/phase-2-study-of-vgt-309-in-lung-cancer 2024-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05501665/split-course-adaptive-radiation-therapy-with-pembrolizumab-with-without-chemotherapy-for 2024-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02364609/pembrolizumab-and-afatinib-in-patients-with-non-small-cell-lung-cancer-with-resistance-t 2024-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04897568/shared-decision-making-in-rural-primary-care-lung-cancer-screening-and-smoking-cessation 2024-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04105283/tc99m-maa-bronchial-artery-injection-during-bronchial-embolization-for-pulmonary-mass-in 2024-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03004183/sbrt-and-oncolytic-virus-therapy-before-pembrolizumab-for-metastatic-tnbc-and-nsclc 2024-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04806399/improving-utilization-of-lung-cancer-screening-in-underserved-pa-populations 2024-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05215574/study-of-ngm831-as-monotherapy-and-in-combination-with-pembrolizumab-or-pembrolizumab-an 2024-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03879798/ds-3201b-and-irinotecan-for-patients-with-recurrent-small-cell-lung-cancer 2024-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03996473/study-to-test-the-safety-and-how-radium-223-dichloride-an-alpha-particle-emitting-radioa 2024-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04308226/lung-cancer-screening-navigation-for-homeless-people 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03207867/a-phase-2-study-of-nir178-in-combination-with-pdr001-in-patients-with-solid-tumors-and-n 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01265433/galinpepimut-s-wt-1-analog-peptide-vaccine-in-malignant-pleural-mesothelioma-after-combi 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03447769/brief-title-study-of-efficacy-and-safety-of-canakinumab-as-adjuvant-therapy-in-adult-sub 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04323436/study-of-capmatinib-and-spartalizumab-placebo-in-advanced-nsclc-patients-with-met-exon-1 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02955758/pembrolizumab-in-patients-with-metastatic-non-squamous-non-small-cell-lung-cancer 2024-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03822351/durvalumab-alone-or-in-combination-with-novel-agents-in-subjects-with-nsclc 2024-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03612804/promoting-smoking-cessation-in-lung-cancer-screening-through-proactive-treatment 2024-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03583086/phase-i-ii-eval-safety-prelim-activity-nivolumab-comb-w-vorolanib-pts-w-refractory-thora 2024-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01899989/stereotactic-body-radiation-therapy-for-inoperable-locally-advanced-non-small-cell-lung 2024-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02294487/study-of-the-immune-response-after-vaccination-in-multiple-myeloma-patients 2024-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02298816/b-cell-hematologic-malignancy-vaccination-registry 2024-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04913337/study-of-ngm707-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-meta 2024-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03376971/real-time-optical-biopsy-in-improving-lung-cancer-diagnosis-in-patients-undergoing-lung 2024-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05397171/a-first-in-human-study-to-evaluate-the-safety-and-tolerability-of-azd8853-in-participant 2024-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01306045/molecular-profiling-and-targeted-therapy-for-advanced-non-small-cell-lung-cancer-small-c 2024-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05191797/bomedemstat-and-maintenance-immunotherapy-for-treatment-of-newly-diagnosed-extensive-sta 2024-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04768296/berzosertib-topotecan-in-relapsed-platinum-resistant-small-cell-lung-cancer-ddriver-sclc 2024-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00807612/quilt-2-017-phase-1b-2-study-of-amg-479-in-combination-with-paclitaxel-and-carboplatin-f 2024-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00365105/zoledronate-vitamin-d-and-calcium-with-or-without-strontium-89-or-samarium-153-in-preven 2024-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02927301/a-study-of-atezolizumab-as-neoadjuvant-and-adjuvant-therapy-in-resectable-non-small-cell 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03426306/a-novel-lung-function-imaging-modality-as-a-preoperative-evaluation-tool-lime 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06064279/harnessing-allo-immunity-to-enhance-immune-checkpoint-inhibitor-responses-in-advanced-ns 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02358473/study-of-mogamulizumab-docetaxel-in-subjects-with-non-small-cell-lung-cancer 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04965818/phase-1b-2-study-of-futibatinib-in-combination-with-binimetinib-in-patients-with-advance 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04750824/real-world-effectiveness-of-afatinib-gilotrif-following-immunotherapy-in-the-treatment-o 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05224271/evaluating-patient-reported-outcomes-in-radiation-therapy-the-pro-rt-study 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02855125/a-randomized-phase-2-trial-of-tas-114-in-combination-with-s-1-versus-s-1 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06172959/the-short-term-impact-of-vocal-intonation-therapy-vit-and-therapeutic-singing-ts-on-resp 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05058339/distress-associated-with-coronavirus-disease-2019-and-telehealth-on-supportive-care-pati 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04351334/anaplastic-lymphoma-kinase-alk-positive-non-small-cell-lung-cancer-nsclc-post-alectinib 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02250326/safety-and-efficacy-study-of-nab-paclitaxel-with-cc-486-or-nab-paclitaxel-with-durvaluma 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04434482/imp4297-in-combination-with-temozolomide-in-patients-with-advanced-solid-tumors-and-smal 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01885299/rssearch-patient-registry-long-term-study-of-use-of-srs-sbrt 2024-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04173507/combination-treatment-talazoparib-plus-avelumab-for-stage-iv-or-recurrent-non-squamous-n 2024-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02664181/rational-epigenetic-immunotherapy-for-second-line-therapy-in-patients-with-nsclc-precise 2024-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03971474/ramucirumab-and-pembrolizumab-versus-standard-of-care-in-treating-patients-with-stage-iv 2024-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02492867/a-pilot-study-of-response-driven-adaptive-radiation-therapy-for-patients-with-locally-ad 2024-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04385368/phase-iii-study-to-determine-the-efficacy-of-durvalumab-in-combination-with-chemotherapy 2024-08-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06577883/next-generation-chest-x-ray-tomosynthesis-for-screening-of-lung-cancer 2024-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03693612/gsk3359609-plus-tremelimumab-for-the-treatment-of-advanced-solid-tumors 2024-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03473925/efficacy-and-safety-study-of-navarixin-mk-7123-in-combination-with-pembrolizumab-mk-3475 2024-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06576232/standalone-observational-study-assessing-the-performance-of-an-ai-ml-tech-based-samd-on 2024-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02431676/survivorship-promotion-in-reducing-igf-1-trial 2024-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05830097/a-study-of-bi-ligand-drug-conjugate-cbp-1019-in-patients-with-advanced-solid-tumors 2024-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03674827/vaccine-based-immunotherapy-regimen-for-nsclc-and-tnbc 2024-08-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03891602/decide-developing-tools-for-lung-cancer-screening-discussion-improvement 2024-08-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02725840/breast-cancer-lung-late-effects 2024-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03664024/biomarkers-of-response-to-pembrolizumab-combined-with-chemotherapy-in-non-small-cell-lun 2024-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04348292/sirolimus-and-durvalumab-for-the-treatment-of-stage-i-iiia-non-small-cell-lung-cancer 2024-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00655655/everolimus-and-vatalanib-in-treating-patients-with-advanced-solid-tumors 2024-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02520778/osimertinib-and-navitoclax-in-treating-patients-with-egfr-positive-previously-treated-ad 2024-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03421353/azd9150-plus-durvalumab-alone-or-in-combination-with-chemotherapy-in-patients-with-advan 2024-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02420314/pharmacological-ascorbate-for-lung-cancer 2024-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04761783/bespoke-study-of-ctdna-guided-immunotherapy 2024-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02773238/flare-rt-for-patients-with-stage-iib-iiib-non-small-cell-lung-cancer-personalizing-radia 2024-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01970865/a-study-of-pf-06463922-an-alk-ros1-inhibitor-in-patients-with-advanced-non-small-cell-lu 2024-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06549088/analysis-of-lung-cancer-tissue-with-spatial-frequency-domain-imaging 2024-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04980521/promoting-radon-testing-via-smartphone-app-a-clinical-trial-in-a-high-radon-state 2024-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05084859/a-study-evaluating-the-safety-pharmacokinetics-and-preliminary-efficacy-of-orally-admini 2024-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03050554/sbrt-combined-with-avelumab-anti-pd-l1-for-management-of-early-stage-non-small-cell-lung 2024-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02595866/testing-the-addition-of-an-experimental-medication-mk-3475-pembrolizumab-to-usual-anti-r 2024-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03127098/quilt-3-040-etbx-011-ad5-e1-e2b-cea-6d-vaccine-in-combination-with-alt-803-super-agonist 2024-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05634551/perceptions-on-expected-outcomes-of-immunotherapy-in-advanced-cancer-patients-with-poor 2024-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04166240/measuring-and-improving-the-safety-of-test-result-follow-up 2024-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02991677/exercise-effect-on-chemotherapy-induced-neuropathic-pain 2024-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06540495/virtual-personalized-exercise-program-for-lung-cancer-patients 2024-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04545710/osimertinib-and-abemaciclib-in-egfr-mutant-non-small-cell-lung-cancer-after-osimertinib 2024-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01712217/a-study-of-at13387-in-patients-with-non-small-cell-lung-cancer-nsclc-alone-and-in-combin 2024-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01357395/a-phase-2-open-label-study-of-amuvatinib-in-combination-with-platinum-etoposide-chemothe 2024-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05016622/booster-dose-trial 2024-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02443324/a-study-of-ramucirumab-plus-pembrolizumab-in-participants-with-gastric-or-gej-adenocarci 2024-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01706432/hypofractionated-image-guided-radiation-therapy-in-treating-patients-with-stage-iv-breas 2024-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02707666/a-pilot-window-of-opportunity-study-of-the-anti-pd-1-antibody-pembrolizumab-in-patients 2024-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03689855/ramucirumab-and-atezolizumab-after-progression-on-any-immune-checkpoint-blocker-in-nsclc 2024-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02554812/a-study-of-avelumab-in-combination-with-other-cancer-immunotherapies-in-advanced-maligna 2024-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00998166/a-study-of-cisplatin-pemetrexed-avastin-as-first-line-therapy 2024-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04628780/study-to-test-the-safety-and-tolerability-of-pf-07209960-in-advanced-or-metastatic-solid 2024-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05062538/cancer-patient-perspectives-during-covid-19 2024-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02352948/a-global-study-to-assess-the-effects-of-medi4736-durvalumab-given-as-monotherapy-or-in-c 2024-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03819387/a-study-of-nbf-006-in-non-small-cell-lung-pancreatic-or-colorectal-cancer 2024-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06517433/first-in-human-dose-escalation-study-of-xmt-1536-in-cancers-likely-to-express-napi2b 2024-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06514248/clinical-evaluation-of-the-v5-lu01-ai-software-in-thoracic-ct-for-v5med-inc 2024-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05013099/study-of-zirconium-zr-89-crefmirlimab-berdoxam-pet-ct-in-subjects-with-advanced-or-metas 2024-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04198818/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-hh2710-in-patient-wi 2024-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05583188/neoadjuvant-aliyatm-pef-soft-tissue-ablation-with-systemic-therapy-in-early-stage-resect 2024-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04712877/testing-tumor-tissue-and-blood-to-help-select-personalized-treatments-for-patients-with 2024-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05271292/chiauranib-for-advanced-solid-malignant-tumors-and-relapsed-refractory-sclc 2024-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03546894/a-study-to-determine-progression-free-survival-pfs-and-evaluate-participant-experience-f 2024-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03535766/an-analysis-of-treatment-timelines-for-lung-cancer-patients-across-system-evolutions 2024-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03560791/a-review-of-low-dose-ct-lung-cancer-screenings-in-a-community-based-healthcare-system-wi 2024-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04072393/cardiac-rehabilitation-for-patients-receiving-radiation-therapy-for-thoracic-cancers 2024-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03091816/dynamic-perfusion-computed-tomography-in-patients-with-localized-non-small-cell-lung-can 2024-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03681483/ro5126766-for-patients-with-advanced-kras-mutant-lung-cancer 2024-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05769959/study-of-ro7515629-in-participants-with-hla-g-positive-solid-tumors 2024-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05364645/testing-the-use-of-targeted-treatment-for-ret-positive-advanced-non-small-cell-lung-canc 2024-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06342427/stomach-cancer-exosome-based-detection 2024-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03752398/a-study-of-xmab-23104-in-subjects-with-selected-advanced-solid-tumors-duet-3 2024-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00254384/docetaxel-cisplatin-and-erlotinib-hydrochloride-in-treating-patients-with-stage-i-iii-no 2024-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04822298/study-of-amg-160-in-subjects-with-non-small-cell-lung-cancer 2024-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06378658/a-study-to-learn-about-how-food-and-esomeprazole-affect-the-level-of-bay2927088-in-the-b 2024-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02954523/dasatinib-and-osimertinib-azd9291-in-advanced-non-small-cell-lung-cancer-with-egfr-mutat 2024-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06360211/a-study-to-learn-about-how-bay2927088-affects-the-level-of-midazolam-in-the-blood-when-b 2024-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03502330/apx005m-with-nivolumab-and-cabiralizumab-in-advanced-melanoma-non-small-cell-lung-cancer 2024-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05538572/a-study-of-prt3645-in-participants-with-select-advanced-or-metastatic-solid-tumors 2024-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00026663/collection-of-blood-bone-marrow-tumor-or-tissue-samples-from-patients-with-cancer-to-stu 2024-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02949843/targeted-therapy-in-treating-patients-with-incurable-non-small-cell-lung-cancer-with-gen 2024-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04717804/4d-cbct-and-intrafractional-imaging-for-the-determination-of-the-most-representative-4d 2024-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04432857/an0025-and-pembrolizumab-combination-in-advanced-solid-tumors 2024-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04740047/cios-mobile-3d-spin-for-robotic-bronchoscopy 2024-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02408406/patientcareanywhere-internet-based-software-in-improving-communication-and-education-in 2024-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03743051/a-study-to-evaluate-the-efficacy-and-safety-of-anamorelin-hcl-for-the-treatment-of-malig 2024-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03743064/a-study-to-evaluate-the-efficacy-and-safety-of-anamorelin-hcl-for-the-treatment-of-malig 2024-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02200757/efficacy-and-safety-of-aldoxorubicin-compared-to-topotecan-in-subjects-with-metastatic-s 2024-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04642469/phase-iii-study-to-determine-efficacy-of-durvalumab-in-stage-ii-iii-non-small-cell-lung 2024-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03726333/hepatic-impairment-study-for-lorlatinib-in-cancer-patients 2024-06-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05060432/study-of-eos-448-with-standard-of-care-and-or-investigational-therapies-in-participants 2024-06-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06110572/phase-i-ii-trial-in-es-sclc-to-enhance-response-to-atezolizumab-plus-chemotherapy-with-t 2024-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03968419/this-study-will-evaluate-the-effect-of-canakinumab-or-pembrolizumab-given-as-monotherapy 2024-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06348888/a-study-to-learn-about-how-itraconazole-and-carbamazepine-affect-the-level-of-bay2927088 2024-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03693300/a-study-to-determine-safety-of-durvalumab-after-sequential-chemo-radiation-in-patients-w 2024-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04037462/induction-of-sensecence-using-dexamethasone-to-re-sensitize-nsclc-to-anti-pd1-therapy 2024-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171491/lunglb-in-subjects-presenting-with-indeterminate-pulmonary-nodules 2024-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03095612/phase-1-2-trial-of-selinexor-kpt-330-with-docetaxel-for-non-small-cell-lung-cancer-nsclc 2024-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00341939/retrospective-analysis-of-a-drug-metabolizing-genotype-in-cancer-patients-and-correlatio 2024-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04161391/study-of-tpx-0046-a-ret-src-inhibitor-in-adult-subjects-with-advanced-solid-tumors-harbo 2024-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03621982/study-of-adct-301-in-patients-with-selected-advanced-solid-tumors 2024-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05435846/capmatinib-plus-trametinib-for-the-treatment-of-metastatic-non-small-cell-lung-cancer-wi 2024-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02759835/local-ablative-therapy-for-treatment-of-oligoprogressive-egfr-mutated-non-small-cell-lun 2024-06-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04404361/pre-vent-study-in-hospitalized-patients-with-severe-covid-19-with-or-without-cancer 2024-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03847519/study-of-adxs-503-with-or-without-pembro-in-subjects-with-metastatic-non-small-cell-lung 2024-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02061800/cd34-malignant-stem-cell-selection-for-patients-receiving-allogenic-stem-cell-transplant 2024-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04336098/study-of-srf617-in-patients-with-advanced-solid-tumors 2024-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02309892/a-dose-escalation-study-of-l-dos47-in-recurrent-or-metastatic-non-squamous-nsclc 2024-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05920850/the-shared-project-lung-cancer-screening-for-african-american-men-aam 2024-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02847728/pattern-of-use-and-safety-effectiveness-of-nivolumab-in-routine-oncology-practice 2024-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02350764/evaluate-the-mediators-of-sensitivity-and-resistance-to-nivolumab-plus-ipilimumab-in-pat 2024-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03629756/a-study-to-evaluate-the-safety-and-tolerability-of-immunotherapy-combinations-in-partici 2024-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04752267/18f-fmau-pet-ct-and-mri-for-the-detection-of-brain-tumors-in-patients-with-brain-cancer 2024-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04604158/evaluating-the-effect-of-a-mobile-audio-companion-elly-to-reduce-anxiety-in-cancer-patie 2024-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02107755/stereotactic-radiation-therapy-and-ipilimumab-in-treating-patients-with-metastatic-melan 2024-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04190628/safety-and-tolerability-of-abm-1310-in-patients-with-advanced-solid-tumors 2024-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02164461/axalimogene-filolisbac-adxs11-001-high-dose-in-women-with-human-papillomavirus-hpv-cervi 2024-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03001882/an-exploratory-study-of-the-effects-of-nivolumab-combined-with-ipilimumab-in-patients-wi 2024-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03516994/reducing-disparities-in-the-quality-of-advance-care-planning-for-older-adults 2024-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03502746/phase-ii-nivolumab-and-ramucirumab-for-patients-with-previously-treated-mesothelioma 2024-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06136923/an-exploratory-study-to-evaluate-attention-biases-in-adults-with-multiple-sclerosis-brea 2024-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02663518/a-trial-of-pf-07901800-tti-621-for-patients-with-hematologic-malignancies-and-selected-s 2024-05-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01941316/study-of-carfilzomib-with-irinotecan-in-irinotecan-sensitive-malignancies-and-small-cell 2024-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04953065/coronavirus-disease-2019-covid-19-vaccination-in-cancer-patients 2024-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04263090/rigosertib-plus-nivolumab-for-kras-nsclc-patients-who-progressed-on-first-line-treatment 2024-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02695680/lung-sbrt-motion-management-gcc-1619 2024-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05956782/breathe-easier-ii-a-dyad-based-multiple-behavior-intervention 2024-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04680377/using-microbiome-to-predict-durvalumab-toxicity-in-post-concurrent-chemoradiation-therap 2024-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02225405/cisplatin-docetaxel-and-nintedanib-before-surgery-in-treating-patients-with-previously-u 2024-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05859217/a-study-of-combining-cabozantinib-and-atezolizumab-for-advanced-metastatic-nsclc-cabatez 2024-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05635266/tissue-repository-providing-annotated-biospecimens-for-approved-investigator-directed-bi 2024-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02635061/selective-hdac6-inhibitor-acy-241-in-combination-with-nivolumab-in-patients-with-unresec 2024-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04682301/tailoring-shared-decision-making-for-lung-cancer-screening-in-persons-living-with-hiv 2024-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01928576/phase-ii-anti-pd1-epigenetic-therapy-study-in-nsclc 2024-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02658097/pembrolizumab-alone-or-sequentially-following-single-fraction-non-ablative-radiation-to 2024-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03146962/high-dose-vitamin-c-intravenous-infusion-in-patients-with-resectable-or-metastatic-solid 2024-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05493501/aumolertinib-with-chemotherapy-or-alone-compared-with-osimertinib-in-patients-with-epide 2024-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04476797/phase-i-ii-study-of-sbrt-and-gc4711-for-centrally-located-or-large-nsclc 2024-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04622007/tomivosertib-combined-with-pembrolizumab-in-subjects-with-pd-l1-positive-nsclc-kickstart 2024-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04742959/study-of-tt-00420-tinengotinib-tablet-as-monotherapy-and-combination-therapy-in-patients 2024-04-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05799976/text-message-based-nudges-prior-to-primary-care-visits-to-increase-care-gap-closure 2024-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01063907/a-study-of-kw-2478-in-combination-with-bortezomib-in-subjects-with-relapsed-and-or-refra 2024-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00940225/study-of-cabozantinib-xl184-in-adults-with-advanced-malignancies 2024-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04913415/a-study-to-evaluate-routine-chest-tube-management-after-minimally-invasive-lung-surgery 2024-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05709821/imm60-and-pembrolizumab-in-melanoma-and-nsclc 2024-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02414672/caresteps-a-supportive-care-program-for-the-caregivers-of-advanced-lung-cancer-patients 2024-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04885439/nextsteps-intervention-for-advanced-cancer-patients-and-caregivers 2024-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02954991/phase-2-study-of-glesatinib-sitravatinib-or-mocetinostat-in-combination-with-nivolumab-i 2024-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00728390/a-safety-and-efficacy-study-of-the-combination-of-oral-pf-00299804-and-intravenous-cp-75 2024-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04772053/molecular-disease-characterization-initiative-mdci 2024-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00342264/a-nested-case-control-study-of-lung-cancer-and-diesel-exhaust-among-non-metal-miners 2024-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01931644/at-home-research-study-for-patients-with-autoimmune-inflammatory-genetic-hematological-i 2024-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05447897/designing-an-implementation-strategy-for-lung-screening-and-smoking-cessation-treatment 2024-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04027946/lmb-100-followed-by-pembrolizumab-in-the-treatment-of-adults-with-mesothelin-expressing 2024-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05412875/pilot-trial-of-e-cigarettes-in-pts-diagnosed-with-cancer-of-the-head-neck-and-lung 2024-04-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05061537/study-of-pf-07263689-in-participants-with-selected-advanced-solid-tumors 2024-04-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05519293/phase-i-iia-study-of-h002-in-nsclc-with-active-egfr-mutation 2024-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02920996/merestinib-in-non-small-cell-lung-cancer-and-solid-tumors 2024-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03250832/study-of-tsr-033-with-an-anti-programmed-cell-death-1-receptor-pd-1-in-participants-with 2024-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04426201/interleukin-7-to-improve-clinical-outcomes-in-lymphopenic-patients-with-covid-19-infecti 2024-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03472560/a-study-of-avelumab-in-combination-with-axitinib-in-non-small-cell-lung-cancer-nsclc-or 2024-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04666025/sars-cov-2-donor-recipient-immunity-transfer 2024-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03490669/study-to-evaluate-safety-pk-pd-immunogenicity-antitumor-activity-of-msc-1-in-patients-wi 2024-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04291755/development-and-analysis-of-a-stool-bank-for-cancer-patients 2024-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04638751/argonaut-stool-and-blood-sample-bank-for-cancer-patients 2024-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04148937/a-study-of-the-cd73-inhibitor-ly3475070-alone-or-in-combination-with-pembrolizumab-in-pa 2024-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00445965/iodine-i-131-monoclonal-antibody-3f8-in-treating-patients-with-central-nervous-system-ca 2024-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03400748/anet-electrosurgery-applicator-pilot-evaluation-study 2024-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03076164/a-phase-1-2-trial-of-trametinib-and-erlotinib-in-patients-with-egfr-mutant-lung-adenocar 2024-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04610658/immune-checkpoint-inhibition-with-lurbinectedin-relapsed-recurrent-sclc 2024-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05311618/study-of-ngm438-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-meta 2024-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05815186/ladarixin-with-sotorasib-in-advanced-nsclc-phase-ii 2024-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03893539/clinical-utility-for-ion-endoluminal-system 2024-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01761240/dose-escalation-study-morab-066-targeting-tissue-factor-tf-expressing-malignancies-inclu 2024-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03329950/a-study-of-cdx-1140-cd40-as-monotherapy-or-in-combination-in-patients-with-advanced-mali 2024-03-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02581787/sabr-atac-a-trial-of-tgf-beta-inhibition-and-stereotactic-ablative-radiotherapy-for-earl 2024-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03699956/rrx-001-sequentially-with-a-platinum-doublet-or-a-platinum-doublet-in-third-line-or-beyo 2024-03-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02619448/concurrent-chemotherapy-plus-hfr-radiation-therapy-in-inoperable-nsclc 2024-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04682431/a-phase-1a-1b-fih-study-of-py159-and-in-combination-with-pembrolizumab-in-subjects-with 2024-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03590054/abexinostat-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-tumor-mali 2024-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04691375/a-study-of-py314-in-subjects-with-advanced-solid-tumors 2024-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03216109/improving-supportive-care-for-patients-with-thoracic-malignancies 2024-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01789983/feasibility-of-an-evidence-based-walking-program-in-cancer-pts-60-during-chemotherapy 2024-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02414139/study-of-oral-cmet-inhibitor-inc280-in-patients-with-egfr-wild-type-wt-advanced-non-smal 2024-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02022982/palbociclib-pd-0325901-for-nsclc-solid-tumors 2024-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03290677/study-of-core-needle-biopsy-and-cryoablation-of-an-enlarging-tumor-in-patients-with-meta 2024-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06225804/a-study-to-assess-safety-tolerability-and-pharmacokinetics-of-absk112-in-patients-with-n 2024-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04903873/a-study-to-evaluate-safety-efficacy-and-pharmacokinetics-in-participants-with-advanced-s 2024-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04396340/first-in-human-study-of-xmt-1592-in-patients-with-ovarian-cancer-and-nsclc-likely-to-exp 2024-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05425576/ot-101-in-combination-with-pembrolizumab-in-subjects-with-malignant-pleural-mesothelioma 2024-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05231746/a-study-of-hstc810-with-advanced-metastatic-solid-tumors-stcube-001 2024-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03535363/osimertinib-with-stereotactic-radiosurgery-srs-in-brain-metastases-from-egfr-positive-ns 2024-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04610684/chemotherapy-and-atezolizumab-for-patients-with-extensive-stage-small-cell-lung-cancer-s 2024-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04102436/non-viral-tcr-gene-therapy 2024-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01953926/basket-study-of-neratinib-in-participants-with-solid-tumors-harboring-somatic-her2-or-eg 2024-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05219734/mrd-assay-evaluates-recurrence-and-response-via-a-tumor-informed-assessment 2024-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05121948/a-study-of-hc-7366-to-establish-the-maximum-tolerated-dose-mtd-and-recommended-phase-2-d 2024-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05546437/a-multicenter-retrospective-review-to-evaluate-the-feasibility-of-dye-marking-using-the 2024-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04834778/a-study-of-hc-5404-fu-to-establish-the-maximum-tolerated-dose-mtd 2024-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03665285/a-safety-and-tolerability-study-of-nc318-in-subjects-with-advanced-or-metastatic-solid-t 2024-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04069026/a-first-in-humans-dose-finding-study-for-an-aryl-hydrocarbon-receptor-inhibitor-ahri-in 2024-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02247349/bms-986012-in-relapsed-refractory-sclc 2024-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03861793/a-dose-escalation-and-cohort-expansion-study-of-subcutaneously-administered-cytokine-alk 2024-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00020202/fr901228-in-treating-patients-with-refractory-or-progressive-small-cell-lung-cancer-or-n 2024-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00019006/vaccine-therapy-in-treating-patients-with-colon-pancreatic-or-lung-cancer 2024-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00020267/vaccine-therapy-in-treating-patients-with-metastatic-cancer 2024-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03403361/dual-energy-ct-on-plan-quality-dose-delivery-accuracy-and-simulated-outcomes-of-patients 2024-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05099549/safety-tolerability-and-anti-tumor-activity-of-afm24-in-combination-with-snk01-in-subjec 2024-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06028152/using-an-end-of-life-conversation-game-to-engage-patients-with-cancer-in-advance-care-pl 2024-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05315908/covid-19-testing-in-underserved-and-vulnerable-populations 2024-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05005273/a-study-to-assess-bms-986207-in-combination-with-nivolumab-and-ipilimumab-as-first-line 2024-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03257722/pembrolizumab-idelalisib-for-lung-cancer-study 2024-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04491084/flt3-ligand-cd40-agonist-antibody-and-stereotactic-radiotherapy 2024-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05332925/using-ex-vivo-tumoroids-to-predict-immunotherapy-response-in-nsclc 2024-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03709706/pilot-immunotherapy-study-with-letetresgene-autoleucel-lete-cel-gsk3377794-t-cells-in-ne 2024-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02922777/trial-of-dose-escalated-bgb324-in-previously-treated-non-small-cell-lung-cancer 2024-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02004028/window-of-opportunity-study-of-vs-6063-defactinib-in-surgical-resectable-malignant-pleur 2024-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03352245/feasibility-of-an-activity-regimen-in-patients-with-advanced-stage-lung-cancer 2024-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03818776/proton-based-cardiac-sparing-accelerated-fractionated-radiotherapy-in-unresectable-nsclc 2024-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05408871/non-invasive-measurement-of-pd-l1-levels-with-positron-emission-tomography-pet-in-head-a 2024-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06245876/lung-epicheck-biomarkers-development-study 2024-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03274479/pbf-1129-in-patients-with-nsclc 2024-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03639194/a-study-of-abbv-011-alone-and-in-combination-with-budigalimab-abbv-181-in-participants-w 2024-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03360695/bridge-proactive-psychiatry-consultation-and-case-management-for-patients-with-cancer 2024-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04282044/study-of-crx100-as-monotherapy-and-in-combination-with-pembrolizumab-in-patients-with-ad 2024-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03892096/development-of-a-cell-free-dna-assay-as-a-biomarker-for-predicting-early-non-response-to 2024-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01871454/safety-of-pentoxifylline-and-vitamin-e-with-stereotactic-ablative-radiotherapy-sabr-in-n 2024-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02789345/a-study-of-ramucirumab-ly3009806-or-necitumumab-ly3012211-plus-osimertinib-in-participan 2024-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04137900/safety-tolerability-and-pharmacokinetics-of-a-monoclonal-antibody-specific-to-b-and-t-ly 2024-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02654587/ose2101-versus-chemotherapy-in-hla-a2-positive-patients-with-advanced-nsclc-after-immune 2024-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05375825/phase-i-evaluation-of-immunotoxin-lmb-100-administered-by-normothermic-intrapleural-perf 2024-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04825912/resilience-measurement-in-older-adults-with-late-stage-lung-cancer 2024-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04676386/biomarker-analysis-in-high-pd-l1-expressing-nsclc-patients-treated-with-pd-1-pd-l1-based 2024-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05137782/the-science-of-the-art-of-palliative-care 2024-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02429479/preparing-family-caregivers-to-make-medical-decisions-for-their-loved-ones 2024-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02567799/bio-300-non-small-cell-lung-cancer-study 2024-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02073968/pet-adjusted-intensity-modulated-radiation-therapy-and-combination-chemotherapy-in-treat 2024-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03446417/a-study-of-zn-e4-in-subjects-with-epidermal-growth-factor-receptor-mutated-non-small-cel 2024-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04025216/a-study-of-cart-tnmuc1-in-patients-with-tnmuc1-positive-advanced-cancers 2024-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05848843/a-phase-i-study-of-adagrasib-and-durvalumab-for-treatment-of-advanced-non-small-cell-lun 2024-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03543813/proclaim-cx-2029-a-trial-to-find-safe-and-active-doses-of-an-investigational-drug-cx-202 2024-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03087760/trial-of-consolidation-pembrolizumab-after-concurrent-chemotherapy-and-proton-reirradiat 2024-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03966807/beyond-the-lung-cancer-diagnosis-leveraging-the-oncology-clinic-setting-for-actively-smo 2024-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01459497/hypofractionated-image-guided-radiation-therapy-igrt-in-patients-with-stage-ii-iii-non-s 2024-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04180176/prospective-clinicogenomic-program 2024-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04804137/immune-response-under-immunotherapy-in-metastatic-nsclc-sputum-blood-samples-and-microbi 2024-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04524195/pet-imaging-with-18f-f-arag-in-advanced-non-small-cell-lung-cancer-nsclc 2024-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05987189/diagnostic-performance-of-small-rna-blood-test-in-patients-undergoing-follow-up-imaging 2024-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03840902/m7824-with-ccrt-in-unresectable-stage-iii-non-small-cell-lung-cancer-nsclc 2024-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04803305/study-to-compare-the-effects-of-repeated-doses-of-an-investigational-new-drug-and-a-plac 2024-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01383135/biodistribution-and-safety-of-the-pet-probes-18f-fprgd2-and-18f-fpprgd2 2024-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04620330/a-study-of-avutometinib-vs-6766-defactinib-in-recurrent-kras-g12v-other-kras-and-braf-no 2024-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03492801/collection-of-blood-samples-in-patients-with-non-small-cell-lung-cancer 2024-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03870529/high-dose-vitamin-a-compound-in-treating-participants-with-resectable-non-small-cell-lun 2024-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04354701/covid-19-and-cancer-consortium-registry 2024-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00250848/lung-cancer-case-registry-and-tissue-resource 2024-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05213078/family-caregivers-in-underserved-populations-providing-complex-cancer-care 2024-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03149549/proclaim-cx-2009-a-trial-to-find-safe-and-active-doses-of-an-investigational-drug-cx-200 2024-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02879617/a-clinical-trial-of-durvalumab-medi4736-as-1st-line-therapy-in-advanced-non-small-cell-l 2024-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02581943/effect-of-pembrolizumab-with-or-without-carboplatin-and-paclitaxel-on-immune-response-in 2024-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05041062/a-study-of-immunotherapy-drugs-nivolumab-and-ipilimumab-in-patients-w-resectable-maligna 2024-01-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03749460/nivolumab-and-ipilimumab-and-stereotactic-body-radiation-therapy-in-treating-patients-wi 2023-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04244552/a-phase-1b-trial-of-atrc-101-in-adults-with-advanced-solid-malignancies 2023-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04540081/enhancing-electronic-health-systems-to-decrease-the-burden-of-colon-cancer-lung-cancer-o 2023-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04187872/litt-and-pembrolizumab-in-recurrent-brain-metastasis 2023-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03123783/cd40-agonistic-antibody-apx005m-sotigalimab-in-combination-with-nivolumab 2023-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04099836/atezolizumab-and-bevacizumab-in-egfr-mutant-nsclc-in-patients-with-progressive-disease-a 2023-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04870034/binimetinib-and-palbociclib-before-surgery-for-the-treatment-of-operable-kras-positive-l 2023-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03219268/a-study-of-mgd013-in-patients-with-unresectable-or-metastatic-neoplasms 2023-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02950337/stereotactic-body-radiation-therapy-for-un-biopsied-early-stage-non-small-cell-lung-canc 2023-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03454451/cpi-006-alone-and-in-combination-with-ciforadenant-and-with-pembrolizumab-for-patients-w 2023-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05071014/a-study-of-pembrolizumab-and-cryoablation-in-people-with-mesothelioma 2023-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03913455/guadecitabine-in-combination-with-carboplatin-in-extensive-stage-small-cell-lung-cancer 2023-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01514864/trial-of-dasatinib-in-patients-with-advanced-cancers-harboring-ddr2-mutation-or-inactiva 2023-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04151563/a-clinical-study-evaluating-nivolumab-containing-treatments-in-patients-with-advanced-no 2023-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05363605/a-study-of-225ac-fpi-1966-in-participants-with-advanced-solid-tumours 2023-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04084561/risk-communication-in-african-american-smokers 2023-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03386929/survival-prolongation-by-rationale-innovative-genomics 2023-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00638352/false-negative-rate-of-lung-percutaneous-needle-biopsy 2023-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00641238/outcome-of-patients-with-lung-masses-who-are-treated-with-radiofrequency-ablation-rfa 2023-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04299048/study-to-assess-the-safety-and-tolerability-of-repeated-doses-of-an-investigational-new 2023-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03014648/evaluating-the-efficacy-of-atezolizumab-in-advanced-non-small-cell-lung-cancer-nsclc 2023-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05059132/inspiratory-muscle-training-and-behavioral-support-to-alleviate-dyspnea-and-promote-walk 2023-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05948462/lorlatinib-in-combination-with-chemotherapy-in-participants-with-metastatic-anaplastic-l 2023-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03840928/patientspot-formerly-known-as-arthritispower 2023-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02571036/a-safety-tolerability-and-pk-study-of-dcc-2618-in-patients-with-advanced-malignancies 2023-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03683940/pilot-study-of-high-risk-lung-cancer-screening 2023-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02312622/phase-2-etirinotecan-pegol-in-refractory-brain-metastases-advanced-lung-cancer-metastati 2023-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01475500/nashville-early-diagnosis-lung-cancer-project 2023-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02716038/neoadjuvant-mpdl3280a-nab-paclitaxel-and-carboplatin-mac-in-nsclc 2023-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04636775/microbiome-in-immunotherapy-nai-ve-nsclc-patients-receiving-pd-1-l1-blockade-mip-nsclc 2023-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05159518/a-study-of-prt2527-in-participants-with-advanced-solid-tumors 2023-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00548730/comparison-trial-of-white-light-autofluorescence-and-narrow-band-imaging-bronchoscopy 2023-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05066776/liquid-biopsy-with-pet-ct-versus-pet-ct-alone-in-diagnosis-of-small-lung-nodules 2023-12-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05692713/polyomic-biomarker-verification-in-adult-chronic-graft-versus-host-disease-able3-0-cttc2 2023-12-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06161051/treatment-patterns-and-real-world-clinical-outcomes-in-patients-with-advanced-nsclc-and 2023-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04992780/comparing-hypo-fractionated-intensity-modulated-radiation-therapy-to-standard-fractionat 2023-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02608268/phase-i-ib-ii-study-of-mbg453-as-single-agent-and-in-combination-with-pdr001-in-patients 2023-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03229278/trigriluzole-with-nivolumab-and-pembrolizumab-in-treating-patients-with-metastatic-or-un 2023-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04450732/safety-of-gq1001-in-adult-patients-with-her2-positive-advanced-solid-tumors 2023-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02949076/skeletal-muscle-atrophy-and-dysfunction-in-human-cancer 2023-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02649673/lcl161-plus-topotecan-for-patients-with-relapsed-refractory-small-cell-lung-cancer-and-s 2023-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02795156/study-assessing-activity-of-molecularly-matched-targeted-therapies-in-select-tumor-types 2023-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04372524/biomarker-verification-in-pediatric-chronic-gvhd-able-2-0-ptctc-gvh-1901-study 2023-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05459311/investigating-radiation-induced-injury-to-airways-and-pulmonary-vasculature-in-lung-ster 2023-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04267874/black-raspberry-nectar-for-the-prevention-of-lung-cancer-be-well-study 2023-12-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02237183/iloprost-in-preventing-lung-cancer-in-former-smokers 2023-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02693080/ct-perfusion-imaging-in-predicting-treatment-response-in-patients-with-non-small-cell-lu 2023-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05669105/prospective-collection-of-whole-blood-from-active-non-small-cell-lung-cancer-patients-fo 2023-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00591552/use-of-harmonic-scalpel-to-decrease-lymphatic-and-chest-tube-drainage-after-lymph-node-d 2023-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02657434/a-study-of-atezolizumab-in-combination-with-carboplatin-or-cisplatin-pemetrexed-compared 2023-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03600649/clinical-trial-of-sp-2577-seclidemstat-in-patients-with-relapsed-or-refractory-ewing-or 2023-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03409458/a-dose-escalation-and-confirmation-study-of-pt-112-in-advanced-solid-tumors-in-combinati 2023-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05174468/analysis-of-volatile-chemicals-in-lung-cancer-screen-eligible-subjects-using-infrared-sp 2023-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04556435/breath-analysis-in-early-stage-lung-cancer-using-infrared-spectroscopy 2023-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02826161/a-study-of-napabucasin-bbi-608-plus-weekly-paclitaxel-versus-weekly-paclitaxel-alone-in 2023-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04229381/resiliency-among-older-adults-receiving-lung-cancer-treatment 2023-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02729298/first-in-human-study-of-oral-tp-0903-a-novel-inhibitor-of-axl-kinase-in-patients-with-ad 2023-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02498665/a-study-of-dsp-7888-dosing-emulsion-in-adult-patients-with-advanced-malignancies 2023-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03319628/first-in-human-study-of-xmt-1536-in-cancers-likely-to-express-napi2b 2023-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02232126/social-work-intervention-focused-on-transitions 2023-11-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05594147/an-observational-study-called-rocurs-to-learn-about-covid-19-related-outcomes-in-people 2023-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04467801/ipatasertib-and-docetaxel-in-metastatic-nsclc-patients-who-have-failed-1st-line-immunoth 2023-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03200236/the-lung-screening-tobacco-and-health-project 2023-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05094804/a-study-of-or2805-a-monoclonal-antibody-targeting-cd163-alone-and-in-combination-with-an 2023-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03871153/chemoradiation-plus-durvalumab-followed-by-surgery-followed-by-adjuvant-durvalumab-in-pa 2023-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02407171/evaluating-the-combination-of-mk-3475-and-sterotactic-body-radiotherapy-in-patients-with 2023-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04788147/performance-and-safety-of-biology-guided-radiotherapy-using-the-reflexion-medical-radiot 2023-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03995667/tumor-treating-fields-ttfields-therapy-to-manage-brain-metastases-in-small-cell-lung-can 2023-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03780517/safety-efficacy-and-tolerability-of-bos172738-in-patients-with-advanced-rearranged-durin 2023-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04247126/a-study-of-sy-5609-a-selective-cdk7-inhibitor-in-advanced-solid-tumors 2023-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04662645/embedded-palliative-care-in-managing-symptoms-in-participants-with-recurrent-stage-iii-i 2023-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02484443/dinutuximab-in-combination-with-sargramostim-in-treating-patients-with-recurrent-osteosa 2023-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02321540/a-phase-i-ii-study-of-ibrutinib-in-previously-treated-epidermal-growth-factor-receptor-e 2023-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01750281/assess-efficacy-and-safety-of-azd6244-in-combination-with-docetaxel-in-patients-receivin 2023-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03399552/stereotactic-body-radiation-therapy-and-avelumab-immunotherapy-for-treatment-of-malignan 2023-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03228186/trial-of-pevonedistat-plus-docetaxel-in-patients-with-previously-treated-advanced-non-sm 2023-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05342571/a-biobehavioral-cognitive-treatment-for-stress-depression-and-anxiety-in-patients-with-s 2023-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03916237/registry-and-screening-tool-to-identify-children-with-asthma-likely-to-benefit-from-home 2023-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01401907/early-palliative-care-in-advanced-lung-and-gastrointestinal-malignancies 2023-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05161533/hypofractionated-radiation-therapy-after-durvalumab-and-chemotherapy-for-the-treatment-o 2023-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03493789/fludeoxyglucose-f-18-pet-in-planning-lung-cancer-radiation-therapy 2023-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04739358/cns-dose-escalation-expansion-of-tepotinib-in-met-driven-nsclc 2023-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05180422/a-phase-i-ii-study-of-amg-510-in-combination-with-mvasi-in-patients-with-advanced-unrese 2023-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01116622/erlotinib-tarceva-and-bexarotene-targretin-oral-capsules-in-advanced-cancers-of-the-aero 2023-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03468985/nivolumab-cabozantinib-s-malate-and-ipilimumab-in-treating-patients-with-recurrent-stage 2023-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03366103/navitoclax-and-vistusertib-in-treating-patients-with-relapsed-small-cell-lung-cancer-and 2023-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02899728/olaparib-cediranib-maleate-and-standard-chemotherapy-in-treating-patients-with-small-cel 2023-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03434418/a-study-osimertinib-in-patients-with-stage-4-non-small-cell-lung-cancer-with-uncommon-eg 2023-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05414123/a-therapy-treatment-response-trial-in-patients-with-leptomeningeal-metastases-lm-using-c 2023-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03308942/effects-of-single-agent-niraparib-and-niraparib-plus-programmed-cell-death-1-pd-1-inhibi 2023-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00590902/ph-ii-osi-774-erlotinib-tarceva-in-advanced-bronchioloalveolar-cell-lung-cancer 2023-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03330405/javelin-parp-medley-avelumab-plus-talazoparib-in-locally-advanced-or-metastatic-solid-tu 2023-10-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03951012/use-peripheral-blood-proteomics-to-predict-the-treatment-response-and-toxicities-in-nscl 2023-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02426658/pemetrexed-disodium-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-and-ec 2023-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02904954/durvalumab-medi4736-with-or-without-sbrt-in-clinical-stage-i-ii-and-iiia-non-small-cell 2023-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03096782/umbilical-cord-blood-transplant-with-added-sugar-and-chemotherapy-and-radiation-therapy 2023-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04040244/exhaled-breath-analysis-to-predict-risk-of-symptomatic-pneumonitis 2023-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02125461/a-global-study-to-assess-the-effects-of-medi4736-following-concurrent-chemoradiation-in 2023-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02897375/palbociclib-with-cisplatin-or-carboplatin-in-advanced-solid-tumors 2023-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05011890/remote-monitoring-of-lung-cancer-patient-reported-outcomes-using-moovcare 2023-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03735628/an-study-to-evaluate-the-safety-and-efficacy-of-copanlisib-in-combination-with-nivolumab 2023-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06067776/osimertinib-cetuximab-and-tucatinib-for-the-treatment-of-egfr-mutant-stage-iv-or-recurre 2023-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02947386/nimotuzumab-and-nivolumab-in-treating-patients-with-advanced-non-small-cell-lung-cancer 2023-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04161157/piloting-pathways-with-lung-cancer-patients 2023-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02673021/mark-1a-series-percutaneous-microwave-ablation-for-patients-with-lung-tumor-s 2023-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02709512/ph-2-3-study-in-subjects-with-mpm-to-assess-adi-peg-20-with-pemetrexed-and-cisplatin 2023-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00084799/monoclonal-antibody-therapy-in-treating-patients-with-progressive-small-cell-lung-cancer 2023-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02744092/direct-oral-anticoagulants-doacs-versus-lmwh-warfarin-for-vte-in-cancer 2023-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00769652/medical-nutrition-therapy-or-standard-care-in-treating-patients-with-lung-cancer-pancrea 2023-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04171700/a-study-to-evaluate-rucaparib-in-participants-with-solid-tumors-and-with-deleterious-mut 2023-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct06060964/enabling-remote-access-to-breathe-easier-a-novel-approach-to-improve-symptom-management 2023-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04726215/imaging-of-t-cell-activation-with-18f-f-arag-in-advanced-non-small-cell-lung-cancer 2023-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02864251/a-study-of-nivolumab-chemotherapy-or-nivolumab-ipilimumab-versus-chemotherapy-in-non-sma 2023-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00856037/topotecan-hydrochloride-and-doxorubicin-hydrochloride-in-treating-relapsed-or-refractory 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03469271/maintain-respiratory-muscle-function-and-reduce-pneumonia-risk-in-cancer-patients 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00625690/ct-scans-in-screening-for-lung-cancer-in-current-and-former-smokers 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03620071/goalkeeper-intelligent-information-sharing-for-children-with-medical-complexity 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03302234/study-of-pembrolizumab-given-with-ipilimumab-or-placebo-in-participants-with-untreated-m 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04989283/testing-the-addition-of-an-immunotherapy-drug-atezolizumab-to-the-usual-chemotherapy-tre 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00602797/vinorelbine-tartrate-and-paclitaxel-in-treating-older-patients-with-advanced-non-small-c 2023-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02803203/osimertinib-and-bevacizumab-as-treatment-for-egfr-mutant-lung-cancers 2023-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02439450/a-study-of-combination-therapies-with-viagenpumatucel-l-hs-110-in-patients-with-non-smal 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05069935/ft538-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04106167/long-term-non-interventional-observational-study-following-treatment-with-fate-therapeut 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02831933/trial-of-radiation-and-gene-therapy-before-nivolumab-for-metastatic-non-small-cell-lung 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05395052/ft536-monotherapy-and-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04551885/ft516-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors 2023-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04940221/testing-informed-decision-making-in-lung-cancer-screening 2023-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04149249/connect-smoking-cessation-and-lung-cancer-screening 2023-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01998529/study-of-cytoreductive-surgery-and-hyperthermic-intrathoracic-pleural-chemotherapy-hitc 2023-09-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03639714/a-study-of-a-personalized-neoantigen-cancer-vaccine 2023-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03953235/a-study-of-a-personalized-cancer-vaccine-targeting-shared-neoantigens 2023-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05908799/emulation-of-the-keynote-189-trial-using-electronic-health-records 2023-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02343952/consolidation-pembrolizumab-following-chemoradiation-in-patients-with-inoperable-unresec 2023-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03425006/pembrolizumab-and-itacitinib-incb039110-for-non-small-cell-lung-cancer 2023-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05438498/real-world-evaluation-of-the-effectiveness-of-azd7442-for-prevention-of-sars-cov-2 2023-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01431326/pharmacokinetics-of-understudied-drugs-administered-to-children-per-standard-of-care 2023-09-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05699213/mri-and-biomarkers-for-lung-nodules-detected-during-lung-cancer-screening 2023-08-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03317496/safety-and-efficacy-study-of-avelumab-plus-chemotherapy-with-or-without-other-anti-cance 2023-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03963414/a-study-of-durvalumab-plus-tremelimumab-with-chemotherapy-in-untreated-es-sclc 2023-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02658890/an-investigational-immuno-therapy-study-of-bms-986205-given-in-combination-with-nivoluma 2023-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01997190/intrapleural-adv-tk-therapy-in-patients-with-malignant-pleural-effusion 2023-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05935774/ot-101-in-combination-with-atezolizumab-for-the-treatment-of-metastatic-or-recurrent-non 2023-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01370278/clearance-of-mucus-in-stents-comis 2023-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03083808/phase-ii-trial-of-continuation-therapy-in-advanced-nsclc 2023-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02726360/physician-use-of-non-english-language-skills-in-cancer-care 2023-08-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01000025/pf-00299804-in-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-not-responding-to-stand 2023-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03840915/m7824-in-combination-with-chemotherapy-in-stage-iv-non-small-cell-lung-cancer-nsclc 2023-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03626545/phase-iii-study-evaluating-efficacy-and-safety-of-canakinumab-in-combination-with-doceta 2023-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03557749/monitoring-of-immune-and-microbial-reconstitution-in-hct-and-novel-immunotherapies 2023-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003692/video-assisted-surgery-in-treating-patients-with-non-small-cell-lung-cancer 2023-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05027867/krt-232-in-subjects-with-relapsed-or-refractory-small-cell-lung-cancer 2023-08-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05025748/ask-questions-asq-implementation-of-a-communication-intervention 2023-08-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04131426/evaluating-the-combined-intervention-of-nutritional-supplementation-remune-and-exercise 2023-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00118131/docetaxel-and-cisplatin-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-l 2023-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04979169/emergency-department-lung-cancer-urmfg-pilot 2023-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04750239/safety-and-clinical-activity-of-nivatrotamab-in-relapsed-recurrent-metastatic-small-cell 2023-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04601402/gen-001-live-biotherapeutic-product-and-avelumab-combination-study-for-patients-with-sol 2023-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03417882/grn-1201-with-pembrolizumab-in-subjects-with-metastatic-pd-l1-nsclc 2023-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04033354/a-randomized-double-blind-placebo-controlled-phase-iii-study-to-investigate-efficacy-and 2023-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04644315/a-home-based-approach-study-to-evaluate-the-efficacy-and-safety-of-alectinib-in-locally 2023-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00526461/photodynamic-therapy-using-hpph-in-treating-patients-with-stage-0-non-small-cell-lung-ca 2023-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05740501/pharmacokinetic-profiling-of-pembrolizumab-and-nivolumab-in-patients-with-melanoma-and-o 2023-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05837598/adapting-the-tumor-board-model-for-mental-illness-and-cancer 2023-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03602079/study-of-a166-in-patients-with-relapsed-refractory-cancers-expressing-her2-antigen-or-ha 2023-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04639245/genetically-engineered-cells-mage-a1-specific-t-cell-receptor-transduced-autologous-t-ce 2023-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01760915/university-of-wisconsin-severe-asthma-research-program-iii 2023-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03576131/gen1029-hexabody-dr5-dr5-safety-trial-in-patients-with-malignant-solid-tumors 2023-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02988817/enapotamab-vedotin-humax-axl-adc-safety-study-in-patients-with-solid-tumors 2023-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01510405/phosphoproteomic-patterns-as-a-novel-biomarker-for-aurora-and-polo-like-kinase-inhibitor 2023-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03520842/regorafenib-and-methotrexate-in-treating-participants-with-recurrent-or-metastatic-kras 2023-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04971187/bintrafusp-alfa-with-chemotherapy-for-tyrosine-kinase-inhibitor-resistant-egfr-mutant-no 2023-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02763579/a-study-of-carboplatin-plus-etoposide-with-or-without-atezolizumab-in-participants-with 2023-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02481830/effectiveness-study-of-nivolumab-compared-to-chemotherapy-in-patients-with-relapsed-smal 2023-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03007953/palliative-care-interventions-for-outpatients-newly-diagnosed-with-lung-cancer-phase-ii 2023-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03837600/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphyrin-tcpp-for-detect 2023-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04705025/cognitive-behavioral-stress-management-device-for-the-treatment-of-anxiety-and-depressiv 2023-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04959981/a-study-of-anti-cancer-therapies-targeting-the-mapk-pathway-in-patients-with-advanced-ns 2023-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04424641/a-study-on-the-safety-of-gen1044-duobody-cd3x5t4-in-patients-with-malignant-solid-tumors 2023-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03215810/nivolumab-and-tumor-infiltrating-lymphocytes-til-in-advanced-non-small-cell-lung-cancer 2023-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02710396/genetic-predictors-of-benefit-to-pembrolizumab 2023-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03679767/a-study-of-incmga00012-in-participants-with-selected-solid-tumors-pod1um-203 2023-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02919449/dose-escalation-trial-of-intra-tumoral-injection-of-nis-measles-virus-in-combination-wit 2023-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05171062/dose-escalation-trial-of-bexmarilimab-fp-1305-plus-pembrolizumab-in-non-small-cell-lung 2023-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05400577/sotorasib-in-kras-g12c-mutated-resectable-stage-ib-iiia-nsclc 2023-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04452214/a-study-of-the-safety-and-tolerance-of-can04-and-pembrolizumab-in-combination-with-and-w 2023-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03919864/connect-oncology-needs-evaluation-tool 2023-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02503774/medi9447-alone-and-in-combination-with-medi4736-in-adult-participants-with-select-advanc 2023-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05870592/detection-of-abnormal-respiratory-cell-populations-in-lung-cancer-screening-patients-usi 2023-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04695847/m1231-in-participants-with-solid-tumors 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03735680/a-study-to-evaluate-onm-100-an-intraoperative-fluorescence-imaging-agent-for-the-detecti 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00062010/interferon-alfa-isotretinoin-and-paclitaxel-in-treating-patients-with-recurrent-small-ce 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01107626/bevacizumab-or-pemetrexed-disodium-alone-or-in-combination-after-induction-therapy-in-tr 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00828009/blp25-liposome-vaccine-and-bevacizumab-after-chemotherapy-and-radiation-therapy-in-treat 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02584634/study-to-evaluate-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-avelumab-in-c 2023-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00750698/a-phase-2-exploratory-study-of-erlotinib-and-sndx-275-in-participants-with-non-small-cel 2023-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00008385/selenium-in-preventing-tumor-growth-in-patients-with-previously-resected-stage-i-non-sma 2023-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02899195/phase-ii-medi4736-in-combination-with-chemotherapy-for-first-line-treatment-of-unresecta 2023-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00057837/comparison-of-two-combination-chemotherapy-regimens-in-treating-patients-with-extensive 2023-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03829436/tpst-1120-as-monotherapy-and-in-combination-with-nivolumab-in-subjects-with-advanced-can 2023-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05127590/rbn-2397-in-combination-with-pembrolizumab-in-patients-with-sccl 2023-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00101283/pemetrexed-plus-gemcitabine-or-carboplatin-for-patients-with-advanced-malignant-pleural 2023-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02482311/safety-tolerance-pk-and-anti-tumour-activity-of-azd1775-monotherapy-in-patients-with-adv 2023-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00064350/sorafenib-in-treating-patients-with-refractory-non-small-cell-lung-cancer 2023-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01824901/docetaxel-with-or-without-fgfr-inhibitor-azd4547-in-treating-patients-with-recurrent-non 2023-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00103207/cetuximab-in-treating-patients-with-recurrent-or-stage-iiib-or-stage-iv-lung-cancer 2023-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03805841/study-of-tarloxotinib-in-pts-with-nsclc-egfr-exon-20-insertion-her2-activating-mutations 2023-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03989115/dose-esc-exp-rmc4630-cobi-in-relapsed-refractory-solid-tumors-rmc4630-osi-in-egfr-locall 2023-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01104155/eribulin-mesylate-in-combination-with-intermittent-erlotinib-in-patients-with-previously 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04381494/mobile-devices-to-detect-early-pneumonitis-in-stage-iii-nsclc-patients-on-durvalumab 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01454934/a-randomized-open-label-multicenter-phase-3-study-to-compare-the-efficacy-and-safety-of 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002667/early-detection-of-second-lung-cancer-in-patients-with-stage-i-non-small-cell-lung-cance 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003649/gene-therapy-in-treating-patients-with-non-small-cell-lung-cancer-that-cannot-be-surgica 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01126736/eribulin-mesylate-administered-in-combination-with-pemetrexed-versus-pemetrexed-alone-as 2023-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00303914/study-of-symptoms-caused-by-cancer-and-cancer-therapy-in-patients-with-invasive-breast-l 2023-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04440943/a-study-of-the-pd-l1xcd27-bispecific-antibody-cdx-527-in-patients-with-advanced-malignan 2023-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02335944/study-of-safety-and-efficacy-of-egfr-tki-egf816-in-combination-with-cmet-inhibitor-inc28 2023-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05153408/harmony-study-of-blu-701-in-egfr-mutant-nsclc 2023-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003329/identification-of-genes-associated-with-cancer-in-patients-and-siblings-who-have-cancer 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00041314/combination-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002520/physician-initiated-stop-smoking-program-for-patients-receiving-treatment-for-early-stag 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02869789/an-investigational-immuno-therapy-study-for-safety-of-nivolumab-in-combination-with-ipil 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003235/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-iii-non 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006004/comparison-of-two-combination-chemotherapy-regimens-in-treating-non-small-cell-lung-canc 2023-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04372927/admiral-trial-adaptive-mediastinal-radiation-with-chemo-immunotherapy 2023-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00632853/radiation-therapy-regimens-in-treating-patients-with-limited-stage-small-cell-lung-cance 2023-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04471415/study-to-investigate-drp-104-in-adults-with-advanced-solid-tumors 2023-06-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05250817/a-study-of-preferences-for-the-first-line-treatment-of-advanced-metastatic-non-small-cel 2023-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03373760/durvalumab-and-tremelimumab-in-treating-patients-with-recurrent-stage-iv-lung-cancer 2023-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00717795/physical-activity-intervention-for-lung-cancer-survivors 2023-06-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00591981/thoracic-oncogeriatric-assessment-toga-trials 2023-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02575404/gr-md-02-plus-pembrolizumab-in-melanoma-non-small-cell-lung-cancer-and-squamous-cell-hea 2023-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03717402/smartphone-technology-to-alleviate-malignant-pain-stamp 2023-06-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03637803/live-biotherapeutic-product-mrx0518-and-pembrolizumab-combination-study-in-solid-tumors 2023-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02154490/lung-map-biomarker-targeted-second-line-therapy-in-treating-patients-with-recurrent-stag 2023-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05498389/emb-01-in-combination-with-osimertinib-in-patients-with-egfr-mutant-lung-cancer 2023-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02666105/exemestane-in-post-menopausal-women-with-nsclc 2023-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03233724/oral-decitabine-and-tetrahydrouridine-as-epigenetic-priming-for-pembrolizumab-mediated-i 2023-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00179348/yoga-based-rehabilitation-program-in-reducing-physical-and-emotional-side-effects-in-pat 2023-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03797391/a-dose-escalation-with-expansion-study-of-emb-01-in-participants-with-advanced-metastati 2023-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02740985/a-phase-1-clinical-study-of-azd4635-in-patients-with-advanced-solid-malignancies 2023-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04849273/a-study-of-tpx-0131-a-novel-oral-alk-tyrosine-kinase-inhibitor-in-patients-with-alk-adva 2023-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02766335/lung-map-durvalumab-as-second-line-therapy-in-treating-patients-with-recurrent-stage-iv 2023-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01004731/study-of-anti-epidermal-growth-factor-receptor-egfr-antibody-cetuximab-in-combination-wi 2023-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02607423/fludeoxyglucose-f-18-pet-ct-in-predicting-response-to-chemotherapy-in-patients-with-stag 2023-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03102242/atezolizumab-immunotherapy-in-patients-with-advanced-nsclc 2023-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03094884/pulsed-low-dose-rate-radiation-with-concurrent-chemotherapy-for-non-small-cell-lung-canc 2023-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00946712/s0819-carboplatin-and-paclitaxel-with-or-without-bevacizumab-and-or-cetuximab-in-treatin 2023-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02382406/carboplatin-nab-paclitaxel-and-pembrolizumab-in-nsclc 2023-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02045446/maintenance-chemotherapy-versus-consolidative-stereotactic-body-radiation-therapy-sbrt-p 2023-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00227617/combination-chemotherapy-and-bevacizumab-in-treating-patients-with-advanced-neuroendocri 2023-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04930055/immune-responses-in-oncology-patients-to-novel-coronavirus-vaccines-iroc 2023-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02379988/prone-breath-hold-technique-to-decrease-cardiac-and-pulmonary-doses-in-women-receiving-l 2023-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04541407/temodar-plus-tyrosine-kinase-inhibitors-for-progressive-cns-disease 2023-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03275597/phase-ib-study-of-stereotactic-body-radiotherapy-sbrt-in-oligometastatic-non-small-lung 2023-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05059691/three-dimensional-fluoroscopic-guidance-during-transbronchial-cryobiopsy 2023-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05014035/feasibility-of-a-hybrid-delivery-of-home-based-cluster-set-resistance-training-in-lung-c 2023-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04535492/technology-based-cancer-screening-intervention 2023-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04983134/women-helping-women-lung-cancer-screening 2023-05-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02961283/study-of-asn003-in-subjects-with-advanced-solid-tumors 2023-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04314284/patient-centered-intervention-to-reduce-cancer-patients-financial-toxicity 2023-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04630015/expanded-evaluation-of-the-survivorship-wellness-group-program-in-the-context-of-covid-1 2023-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02043665/cva21-and-pembrolizumab-in-nsclc-bladder-cancer-vla-009-storm-keynote-200 2023-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00301808/cisplatin-pemetrexed-disodium-and-radiation-therapy-followed-by-docetaxel-in-treating-pa 2023-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03488472/radiosurgery-plus-novottf-200a-for-metastatic-small-cell-lung-cancer-to-the-brain 2023-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01912625/trametinib-combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-stag 2023-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03455829/g1t38-a-cdk-4-6-inhibitor-in-combination-with-osimertinib-in-egfr-mutant-non-small-cell 2023-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04445402/pediatrics-hot-covid-19-database-in-ny-tristate 2023-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03217669/epacadostat-incb24360-in-combination-with-sirolimus-in-advanced-malignancy 2023-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04879927/routine-evaluation-of-the-social-determinants-of-health-in-oncology-user-centered-resour 2023-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03841110/ft500-as-monotherapy-and-in-combination-with-immune-checkpoint-inhibitors-in-subjects-wi 2023-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02376699/safety-study-of-sea-cd40-in-cancer-patients 2023-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05826756/project-peer-understanding-the-lung-cancer-patient-experience-in-the-real-world-setting 2023-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01971489/buparlisib-gemcitabine-hydrochloride-and-cisplatin-in-treating-patients-with-advanced-so 2023-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01908504/adaptive-pet-study 2023-04-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03574194/methionine-restricted-diet-to-potentiate-the-effects-of-radiation-therapy 2023-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03168464/radiation-and-immune-checkpoints-blockade-in-metastatic-nsclc-bms-ca209-632 2023-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04397614/mobile-health-study-and-enhanced-symptom-monitoring-in-covid-19-cancer-patients 2023-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04179305/giving-information-systematically-and-transparently-in-lung-and-gi-cancer-phase-2 2023-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02658032/personalized-intervention-program-tobacco-treatment-for-patients-at-risk-for-lung-cancer 2023-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04158908/giving-information-systematically-and-transparently-in-lung-and-gi-cancer-phase-1 2023-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04857697/effects-of-probiotics-on-the-gut-microbiome-and-immune-system-in-operable-stage-i-iii-br 2023-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04590781/safety-and-efficacy-of-xmab18087-pembrolizumab-in-advanced-merkel-cell-carcinoma-or-exte 2023-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05030454/novel-optical-surface-image-guidance-system-for-beam-gated-online-adaptive-sbrt-delivery 2023-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05054218/covid-19-immunogenicity-of-a-third-dose-of-mrna-1273-vaccine-among-cancer-patients 2023-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03758781/irx-2-regimen-combined-with-nivolumab-in-recurrent-metastatic-solid-tumors 2023-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04863248/trilaciclib-a-cdk-4-6-inhibitor-in-patients-receiving-docetaxel-for-metastatic-non-small 2023-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05769764/a-study-of-prevalence-of-her3-expression-in-non-small-cell-lung-cancer 2023-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01158456/metabolism-of-nnk-among-african-americans 2023-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02758054/patient-navigation-for-lung-cancer-screening-in-an-urban-safety-net-system 2023-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02659059/nivolumab-in-combination-with-ipilimumab-part-1-nivolumab-plus-ipilimumab-in-combination 2023-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04821570/to-assess-immunogenicity-of-coronavirus-disease-2019-covid-19-vaccine-in-cancer-patients 2023-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03849469/a-study-of-xmab-22841-monotherapy-in-combination-w-pembrolizumab-in-subjects-w-selected 2023-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03406715/combination-immunotherapy-ipilimumab-nivolumab-dendritic-cell-p53-vac-patients-with-smal 2023-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00611598/dna-repair-and-genetic-susceptibility-to-lung-cancer 2023-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05046951/educating-quitline-callers-about-lung-cancer-screening 2023-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05276258/cryoablation-of-intercostal-nerves-for-post-operative-pain-management-in-opioid-tolerant 2023-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02872701/otl38-injection-for-intraoperative-imaging-of-folate-receptor-positive-lung-nodules 2023-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03775850/a-study-of-edp1503-in-patients-with-colorectal-cancer-breast-cancer-and-checkpoint-inhib 2023-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04241315/elucidate-enabling-lung-cancer-identification-using-folate-receptor-targeting 2023-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04042480/a-study-of-sgn-cd228a-in-advanced-solid-tumors 2023-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03418532/mp0250-darpin-protein-plus-osimertinib-in-patients-with-egfr-mutated-nsclc 2023-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04225026/effects-of-intravenous-gc4419-on-the-incidence-and-severity-of-esophagitis-due-to-chemor 2023-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02503358/selumetinib-and-paclitaxel-as-second-line-treatment-in-treating-patients-with-stage-iiib 2023-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03507452/first-in-human-study-of-bay2287411-injection-a-thorium-227-labeled-antibody-chelator-con 2023-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02771626/study-cb-839-in-combination-with-nivolumab-in-patients-with-melanoma-clear-cell-renal-ce 2023-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01567722/collecting-and-studying-tissue-samples-from-patients-with-hiv-associated-malignancies 2023-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02459002/prospective-study-to-determine-impact-of-early-palliative-care-consult-on-quality-of-lif 2023-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04837677/a-study-of-prt1419-in-patients-with-advanced-solid-tumors 2023-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02409342/a-study-of-atezolizumab-mpdl3280a-compared-with-a-platinum-agent-cisplatin-or-carboplati 2023-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04698681/ngs-screening-protocol-to-detect-mutation-of-keap1-or-nrf2-nfe2l2-genes-for-the-keapsake 2023-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02983045/a-dose-escalation-and-cohort-expansion-study-of-nktr-214-in-combination-with-nivolumab-a 2023-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01840150/study-to-evaluate-na-nose-for-monitoring-and-detecting-recurrence-in-early-stage-lung-ca 2023-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03138889/bempegaldesleukin-and-pembrolizumab-with-or-without-chemotherapy-in-locally-advanced-or 2023-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05733000/cpi-613-devimistat-in-combination-with-hydroxychloroquine-and-5-fluorouracil-or-gemcitab 2023-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04276597/phase-ii-study-of-lu177dotatoc-in-adults-with-sttr-pulmonary-pheochromocytoma-paragangli 2023-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04703153/liquik-liquid-biopsy-for-detection-of-actionable-genomic-biomarkers-in-patients-with-adv 2023-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02121652/cognitive-behavioral-therapy-cbt-insomnia-for-lung-cancer 2023-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05693090/tipifarnib-and-osimertinib-in-egfr-mutated-non-small-cell-lung-cancer 2023-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02219711/phase-1-1b-study-of-mgcd516-in-patients-with-advanced-cancer 2023-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03825510/immunotherapy-sbrt-sensitization-of-the-programmed-death-1-pd-1-effect 2023-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01253161/study-of-pasireotide-long-acting-release-lar-in-patients-with-metastatic-neuroendocrine 2023-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05160571/a-retrospective-multicenter-review-to-evaluate-the-performance-of-the-ion-endoluminal-sy 2023-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02041533/an-open-label-randomized-phase-3-trial-of-nivolumab-versus-investigator-s-choice-chemoth 2023-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04650490/srs-timing-with-immune-checkpoint-inhibition-in-patients-with-untreated-brain-metastases 2023-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03713944/carboplatin-plus-pemetrexed-plus-atezolizumab-plus-bevacizumab-in-chemotherapy-and-immun 2023-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04159025/ebus-miniforceps-biopsy-specimen-acquisition-for-pd-l1-testing-in-nonsmall-cell-lung-can 2023-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01792882/prospective-collection-of-surplus-surgical-tumor-tissues-and-pre-surgical-blood-samples 2023-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01949506/sbrt-and-art-for-pulmonary-metastases-from-soft-tissue-sarcomas 2023-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02803333/oncology-research-information-exchange-network-orien-lung-cancer-study 2023-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03265080/a-study-of-adxs-neo-expressing-personalized-tumor-antigens 2023-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03902535/geriatric-and-quality-of-life-assessments-in-older-patients-with-non-metastatic-or-metas 2023-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04311710/a-study-evaluating-the-drug-levels-of-iplimumab-given-under-the-skin-alone-and-in-combin 2023-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04548531/engaging-patients-in-colon-cancer-screening-decisions-during-covid-19 2023-02-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05736029/predicting-responsiveness-in-oncology-patients-based-on-host-response-evaluation-during 2023-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02999399/glucobrassicin-brussel-sprout-effect-on-d10-phe-metabolism 2023-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02196844/yoga-program-for-lung-cancer-patients-and-caregivers 2023-02-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03707925/bronchoscopic-laser-ablation-of-peripheral-lung-tumors 2023-02-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02963090/pembrolizumab-vs-topotecan-in-patients-with-small-cell-lung-cancer 2023-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03663166/radiation-and-chemotherapy-with-ipilimumab-followed-by-nivolumab-for-patients-with-stage 2023-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03656627/nivolumab-in-patients-with-advanced-non-small-cell-lung-cancer-and-pre-existing-autoimmu 2023-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02713867/a-dose-frequency-optimization-trial-of-nivolumab-240-mg-every-2-weeks-vs-nivolumab-480-m 2023-02-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02217891/ifact-incidental-findings-in-advanced-cancer-therapy 2023-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02743351/study-of-protmune-for-allogeneic-hct-in-adult-patients-with-hematologic-malignancies 2023-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01673867/study-of-bms-936558-nivolumab-compared-to-docetaxel-in-previously-treated-metastatic-non 2023-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02834247/a-study-of-tak-659-in-combination-with-nivolumab-in-participants-with-advanced-solid-tum 2023-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00585195/a-study-of-oral-pf-02341066-a-c-met-hepatocyte-growth-factor-tyrosine-kinase-inhibitor-i 2023-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02513667/ceritinib-in-combination-with-stereotactic-ablative-radiation-metastatic-lung-adenocarci 2023-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02120807/certolizumab-in-combination-with-chemotherapy-for-patients-with-stage-iv-lung-adenocarci 2023-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02706626/trial-of-brigatinib-after-treatment-with-next-generation-alk-inhibitors 2023-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02213133/selinexor-treatment-of-advanced-relapsed-refractory-squamous-cell-carcinomas 2023-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04239261/serum-derived-bovine-immunoglobulin-effect-on-mucositis 2023-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02981108/a-study-to-evaluate-safety-pk-and-efficacy-of-hs-10296-in-patients-with-nsclc 2023-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02713529/safety-and-efficacy-study-of-amg-820-and-pembrolizumab-combination-in-select-advanced-so 2023-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05553808/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-sm 2023-01-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01859026/a-phase-i-ib-trial-of-mek162-in-combination-with-erlotinib-in-nsclc-harboring-kras-or-eg 2023-01-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03867916/patient-portal-and-navigation-program-in-providing-information-for-asian-american-cancer 2023-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02454842/study-for-treatment-with-th-4000-tarloxotinib-in-epidermal-growth-factor-receptor-egfr-m 2023-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03682224/exparel-and-marcaine-for-pain-management-in-thoracoscopic-lobectomy-patients 2023-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02890069/a-study-of-pdr001-in-combination-with-lcl161-everolimus-or-panobinostat 2023-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05675683/real-world-assessment-of-clinical-outcomes-in-metastatic-nsclc-patients-with-met-exon-14 2023-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05537922/i3lung-integrative-science-intelligent-data-platform-for-individualized-lung-cancer-care 2023-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03455556/anetumab-ravtansine-and-atezolizumab-in-treating-participants-with-advanced-non-small-ce 2023-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02393248/open-label-dose-escalation-study-of-pemigatinib-in-subjects-with-advanced-malignancies-f 2023-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02538666/an-investigational-immuno-therapy-study-of-nivolumab-or-nivolumab-in-combination-with-ip 2023-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02591615/optimal-sequencing-of-pembrolizumab-mk-3475-and-standard-platinum-based-chemotherapy-in 2022-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01642004/study-of-bms-936558-nivolumab-compared-to-docetaxel-in-previously-treated-advanced-or-me 2022-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03087448/ceritinib-trametinib-in-patients-with-advanced-alk-positive-non-small-cell-lung-cancer-n 2022-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04444427/evaluation-of-glr2007-for-advanced-solid-tumors 2022-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02987998/neoadjuvant-chemoradiation-plus-pembrolizumab-followed-by-consolidation-pembrolizumab-in 2022-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01416688/s1013-validation-of-cancer-questionnaire-for-skin-toxicities-in-patients-with-colorectal 2022-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01177397/study-to-assess-safety-pharmacokinetics-and-efficacy-of-oral-cc-223-for-patients-with-ad 2022-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04916223/study-to-determine-therapeutic-massage-dosing-to-improve-quality-of-life-in-hospitalized 2022-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05219578/rtx-224-monotherapy-in-patients-with-solid-tumors 2022-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05061940/this-scr-103-protocol-will-permit-sites-to-proactively-assess-taa-hla-and-hpv-16-status 2022-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03090737/safety-study-of-nivolumab-to-treat-advanced-or-metastatic-non-small-cell-lung-cancer 2022-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00017407/carboplatin-and-paclitaxel-with-or-without-isis-3521-in-treating-patients-with-non-small 2022-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03517488/a-study-of-xmab-20717-in-subjects-with-selected-advanced-solid-tumors 2022-12-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00858364/anemia-treatment-for-advanced-non-small-cell-lung-cancer-nsclc-patients-receiving-chemot 2022-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05627960/first-in-human-phase-1-study-of-ag01-anti-progranulin-gp88-antibody-in-advanced-solid-tu 2022-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02857270/a-study-of-ly3214996-administered-alone-or-in-combination-with-other-agents-in-participa 2022-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01649947/modulation-of-autophagy-in-patients-with-advanced-recurrent-non-small-cell-lung-cancer-p 2022-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04155008/nutrition-and-pharmacological-algorithm-for-oncology-patients-study 2022-11-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03515629/regn2810-anti-pd-1-antibody-platinum-based-doublet-chemotherapy-and-ipilimumab-anti-ctla 2022-11-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05032352/predictive-assay-for-decision-making-in-adjuvant-therapy 2022-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02308709/novel-lung-functional-imaging-for-personalized-radiotherapy 2022-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02437916/safety-study-of-amg-228-to-treat-solid-tumors 2022-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00100256/rhenium-re-188-p2045-in-patients-with-lung-cancer-who-have-received-or-refused-to-receiv 2022-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03430063/a-study-of-regn2810-and-ipilimumab-in-patients-with-lung-cancer 2022-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00986661/a-study-to-assess-pv-10-chemoablation-of-cancer-of-the-liver 2022-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05319457/testing-radon-com-methods-clinical-trial-smartphone-app-vs-print-brochures 2022-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00890617/cryotherapy-in-treating-patients-with-primary-stage-i-non-small-cell-lung-cancer-or-lung 2022-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00652574/dasatinib-in-resectable-malignant-pleural-mesothelioma 2022-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02066636/a-safety-trial-of-nivolumab-in-patients-with-advanced-or-metastatic-non-small-cell-lung 2022-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01266018/study-of-adi-peg-20-in-patients-with-relapsed-sensitive-or-refractory-small-cell-lung-ca 2022-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05227898/virtual-trial-to-compare-two-digital-therapeutics-as-interventions-for-physical-and-ment 2022-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04634110/brigatinib-before-brain-irradiation-trial-b3i-trial 2022-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00581503/early-detection-and-staging-of-endobronchial-lung-and-pleural-cancer-airway-injury-and-p 2022-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04146571/expanded-access-to-ensartinib-for-participants-with-alk-nsclc 2022-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02728596/s1415cd-trial-assessing-csf-prescribing-effectiveness-and-risk-tracer 2022-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02448225/18f-fspg-pet-ct-in-imaging-patients-with-newly-diagnosed-lung-cancer-or-indeterminate-pu 2022-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01670539/home-telemonitoring-for-patients-with-lung-cancer 2022-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04005144/brigatinib-and-binimetinib-in-treating-patients-with-stage-iiib-iv-alk-or-ros1-rearrange 2022-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05580172/phase-1-study-of-oral-rh324-in-advanced-non-small-cell-lung-cancer 2022-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02357992/lung-cancer-stars-trial-stars-revised-clinical-trial-protocol-stereotactic-ablative-radi 2022-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02359019/mk-3475-as-maintenance-therapy-in-extensive-stage-sclc 2022-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02688166/cardiac-mri-biomarker-testing-gcc-1618 2022-10-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02898116/phase-1-2-study-of-ensartinib-and-durvalumab-in-alk-rearranged-non-small-cell-lung-cance 2022-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04022876/a-study-of-alrn-6924-for-the-prevention-of-chemotherapy-induced-side-effects-chemoprotec 2022-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00199849/ny-eso-1-plasmid-dna-ppjv7611-cancer-vaccine 2022-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03164772/phase-1-2-study-of-combination-immunotherapy-and-messenger-ribonucleic-acid-mrna-vaccine 2022-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04398199/study-of-hypofractionated-radiotherapy-alone-in-locally-advanced-nonsmall-cell-lung-canc 2022-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02293005/phase-ii-trial-of-alisertib-mln8237-in-salvage-malignant-mesothelioma 2022-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03066778/a-study-of-pembrolizumab-mk-3475-in-combination-with-etoposide-platinum-cisplatin-or-car 2022-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00560495/radiation-therapy-and-ammonium-tetrathiomolybdate-in-treating-patients-with-stage-i-stag 2022-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04635761/awareness-information-and-resources-for-lung-cancer-screening-program-for-community-part 2022-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01860898/a-phase-i-study-of-ips-cell-generation-from-patients-with-copd 2022-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03241173/a-study-exploring-the-safety-and-efficacy-of-incagn01949-in-combination-with-immune-ther 2022-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02053285/pilot-study-of-a-novel-type-of-ct-scan-to-assess-treatment-response-during-chemoradiothe 2022-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03085914/a-study-of-epacadostat-in-combination-with-pembrolizumab-and-chemotherapy-in-participant 2022-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00738582/an-efficacy-study-of-morab-009-amatuximab-in-subjects-with-pleural-mesothelioma 2022-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04265534/keapsake-a-study-of-telaglenastat-cb-839-with-standard-of-care-chemoimmunotherapy-in-1l 2022-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05116618/detection-of-resistance-mechanisms-in-cerebrospinal-fluid-for-egfr-mutant-alk-and-ros1-r 2022-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00377156/stereotactic-radiation-therapy-with-or-without-whole-brain-radiation-therapy-in-treating 2022-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04862195/registrational-trial-to-compare-effectiveness-of-two-digital-software-medical-devices-as 2022-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03773133/evaluate-the-safety-tolerability-biodistribution-and-anti-tumour-activity-of-177lu-ops20 2022-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05041972/arx788-in-selected-her2-mutated-or-her2-amplified-overexpressed-solid-tumors-ace-pan-tum 2022-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03989362/vopratelimab-and-a-ctla-4-inhibitor-in-pd-1-pd-l1-inhibitor-experienced-subjects-with-ns 2022-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02967133/a-study-of-nivolumab-nab-paclitaxel-in-non-small-cell-lung-cancer 2022-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04272203/a-study-to-determine-safety-tolerability-pharmacokinetics-and-recommended-phase-2-dose-r 2022-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03662204/blood-sample-collection-to-evaluate-biomarkers-in-subjects-with-untreated-solid-tumors 2022-09-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03634982/dose-escalation-of-rmc-4630-monotherapy-in-relapsed-refractory-solid-tumors 2022-09-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04506528/covid-ehr-cohort-at-the-university-of-wisconsin 2022-08-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02706392/genetically-modified-t-cell-therapy-in-treating-patients-with-advanced-ror1-malignancies 2022-08-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04430712/immune-checkpoint-inhibitors-and-atherosclerotic-plaque-volume 2022-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00602030/study-to-evaluate-erlotinib-with-or-without-sndx-275-entinostat-in-the-treatment-of-pati 2022-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05091528/a-safety-and-activity-study-of-sbt6050-in-combination-with-other-her2-directed-therapies 2022-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03970382/a-study-of-gene-edited-autologous-neoantigen-targeted-tcr-t-cells-with-or-without-anti-p 2022-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04060342/gb1275-monotherapy-and-in-combination-with-an-anti-pd1-antibody-in-patients-with-specifi 2022-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04898985/the-leukemia-and-lymphoma-society-lls-t-cells-in-blood-cancer-and-covid-19 2022-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00970684/bevacizumab-docetaxel-and-gemcitabine-patients-with-stage-iiib-stage-iv-or-recurrent-non 2022-08-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03681873/validation-of-low-dose-ct-for-diagnosis-of-lung-nodules 2022-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03064854/pdr001-in-combination-with-platinum-doublet-chemotherapy-and-other-immunology-agents-in 2022-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03325166/pembrolizumab-and-magnetic-resonance-imaging-with-ferumoxytol-in-treating-patients-with 2022-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02328105/lci-lun-abr-001-carbo-with-nab-paclitaxel-in-patients-with-advanced-nscl-cancer 2022-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04735341/prospective-post-market-data-collection-for-ion-endoluminal-system-to-understand-ct-to-b 2022-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04076696/clinical-evaluation-of-primary-sampling-scatter-correction-for-chest-tomosynthesis 2022-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05064046/educating-providers-about-lung-screening 2022-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02400814/mpdl3280a-and-stereotactic-ablative-radiotherapy-in-patients-with-non-small-cell-lung-ca 2022-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00899782/collection-and-storage-of-blood-and-tissue-samples-from-patients-who-are-undergoing-surg 2022-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03438318/study-evaluating-cmp-001-in-combination-with-atezolizumab-in-participants-with-non-small 2022-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04057196/self-system-therapy-for-older-adults-with-lung-cancer 2022-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02404441/phase-i-ii-study-of-pdr001-in-patients-with-advanced-malignancies 2022-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04069936/marrow-infiltrating-lymphocytes-non-small-cell-lung-cancer-milstm-nsclc-alone-or-in-comb 2022-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04270591/assessment-of-anti-tumor-and-safety-in-glumetinib-in-patients-with-c-met-positive-non-sm 2022-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05430009/liver-sbrt-in-combination-with-immune-checkpoint-inhibition-in-patients-with-metastatic 2022-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04560686/bintrafusp-alfa-before-surgery-for-the-treatment-of-untreated-resectable-non-small-cell 2022-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03750864/innovative-approach-to-reduce-lung-cancer-stigma 2022-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02856581/management-of-tobacco-treatment-intervention-in-reducing-surgical-complications-in-patie 2022-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02926768/phase-i-ii-study-of-ck-101-in-nsclc-patients-and-other-advanced-solid-tumors 2022-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03321747/five-fraction-sabr-dose-escalation-for-early-stage-squamous-cell-carcinoma-of-the-lung 2022-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04685551/improving-survivorship-among-minority-cancer-dyads 2022-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04434560/neoadjuvant-immunotherapy-in-brain-metastases 2022-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05068024/a-study-of-fwd1509-in-adults-with-non-small-cell-lung-cancer 2022-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03297424/a-study-of-plx2853-in-advanced-malignancies 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01896778/body-warming-in-improving-blood-flow-and-oxygen-delivery-to-tumors-in-patients-with-canc 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01014598/cisplatin-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-or-lung-met 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01802203/tru-freeze-spray-cryotherapy-patient-registry 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03291587/implementation-of-smoking-cessation-within-nci-community-oncology-research-program-ncorp 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00347412/study-of-nov-002-in-combination-with-chemotherapy-to-treat-lung-cancer 2022-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01781741/stereotactic-body-radiation-therapy-after-surgery-in-treating-patients-with-stage-iii-iv 2022-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02130427/a-volume-motion-and-anatomically-adaptive-approach-to-photon-and-proton-beam-radiotherap 2022-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01854684/photodynamic-therapy-during-surgery-in-treating-patients-with-non-small-cell-lung-cancer 2022-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04922697/educational-intervention-for-the-promotion-of-knowledge-and-preventive-health-behaviors 2022-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04187768/immunological-profile-changes-in-patients-with-advanced-non-small-cell-lung-cancer 2022-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02071862/study-of-the-glutaminase-inhibitor-cb-839-in-solid-tumors 2022-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04596033/titan-1-safety-proliferation-and-persistence-of-gen-011-autologous-cell-therapy 2022-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00966914/phase-3-study-of-tavocept-versus-placebo-in-patients-with-newly-diagnosed-or-relapsed-ad 2022-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03080311/a-study-of-apg-1252-in-patients-with-sclc-or-other-solid-tumors 2022-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04210037/study-of-apg-1252-plus-paclitaxel-in-patients-with-relapsed-refractory-small-cell-lung-c 2022-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00553800/study-of-bevacizumab-and-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer 2022-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03041181/single-agent-chemotherapy-nivolumab-in-patients-with-advanced-squamous-or-non-squamous-n 2022-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04844736/testing-the-feasibility-of-a-simplified-workflow-for-lung-cancer 2022-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02683941/efficacy-and-safety-of-lanreotide-autogel-depot-120-mg-vs-placebo-in-subjects-with-lung 2022-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02921828/a-safety-and-efficacy-of-pomalyst-capsules-under-the-actual-use-in-all-patients-who-are 2022-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02535325/methoxyamine-hydrochloride-pemetrexed-disodium-cisplatin-and-radiation-therapy-in-treati 2022-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04460456/a-study-of-sbt6050-alone-and-in-combination-with-pd-1-inhibitors-in-subjects-with-advanc 2022-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03102320/phase-1b-multi-indication-study-of-anetumab-ravtansine-in-mesothelin-expressing-advanced 2022-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01721759/study-of-nivolumab-bms-936558-in-patients-with-advanced-or-metastatic-squamous-cell-nons 2022-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02602119/intraoperative-imaging-of-pulmonary-nodules-by-otl38 2022-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04251312/minimizing-pathologic-aspiration-in-patients-undergoing-esophageal-and-lung-resections-f 2022-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02920476/tas-102-in-previously-treated-unresectable-or-metastatic-squamous-cell-lung-carcinoma-uf 2022-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02648724/sym015-anti-met-in-patients-with-advanced-solid-tumor-malignancies 2022-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00412880/bi-2536-second-line-monotherapy-in-sclc 2022-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03004586/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-using-a-22-vs-25-gauge 2022-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03050060/image-guided-hypofractionated-radiation-therapy-nelfinavir-mesylate-pembrolizumab-nivolu 2022-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00568282/identification-of-circulating-tumor-cells-in-the-peripheral-blood-of-lung-cancer-patient 2022-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00533949/high-dose-or-standard-dose-radiation-therapy-and-chemotherapy-with-or-without-cetuximab 2022-06-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01991184/a-study-of-gdc-0853-in-patients-with-resistant-b-cell-lymphoma-or-chronic-lymphocytic-le 2022-06-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04013334/mtg201-plus-nivolumab-in-patients-with-relapsed-pleural-mesothelioma 2022-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04315467/intraoperative-imaging-of-pulmonary-nodules-by-sgm-101 2022-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00979212/chemotherapy-and-radiation-therapy-with-or-without-panitumumab-in-treating-patients-with 2022-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04173325/feasibility-and-safety-study-of-nivolumab-with-irinotecan-for-small-cell-lung-cancer 2022-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04173338/cabozantinib-with-pemetrexed-in-advanced-non-small-cell-lung-cancer-urothelial-cancer-an 2022-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03023319/bosutinib-in-combination-with-pemetrexed-in-patients-with-selected-metastatic-solid-tumo 2022-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00750269/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lun 2022-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02684461/phase-ii-trial-of-sequential-consolidation-with-pembrolizumab-followed-by-nab-paclitaxel 2022-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03944447/outcomes-mandate-national-integration-with-cannabis-as-medicine 2022-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03365791/pdr001-plus-lag525-for-patients-with-advanced-solid-and-hematologic-malignancies 2022-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03904108/platinum-based-chemotherapy-plus-ramucirumab-in-patients-with-advanced-nsclc-who-have-pr 2022-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04936997/immune-response-to-the-covid-19-vaccine 2022-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00248404/nb1011-administered-by-continuous-infusion-in-cancers-that-overexpress-thymidylate-synth 2022-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03367819/isatuximab-in-combination-with-regn2810-cemiplimab-in-patients-with-advanced-malignancie 2022-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04052412/biodistribution-and-kinetics-of-18f-arag-in-non-small-cell-lung-cancer 2022-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01487174/kd019-versus-erlotinib-in-subjects-with-stage-iiib-iv-non-small-cell-lung-cancer-with-pr 2022-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00364780/study-of-xl647-in-subjects-with-non-small-cell-lung-cancer 2022-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00522145/study-of-xl647-in-subjects-with-nsclc-who-have-progressed-after-responding-to-treatment 2022-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03700437/fasting-mimicking-diet-with-chemo-immunotherapy-in-non-small-cell-lung-cancer-nsclc 2022-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01741480/early-warning-system 2022-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03688347/microbiome-in-lung-cancer-and-other-malignancies 2022-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00263731/metabolomic-analysis-of-lung-cancer 2022-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04362852/patient-forward-access-to-clinical-and-technological-research-genetic-influences-on-canc 2022-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01067144/stanford-accelerated-recovery-trial-start 2022-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00456261/first-line-treatment-of-a-comparison-of-2-treatments-in-elderly-patients-with-advanced-n 2022-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05358041/cone-beam-ct-guided-robotic-navigational-bronchoscopy 2022-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03268057/vx15-2503-in-combination-with-avelumab-in-advanced-non-small-cell-lung-cancer 2022-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03071757/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-abbv-368-as-a-single-agent-an 2022-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02897778/cardiac-safety-study-of-entinostat-in-men-and-women-with-advanced-solid-tumors 2022-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05037825/the-gut-microbiome-and-immune-checkpoint-inhibitor-therapy-in-solid-tumors 2022-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02315066/study-of-ox40-agonist-pf-04518600-alone-and-in-combination-with-4-1bb-agonist-pf-0508256 2022-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03633110/safety-tolerability-immunogenicity-and-antitumor-activity-of-gen-009-adjuvanted-vaccine 2022-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03054038/afatinib-and-necitumumab-in-patients-with-egfr-mutation-positive-advanced-or-metastatic 2022-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03000257/a-study-of-budigalimab-abbv-181-in-participants-with-advanced-solid-tumors 2022-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02705404/a-clinical-test-for-the-treatment-of-multifocal-lung-cancers-using-genome-sequencing 2022-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01655225/a-study-of-ly3023414-in-participants-with-advanced-cancer 2022-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02460367/immunotherapy-combination-study-in-advanced-previously-treated-non-small-cell-lung-cance 2022-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01994382/phase-1-2a-dose-escalation-study-in-participants-with-cll-sll-or-nhl 2022-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02859415/continuous-24h-intravenous-infusion-of-mithramycin-an-inhibitor-of-cancer-stem-cell-sign 2022-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02417701/sapanisertib-in-treating-patients-with-stage-iv-or-recurrent-lung-cancer 2022-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02088112/medi4736-anti-pd-l1-combined-with-gefitinib-in-subjects-with-non-small-cell-lung-cancer 2022-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01336634/study-of-selective-braf-kinase-inhibitor-dabrafenib-monotherapy-twice-daily-and-in-combi 2022-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02637531/a-dose-escalation-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmac 2022-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02646748/pembrolizumab-combined-with-itacitinib-incb039110-and-or-pembrolizumab-combined-with-inc 2022-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03836352/study-of-an-immunotherapeutic-dpx-survivac-in-combination-with-low-dose-cyclophosphamide 2022-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02900664/a-study-of-pdr001-in-combination-with-cjm112-egf816-ilaris-canakinumab-or-mekinist-trame 2022-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02502396/rivaroxaban-utilization-for-treatment-and-prevention-of-thromboembolism-in-cancer-patien 2022-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00875901/proton-therapy-for-stage-i-non-small-cell-lung-cancer-lu03 2022-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03759184/human-il-15-rhil-15-and-obinutuzumab-for-relapsed-and-refractory-chronic-lymphocyte-leuk 2022-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02367794/a-study-of-atezolizumab-in-combination-with-carboplatin-paclitaxel-or-carboplatin-nab-pa 2022-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02662634/a-safety-and-feasibility-study-of-ags-003-lng-for-the-treatment-of-stage-3-non-small-cel 2022-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02616393/phase-2-study-of-study-of-tesevatinib-in-subjects-with-nsclc-and-brain-or-leptomeningeal 2022-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03735290/a-study-to-evaluate-the-safety-and-effectiveness-of-ilixadencel-administered-into-tumors 2022-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01061840/trial-of-bi-shrna-furin-and-gmcsf-augmented-autologous-tumor-cell-vaccine-for-advanced-c 2022-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01785342/decamp-1-diagnosis-and-surveillance-of-indeterminate-pulmonary-nodules 2022-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02750215/a-study-of-capmatinib-inc280-in-nsclc-patients-with-met-exon-14-alterations-who-have-rec 2022-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02810457/evaluation-of-fkb238-and-avastin-in-patients-with-advanced-recurrent-non-squamous-non-sm 2022-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00600015/sorafenib-erlotinib-versus-erlotinib-alone-in-previously-treated-advanced-non-small-cell 2022-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02526017/study-of-cabiralizumab-in-combination-with-nivolumab-in-patients-with-selected-advanced 2022-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02866695/safety-and-efficacy-of-ingenol-mebutate-gel-0-015-for-treatment-of-ak-on-the-face-in-sol 2022-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02442414/a-phase-1-study-of-kbp-5209-in-patients-with-advanced-solid-tumors 2022-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04061590/pembrolizumab-with-or-without-chemotherapy-before-surgery-in-treating-patients-with-stag 2022-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05265897/improving-implementation-of-lung-cancer-screening-in-diverse-populations-ii 2022-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00193427/preoperative-therapy-in-patients-with-stages-ib-ii-iiia-and-selected-iiib-patients-with 2022-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00193414/pemetrexed-and-gemcitabine-in-patients-with-advanced-non-small-cell-lung-cancer 2022-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04470674/study-of-durvalumab-or-durvalumab-plus-chemotherapy-in-kras-mutation-positive-and-pd-l1 2022-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01455389/tusc2-nanoparticles-and-erlotinib-in-stage-iv-lung-cancer 2022-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02323126/study-of-efficacy-and-safety-of-nivolumab-in-combination-with-egf816-and-of-nivolumab-in 2022-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03347123/a-study-of-epacadostat-and-nivolumab-in-combination-with-immune-therapies-in-participant 2022-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03794544/neoadjuvant-durvalumab-alone-or-in-combination-with-novel-agents-in-resectable-non-small 2022-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00101972/rav12-in-treating-patients-with-metastatic-or-recurrent-adenocarcinoma 2022-02-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02549222/a-open-label-post-marketing-surveillance-study-following-transfusion-of-intercept-platel 2022-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03868423/brigatinib-in-treating-patients-with-alk-and-ros1-gene-alterations-and-locally-advanced 2022-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03221400/pen-866-in-patients-with-advanced-solid-malignancies 2022-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04351880/meals-matter-a-trial-of-medically-tailored-meals-2-weeks-vs-4-weeks-post-hospital-discha 2022-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00351988/effects-of-cancer-symptoms-on-caregivers 2022-02-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02178722/study-to-explore-the-safety-tolerability-and-efficacy-of-mk-3475-in-combination-with-inc 2022-02-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03088930/evaluating-crizotinib-in-the-neoadjuvant-setting-in-patients-with-non-small-cell-lung-ca 2022-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01935336/study-of-ponatinib-in-patients-with-lung-cancer-preselected-using-different-candidate-pr 2022-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02460224/safety-and-efficacy-of-lag525-single-agent-and-in-combination-with-pdr001-in-patients-wi 2022-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02299505/pharmacokinetic-and-safety-study-of-lower-doses-of-ceritinib-taken-with-a-low-fat-meal-v 2022-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05230186/a-tissue-collection-study-in-patients-who-respond-to-immune-checkpoint-inhibitors-to-ide 2022-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03321760/sabr-for-t1-2a-n1-nsclc 2022-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02628535/safety-study-of-mgd009-in-b7-h3-expressing-tumors 2022-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02381314/safety-study-of-enoblituzumab-mga271-in-combination-with-ipilimumab-in-refractory-cancer 2022-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01391143/safety-study-of-mga271-in-refractory-cancer 2022-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00698815/pemetrexed-and-or-sunitinib-as-second-line-therapy-in-treating-patients-with-stage-iiib 2022-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02446704/study-of-olaparib-and-temozolomide-in-patients-with-recurrent-small-cell-lung-cancer-fol 2022-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct05137912/neoadjuvant-immunotherapy-in-advanced-nsclc 2022-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04612946/using-connected-health-to-increase-lung-cancer-screening 2022-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00043108/combination-chemotherapy-surgery-and-radiation-therapy-in-treating-patients-with-non-sma 2022-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00967577/177lu-j591-antibody-in-patients-with-nonprostate-metastatic-solid-tumors 2022-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02947165/phase-i-ib-study-of-nis793-in-combination-with-pdr001-in-patients-with-advanced-malignan 2022-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02054104/adjuvant-tumor-lysate-vaccine-and-iscomatrix-with-or-without-metronomic-oral-cyclophosph 2022-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02909452/continuation-study-of-entinostat-in-combination-with-pembrolizumab-in-patients-with-adva 2022-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03647488/study-of-capmatinib-and-spartalizumab-combination-therapy-vs-docetaxel-in-non-small-cell 2022-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03322566/a-study-of-pembrolizumab-plus-epacadostat-with-platinum-based-chemotherapy-versus-pembro 2022-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04772118/improving-cancer-outcomes-through-personalized-care-planning-and-symptom-management 2022-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04652505/effect-of-the-covid-19-public-health-crisis-on-the-mental-health-and-physical-well-being 2022-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02318277/a-study-of-epacadostat-incb024360-in-combination-with-durvalumab-medi4736-in-subjects-wi 2022-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02403193/trial-of-pbf-509-and-pdr001-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc 2022-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01248247/battle-2-program-a-biomarker-integrated-targeted-therapy-study-in-previously-treated-pat 2022-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00982111/first-line-treatment-of-patients-with-stage-iv-nonsquamous-non-small-cell-lung-cancer-wi 2022-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04552535/a-study-in-the-united-states-using-electronic-medical-records-emr-to-assess-effectivenes 2022-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03353675/a-study-evaluating-the-efficacy-and-the-safety-of-first-line-chemotherapy-combined-with 2022-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04803227/safety-and-tolerability-of-emricasan-in-symptomatic-outpatients-diagnosed-with-mild-covi 2022-01-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02228382/safety-and-efficacy-study-of-bosutinib-in-patients-with-philadelphia-chromosome-positive 2021-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02963610/phase-i-ii-study-of-lenalidomide-plus-pembrolizumab-in-patients-with-solid-tumors-with-e 2021-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02001623/tisotumab-vedotin-humax-tf-adc-safety-study-in-patients-with-solid-tumors 2021-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04191928/pharmacokinetics-of-apixaban-in-patients-undergoing-pancreaticoduodenectomy 2021-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00885963/a-study-of-oral-sapacitabine-in-patients-with-previously-treated-non-small-cell-lung-can 2021-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00372073/efficacy-study-of-oral-seliciclib-to-treat-non-small-cell-lung-cancer 2021-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01772004/avelumab-in-metastatic-or-locally-advanced-solid-tumors-javelin-solid-tumor 2021-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04648826/aerosolized-azacytidine-as-epigenetic-priming-for-bintrafusp-alfa-mediated-immune-checkp 2021-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03443908/early-diagnosis-and-treatment-of-sleep-disordered-breathing-in-lung-cancer 2021-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00741988/ixabepilone-and-carboplatin-bevacizumab-in-advanced-non-small-cell-lung-cancer 2021-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02259725/regorafenib-in-treating-patients-with-advanced-or-metastatic-neuroendocrine-tumors 2021-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02936323/pen-221-in-somatostatin-receptor-2-expressing-advanced-cancers-including-neuroendocrine 2021-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02573259/a-dose-escalation-study-of-pf-06801591-in-melanoma-head-and-neck-cancer-scchn-ovarian-sa 2021-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02568449/nintedanib-in-treating-patients-with-malignant-pleural-mesothelioma-that-is-recurrent 2021-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02394548/phase-i-trial-of-imrt-using-a-contralateral-esophagus-sparing-technique-cest-in-locally 2021-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00960297/preoperative-chemotherapy-and-bevacizumab-in-patients-with-stage-ib-4-cm-ii-or-select-st 2021-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00730639/a-phase-1-study-of-nivolumab-bms-936558-in-subjects-with-advanced-or-recurrent-malignanc 2021-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02189174/study-of-clr457-administered-orally-in-adult-patients-with-advanced-solid-malignancies 2021-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04165031/a-study-of-ly3499446-in-participants-with-advanced-solid-tumors-with-kras-g12c-mutation 2021-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03319459/fate-nk100-as-monotherapy-and-in-combination-with-monoclonal-antibody-in-subjects-with-a 2021-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00695292/irinotecan-carboplatin-and-sunitinib-in-first-line-extensive-stage-small-cell-lung-cance 2021-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01594398/study-to-assess-food-effect-on-pharmacokinetics-of-entinostat-in-subjects-with-breast-ca 2021-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02273336/comprehensive-genomic-analysis-in-tissue-and-blood-samples-from-young-patients-with-lung 2021-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02934503/study-of-pembrolizumab-and-chemotherapy-with-or-without-radiation-in-small-cell-lung-can 2021-11-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03652077/a-safety-and-tolerability-study-of-incagn02390-in-select-advanced-malignancies 2021-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03497026/auris-robotic-endoscopy-system-for-bronchoscopy 2021-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02871115/pilot-study-of-a-pharmacy-intervention-for-older-adults-with-cancer 2021-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00618917/mnsod-esophageal-protectant-to-prevent-esophagitis-during-radiation-chemotherapy-treatme 2021-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03407040/generation-of-cancer-antigen-specific-t-cells-from-human-induced-pluripotent-stem-cells 2021-11-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00402883/chemotherapy-radiotherapy-and-bevacizumab-in-patients-with-unresectable-stage-iii-non-sm 2021-11-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04422210/a-study-evaluating-the-safety-tolerability-pharmacokinetics-and-efficacy-of-venetoclax-i 2021-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03998189/metabolic-and-microbial-profiling-of-lung-cancer 2021-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03371979/pegzilarginase-and-pembrolizumab-for-extensive-disease-small-cell-lung-cancer 2021-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03245736/tisotumab-vedotin-continued-treatment-in-patients-with-solid-tumors 2021-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02440139/evaluation-of-computer-aided-lung-nodule-detection-software-in-thoracic-ct-for-riverain 2021-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00421174/effectiveness-of-etanercept-for-idiopathic-pneumonia-syndrome-following-stem-cell-transp 2021-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00948675/study-of-participants-with-advanced-non-small-cell-lung-cancer 2021-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02566993/clinical-trial-of-lurbinectedin-pm01183-doxorubicin-versus-cav-or-topotecan-as-treatment 2021-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01757288/phase-i-ii-nabpaclitaxel-paclitaxel-carboplatin-w-rtx-followed-by-consolidation-in-patie 2021-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04381988/a-study-of-hydroxychloroquine-vs-placebo-to-prevent-covid-19-infection-in-patients-recei 2021-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01951586/denosumab-in-combination-with-chemotherapy-as-first-line-treatment-of-metastatic-non-sma 2021-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03158883/ucdcc-270-avelumab-and-stereotactic-ablative-radiotherapy-in-non-responding-and-progress 2021-10-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01797159/hippocampal-prophylactic-cranial-irradiation-for-small-cell-lung-cancer 2021-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03574753/lung-map-s1400k-c-met-positive 2021-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03644173/personal-resilience-empowerment-program-study 2021-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01741155/study-of-spi-1620-in-combination-with-docetaxel-versus-docetaxel-alone-for-patients-with 2021-10-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01911507/inc280-and-erlotinib-hydrochloride-in-treating-patients-with-non-small-cell-lung-cancer 2021-10-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01799135/feasibility-study-of-enhanced-mri-for-early-stage-non-small-cell-lung-cancer-nsclc 2021-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02387216/a-study-of-mm-121-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-hereguli 2021-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03095209/observation-study-of-patients-with-non-small-cell-lung-cancer-and-esophageal-cancer-trea 2021-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01454102/study-of-nivolumab-bms-936558-in-combination-with-gemcitabine-cisplatin-pemetrexed-cispl 2021-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03829618/lidocaine-administration-during-flexible-bronchoscopy-and-endobronchial-ultrasound 2021-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00365963/web-based-intervention-for-lung-cancer-patients-and-their-informal-caregivers 2021-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01288430/a-study-of-ds-2248-in-participants-with-advanced-solid-tumors 2021-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03624907/daily-vs-non-daily-sbrt-for-nsclc 2021-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03236675/detection-of-either-the-eml4-alk-gene-rearrangements-or-the-t790m-egfr-mutation-in-the-p 2021-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01535040/memantine-hydrochloride-in-helping-cancer-survivors-stop-smoking 2021-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01434342/feasibility-of-delivering-a-quitline-based-smoking-cessation-intervention-in-cancer-pati 2021-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03131206/a-study-of-alectinib-in-ret-rearranged-non-small-cell-lung-cancer-or-ret-mutated-thyroid 2021-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02366143/a-study-of-atezolizumab-in-combination-with-carboplatin-plus-paclitaxel-with-or-without 2021-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03261947/a-study-to-evaluate-the-safety-tolerability-and-activity-of-tak-931-in-participants-with 2021-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02111824/a-multimodality-image-guided-system-for-peripheral-lung-cancer-diagnosis-and-therapy 2021-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03972228/microdevice-for-evaluating-drug-response-in-site-in-lung-lesions 2021-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00871923/tarceva-with-whole-brain-radiation-therapy-brain-mets-from-non-small-cell-lung-cancer 2021-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02408016/genetically-modified-t-cells-in-treating-patients-with-stage-iii-iv-non-small-cell-lung 2021-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02423343/a-study-of-galunisertib-ly2157299-in-combination-with-nivolumab-in-advanced-refractory-s 2021-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00025285/combination-chemotherapy-plus-thalidomide-in-treating-patients-with-stage-iiib-or-stage 2021-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00031785/megestrol-in-treating-patients-who-are-undergoing-radiation-therapy-for-lung-cancer 2021-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00028938/chemotherapy-and-radiation-therapy-with-or-without-epoetin-alfa-in-treating-patients-wit 2021-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00025272/combination-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cance 2021-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02588612/letetresgene-autoleucel-engineered-t-cells-in-ny-eso-1-positive-advanced-non-small-cell 2021-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04432870/patients-preferences-about-rescheduling-colonoscopies-delayed-due-to-covid-19-cross-sect 2021-09-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004202/combination-chemotherapy-radiation-therapy-and-rsr13-in-treating-patients-with-stage-iii 2021-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02737501/alta-1l-study-a-study-of-brigatinib-versus-crizotinib-in-anaplastic-lymphoma-kinase-posi 2021-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01663766/phase-i-study-of-milatuzumab-for-graft-versus-host-disease 2021-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01085630/pemetrexed-disodium-observation-in-treating-patients-w-malignant-pleural-mesothelioma-w 2021-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01503619/studying-biomarkers-in-tumor-tissue-and-blood-samples-from-patients-with-small-cell-lung 2021-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01517971/studying-tumor-tissue-samples-from-patients-with-early-stage-non-small-cell-lung-cancer 2021-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01617915/tumor-specific-plasma-dna 2021-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02450539/a-study-of-abemaciclib-ly2835219-in-participants-with-stage-iv-squamous-non-small-cell-l 2021-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01631552/study-of-sacituzumab-govitecan-hziy-immu-132-in-adults-with-epithelial-cancer 2021-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01497808/radvaxtm-a-stratified-phase-i-ii-dose-escalation-trial-of-hypofractionated-radiotherapy 2021-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00857025/beta-glucan-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung 2021-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04697446/external-control-observational-retrospective-study-comparing-pralsetinib-to-best-availab 2021-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02367781/a-study-of-atezolizumab-in-combination-with-carboplatin-plus-nab-paclitaxel-compared-wit 2021-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04267575/canady-helios-cold-plasma-scalpel-treatment-at-the-surgical-margin-and-macroscopic-tumor 2021-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01524783/everolimus-plus-best-supportive-care-vs-placebo-plus-best-supportive-care-in-the-treatme 2021-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03898791/a-study-of-ly3295668-erbumine-in-participants-with-extensive-stage-small-cell-lung-cance 2021-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02948946/clinical-utility-assay-as-a-biomarker-for-gastroenteropancreatic-and-lung-neuroendocrine 2021-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04503044/ilas-in-ct-lung-cancer-screening-population 2021-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00366509/role-of-helicobacter-pylori-and-its-toxins-in-lung-and-digestive-system-diseases 2021-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03033511/a-study-of-rovalpituzumab-tesirine-as-maintenance-therapy-following-first-line-platinum 2021-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03098550/a-study-to-test-the-safety-and-effectiveness-of-nivolumab-combined-with-daratumumab-in-p 2021-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03277352/incagn01876-in-combination-with-immune-therapies-in-subjects-with-advanced-or-metastatic 2021-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02528942/feasibility-study-incorporating-lung-function-imaging-into-radiation-therapy-for-lung-ca 2021-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02410603/isolating-and-testing-circulating-tumor-dna-and-soluble-immune-markers-during-the-course 2021-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00700336/study-of-cbp501-pemetrexed-cisplatin-on-mpm-phase-i-ii 2021-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01957787/study-of-cryoablation-for-metastatic-lung-tumors 2021-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01307501/safety-and-efficacy-of-cryoablation-for-metastatic-lung-tumors 2021-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01620190/paclitaxel-albumin-stabilized-nanoparticle-formulation-in-treating-patients-with-previou 2021-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01394978/neomend-progeltm-pleural-air-leak-sealant-post-approval-study 2021-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03351140/patient-reported-outcome-measurement-information-system-promis-physical-function 2021-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02124772/study-to-investigate-safety-pharmacokinetic-pk-pharmacodynamic-pd-and-clinical-activity 2021-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04962191/idylla-egfr-lung-trial 2021-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02879994/pembrolizumab-in-treating-patients-with-egfr-mutant-tyrosine-kinase-inhibitor-naive-adva 2021-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02197247/study-to-assess-the-effect-of-rifampicin-on-blood-levels-and-safety-of-azd9291-in-patien 2021-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01108666/proton-beam-radiation-with-concurrent-chemotherapy-and-nelfinavir-for-inoperable-stage-i 2021-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02181829/whole-lung-imrt-in-children-and-adults-with-synovial-sarcoma-and-lung-metastases 2021-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02429843/a-study-of-trc105-in-combination-with-paclitaxel-carboplatin-and-bevacizumab-in-non-squa 2021-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02651246/optional-sub-study-to-intraoperative-imaging-with-icg-registry 2021-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01711697/an-alternative-radiation-fractionation-strategy-for-locally-advanced-non-small-cell-lung 2021-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03377556/lung-map-talazoparib-in-treating-patients-with-hrrd-positive-recurrent-stage-iv-squamous 2021-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01500876/a-feasibility-study-using-four-dimensional-ct-imaging-for-primary-lung-cancer 2021-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02701400/tremelimumab-and-durvalumab-with-or-without-radiation-therapy-in-patients-with-relapsed 2021-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02123030/a-micro-nano-device-for-exhaled-breath-analysis 2021-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01211483/study-of-erlotinib-with-or-without-investigational-drug-u3-1287-in-subjects-with-advance 2021-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00843726/radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-canc 2021-06-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02349633/study-for-patients-with-nsclc-egfr-mutations-del-19-or-l858r-t790m 2021-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03670030/a-study-to-testabi-009-in-patients-with-metastatic-unresectable-low-or-intermediate-grad 2021-06-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02475330/dietary-flaxseed-in-nsclc 2021-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02756767/assessing-the-impact-of-electronic-capture-of-patient-reported-outcomes-in-radiation-onc 2021-06-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02768558/cisplatin-and-etoposide-plus-radiation-followed-by-nivolumab-placebo-for-locally-advance 2021-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01032850/sorafenib-with-capecitabine-for-patients-with-measurable-hepatocellular-carcinoma 2021-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03128008/locally-advanced-nsclc-hyperfractionated-rt 2021-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02785939/lung-map-palbociclib-as-second-line-therapy-in-treating-cell-cycle-gene-alteration-posit 2021-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02965378/lung-map-azd4547-as-second-line-therapy-in-treating-fgfr-positive-patients-with-recurren 2021-05-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00832780/phase-ii-study-of-stereotactic-body-radiation-therapy-using-tomotherapy-for-tumors-of-th 2021-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02130557/a-multicenter-phase-3-open-label-study-of-bosutinib-versus-imatinib-in-adult-patients-wi 2021-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02528357/gsk3174998-alone-and-with-pembrolizumab-in-participants-with-advanced-solid-tumors-engag 2021-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01076231/proton-beam-radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-iii-non-s 2021-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00308750/first-line-chemotherapy-treatment-of-advanced-non-small-cell-lung-cancer-nsclc 2021-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00533429/study-of-pemetrexed-carboplatin-bevacizumab-enzastaurin-versus-pemetrexed-carboplatin-be 2021-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00452413/a-study-of-enzastaurin-and-erlotinib-in-participants-with-solid-tumors-and-lung-cancer 2021-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04419623/a-study-of-tl-895-with-standard-available-treatment-versus-standard-available-treatment 2021-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02274038/serial-18f-thymidine-flt-pet-ct-as-a-biomarker-of-response-in-pemetrexed-therapy-for-non 2021-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02978586/a-pilot-study-of-ga-68-psma-pet-mri-for-the-assessment-of-psma-positive-tumors 2021-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01976741/dose-escalation-pan-fgfr-fibroblast-growth-factor-receptor-inhibitor-rogaratinib 2021-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03577002/team-based-versus-primary-care-clinician-led-advance-care-planning-in-practice-based-res 2021-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02574078/a-study-of-nivolumab-in-advanced-non-small-cell-lung-cancer-nsclc 2021-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03234712/a-study-evaluating-the-safety-pharmacokinetics-and-anti-tumor-activity-of-abbv-321-in-su 2021-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02357836/neoadjuvant-itraconazole-in-non-small-cell-lung-cancer 2021-05-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02038699/a-first-in-man-phase-i-ii-study-of-oral-onc201-in-patients-with-advanced-cancer 2021-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02581384/stereotactic-body-radiotherapy-sbrt-for-pulmonary-metastases-in-ewing-sarcoma-rhabdomyos 2021-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003508/antineoplaston-therapy-in-treating-patients-with-advanced-mesothelioma 2021-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01844765/open-label-phase-ii-study-to-evaluate-efficacy-and-safety-of-oral-nilotinib-in-philadelp 2021-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03597009/a-study-of-nivolumab-and-intrapleural-talimogene-laherparepvec-for-malignant-pleural-eff 2021-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03047616/a-pilot-study-to-develop-predictive-biomarkers-for-the-response-to-immunotherapy-in-lung 2021-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01759303/study-of-pazopanib-in-the-treatment-of-osteosarcoma-metastatic-to-the-lung 2021-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00438204/pemetrexed-disodium-gemcitabine-and-bevacizumab-in-treating-patients-with-stage-iiib-or 2021-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02552121/tisotumab-vedotin-humax-tf-adc-safety-study-in-patients-with-solid-tumors 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01002924/extension-study-of-ec145-vintafolide-for-subjects-enrolled-in-a-previous-study-with-ec14 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03112668/acceptance-and-commitment-therapy-in-improving-well-being-in-patients-with-stage-iii-iv 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01573338/clinical-study-to-evaluate-the-maximum-tolerated-dose-of-bay1000394-when-given-together 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03958253/lung-cancer-screening-protocol 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02562027/sbrt-stereotactic-body-radiation-therapy-vs-surgery-in-high-risk-patients-with-early-sta 2021-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02805660/phase-1-2-study-of-mocetinostat-and-durvalumab-in-patients-with-advanced-solid-tumors-an 2021-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01244191/tivantinib-plus-erlotinib-versus-placebo-plus-erlotinib-for-the-treatment-of-non-squamou 2021-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02808689/functional-medicine-in-asthma-fast-study 2021-04-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01237171/a-study-of-cesium-131-brachytherapy-following-sub-lobar-resection-for-early-stage-non-sm 2021-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01967823/t-cell-receptor-immunotherapy-targeting-ny-eso-1-for-patients-with-ny-eso-1-expressing-c 2021-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02085070/mk-3475-in-melanoma-and-nsclc-patients-with-brain-metastases 2021-03-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03878537/recurrence-monitoring-in-nsclc-using-circulating-tumor-dna 2021-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02750514/an-investigational-immuno-therapy-study-to-test-combination-treatments-in-patients-with 2021-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03016403/a-stepped-care-intervention-to-reduce-disparities-in-mental-health-services-among-cancer 2021-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02608528/serial-18f-fluorodeoxyglucose-18f-fdg-pet-ct-as-a-biomarker-of-therapeutic-response-in-a 2021-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03325816/nivolumab-and-177lu-dota0-tyr3-octreotate-for-patients-with-extensive-stage-small-cell-l 2021-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02020252/effect-of-multi-media-tool-on-enrollment-in-oncology-clinical-trials 2021-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04292119/lorlatinib-combinations-in-lung-cancer 2021-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02132598/trial-of-cabozantinib-xl184-in-non-small-cell-lung-cancer-with-brain-metastases 2021-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02927340/a-study-of-lorlatinib-in-advanced-alk-and-ros1-rearranged-lung-cancer-with-cns-metastasi 2021-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00914147/lung-function-testing-in-patients-with-locally-advanced-or-metastatic-solid-tumors 2021-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02063828/reducing-lung-cancer-related-anxiety-relax 2021-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00643318/cyberknife-radiosurgical-treatment-of-inoperable-early-stage-non-small-cell-lung-cancer 2021-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00606502/study-of-pralatrexate-vs-erlotinib-for-non-small-cell-lung-cancer-after-at-least-1-prior 2021-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03135782/provider-training-in-increasing-patient-tobacco-cessation-counseling-and-referrals-for-p 2021-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02445183/copdgene-lung-cancer-center-database 2021-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02195232/cancer-associated-thrombosis-and-isoquercetin-catiq 2021-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01820754/evaluation-of-circulating-t-cells-and-tumor-infiltrating-lymphocytes-tils-during-after-p 2021-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03380871/a-personal-cancer-vaccine-neo-pv-01-with-pembrolizumab-and-chemotherapy-for-patients-wit 2021-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02264990/study-comparing-veliparib-plus-carboplatin-and-paclitaxel-versus-investigator-s-choice-o 2021-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02697591/a-study-of-incagn01876-in-participants-with-advanced-or-metastatic-solid-tumors 2021-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02897765/a-personal-cancer-vaccine-neo-pv-01-w-nivolumab-for-patients-with-melanoma-lung-cancer-o 2021-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03452514/addition-of-microrna-blood-test-to-lung-cancer-screening-low-dose-ct 2021-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02952729/study-of-antibody-drug-conjugate-in-patients-with-advanced-breast-cancer-expressing-her2 2021-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03115541/incidence-of-venous-thromboembolism-in-patients-undergoing-major-esophageal-resection 2021-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03061812/study-comparing-rovalpituzumab-tesirine-versus-topotecan-in-subjects-with-advanced-or-me 2021-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03157089/testing-afatinib-in-combination-with-pembrolizumab-in-patients-with-squamous-cell-carcin 2021-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00879879/losartan-in-treating-patients-with-idiopathic-pulmonary-fibrosis 2021-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01885195/mek162-for-patients-with-ras-raf-mek-activated-tumors 2021-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00219297/study-of-patupilone-in-patients-with-brain-metastasis-from-non-small-cell-lung-cancer 2021-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01327612/open-label-extension-study-of-conatumumab-and-ganitumab-amg-479 2021-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03696212/grapiprant-ary-007-and-pembrolizumab-in-patients-with-advanced-or-metastatic-post-pd-1-l 2021-02-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03391115/personalized-experiences-to-inform-improved-communication-for-minorities-with-life-limit 2021-02-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01470248/study-of-arsenic-trioxide-in-small-cell-lung-cancer 2021-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01212627/ridaforolimus-with-cetuximab-adv-non-small-cell-lung-colorectal-head-neck-cancer 2021-02-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01502072/respiratory-syncytial-virus-rsv-protocol 2021-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03633006/blood-sample-collection-in-subjects-with-pulmonary-nodules-or-ct-suspicion-of-lung-cance 2021-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03628638/blood-sample-collection-in-subjects-participating-in-a-lung-cancer-screening-program 2021-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04274907/a-safety-study-of-oral-venetoclax-in-combination-with-intravenous-pembrolizumab-in-adult 2021-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02127359/whole-exome-sequencing-wes-of-cancer-patients 2021-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02187822/fractionated-stereotactic-radiotherapy-fsrt-in-treatment-of-brain-metastases 2021-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03347825/retrospective-multi-center-study-to-compare-perioperative-outcomes-for-robotic-assisted 2021-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02283749/bruog-l301-with-non-small-cell-lung-cancer-and-bone-metastases 2021-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03500393/a-remotely-supervised-exercise-program-for-lung-cancer-patients-undergoing-chemoradiatio 2021-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03125200/study-of-adct-502-in-patients-with-advanced-solid-tumors-withhuman-epidermal-growth-fact 2021-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02286713/pcori-cer-1306-03385-informed-decisions-about-lung-cancer-screening 2021-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02179515/safety-and-tolerability-of-a-modified-vaccinia-ankara-mva-based-vaccine-modified-to-expr 2021-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03901378/pembrolizumab-with-chemotherapy-in-metastatic-or-unresectable-high-grade-gastroenteropan 2021-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02262000/phase-ii-image-guided-stereotactic-ablative-radiotherapy-for-non-small-cell-lung-cancer 2021-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02485652/phase-ii-trial-of-hm61713-for-the-treatment-of-2nd-line-t790m-mutation-positive-adenocar 2021-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01302808/romidepsin-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iii-or-stage-iv-n 2021-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03382899/study-of-pegilodecakin-ly3500518-with-pembrolizumab-compared-to-pembrolizumab-alone-firs 2021-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01294280/biomarkers-in-predicting-response-in-patients-with-early-stage-non-small-cell-lung-cance 2021-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02572687/a-study-of-ramucirumab-ly3009806-plus-medi4736-in-participants-with-advanced-gastrointes 2021-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00130728/a-study-to-evaluate-the-efficacy-of-bevacizumab-in-combination-with-tarceva-for-advanced 2021-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01573702/stereotactic-radiosurgery-or-other-local-ablation-then-erlotinib-in-epidermal-growth-fac 2021-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02525653/albumin-bound-paclitaxel-and-gemcitabine-in-patients-with-untreated-stage-iv-or-recurren 2021-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01503177/intrapleural-measles-virus-therapy-in-patients-with-malignant-pleural-mesothelioma 2021-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01300429/molecular-determinants-of-acquired-clinical-resistance-to-crizotinib-in-non-small-cell-l 2021-01-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02228369/oral-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors-azd3759-or-azd9291-in-p 2021-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00760929/a-study-of-the-effect-of-r1507-in-combination-with-tarceva-erlotinib-on-progression-free 2021-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01700257/lung-cancer-screening-study-with-low-dose-ct-scan-and-blood-biomarker 2020-12-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01579994/crizotinib-and-ganetespib-sta-9090-in-alk-positive-lung-cancers 2020-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00662597/asa404-or-placebo-in-combination-with-paclitaxel-and-carboplatin-as-first-line-treatment 2020-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00738387/a-study-of-asa404-or-placebo-in-combination-with-docetaxel-in-second-line-treatment-for 2020-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01268059/a-study-of-carboplatin-and-paclitaxel-with-or-without-medi-575-in-untreated-advanced-non 2020-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00480025/gsk1572932a-antigen-specific-cancer-immunotherapeutic-as-adjuvant-therapy-in-patients-wi 2020-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03603652/neuwave-flex-microwave-ablation-system-in-the-ablation-of-primary-soft-tissue-lesions-of 2020-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00466466/safety-of-rad001-in-combination-with-cisplatin-and-etoposide-in-lung-cancer-patients 2020-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00456833/combination-of-rad001-and-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer 2020-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01324479/study-of-inc280-in-patients-with-c-met-dependent-advanced-solid-tumors 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02422589/a-phase-i-multi-center-open-label-drug-drug-interaction-study-to-assess-the-effect-of-ce 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01103037/efficacy-safety-and-pharmacokinetics-of-qav680-versus-placebo-in-patients-with-asthma 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02082210/a-study-of-emibetuzumab-in-combination-with-ramucirumab-ly3009806-in-participants-with-a 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01772797/phase-ib-study-of-ldk378-and-auy922-in-alk-rearranged-non-small-cell-lung-cancer 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00535951/pharmacokinetic-safety-and-efficacy-effects-of-oral-lbh589-on-dextromethorphan-in-patien 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02308020/a-study-of-abemaciclib-ly2835219-in-participants-with-breast-cancer-non-small-cell-lung 2020-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02222922/a-study-of-pf-06647020-for-adult-patients-with-advanced-solid-tumors 2020-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02292550/study-of-safety-and-efficacy-of-lee011-and-ceritinib-in-patients-with-alk-positive-non-s 2020-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03891615/niraparib-in-combination-with-osimertinib-in-egfr-mutated-advanced-lung-cancer 2020-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003492/antineoplaston-therapy-in-treating-patients-with-stage-iv-lung-cancer 2020-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03727425/robotic-bronchoscopy-for-peripheral-pulmonary-lesions 2020-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00794417/a-study-of-aflibercept-administered-in-combination-with-pemetrexed-and-cisplatin-in-part 2020-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04432753/effect-of-incidental-findings-information-on-lung-cancer-screening-intent 2020-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03098030/dinutuximab-and-irinotecan-versus-irinotecan-to-treat-subjects-with-relapsed-or-refracto 2020-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03649737/exercise-program-among-lung-cancer-dyads 2020-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02443337/a-study-of-ly3023414-and-necitumumab-in-squamous-lung-cancer 2020-12-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03896958/the-pioneer-initiative-precision-insights-on-n-of-1-ex-vivo-effectiveness-research-based 2020-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04007458/maine-lung-cancer-coalition-using-chws-for-the-annual-lung-cancer-screening-reminder 2020-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02239900/ipilimumab-and-stereotactic-body-radiation-therapy-sbrt-in-advanced-solid-tumors 2020-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01999985/phase-i-trial-of-afatinib-bibw-2992-and-dasatinib-in-non-small-cell-lung-cancer-nsclc 2020-11-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00269828/a-survival-study-for-women-with-advanced-lung-cancer-who-have-not-previously-received-ch 2020-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00601848/photodynamic-therapy-in-treating-patients-with-resectable-non-small-cell-lung-cancer-tha 2020-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01958372/radiation-therapy-chemotherapy-and-soy-isoflavones-in-treating-patients-with-stage-iiia 2020-11-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00821951/vorinostat-in-combination-with-palliative-radiotherapy-for-patients-with-non-small-cell 2020-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02730247/clinical-trial-of-the-safety-and-efficacy-of-the-addition-of-ramucirumab-to-nab-paclitax 2020-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02392507/a-study-of-nab-paclitaxel-and-carboplatin-plus-necitumumab-ly3012211-in-participants-wit 2020-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03553550/role-of-circulating-tumor-dna-ctdna-from-liquid-biopsy-in-early-stage-nsclc-resected-lun 2020-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02106546/study-comparing-veliparib-plus-carboplatin-and-paclitaxel-versus-placebo-plus-carboplati 2020-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02762877/concordance-of-key-actionable-genomic-alterations-as-assessed-in-tumor-tissue-and-plasma 2020-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04201145/pembrolizumab-defactinib-in-pleural-mesothelioma 2020-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02109653/efficacy-and-safety-of-lgx818-in-patients-with-advanced-or-metastatic-braf-v600-mutant-n 2020-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00765973/topotecan-liposomes-injection-for-small-cell-lung-cancer-sclc-ovarian-cancer-and-other-a 2020-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03523689/radial-probe-endobronchial-ultrasound-in-detecting-atelectasis-in-patients-undergoing-pe 2020-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02458482/trial-of-accupap-device-versus-standard-nebulizer-therapy-in-acute-asthma-exacerbation-i 2020-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01355497/effect-of-gtx-024-on-muscle-wasting-in-patients-with-non-small-cell-lung-cancer-nsclc-on 2020-11-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03672422/pediatric-longitudinal-cohort-study-of-chronic-pancreatitis 2020-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04006301/first-in-human-study-of-jnj-74699157-in-participants-with-tumors-harboring-the-kras-g12c 2020-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03699033/hypofractionated-radiotherapy-with-carboplatin-and-paclitaxel-in-non-small-cell-lung-can 2020-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02271581/effect-of-symptom-management-on-inflammation-and-survival-in-metastatic-lung-cancer 2020-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03256136/nivolumab-in-combination-with-chemotherapy-or-nivolumab-in-combination-with-ipilimumab-i 2020-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01947608/expanded-treatment-protocol-with-ldk378-in-alk-nsclc 2020-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02605083/a-dose-escalation-and-cohort-expansion-study-of-oral-eft508-in-subjects-with-advanced-so 2020-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03538028/a-safety-and-tolerability-study-of-incagn02385-in-select-advanced-malignancies 2020-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02420691/ribociclib-in-treating-patients-with-advanced-neuroendocrine-tumors-of-foregut-origin 2020-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02989974/kentucky-leads-collaborative-lung-cancer-survivorship-care-program 2020-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00453661/cancer-prevention-and-treatment-demonstration-for-ethnic-and-racial-minorities 2020-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00723957/a-randomized-phase-2-study-of-ixabepilone-plus-carboplatin-and-paclitaxel-plus-carboplat 2020-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03302247/depletion-of-myeloid-derived-suppressor-cells-to-enhance-anti-pd-1-therapy 2020-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00832117/phase-i-combination-ixabepilone-cisplatin 2020-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02785913/lung-map-taselisib-as-therapy-in-treating-patients-with-stage-iv-squamous-cell-lung-canc 2020-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03862001/lung-cancer-screening-a-multilevel-intervention 2020-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02318368/a-phase-2-study-of-ficlatuzumab-plus-erlotinib-vs-placebo-plus-erlotinib-in-subjects-wit 2020-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02616211/an-integrated-approach-to-treating-recurrent-thoracic-carcinomas-resistant-to-tyrosine-k 2020-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02642939/study-of-oral-mifepristone-as-salvage-therapy-in-patients-with-advanced-or-metastatic-no 2020-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00576225/ct-2103-carboplatin-vs-paclitaxel-carboplatin-for-nsclc-in-women-with-estradiol-25-pg-ml 2020-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02012231/phase-i-iia-study-to-evaluate-the-safety-pk-pd-and-preliminary-efficacy-of-plx8394-in-pa 2020-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04587258/improving-cancer-screening-and-prevention-during-the-covid-19-pandemic-in-underserved-po 2020-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03048500/nivolumab-and-metformin-hydrochloride-in-treating-patients-with-stage-iii-iv-non-small-c 2020-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03311620/pilot-study-to-investigate-the-diagnostic-yield-and-utility-of-22g-and-19g-endobronchial 2020-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01702844/single-arm-on-the-tolerability-of-weekly-nab-paclitaxel 2020-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01532089/erlotinib-hydrochloride-with-or-without-bevacizumab-in-treating-patients-with-stage-iv-n 2020-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00551733/carboplatin-with-either-paclitaxel-poliglumex-or-paclitaxel-in-treating-women-with-stage 2020-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00054197/polyglutamate-paclitaxel-compared-with-gemcitabine-or-vinorelbine-in-treating-patients-w 2020-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00054210/polyglutamate-paclitaxel-plus-carboplatin-compared-with-paclitaxel-plus-carboplatin-in-t 2020-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02451930/a-study-of-the-combination-of-necitumumab-ly3012211-and-pembrolizumab-mk3475-in-particip 2020-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00054184/polyglutamate-paclitaxel-compared-with-docetaxel-in-treating-patients-with-progressive-n 2020-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03642457/efficacy-between-serratus-plane-block-and-local-infiltration-in-vats 2020-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01675765/safety-and-efficacy-of-listeria-in-combination-with-chemotherapy-as-front-line-treatment 2020-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01588821/cabozantinib-in-advanced-solid-malignancies 2020-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02029690/ph-1-study-in-subjects-with-tumors-requiring-arginine-to-assess-adi-peg-20-with-pemetrex 2020-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02063438/thoracotomy-closure-technique-and-postoperative-pain-study-a-randomized-controlled-trial 2020-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03409341/personalizing-immune-checkpoint-inhibitor-therapy 2020-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02145078/gene-expression-levels-in-predicting-treatment-response-in-patients-with-stage-iv-non-sm 2020-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01532362/evaluation-of-apricoxib-selective-cyclooxygenase-2-inhibition-in-modulating-t-regulatory 2020-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00414960/a-trial-of-placebo-versus-enzastaurin-for-lung-cancer-prevention-in-former-smokers 2020-09-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03957096/a-safety-study-of-sgn-cd47m-in-patients-with-solid-tumors 2020-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00950365/pemetrexed-disodium-with-or-without-erlotinib-hydrochloride-in-treating-patients-with-st 2020-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02038218/study-of-4-demethyl-4-cholesteryloxycarbonylpenclome-dm-choc-pen-in-patients-with-brain 2020-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03116971/phase-ib-ii-study-of-m3814-with-etoposide-and-cisplatin-in-small-cell-lung-cancer-sclc-e 2020-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03794128/a-study-of-personalized-neoantigen-cancer-vaccines 2020-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03382912/study-of-pegilodecakin-ly3500518-with-nivolumab-compared-to-nivolumab-alone-second-line 2020-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02079636/a-study-of-abemaciclib-ly2835219-in-combination-with-another-anti-cancer-drug-in-partici 2020-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01622621/stereotactic-body-radiotherapy-sbrt-versus-sublobar-resection-for-high-risk-patients-non 2020-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03628144/immunonutrition-to-reduce-toxicities-in-non-small-cell-lung-cancer 2020-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03384316/multi-targeted-recombinant-ad5-cea-muc1-brachyury-based-immunotherapy-vaccine-regimen-in 2020-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01859741/a-phase-1b-2-study-of-omp-59r5-tarextumab-in-combination-with-etoposide-and-platinum-the 2020-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02259582/a-study-of-carboplatin-pemetrexed-plus-placebo-vs-carboplatin-pemetrexed-plus-1-or-2-tru 2020-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01957007/a-study-of-vantictumab-omp-18r5-in-combination-with-docetaxel-in-patients-with-previousl 2020-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01784640/pemetrexed-disodium-and-hsp90-inhibitor-auy922-in-treating-patients-with-previously-trea 2020-09-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01944137/improving-care-after-chemotherapy 2020-09-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02346955/study-of-cm-24-mk-6018-alone-and-in-combination-with-pembrolizumab-mk-3475-in-participan 2020-08-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02061397/safety-of-simvastatin-in-lam-and-tsc 2020-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00859495/trimodal-lung-sparing-treatment-of-pleural-mesothelioma 2020-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00547105/erlotinib-and-sbrt-in-treating-patients-with-locally-advanced-or-metastatic-non-small-ce 2020-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02499770/trilaciclib-g1t28-a-cdk-4-6-inhibitor-in-combination-with-etoposide-and-carboplatin-in-e 2020-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03551405/4d-cone-beam-ct-reconstruction-for-radiotherapy-via-motion-vector-optimization 2020-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00986297/specialized-radiation-therapy-in-treating-patients-with-stage-ii-stage-iii-stage-iv-or-r 2020-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00866086/comfort-level-of-two-abdominal-compression-methods-used-to-hold-patients-still-while-und 2020-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01421784/using-rapid-cine-mri-for-monitoring-moving-and-deforming-tumors 2020-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01218516/a-safety-and-efficacy-study-of-farletuzumab-in-participants-with-adenocarcinoma-of-the-l 2020-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006469/combination-chemotherapy-and-radiation-therapy-followed-by-surgery-in-treating-patients 2020-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02027428/safety-and-efficacy-study-of-abraxane-as-maintenance-treatment-after-abraxane-plus-carbo 2020-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02276664/capitalizing-on-a-teachable-moment-to-promote-smoking-cessation 2020-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02147990/multicenter-study-of-rociletinib-administered-to-patients-with-previously-treated-mutant 2020-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02320123/end-of-life-care-for-african-americans 2020-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00444223/fluorine-f-18-feqa-in-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-and 2020-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03006562/prevention-of-venous-thromboembolism-following-radical-prostatectomy 2020-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01526928/study-to-evaluate-safety-pharmacokinetics-and-efficacy-of-rociletinib-co-1686-in-previou 2020-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02585713/apixaban-or-dalteparin-in-reducing-blood-clots-in-patients-with-cancer-related-venous-th 2020-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03607682/tumor-treating-fields-therapy-in-preventing-brain-tumors-in-participants-with-extensive 2020-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01833143/bortezomib-in-kras-mutant-non-small-cell-lung-cancer-in-never-smokers-or-those-with-kras 2020-08-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00450567/glucose-metabolism-in-patients-with-non-small-cell-lung-cancer-treated-with-targeted-the 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00601094/vaccine-therapy-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cel 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00024076/radiofrequency-ablation-in-treating-patients-with-refractory-or-advanced-lung-cancer 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02395172/avelumab-in-non-small-cell-lung-cancer-javelin-lung-200 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00062179/paclitaxel-and-carboplatin-with-or-without-celecoxib-before-surgery-in-treating-patients 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00020878/celecoxib-in-preventing-non-small-cell-lung-cancer-in-tobacco-smokers 2020-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01249443/paclitaxel-and-carboplatin-in-treating-patients-with-metastatic-or-recurrent-solid-tumor 2020-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04119960/clinical-validation-of-inferread-lung-ct-ai 2020-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03741868/symptom-burden-and-unmet-supportive-care-needs-in-lung-cancer-patients-undergoing-first 2020-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01982149/incorporation-of-genetic-expression-of-airway-epithelium-with-ct-screening-for-lung-canc 2020-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02451865/binimetinib-with-docetaxel-in-treating-patients-with-previously-treated-stage-iv-non-sma 2020-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02672033/accelerated-hypofractionated-radiation-therapy-immediately-before-surgery-in-treating-pa 2020-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03275688/nanospectrometer-biomarker-discovery-and-confirmation-study 2020-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01656460/stereotactic-body-radiation-for-consolidation-after-standard-chemoradiation-for-stage-3 2020-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03695835/a-data-collection-study-for-patients-with-adenocarcinoma-treated-with-the-myvaccx-immuno 2020-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00303901/cryotherapy-in-treating-patients-with-primary-lung-cancer-or-lung-metastases-that-cannot 2020-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02412371/a-study-evaluating-the-efficacy-and-tolerability-of-veliparib-in-combination-with-paclit 2020-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02955251/a-study-of-abbv-428-an-immunotherapy-in-subjects-with-advanced-solid-tumors 2020-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00278148/erlotinib-paclitaxel-and-carboplatin-combined-with-radiation-therapy-for-stage-iii-non-s 2020-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01636934/minocycline-study-in-non-small-cell-lung-cancer-nsclc-patients-for-chemoradiation-therap 2020-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03026166/a-study-of-rovalpituzumab-tesirine-administered-in-combination-with-nivolumab-and-with-o 2020-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03923777/active-surveillance-in-early-lung-cancer 2020-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03745222/a-study-of-tislelizumab-bgb-a317-plus-chemoradiotherapy-followed-by-tislelizumab-monothe 2020-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02193152/pazopanib-in-molecularly-selected-patients-with-advanced-nsclc 2020-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00342953/study-of-health-effects-of-cosmetic-breast-augmentation 2020-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00840749/randomized-study-to-compare-cyberknife-to-surgical-resection-in-stage-i-non-small-cell-l 2020-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03415126/a-study-of-asn007-in-patients-with-advanced-solid-tumors 2020-07-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04385147/advanced-endoscopy-during-covid-19 2020-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01857271/erlotinib-hydrochloride-before-surgery-in-treating-patients-with-stage-iii-non-small-cel 2020-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01450761/trial-in-extensive-disease-small-cell-lung-cancer-ed-sclc-subjects-comparing-ipilimumab 2020-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03793894/inpatient-smokers-and-ldct-screening-part-2 2020-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01746251/adjuvant-afatinib-in-stage-i-iii-nsclc-with-egfr-mutation 2020-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02123797/building-a-multidisciplinary-bridge-across-the-quality-chasm-in-thoracic-oncology 2020-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00530621/study-of-enzastaurin-versus-placebo-with-pemetrexed-for-participants-with-advanced-or-me 2020-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01773655/clinical-and-histopathologic-characteristics-of-bap1-mutations 2020-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02387125/phase-1b-safety-study-of-cmb305-in-patients-with-locally-advanced-relapsed-or-metastatic 2020-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01862809/cigarette-smoking-and-oral-microbiota 2020-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01803269/topotecan-hydrochloride-or-cyclodextrin-based-polymer-camptothecin-crlx101-in-treating-p 2020-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02565017/examining-patient-preferences-about-the-ibm-watson-oncology-clinical-decision-support-sy 2020-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03181308/study-of-carotuximab-trc105-plus-nivolumab-in-patients-with-metastatic-nsclc 2020-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04361552/tocilizumab-for-the-treatment-of-cytokine-release-syndrome-in-patients-with-covid-19-sar 2020-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01285609/phase-3-trial-in-squamous-non-small-cell-lung-cancer-subjects-comparing-ipilimumab-versu 2020-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03326752/phase-1b-dv281-with-an-anti-pd-1-inhibitor-in-nsclc 2020-06-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01101334/study-of-erlotinib-with-or-without-investigational-drug-cs-7017-in-subjects-with-advance 2020-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02489838/lung-dose-in-patients-treated-with-yttrium-90-for-hepatocellular-carcinoma 2020-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02887235/food-as-medicine-an-rct-to-study-the-effect-of-home-delivered-medically-tailored-meals-o 2020-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03544723/safety-and-efficacy-of-p53-gene-therapy-combined-with-immune-checkpoint-inhibitors-in-so 2020-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03343613/a-study-of-ly3381916-alone-or-in-combination-with-ly3300054-in-participants-with-solid-t 2020-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03713099/neuwave-flexible-probe-study-2 2020-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01479348/imaging-study-for-fdcyd-and-thu-cancer-treatment 2020-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01803282/study-to-evaluate-the-safety-and-tolerability-of-andecaliximab-as-monotherapy-and-in-com 2020-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01884285/azd8186-first-time-in-patient-ascending-dose-study 2020-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00420732/vaccine-maintenance-treatment-for-non-small-cell-lung-cancer 2020-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00333502/study-of-crlx101-nlg207-in-the-treatment-of-advanced-solid-tumors 2020-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00739609/ido-inhibitor-study-for-relapsed-or-refractory-solid-tumors 2020-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01774578/immunotherapy-study-in-progressive-or-relapsed-non-small-cell-lung-cancer 2020-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00073398/vaccine-treatment-for-advanced-non-small-cell-lung-cancer 2020-05-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00915005/trial-of-image-guided-adaptive-conformal-photon-vs-proton-therapy-with-concurrent-chemot 2020-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02169271/acetylsalicylic-acid-compared-to-placebo-in-treating-high-risk-patients-with-subsolid-lu 2020-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03361228/a-study-to-evaluate-the-safety-tolerability-and-antitumor-activity-of-incb001158-plus-ep 2020-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03338049/all-in-one-study-a-prospective-trial-of-electromagnetic-navigation-for-biopsy-of-pulmona 2020-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00897364/biomarkers-in-the-nose-throat-and-lung-tissue-of-smokers-and-non-smokers 2020-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002586/13-cis-retinoic-acid-with-or-without-vitamin-e-for-prevention-of-lung-cancer 2020-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00084409/iloprost-in-preventing-lung-cancer-in-patients-at-high-risk-for-this-disease 2020-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02289690/dose-escalation-and-double-blind-study-of-veliparib-in-combination-with-carboplatin-and 2020-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00806286/study-of-carboplatin-paclitaxel-with-or-without-investigational-drug-cs-7017-in-subjects 2020-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00066404/intrapleural-bg00001-in-treating-patients-with-malignant-pleural-mesothelioma-or-maligna 2020-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02223052/bioequivalence-food-effect-study-in-patients-with-solid-tumor-or-hematologic-malignancie 2020-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01885455/improving-resection-rates-among-african-americans-with-nsclc 2020-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01671332/docetaxel-suramin-in-2nd-line-advanced-non-small-cell-lung-cancer 2020-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02221739/study-of-combined-ionizing-radiation-and-ipilimumab-in-metastatic-non-small-cell-lung-ca 2020-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00339859/dna-repair-p53-and-apoptosis-phenotypes-in-lung-cancer 2020-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00271505/avastin-docetaxel-carboplatin-in-non-small-cell-lung-cancer 2020-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02659631/pf-06671008-dose-escalation-study-in-advanced-solid-tumors 2020-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02579226/a-phase-i-study-of-safety-tolerability-and-pk-of-azd2811-in-patients-with-advanced-solid 2020-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03585959/superdimensiontm-navigation-system-version-7-2-with-fluoroscopic-navigation-technology 2020-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02848651/a-study-of-atezolizumab-as-first-line-monotherapy-for-advanced-or-metastatic-non-small-c 2020-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00589056/nelfinavir-radiation-therapy-cisplatin-and-etoposide-in-treating-patients-with-stage-iii 2020-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02336451/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-oral-ceritinib-in-patients-with 2020-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02013219/a-phase-1b-study-of-atezolizumab-in-combination-with-erlotinib-or-alectinib-in-participa 2020-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00341835/genetic-epidemiology-of-lung-cancer 2020-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00597961/health-communication-in-families 2020-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02380196/the-utility-of-circulating-tumor-cells-as-confirmation-of-pathologic-diagnosis-in-patien 2020-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00862680/4d-pet-ct-in-diagnosing-participants-with-lung-and-colorectal-cancer-with-liver-and-lung 2020-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03267368/comprehensive-care-program-sbrt 2020-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01112293/anti-tgf-monoclonal-antibody-gc1008-in-relapsed-malignant-pleural-mesothelioma 2020-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02804945/mesenchymal-stem-cells-mscs-for-treatment-of-acute-respiratory-distress-syndrome-ard-in 2020-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01831089/phase-i-study-of-lurbinectedin-pm01183-in-combination-with-paclitaxel-with-or-without-be 2020-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03674450/lung-heart-rate-variability 2020-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03224871/ucdcc-269-a-pilot-study-of-interlesional-il-2-and-rt-in-patients-with-nsclc 2020-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02452463/nintedanib-compared-with-placebo-in-treating-against-radiation-induced-pneumonitis-in-pa 2020-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02559349/gut-microbiota-and-radiotherapy 2020-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006229/paclitaxel-carboplatin-with-ut-bms-275291-in-advanced-or-metastatic-non-small-cell-lung 2020-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00137800/study-of-osi-774-tarceva-in-previously-untreated-elderly-lung-cancer-patients 2020-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00454363/pazopanib-hydrochloride-in-treating-patients-with-advanced-neuroendocrine-cancer 2020-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002583/vinorelbine-cisplatin-or-no-further-therapy-in-non-small-cell-lung-cancer-that-has-been 2020-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01773109/etirinotecan-pegol-nktr-102-in-nsclc 2020-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00921739/esophageal-sparing-intensity-modulated-radiation-therapy-imrt-for-locally-advanced-thora 2020-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00955942/flaxseed-supplement-in-treating-patients-with-locally-advanced-or-metastatic-non-small-c 2020-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00436332/s0635-erlotinib-and-bevacizumab-in-stage-iiib-and-iv-bronchioloalveolar-carcinoma 2020-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02514174/afatinib-treatment-for-patients-with-egfr-mutation-positive-nsclc-who-are-age-70-or-olde 2020-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00489008/srs-study-in-patients-with-non-small-cell-lung-cancer 2020-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03371992/pilot-study-of-nilogen-3d-ex-and-its-ability-to-predict-therapeutic-response-to-anti-pd1 2020-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02983903/cryobiopsy-versus-forceps-biopsy-for-pulmonary-lesions 2020-03-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02926638/lung-map-rilotumumab-and-erlotinib-hydrochloride-or-erlotinib-hydrochloride-alone-as-sec 2020-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00299962/gene-therapy-for-pleural-malignancies 2020-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00780611/investigating-the-improvement-in-4d-ct-images-using-av-biofeedback 2020-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03574818/necitumumab-in-the-neoadjuvant-setting-with-gemcitabine-in-surgically-resectable-14x-us 2020-03-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01876446/pegylated-irinotecan-nktr-102-in-treating-patients-with-relapsed-small-cell-lung-cancer 2020-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02357147/study-of-the-safety-and-efficacy-of-amatuximab-in-combination-with-pemetrexed-and-cispla 2020-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01307267/a-study-of-pf-05082566-as-a-single-agent-and-in-combination-with-rituximab 2020-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02735980/a-study-of-prexasertib-ly2606368-in-participants-with-extensive-stage-disease-small-cell 2020-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01110226/trial-of-cisplatin-and-kml-001-in-platinum-responsive-malignancies 2020-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01587703/a-study-to-investigate-the-safety-pharmacokinetics-pharmacodynamics-and-clinical-activit 2020-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03580694/study-of-regn4659-in-combination-with-cemiplimab-in-patients-with-advanced-or-metastatic 2020-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02819999/a-study-of-rovalpituzumab-tesirine-sc16ld6-5-in-the-frontline-treatment-of-patients-with 2020-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00097903/trial-of-oral-karenitecin-in-patients-with-solid-tumors-and-lung-cancer 2020-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00981578/exablate-conformal-bone-system-treatment-of-metastatic-bone-tumors-for-the-palliation-of 2020-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01717482/metformin-as-a-chemoprevention-agent-in-non-small-cell-lung-cancer 2020-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01386697/dibh-proton-planning 2020-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00792701/s0720-adjuvant-therapy-based-on-gene-expression-in-stage-ia-and-ib-non-small-cell-lung-c 2020-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00770120/s0722-everolimus-in-treating-patients-with-pleural-malignant-mesothelioma-that-cannot-be 2020-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02452424/a-combination-clinical-study-of-plx3397-and-pembrolizumab-to-treat-advanced-melanoma-and 2020-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00445848/s0636-erlotinib-and-bevacizumab-in-never-smokers-with-stage-iiib-or-stage-iv-primary-non 2020-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00514215/cryotherapy-and-gm-csf-in-treating-patients-with-lung-metastases-or-primary-lung-cancer 2020-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00960999/radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer 2020-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02544633/phase-2-study-of-mgcd265-in-patients-with-non-small-cell-lung-cancer-with-activating-gen 2020-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02916745/feasibility-study-of-using-navigational-bronchoscopy-to-perform-pdt-photofrin-in-unresec 2020-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01143545/pilot-study-of-allogeneic-tumor-cell-vaccine-with-metronomic-oral-cyclophosphamide-and-c 2020-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01313429/tumor-cell-vaccine-for-patients-undergoing-surgery-for-sarcomas-melanomas-germ-cell-tumo 2020-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00372840/printed-education-materials-in-patients-who-are-finishing-treatment-for-stage-i-stage-ii 2020-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03524248/development-of-real-time-image-guided-radiotherapy 2020-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02840994/a-trial-of-cv301-in-combination-with-anti-pd-1-therapy-in-subjects-with-non-small-cell-l 2020-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01557881/positron-emission-tomography-magnetic-resonance-imaging-in-patients 2020-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03589456/establishment-of-a-pdt-patient-registry 2020-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02468661/a-safety-and-efficacy-study-of-inc280-alone-and-in-combination-with-erlotinib-compared-t 2020-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02134912/s1300-pemetrexed-disodium-with-or-without-crizotinib-in-treating-patients-with-stage-iv 2020-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03694431/comparative-trial-of-home-based-palliative-care 2020-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00661193/s0709-erlotinib-with-or-without-carboplatin-and-paclitaxel-in-stage-iiib-or-stage-iv-non 2020-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03616522/a-prospective-study-of-electronic-symptom-reporting-via-mobile-phone-among-patients-with 2020-02-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct04158700/a-study-of-ly3200882-and-pembrolizumab-in-participants-with-advanced-cancer 2020-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02469701/advanced-non-small-cell-lung-cancer-progressing-after-at-least-one-prior-therapy-for-met 2020-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00596310/early-detection-of-lung-cancer-in-a-high-risk-population-defined-by-pft-biomarkers-and-c 2020-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00582348/physical-activity-and-inactivity-in-lung-cancer-survivors 2020-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00613626/cisplatin-etoposide-concurrent-zd6474-in-previously-untreated-extensive-stage-small-cell 2020-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01114958/pilot-study-of-intra-arterial-cisplatin-with-iv-thiosulfate-in-patients-with-lung-cancer 2020-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01317550/a-study-for-reducing-symptom-burden-produced-by-chemoradiation-treatment-for-non-small-c 2020-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02009436/azacitidine-in-treating-patients-with-stage-iv-or-recurrent-non-small-cell-lung-cancer 2020-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02576665/a-study-of-toca-511-a-retroviral-replicating-vector-combined-with-toca-fc-in-patients-wi 2020-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02558998/improving-clinical-trial-awareness-in-nsclc-pilot-testing-a-novel-healthcare-it-platform 2020-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00656305/exablate-mrgfus-treatment-of-metastatic-bone-tumors-for-the-palliation-of-pain 2020-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02663817/dmh-based-plan-evaluation-and-inverse-optimization-in-radiotherapy 2020-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03741829/ts-overexpression-in-sclc-mechanism-and-therapeutic-targeting 2020-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02117024/a-phase-2-study-of-viagenpumatucel-l-hs-110-in-patients-with-non-small-cell-lung-cancer 2020-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02048917/optimization-of-smoking-cessation-strategies-concurrent-with-treatment-of-tobacco-relate 2020-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00411632/battle-program-tarceva-and-targretin-in-patients-with-advanced-non-small-cell-lung-cance 2020-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02743637/a-dose-escalation-study-of-sdx-7320-in-patients-with-advanced-refractory-or-late-stage-s 2020-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02292485/pcori-cer-1306-03385-lung-cancer-screening-readiness-study 2020-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01846520/family-caregiver-palliative-care-intervention-in-supporting-caregivers-of-patients-with 2020-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00601146/low-dose-chest-computed-tomography-screening-for-lung-cancer-in-survivors-of-hodgkin-s-d 2020-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00752206/a-placebo-controlled-study-of-saracatinib-azd0530-in-patients-with-recurrent-osteosarcom 2020-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01707823/low-dose-acetylsalicylic-acid-in-treating-patients-with-stage-i-iii-non-small-cell-lung 2020-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02272413/phase-iii-trial-bi-695502-plus-chemotherapy-vs-avastin-plus-chemotherapy-in-patients-wit 2020-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00409968/battle-program-umbrella-protocol-for-patients-with-non-small-cell-lung-cancer-nsclc 2020-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02502695/a-study-to-optimize-care-for-lung-cancer-patients-undergoing-video-assisted-thoracoscopi 2020-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03344861/safety-of-pdt-photofrin-prior-to-lung-surgery 2020-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03872440/pdx-models-from-egfr-mutant-tumors 2020-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02285855/metformin-in-non-small-cell-lung-cancer-nsclc 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01310244/mtd-study-pxd-101-in-combination-with-paclitaxel-carboplatin-in-chemotherapy-naive-patie 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02031458/a-study-of-atezolizumab-in-participants-with-programmed-death-ligand-1-pd-l1-positive-lo 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00586937/quality-of-life-in-lung-cancer-survivors 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03041571/impact-of-early-implementation-of-narrative-medicine-techniques-on-patient-centered-atti 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00341380/prevention-of-tumor-spread-due-to-lung-cancer-surgery 2020-01-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01952860/hatha-yoga-in-lung-cancer-couples 2020-01-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01165658/study-of-hypofractionated-proton-radiation-therapy-in-thoracic-malignancies 2020-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01880528/lisinopril-in-reducing-shortness-of-breath-caused-by-radiation-therapy-in-patients-with 2020-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00200395/osi-774-erlotinib-tarceva-in-elderly-patients 2019-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01624090/mithramycin-for-lung-esophagus-and-other-chest-cancers 2019-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03811652/a-multiple-ascending-dose-study-of-medi7247-in-advanced-or-metastatic-solid-tumors 2019-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00978250/a-multi-histology-phase-ii-study-of-5-fluoro-2-deoxycytidine-with-tetrahydrouridine-fdcy 2019-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02014116/a-study-of-ly3009120-in-participants-with-advanced-cancer-or-cancer-that-has-spread-to-o 2019-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02047344/efficacy-safety-and-pharmacokinetics-study-of-antroquinonol-to-treat-nsclc 2019-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01813734/ponatinib-in-advanced-nsclc-w-ret-translocations 2019-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02008227/a-study-of-atezolizumab-compared-with-docetaxel-in-participants-with-locally-advanced-or 2019-12-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01578707/a-phase-3-study-of-ibrutinib-pci-32765-versus-ofatumumab-in-patients-with-relapsed-or-re 2019-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03564054/trial-of-photodynamic-therapy-versus-argon-plasma-coagulation-for-lung-cancer-with-endob 2019-12-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01441128/02341066-and-pf-00299804-for-advanced-non-small-cell-lung-cancer 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00137839/erlotinib-in-women-with-previously-untreated-adenocarcinoma-of-the-lung 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01086696/a-pilot-study-of-f-18-paclitaxel-fpac-pet-for-evaluating-drug-delivery-of-solid-tumors-i 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00036790/motexafin-gadolinium-and-doxorubicin-in-treating-patients-with-advanced-cancer 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01346280/evaluation-of-cancer-care-coordination-in-the-national-cancer-institutes-community-cance 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01413451/amatuximab-for-high-mesothelin-cancers 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005655/combination-therapy-of-interleukin-12-and-interleukin-2-to-treat-advanced-cancer 2019-12-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01517152/testing-a-spanish-version-of-a-patient-toxicity-questionnaire 2019-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01902823/effect-of-cancer-nurse-navigators-on-patient-outcomes 2019-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00214123/hypofractionated-radiotherapy-for-lung-cancer 2019-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00585117/pilot-study-of-61-cuatsm-pet-imaging-in-cancer-patients 2019-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00064012/bortezomib-with-or-without-docetaxel-in-treating-patients-with-relapsed-or-refractory-ad 2019-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00924092/an-open-label-phase-i-study-to-eval-the-safety-and-tolerability-of-a-vaccine-gi-6207-con 2019-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00094978/depsipeptide-flavopiridol-infusion-for-cancers-of-the-lungs-esophagus-pleura-thymus-or-m 2019-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00026689/evaluation-for-nci-radiation-oncology-branch-clinical-research-protocols 2019-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02034123/investigation-of-gsk2879552-in-subjects-with-relapsed-refractory-small-cell-lung-carcino 2019-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03232892/trametinib-in-patients-with-advanced-neurofibromatosis-type-1-nf1-mutant-non-small-cell 2019-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01258868/tumor-cell-vaccines-with-iscomatrix-adjuvant-and-celecoxib-in-patients-undergoing-resect 2019-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02391480/a-study-evaluating-the-safety-and-pharmacokinetics-of-abbv-075-in-subjects-with-cancer 2019-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01185639/stereotactic-body-radiation-therapy-sbrt-in-metastatic-non-small-cell-lung-cancer 2019-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01059552/treatment-of-locally-advanced-non-small-cell-lung-cancer-nsclc 2019-11-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923273/sirolimus-and-pemetrexed-to-treat-non-small-cell-lung-cancer 2019-11-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00557895/evaluation-and-long-term-follow-up-of-patients-with-allergic-and-inflammatory-disorders 2019-11-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02770014/rapid-plasma-genotyping-for-early-initiation-of-erlotinib-in-egfr-mutant-lung-cancer 2019-11-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01255150/frequency-of-egfr-mutations-in-latinos-hispanics-with-non-small-cell-lung-cancer 2019-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00512642/fluorescence-bronchoscopy-and-molecular-characterization-of-abnormal-bronchial-lesions-n 2019-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03023423/a-study-of-daratumumab-in-combination-with-atezolizumab-compared-with-atezolizumab-alone 2019-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00563784/tarceva-erlotinib-in-combination-with-chemoradiation-in-patients-with-stage-iiia-b-non-s 2019-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00581789/erlotinib-and-sunitinib-in-nsclc 2019-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00537511/a-phase-i-ii-study-to-determine-the-maximum-tolerated-dose-mtd-and-safety-of-cc-4047-pom 2019-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00582634/adjuvant-cisplatin-and-docetaxel-in-non-small-cell-lung-cancer 2019-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01063283/dose-escalation-of-bevacizumab-with-ambulatory-blood-pressure-monitoring-in-patients-wit 2019-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02313012/safety-and-pk-study-of-cc-90003-in-relapsed-refractory-solid-tumors 2019-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01999881/impacts-of-exercise-on-prognostic-biomarkers-in-lung-cancer-patients 2019-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02586987/a-study-to-assess-the-safety-tolerability-and-anti-tumour-activity-of-ascending-doses-of 2019-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01012401/evaluating-an-interactive-cancer-communication-system-iccs-in-lung-cancer 2019-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00205439/surveillance-for-new-lung-primaries 2019-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00954278/intra-patient-dose-escalation-study-of-sorafenib-in-advanced-non-small-cell-lung-cancer 2019-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01478685/a-phase-1-study-of-cc-486-as-a-single-agent-and-in-combination-with-carboplatin-or-abi-0 2019-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01545947/study-assessing-safety-pharmacokinetics-and-efficacy-of-cc-223-with-either-erlotinib-or 2019-11-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00617409/to-immunize-patients-with-extensive-stage-sclc-combined-with-chemo-with-or-without-all-t 2019-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02639091/phase-ib-study-of-anetumab-ravtansine-in-combination-with-pemetrexed-and-cisplatin-in-me 2019-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02511795/azd1775-combined-with-olaparib-in-patients-with-refractory-solid-tumors 2019-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03137264/resistance-activating-mutations-diagnosed-among-nsclc-community-dwelling-egfr-mutation-p 2019-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01648166/study-of-lung-cancer-in-appalachian-kentucky-the-role-of-environmental-carcinogens 2019-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00547651/amr-ph-gl-2007-cl001-phase-3-trial-in-patients-with-small-cell-lung-cancer-after-failure 2019-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03178071/expanded-access-for-lorlatinib-for-patients-with-non-small-cell-lung-cancer-alk-positive 2019-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005858/lmb-9-immunotoxin-in-treating-patients-with-advanced-colon-breast-non-small-cell-lung-bl 2019-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02867371/evaluation-of-the-archimedestm-system-for-transparenchymal-nodule-access-2 2019-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02000947/a-phase-1b-study-of-medi4736-in-combination-with-tremelimumab-in-subjects-with-advanced 2019-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00771953/0822gcc-phase-2-study-of-efficacy-and-safety-of-apricoxib-placebo-with-docetaxel-or-peme 2019-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00894127/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphine-tcpp-for-detecti 2019-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02448251/safety-pharmacokinetic-and-preliminary-efficacy-study-of-ac0010ma-in-advanced-non-small 2019-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00540514/albumin-bound-paclitaxel-abi-007-for-patients-with-advanced-non-small-cell-lung-cancer 2019-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00375193/study-of-amrubicin-in-patients-with-small-cell-lung-cancer-refractory-or-progressive-to 2019-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02944396/study-of-veliparib-in-combination-with-nivolumab-and-platinum-doublet-chemotherapy-in-pa 2019-10-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00647426/phase-ii-study-of-sorafenib-carboplatin-and-docetaxel-in-first-line-treatment-of-stage-i 2019-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00107172/surgery-with-or-without-internal-radiation-therapy-in-treating-patients-with-stage-i-non 2019-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03121300/functional-imaging-in-lung-sbrt 2019-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02030184/phase-i-ii-trial-of-rhenium-188-p2045-in-small-cell-lung-cancer-and-other-advanced-neuro 2019-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01583686/car-t-cell-receptor-immunotherapy-targeting-mesothelin-for-patients-with-metastatic-canc 2019-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00603057/using-imaging-and-molecular-markers-to-predict-tumor-response-and-lung-toxicity-in-lung 2019-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03477474/registry-of-guardant360-use-and-outcomes-in-people-with-advanced-cancer 2019-10-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01673711/deuterated-phenanthrene-tetraol-in-smokers-who-are-at-high-risk-for-lung-cancer 2019-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923884/prospective-analysis-of-genotypes-in-adults-undergoing-therapy-for-lung-cancer 2019-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01754909/mitigation-of-radiation-pneumonitis-and-fibrosis 2019-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03101839/phase-i-dose-escalation-study-of-azd4785-in-patients-with-advanced-solid-tumours 2019-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02920450/study-of-paclitaxel-carboplatin-and-pf-05212384-in-advanced-or-metastatic-nsclc-uf-sto-l 2019-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01004224/a-dose-escalation-study-in-adult-patients-with-advanced-solid-malignancies 2019-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01806675/18f-fpprgd2-pet-ct-or-pet-mri-in-predicting-early-response-in-patients-with-cancer-recei 2019-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01903993/a-randomized-phase-2-study-of-atezolizumab-an-engineered-anti-pdl1-antibody-compared-wit 2019-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02062632/doxepin-hydrochloride-in-treating-esophageal-pain-in-patients-with-thoracic-cancer-recei 2019-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02374255/improving-goals-of-care-discussion-in-advanced-cancer-patients 2019-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01606748/a-drug-interaction-study-of-necitumumab-imc-11f8-in-combination-with-gemcitabine-cisplat 2019-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00037817/phase-i-study-of-gene-induction-mediated-by-sequential-decitabine-depsipeptide-infusion 2019-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02941601/a-study-of-gemcitabine-carboplatin-plus-necitumumab-ly3012211-in-chemotherapy-nai-ve-par 2019-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01490632/a-phase-2b-study-of-baricitinib-in-participants-with-moderate-to-severe-psoriasis 2019-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02848872/evaluation-of-tumor-and-blood-immune-biomarkers-in-resected-non-small-cell-lung-cancer 2019-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01168973/a-study-of-chemotherapy-and-ramucirumab-versus-chemotherapy-alone-in-second-line-non-sma 2019-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03396497/study-of-lyc-55716-with-pembrolizumab-in-adult-subjects-with-non-small-cell-lung-cancer 2019-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01951157/a-clinical-study-in-three-arm-of-lurbinectedin-pm01183-alone-or-in-combination-with-gemc 2019-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01107457/a-study-in-participants-with-moderate-to-severe-psoriasis 2019-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01281124/azacitidine-in-treating-patients-with-previously-treated-advanced-non-small-cell-lung-ca 2019-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01769391/a-study-of-necitumumab-and-chemotherapy-in-participants-with-stage-iv-squamous-non-small 2019-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01232452/a-study-in-non-small-cell-lung-cancer 2019-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02648178/evaluation-of-appeal-and-impact-of-e-cigarettes-among-chronic-smokers-with-smoking-relat 2019-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02711345/a-phase-i-clinical-study-with-investigational-compound-ltt462-in-adult-patients-with-spe 2019-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01059643/a-study-in-ovarian-non-small-cell-lung-prostate-colorectal-gastroesophageal-cancers-and 2019-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00096226/paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-who-are-undergoing-sur 2019-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01900652/a-study-of-emibetuzumab-in-non-small-cell-lung-cancer-nsclc-participants 2019-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02250885/kpt-330-to-treat-poorly-differentiated-lung-and-gastroenteropancreatic-tumors 2019-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01025284/a-study-for-participants-with-small-cell-lung-cancer 2019-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03408561/social-media-listening-in-improving-clinical-trial-recruitment-in-patients-with-cancer 2019-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00988858/a-study-of-advanced-or-metastatic-non-small-cell-lung-cancer 2019-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01098266/ngr015-study-in-second-line-for-patient-with-advanced-malignant-pleural-mesothelioma-pre 2019-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01160744/a-study-of-pemetrexed-and-carboplatin-cisplatin-or-gemcitabine-and-carboplatin-cisplatin 2019-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03416582/feasibility-study-of-a-nurse-intervention-to-impact-mucositis-severity-and-prevent-dehyd 2019-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00087711/a-randomized-phase-3-trial-of-pemetrexed-and-cisplatin-versus-gemcitabine-and-cisplatin 2019-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02448303/pembrolizumab-alone-and-in-combination-with-acalabrutinib-acp-196-in-subjects-with-advan 2019-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01259089/hsp90-inhibitor-auy922-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iiib 2019-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01107444/study-of-ly2181308-in-combination-with-docetaxel-versus-docetaxel-in-patients-with-non-s 2019-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02937402/bronchoscopy-with-bronchoalveolar-lavage-in-identifying-biomarkers-of-response-to-immune 2019-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03270670/olympus-19-gauge-needle 2019-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00153803/erlotinib-or-placebo-following-chemoradiotherapy-chemo-rt-in-stage-iii-non-small-cell-lu 2019-09-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01566682/a-multi-center-trial-of-the-prolung-testtm 2019-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02132884/genetic-sequencing-informed-targeted-therapy-in-treating-patients-with-stage-iiib-iv-non 2019-09-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03084835/low-dose-computed-tomography-for-lung-cancer-screening 2019-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03107156/understanding-evidence-based-practice-patterns-in-advanced-nsclc 2019-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01061788/a-trial-of-amg-479-everolimus-rad001-and-panitumumab-in-patients-with-advanced-cancer-qu 2019-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01853878/a-study-to-demonstrate-the-benefit-of-a-new-kind-of-anti-cancer-treatment-preferentially 2019-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02275806/cisplatin-irinotecan-with-concurrent-radiation-for-inoperable-nsclc 2019-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02054819/treating-nsclc-minimal-stage-iv-with-curative-intent 2019-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01868022/study-to-evaluate-gsk3052230-in-combination-with-paclitaxel-and-carboplatin-or-docetaxel 2019-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01016938/dynamic-magnetic-resonance-imaging-mri-for-lung-tumor-motion-and-lung-function-gcc-0943 2019-08-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02322281/tiger-3-open-label-multicenter-study-of-rociletinib-co-1686-mono-therapy-versus-single-a 2019-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01877083/study-of-the-safety-and-activity-of-lenvatinib-e7080-in-subjects-with-kif5b-ret-positive 2019-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03029871/oncolytic-adenovirus-mediated-gene-therapy-for-lung-cancer 2019-08-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03785808/reducing-insulin-growth-hormones-and-tumors 2019-08-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02751879/real-world-data-on-gi-l-otrif-dose-adjustment 2019-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01727427/prospective-study-on-the-treatment-of-unsuspected-pulmonary-embolism-in-cancer-patients 2019-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00126581/erlotinib-hydrochloride-with-or-without-carboplatin-and-paclitaxel-in-treating-patients 2019-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01650090/phase-2-study-of-inhaled-lipid-cisplatin-in-pulmonary-recurrent-osteosarcoma 2019-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02289833/a-study-of-trastuzumab-emtansine-in-participants-with-human-epidermal-growth-factor-rece 2019-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01433172/combination-immunotherapy-of-gm-cd40l-vaccine-with-ccl21-in-lung-cancer 2019-08-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01822496/erlotinib-hydrochloride-or-crizotinib-and-chemoradiation-therapy-in-treating-patients-wi 2019-08-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02179671/immune-modulated-study-of-selected-small-molecules-gefitinib-azd9291-or-selumetinib-doce 2019-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00591838/a-phase-i-ii-trial-of-stereotactic-body-radiation-therapy 2019-07-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02109016/a-study-to-assess-the-efficacy-and-safety-of-the-vegfr-fgfr-inhibitor-lucitanib-given-to 2019-07-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01417520/clinical-and-pathophysiological-investigations-into-erdheim-chester-disease 2019-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02430948/improving-compliance-with-medical-testing-guidelines 2019-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01646125/an-open-label-randomized-phase-ii-study-to-evaluate-the-efficacy-of-auy922-vs-pemetrexed 2019-07-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01439568/a-study-of-ly2510924-in-participants-with-extensive-stage-small-cell-lung-carcinoma 2019-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02094950/acupuncture-feasibility-trial-for-dyspnea-in-lung-cancer 2019-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02952989/a-safety-study-of-sgn-2ff-for-patients-with-advanced-solid-tumors 2019-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01837329/phase-i-study-of-tetrathiomolybdate-in-combination-with-carboplatin-pemetrexed-in-metast 2019-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03369847/inhaled-steroids-for-pediatric-asthma-at-pediatric-emergency-medicine-discharge 2019-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02431169/genomic-landscape-of-egfr-mutant-nsclc-prior-to-erlotinib-and-at-the-time-of-disease-pro 2019-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01389830/end-of-life-treatment-preferences-of-latino-medicare-beneficiaries-with-cancer 2019-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03315065/19f-thoracic-radiotherapy-for-lung-cancer 2019-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02713828/study-of-glembatumumab-vedotin-in-gpnmb-expressing-advanced-or-metastatic-scc-of-the-lun 2019-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03276806/inpatient-smokers-and-ldct-screening-rct 2019-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00874211/s0702-osteonecrosis-of-the-jaw-in-patients-with-cancer-receiving-zoledronic-acid-for-bon 2019-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02630186/a-phase-1b-2-study-of-safety-and-efficacy-of-rociletinib-in-combination-with-mpdl3280a-i 2019-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02511184/crizotinib-plus-pembrolizumab-in-alk-positive-advanced-non-small-cell-lung-cancer-patien 2019-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02005614/a-pilot-phase-ii-study-of-gamma-knife-radiosurgery-for-brain-metastases-using-3tesla-mri 2019-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01543672/irradiation-of-large-lung-tumors-or-two-or-more-lung-metastases-simultaneously 2019-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00428220/a-continuation-study-using-sunitinib-malate-for-patients-leaving-treatment-on-a-previous 2019-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00065182/comparison-of-iv-topotecan-docetaxel-to-docetaxel-alone-in-second-line-stage-iiib-iv-non 2019-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00714246/bortezomib-ps-341-in-combination-with-carboplatin-and-docetaxel-for-patients-with-advanc 2019-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00685750/expression-analysis-of-specific-markers-in-non-small-cell-lung-cancer-or-melanoma 2019-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02431260/an-open-label-dose-escalation-study-of-incb054329-in-patients-with-advanced-malignancies 2019-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03348904/nivolumab-and-epacadostat-with-platinum-doublet-chemotherapy-versus-platinum-doublet-che 2019-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01362790/ss1p-and-pentostatin-plus-cyclophosphamide-for-mesothelioma 2019-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00504374/gene-polymorphisms-and-symptoms-in-lung-cancer-patients 2019-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00234052/carboplatin-pemetrexed-disodium-and-bevacizumab-in-treating-patients-with-stage-iiib-sta 2019-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02978170/cbct-in-guiding-bronchoscopy-in-patients-with-lung-lesions 2019-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02309177/safety-study-of-nivolumab-with-nab-paclitaxel-plus-or-minus-gemcitabine-in-pancreatic-ca 2019-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00554463/g-csf-and-pegfilgrastim-in-treating-neutropenia-in-patients-undergoing-radiation-therapy 2019-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00582283/nm404-as-an-imaging-agent-in-patients-with-nsclc 2019-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00548093/pf-00299804-as-a-single-agent-in-patients-with-advanced-non-small-cell-lung-cancer-who-h 2019-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03235427/the-carole-cardiac-related-oncologic-late-effects-study 2019-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03121417/nivolumab-in-treating-patients-with-advanced-metastatic-non-small-cell-lung-cancer 2019-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02839681/anti-mesothelin-antibody-drug-conjugate-anetumab-ravtansine-for-mesothelin-expressing-lu 2019-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03116633/concordance-of-inivata-liquid-biopsy-with-standard-tissue-biopsy 2019-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02906852/concordance-of-inivata-liquid-biopsy-with-standard-of-care-tissue-testing 2019-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01866410/cabozantinib-s-malate-and-erlotinib-hydrochloride-in-treating-patients-with-previously-t 2019-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01263782/battle-fl-front-line-biomarker-integrated-treatment-study-in-non-small-cell-lung-cancer 2019-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00450125/six-minute-walk-test-in-patients-at-high-risk-for-complications-from-lung-resection 2019-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02410382/dexamethasone-for-treatment-of-radiation-related-fatigue-in-patients-receiving-rt-for-he 2019-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00387465/azacitidine-and-entinostat-in-treating-patients-with-recurrent-advanced-non-small-cell-l 2019-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00499447/radiofrequency-ablation-and-external-beam-radiation-therapy-in-treating-patients-with-st 2019-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02243748/palliative-care-intervention-in-improving-symptom-control-and-quality-of-life-in-patient 2019-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02186301/tiger-1-safety-and-efficacy-study-of-rociletinib-co-1686-or-erlotinib-in-patients-with-e 2019-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01664754/exemestane-pemetrexed-disodium-and-carboplatin-in-treating-post-menopausal-women-with-st 2019-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01051037/stereotactic-body-radiotherapy-and-radiofrequency-ablation-for-lung-tumors-near-central 2019-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00407550/pemetrexed-disodium-and-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-non 2019-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00568906/microarray-analysis-of-gene-expression-and-identification-of-progenitor-cells-in-lung-ca 2019-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00551369/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-non-sm 2019-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02271906/the-attain-study-a-therapeutic-trial-of-afatinib-in-the-neoadjuvant-setting 2019-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02702830/mri-and-cardio-pulmonary-exercise-testing-in-evaluating-exercise-intolerance-in-patients 2019-04-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03454243/oral-immunomodulatory-tyrosine-kinase-inhibitor-in-patients-with-locally-advanced-or-met 2019-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01877811/study-of-rxdx-105-potent-ret-inhibitor-in-patients-with-advanced-lung-cancer-and-other-s 2019-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01253369/pazopanib-in-patients-with-relapsed-or-refractory-small-cell-lung-cancer 2019-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02145559/a-pharmacodynamic-study-of-sirolimus-and-metformin-in-patients-with-advanced-solid-tumor 2019-04-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01654068/conformal-high-dose-intensity-modulated-radiation-therapy-for-disease-to-thoracic-and-lu 2019-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01173523/study-of-hsp90-inhibitor-sta-9090-for-relapsed-or-refractory-small-cell-lung-cancer 2019-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03419559/study-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-combo-with-durvalumab-in-no 2019-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03326570/effectiveness-of-bronchoscopic-interventions-for-malignant-airway-obstruction 2019-04-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00793208/immunization-of-patients-with-non-small-cell-lung-cancer-nsclc 2019-04-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02409108/perfusion-induced-hyperthermia-for-metastatic-carcinoma 2019-04-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00780234/pioglitazone-for-lung-cancer-chemoprevention 2019-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03694054/care-coordination-in-oncology-quality-among-patients-with-lung-cancer-and-their-caregive 2019-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03253575/canscripttm-clinical-outcomes-in-a-real-world-setting-ancers-2 2019-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03175172/evaluation-of-crs-207-with-pembrolizumab-in-previously-treated-malignant-pleural-mesothe 2019-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02790866/development-and-feasibility-testing-of-a-lung-cancer-screening-decision-aid 2019-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02900248/cureone-registry-advanced-malignancy-or-myelodysplasia-tested-by-standard-sequencing-and 2019-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01898767/eicosanoid-lipids-by-airway-cells-during-infection-with-human-rhinoviruses 2019-03-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00541099/bevacizumab-and-docetaxel-in-treating-older-patients-with-stage-iii-or-stage-iv-non-smal 2019-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00459121/vandetanib-carboplatin-and-paclitaxel-in-treating-patients-with-stage-i-stage-ii-or-stag 2019-03-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02048488/a-phase-i-iia-open-label-dose-escalation-and-cohort-expansion-trial-of-oral-tsr-011-in-p 2019-03-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01685138/ldk378-in-crizotinib-nai-ve-adult-patients-with-alk-activated-non-small-cell-lung-cancer 2019-03-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01862900/stereotactic-body-radiation-and-monoclonal-antibody-to-ox40-medi6469-in-breast-cancer-pa 2019-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01933789/improving-communication-about-serious-illness 2019-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01283516/a-dose-escalation-expansion-study-of-ldk378-in-patients-with-tumors-characterized-by-gen 2019-03-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00025480/tipifarnib-plus-radiation-therapy-after-combination-chemotherapy-in-treating-patients-wi 2019-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00784329/pilot-study-to-evaluate-optical-frequency-domain-imaging-for-diagnosis-of-central-airway 2019-03-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01445054/111-indium-chx-a-dtpa-trastuzumab-indium-herceptin-for-imaging-breast-cancer 2019-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03220100/study-of-stepped-palliative-care-in-patients-with-advanced-lung-cancer-df-hcc-social-beh 2019-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02355431/itacitinib-in-combination-with-erlotinib-in-non-small-cell-lung-cancer-patients-with-epi 2019-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00754923/sorafenib-in-treating-non-smokers-or-former-light-smokers-with-relapsed-or-refractory-st 2019-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02073682/cancer-venous-thromboembolism-vte 2019-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02122861/phase-1-study-of-intradermal-lv305-in-patients-with-locally-advanced-relapsed-or-metasta 2019-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00153842/a-study-of-paclitaxel-and-carboplatin-in-combination-with-bexarotene-oral-capsules-in-pa 2019-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01487265/trial-of-erlotinib-and-bkm120-in-patients-with-advanced-non-small-cell-lung-cancer-previ 2019-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00100854/erlotinib-with-or-without-fulvestrant-in-treating-patients-with-stage-iiib-or-stage-iv-n 2019-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03162718/a-feasibility-study-of-unsupervised-pre-operative-exercise-program-for-patients-schedule 2019-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00459342/dasatinib-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung 2019-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02846792/nivolumab-and-plinabulin-in-treating-patients-with-stage-iiib-iv-recurrent-or-metastatic 2019-03-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003002/her-2-neu-vaccine-plus-gm-csf-in-treating-patients-with-stage-iii-or-stage-iv-breast-ova 2019-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01786187/the-symptom-experience-study-in-persons-with-non-small-cell-lung-cancer 2019-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02117440/functional-image-and-molecular-markers-to-predict-treatment-outcomes-in-lung-cancer 2019-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01523587/lux-lung-8-a-phase-iii-trial-of-afatinib-bibw-2992-versus-erlotinib-for-the-treatment-of 2019-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02409355/a-study-of-atezolizumab-compared-with-gemcitabine-plus-cisplatin-or-carboplatin-for-pd-l 2019-02-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01666353/pet-quantitative-assessments-of-solid-tumor-response-to-immune-checkpoint-blockade-thera 2019-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02463994/a-pilot-study-of-mpdl3280a-and-higrt-in-metastatic-nsclc 2019-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02346370/a-phase-1b-study-of-pegylated-recombinant-human-hyaluronidase-pegph20-combined-with-doce 2019-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01999738/folic-acid-tubulysin-conjugate-ec1456-in-patients-with-advanced-solid-tumors 2019-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02364999/a-comparative-study-of-pf-06439535-plus-paclitaxel-carboplatin-and-bevacizumab-plus-pacl 2019-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00495170/concurrent-proton-and-chemotherapy-in-locally-advanced-stage-iiia-b-non-small-cell-lung 2019-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01207726/azacitidine-and-entinostat-in-treating-patients-with-stage-i-non-small-cell-lung-cancer 2019-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01115803/a-study-of-ly2584702-with-erlotinib-or-everolimus-in-participants-with-solid-tumors 2019-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00769600/phase-ii-study-of-itraconazole-and-pemetrexed-in-patients-with-previously-treated-non-sq 2019-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02258607/efficacy-and-safety-of-momelotinib-combined-with-trametinib-in-adults-with-metastatic-kr 2019-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00424840/phase-i-ii-study-to-evaluate-the-efficacy-and-safety-of-a-combination-chemotherapy 2019-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02433626/study-of-coti-2-as-monotherapy-or-combination-therapy-for-the-treatment-of-malignancies 2019-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02206763/erlotinib-and-momelotinib-for-the-treatment-of-epidermal-growth-factor-receptor-egfr-mut 2019-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01010126/temsirolimus-and-bevacizumab-in-treating-patients-with-advanced-endometrial-ovarian-live 2019-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01415739/study-of-proteins-in-tumor-samples-from-patients-with-non-small-cell-lung-cancer 2019-01-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01497665/grn1005-in-non-small-cell-lung-cancer-nsclc-patients-with-brain-metastases-grabm-l 2019-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00094562/a-fish-oil-supplement-to-maintain-body-weight-in-patients-with-disease-related-weight-lo 2019-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00499733/cyclophosphamide-and-cryoablation-in-treating-patients-with-advanced-or-metastatic-epith 2019-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00281970/docetaxel-and-cisplatin-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-smal 2019-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02188563/a-comprehensive-smoking-cessation-intervention-duration-radiation-for-upper-aerodigestiv 2019-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02155465/trial-of-ruxolitinib-and-erlotinib-in-patients-with-egfr-mutant-lung-adenocarcinoma-with 2019-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00087438/stereotactic-body-radiation-therapy-in-treating-patients-with-inoperable-stage-i-or-stag 2019-01-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00495040/proton-radiotherapy-for-patients-with-non-small-cell-lung-cancer-nsclc 2019-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00918203/a-study-of-paclitaxel-carboplatin-with-or-without-olaratumab-imc-3g3-in-previously-untre 2019-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00547443/sorafenib-and-high-dose-carboplatin-paclitaxel-and-external-beam-radiation-therapy-in-tr 2019-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01286987/study-of-talazoparib-a-parp-inhibitor-in-patients-with-advanced-or-recurrent-solid-tumor 2019-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01465802/study-of-dacomitinib-pf-00299804-in-advanced-nsclc-patients-post-chemo-or-select-first-l 2019-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02769299/cardiotoxicity-of-radiation-therapy-ctrt 2019-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01891669/a-study-of-pf-06263507-in-patients-with-advanced-solid-tumors 2019-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01846416/a-study-of-atezolizumab-in-participants-with-programmed-death-ligand-1-pd-l1-positive-lo 2019-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00818441/dacomitinib-pf-00299804-as-a-single-oral-agent-in-selected-patients-with-adenocarcinoma 2019-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00125372/study-of-tarceva-and-targretin-in-stage-i-ii-lung-cancer 2019-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00125359/study-of-tarceva-and-targretin-oral-capsules-in-patients-with-advanced-lung-cancer 2019-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02403271/a-multi-center-study-of-ibrutinib-in-combination-with-medi4736-in-subjects-with-relapsed 2019-01-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02599194/18f-fspg-pet-ct-for-cancer-patients-on-therapy 2019-01-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01396551/evaluating-an-anchored-transponder-in-lung-cancer-patients-receiving-radiation-therapy 2019-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00385996/pilot-study-of-preoperative-tarceva-erlotinib-for-stages-i-ii-non-small-cell-lung-cancer 2018-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01722292/a-study-of-ly2940680-in-small-cell-lung-cancer 2018-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02038647/phase-2-study-of-alisertib-mln8237-in-combination-with-paclitaxel-versus-placebo-in-comb 2018-12-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01186744/a-study-to-evaluate-the-effects-and-safety-of-treatment-treatment-withdrawal-followed-by 2018-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03334487/study-evaluating-the-safety-of-rovalpituzumab-tesirine-for-third-line-and-later-treatmen 2018-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01578551/study-of-metformin-plus-paclitaxel-carboplatin-bevacizumab-in-patients-with-adenocarcino 2018-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02860780/a-study-of-prexasertib-ly2606368-in-combination-with-ralimetinib-in-participants-with-ad 2018-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01982123/spect-ct-in-measuring-lung-function-in-patients-with-cancer-undergoing-radiation-therapy 2018-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01055197/radiation-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer 2018-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00567359/erlotinib-in-patients-with-resected-early-stage-nsclc-with-confirmed-mutations-in-the-eg 2018-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03085849/sgi-110-plus-durvalumab-tremelimumab-in-sclc 2018-12-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02289456/phase-ii-safety-and-tolerability-trial-with-nab-paclitaxel-plus-carboplatin-followed-by 2018-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00287989/erlotinib-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iii-stage-iv-or-rec 2018-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00390429/docetaxel-and-erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or 2018-12-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923520/a-phase-1-dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-intra 2018-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01323062/bavituximab-plus-carbo-and-pemetrexed-in-chemo-naive-stage-iv-non-squamous-non-small-cel 2018-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00924209/a-phase-ii-study-of-neo-adjuvant-gemcitabine-cisplatin-and-bevacizumab-in-stage-iiia-n2 2018-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03746262/changes-in-circulating-tumor-specific-dna-in-patients-with-non-metastatic-non-small-cell 2018-11-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02457793/a-study-of-the-safety-tolerability-and-effects-of-cobimetinib-and-gdc-0994-in-patients-w 2018-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02204761/proton-beam-re-irradiation-in-thoracic-cancers 2018-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03517332/circulating-tumor-dna-exposure-in-peripheral-blood 2018-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02960594/htert-immunotherapy-alone-or-in-combination-with-il-12-dna-followed-by-electroporation-i 2018-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02575898/feasibility-of-a-creative-writing-intervention-in-an-advanced-cancer-population-a-single 2018-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02833246/using-a-patient-centered-mhealth-intervention-to-improve-adherence-to-oral-anticancer-me 2018-11-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00543335/sorafenib-and-thoracic-radiation-for-patients-with-non-small-cell-lung-cancer 2018-11-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00745732/radiation-therapy-xrt-and-zd6474-in-non-small-cell-lung-cancer-nsclc 2018-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01967095/low-dose-daily-erlotinib-in-combination-with-high-dose-twice-weekly-erlotinib-in-patient 2018-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01446874/prevention-of-post-operative-pneumonia-popp 2018-11-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00043823/avastin-and-tarceva-for-locally-advanced-or-metastatic-non-squamous-non-small-cell-lung 2018-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00075179/natrecor-in-pulmonary-hypertension 2018-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02218242/thoracoscopic-lung-cancer-staging-with-the-use-of-intraoperative-ultrasound 2018-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01262040/narrow-band-imaging-nbi-a-novel-imaging-modality-in-minimally-invasive 2018-11-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02669914/medi4736-durvalumab-in-patients-with-brain-metastasis-from-epithelial-derived-tumors 2018-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01801111/a-study-of-alectinib-ro5424802-in-participants-with-non-small-cell-lung-cancer-who-have 2018-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01829217/sunitinib-in-never-smokers-with-lung-adenocarcinoma 2018-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00389805/bortezomib-and-pemetrexed-disodium-in-treating-patients-with-advanced-non-small-cell-lun 2018-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00038597/phase-ii-study-of-sch66336-a-farnesyltransferase-inhibitor-in-chronic-myelogenous-leukem 2018-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00016367/cisplatin-and-gemcitabine-plus-trastuzumab-in-treating-patients-with-stage-iiib-or-stage 2018-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02239328/a-study-of-patient-reported-outcomes-in-patients-with-lung-or-esophageal-cancer 2018-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00531180/4-dimensional-ct-derived-ventilation-versus-spect-aerosol-ventilation-in-patients-with-t 2018-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00702962/carboplatin-and-etoposide-in-combination-with-vorinostat-for-patients-with-extensive-sta 2018-10-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02913443/a-dose-finding-and-expansion-study-of-ro7051790-administered-orally-in-participants-with 2018-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00926640/a-phase-i-study-of-belinostat-in-combination-with-cisplatin-and-etoposide-in-adults-with 2018-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01752023/a-randomized-phase-ii-study-of-subatm-itraconazole-in-patients-with-untreated-squamous-n 2018-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00896454/study-of-denosumab-in-the-treatment-of-hypercalcemia-of-malignancy-in-subjects-with-elev 2018-10-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00864721/sunitinib-non-small-cell-lung-cancer-patients-over-70 2018-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03029416/two-radiation-dose-schedules-of-sbrt-to-lung-metastases-5cm-in-dimension 2018-10-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00580398/smoking-cessation-intervention-for-thoracic-patients 2018-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00735878/pharmacokinetic-pharmacodynamic-study-of-abt-751-with-carboplatin-in-patients-with-advan 2018-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00735826/a-clinical-trial-to-validate-molecular-targets-of-vorinostat-in-patients-with-aerodigest 2018-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01684696/virtual-intervention-for-lung-cancer 2018-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01820325/safety-and-efficacy-of-buparlisib-bkm120-in-patients-with-untreated-squamous-non-small-c 2018-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02702921/powered-vascular-stapler-in-video-assisted-thoracoscopic-vat-lobectomies 2018-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00424138/fdg-pet-ct-scans-in-patients-with-stage-iiib-or-stage-iv-nsclc-undergoing-chemotherapy 2018-10-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02763761/an-investigational-study-of-infliximab-with-prednisone-or-methylprednisolone-versus-pred 2018-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00575393/gold-sodium-thiomalate-in-treating-patients-with-advanced-non-small-cell-lung-cancer 2018-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01657617/stereotactic-body-radiation-therapy-in-stage-ii-iii-non-small-cell-lung-cancer 2018-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02500914/sc-002-in-small-cell-lung-cancer-and-large-cell-neuroendocrine-carcinoma 2018-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00520702/3-dimensional-conformal-radiation-therapy-versus-intensity-modulated-radiation-therapy 2018-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02580708/phase-1-2-study-of-the-safety-and-efficacy-of-rociletinib-in-combination-with-trametinib 2018-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01435122/a-study-of-axitinib-in-advanced-carcinoid-tumors 2018-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02146131/ultrathin-bronchoscope-and-radial-endobronchial-ultrasound-r-ebus-with-fluoroscopy-versu 2018-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02547675/rociletinib-co-1686-usa-expanded-access-program 2018-09-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00252382/safety-and-efficacy-clinical-study-of-sns-595-for-second-line-therapy-in-patients-with-a 2018-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02151149/safety-and-efficacy-study-of-abraxane-in-combination-with-carboplatin-to-treat-advanced 2018-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02874664/a-study-of-rovalpituzumab-tesirine-to-study-cardiac-ventricular-repolarization-in-subjec 2018-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03107663/89zr-df-iab22m2c-pet-ct-in-patients-with-selected-solid-malignancies-or-hodgkin-s-lympho 2018-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00260598/life-lung-bronchoscopy-in-patients-at-risk-for-developing-lung-cancer 2018-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01497925/ph-1-trial-of-adi-peg-20-plus-docetaxel-in-solid-tumors-with-emphasis-on-prostate-cancer 2018-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02288416/video-based-intervention-in-reducing-anxiety-in-patients-undergoing-lung-cancer-screenin 2018-09-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01273766/deferasirox-in-treating-iron-overload-caused-by-blood-transfusions-in-patients-with-hema 2018-09-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02650635/tlr8-agonist-vtx-2337-and-cyclophosphamide-in-treating-patients-with-metastatic-persiste 2018-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00039091/monoclonal-antibody-therapy-in-treating-patients-with-ovarian-epithelial-cancer-melanoma 2018-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02123849/intermittent-or-continuous-acetylsalicylic-acid-and-gene-expression-in-the-nasal-tissue 2018-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01842555/photodynamic-therapy-pdt-oncology-registry 2018-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01871805/a-study-of-alectinib-ch5424802-ro5424802-in-participants-with-anaplastic-lymphoma-kinase 2018-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03638765/dendritic-cell-therapy-for-brain-metastases-from-breast-or-lung-cancer 2018-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00315211/weekly-topotecan-with-docetaxel-in-recurrent-small-cell-lung-cancer 2018-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01911325/phase-ii-study-of-buparlisib-docetaxel-in-advanced-or-metastatic-squamous-non-small-cell 2018-08-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003202/gemcitabine-plus-radiation-therapy-or-combination-chemotherapy-in-treating-patients-with 2018-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01901653/rovalpituzumab-tesirine-sc16ld6-5-in-recurrent-small-cell-lung-cancer 2018-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02694380/measuring-the-effect-of-radiation-therapy-on-patient-activity-levels 2018-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01443078/neoadjuvant-platinum-based-chemotherapy-for-patients-with-resectable-non-small-cell-lung 2018-08-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03212079/physical-activities-by-technology-help-path 2018-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01445392/ss1-dsfv-pe38-plus-pemetrexed-and-cisplatin-to-treat-malignant-pleural-mesothelioma 2018-08-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00200382/phase-ii-study-of-therapy-with-ps-341-in-patients-with-advanced-stage-non-small-cell-lun 2018-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01457469/enhanced-quitline-intervention-in-smoking-cessation-for-patients-with-non-metastatic-lun 2018-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01954641/accountability-for-cancer-care-through-undoing-racism-and-equity 2018-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01028612/thermal-ablation-combined-with-external-beam-radiation-therapy-for-patients-with-inopera 2018-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03370159/cpi-613-and-docetaxel-in-treating-patients-with-stage-iiib-or-iv-non-small-cell-lung-can 2018-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03297463/radiation-therapy-with-combination-immunotherapy-for-relapsed-refractory-metastatic-mela 2018-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02317016/study-to-assess-the-effect-of-azd9291-on-the-blood-levels-of-rosuvastatin-in-patients-wi 2018-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00045162/s0124-cisplatin-combined-with-irinotecan-or-etoposide-for-extensive-stage-small-cell-lun 2018-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01935947/azacitidine-and-entinostat-before-chemotherapy-in-treating-patients-with-advanced-non-sm 2018-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02835066/patient-function-fitness-and-psychosocial-health-in-improving-health-related-quality-of 2018-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00298896/safety-and-efficacy-clinical-study-of-sns-595-in-patients-with-advanced-small-cell-lung 2018-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01041781/gemcitabine-hydrochloride-or-pemetrexed-disodium-and-carboplatin-with-or-without-celecox 2018-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03073473/evaluation-of-the-nanthealth-gps-cancer-test-in-patients-with-advanced-cancers 2018-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02671045/genomic-profiling-in-previously-untreated-metastatic-non-small-cell-lung-cancer 2018-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00527735/phase-ii-study-for-previously-untreated-subjects-with-non-small-cell-lung-cancer-nsclc-o 2018-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02067858/an-outcome-analysis-for-stereotactic-body-radiation-therapy-sbrt-treatment-of-non-small 2018-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02835833/study-of-nintedanib-plus-bevacizumab-in-advanced-solid-tumors 2018-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01553916/neuroprotective-effects-of-lithium-in-patients-with-small-cell-lung-cancer-undergoing-ra 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01341496/tumor-cell-vaccines-and-iscomatrix-with-chemotherapy-after-tumor-removal 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923741/effect-of-talactoferrin-in-adults-with-non-small-cell-lung-cancer 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00754910/photodynamic-therapy-using-porfimer-sodium-in-treating-patients-with-non-small-cell-lung 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02014545/evaluation-of-lucanthone-to-whole-brain-radiation-therapy-in-patients-with-brain-metasta 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01026467/frailty-index-and-geriatric-assessment-in-predicting-toxicity-to-front-line-chemotherapy 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02011087/bioelectrical-impedance-phase-angle-in-predicting-treatment-outcome-in-patients-with-ext 2018-07-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02403895/azd2014-and-weekly-paclitaxel-in-squamous-nsclc 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01931787/cpi-613-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01126346/quality-of-life-and-survivorship-care-in-patients-undergoing-hyperthermic-intraperitonea 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01827267/neratinib-with-and-without-temsirolimus-for-patients-with-her2-activating-mutations-in-n 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01593657/mindful-movement-and-breathing-to-improve-outcomes-of-gynecologic-surgery 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01630122/molecular-and-diagnostic-classification-of-non-small-cell-lung-cancer-from-fine-needle-a 2018-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02135211/healthy-directions-after-lung-surgery-pilot 2018-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02748889/carboplatin-plus-etoposide-with-or-without-mpdl3280a-in-untreated-extensive-stage-small 2018-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02566421/genomic-sequencing-in-determining-treatment-in-patients-with-metastatic-cancer-or-cancer 2018-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02423954/study-of-nivolumab-plus-chemotherapy-in-patients-with-advanced-cancer-nivoplus 2018-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02331251/study-of-pembrolizumab-plus-chemotherapy-in-patients-with-advanced-cancer-pembroplus 2018-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01557959/docetaxel-cisplatin-pegfilgrastim-and-erlotinib-hydrochloride-in-treating-patients-with 2018-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01234038/safety-and-tolerability-study-of-isis-eif4e-rx-in-combination-with-carboplatin-and-pacli 2018-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02532062/the-pittsburgh-vitamin-d-study-vitamin-d-supplementation-in-vitamin-d-deficient-subjects 2018-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02161419/roniciclib-placebo-in-combination-with-chemotherapy-in-small-cell-lung-cancer 2018-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03146117/pet-dect-for-staging-and-imaged-based-radiotherapy-planning-in-lung-cancer 2018-06-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03560362/postoperative-pain-control-with-lipossomic-extended-release-bupivacaine 2018-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00890825/azd6244-in-combination-with-docetaxel-versus-docetaxel-alone-in-kras-mutation-positive-n 2018-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01159964/evaluation-of-a-new-anti-cancer-vaccine-for-patients-with-non-small-cell-lung-cancer-aft 2018-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00048997/radiation-therapy-in-preventing-central-nervous-system-cns-metastases-in-patients-with-n 2018-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01829113/phase-ii-trial-of-carboplatin-and-pemetrexed-ogx-427-in-untreated-stage-iv-non-squamous 2018-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00365053/pxd101-as-second-line-therapy-in-treating-patients-with-malignant-mesothelioma-of-the-ch 2018-06-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00445198/a-phase-1-2a-study-of-abt-263-in-subjects-with-small-cell-lung-cancer-sclc-or-other-non 2018-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00790569/varenicline-or-nicotine-patch-and-nicotine-gum-in-helping-smokers-in-a-methadone-treatme 2018-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00955305/paclitaxel-carboplatin-and-bevacizumab-with-or-without-cixutumumab-in-treating-patients 2018-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01752751/predicting-tolerance-to-radiation-therapy-in-older-adults-with-cancer 2018-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00690924/calcitriol-in-preventing-lung-cancer-in-smokers-and-former-smokers-at-high-risk-of-lung 2018-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00870870/a-study-of-imc-a12-cixutumumab-with-and-without-other-standard-chemotherapies-in-partici 2018-06-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02252796/phase-i-hypofractionated-stereotactic-boost-radiotherapy-for-non-small-cell-lung-cancer 2018-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00687297/study-of-vandetanib-combined-with-chemotherapy-to-treat-advanced-non-small-cell-lung-can 2018-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01987193/feasibility-study-of-tumor-blood-flow-measurement-by-detection-of-positron-activation-po 2018-05-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02250404/molecular-signatures-of-relapse-in-tissue-samples-from-patients-with-small-cell-lung-can 2018-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01607554/irinotecan-for-previously-treated-advanced-non-small-cell-lung-cancer 2018-05-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02450591/local-therapies-for-oligometastatic-non-small-cell-lung-cancer-harboring-sensitizing-egf 2018-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01939210/meditation-based-breathing-training-in-improving-target-motion-management-and-reducing-d 2018-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01471964/study-to-assess-safety-and-tolerability-of-mln8237-in-combination-with-erlotinib-to-trea 2018-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00287963/topotecan-and-vinorelbine-in-treating-patients-with-recurrent-lung-cancer 2018-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01117714/surgical-versus-non-surgical-staging-of-lung-cancer 2018-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01204099/study-of-px-866-and-docetaxel-in-solid-tumors 2018-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02661659/a-phase-ib-trial-of-a-maintenance-multipeptide-vaccine-s-588210-in-patients-with-unresec 2018-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02583815/feasibility-of-activity-monitoring-in-patients-with-cancer-physical-activity-monitoring 2018-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02840578/nk-cell-activity-in-smokers-screened-for-lung-cancer 2018-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00852644/stereotactic-radiosurgery-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-l 2018-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02323854/the-emprinttm-ablate-and-resect-study-in-patients-with-metastatic-lung-tumors-empress 2018-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01710319/mechanisms-of-immunosurveillance-for-lung-cancer 2018-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02019979/metformin-and-carbohydrate-restriction-with-platinum-based-chemotherapy-in-stage-iiib-iv 2018-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00078390/study-of-s-3304-in-patients-with-locally-advanced-non-small-cell-lung-cancer 2018-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03417037/an-immuno-therapy-study-of-experimental-medication-bms-986205-given-with-nivolumab-with 2018-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02543645/a-study-of-varlilumab-and-atezolizumab-in-patients-with-advanced-cancer 2018-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02261805/a-phase-i-ii-study-of-ganetespib-in-combination-with-doxorubicin 2018-04-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02066103/broncho-adventitial-delivery-of-paclitaxel-to-extend-airway-patency-in-malignant-airway 2018-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00901537/azacitidine-and-cisplatin-in-patients-with-advanced-lung-or-head-and-neck-cancer 2018-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01188486/pulmonary-interstitial-lymphography-in-early-stage-lung-cancer 2018-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03048136/a-safety-study-of-nivolumab-in-combination-with-ipilimumab-in-participants-with-advanced 2018-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00266877/study-evaluating-the-safety-of-hki-272-neratinib-in-subjects-with-advanced-non-small-cel 2018-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00410904/azd2171-and-pemetrexed-disodium-in-treating-patients-with-relapsed-non-small-cell-lung-c 2018-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02294578/salivary-biomarkers-for-non-small-cell-lung-cancer-detection 2018-04-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01854034/phase-2-study-of-auy922-in-nsclc-patients-with-exon-20-insertion-mutations-in-egfr 2018-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01160458/phase-ii-study-of-imc-a12-in-patients-with-mesothelioma-who-have-been-previously-treated 2018-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02080897/evaluating-quality-of-life-in-patients-with-soft-tissue-sarcoma-presenting-with-metastat 2018-04-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00654030/allogeneic-cellular-vaccine-1650-g-for-non-small-cell-lung-cancer 2018-04-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00949650/bibw-2992-afatinib-versus-chemotherapy-as-first-line-treatment-in-nsclc-with-egfr-mutati 2018-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00111839/effects-of-matuzumab-in-combination-with-pemetrexed-for-the-treatment-of-advanced-lung-c 2018-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01862770/effect-of-lung-cancer-diagnoses-on-family-behaviors 2018-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01395758/erlotinib-plus-tivantinib-arq-197-versus-single-agent-chemotherapy-in-locally-advanced-o 2018-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01654965/tivantinib-and-topotecan-hydrochloride-in-treating-patients-with-advanced-or-metastatic 2018-04-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00729612/paclitaxel-albumin-stabilized-nanoparticle-formulation-and-carboplatin-in-treating-patie 2018-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01998126/combination-checkpoint-inhibitor-plus-erlotinib-or-crizotinib-for-egfr-or-alk-mutated-st 2018-04-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02365662/a-study-evaluating-safety-and-pharmacokinetics-of-abbv-221-in-subjects-with-advanced-sol 2018-03-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00559611/endobronchial-ultrasound-versus-mediastinoscopy-in-patients-with-non-small-cell-lung-can 2018-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02192541/ganetespib-and-ziv-aflibercept-in-refractory-gastrointestinal-carcinomas-non-squamous-no 2018-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01752400/auy922-for-advanced-alk-positive-nsclc 2018-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01396603/pilot-study-to-evaluate-optical-frequency-domain-imaging-for-diagnosis-of-central-airway 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01038271/integrated-versus-standard-palliative-care-in-patients-with-advanced-non-small-cell-lung 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01658813/5-fluorouracil-followed-by-interferon-alfa-2b-in-previously-treated-metastatic-gastroint 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02132325/dignity-therapy-life-plan-in-patients-with-pancreatic-or-advanced-lung-cancer 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01520389/safety-study-of-the-drug-mm-151-in-patients-with-advanced-solid-tumors-resisting-ordinar 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02370303/a-study-to-isolate-and-test-circulating-tumor-cells-using-the-clearcell-fx-ep-system 2018-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01470209/a-phase-i-study-of-bkm120-and-everolimus-in-advanced-solid-malignancies 2018-03-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00999713/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology 2018-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00449657/phase-ii-trial-of-pulsed-taxol-with-concurrent-thoracic-radiotherapy-adjuvant-chemo-in-s 2018-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01074177/understanding-mechanisms-of-acquired-resistance-to-bibw2992 2018-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00096265/radiation-therapy-and-stereotactic-radiosurgery-with-or-without-temozolomide-or-erlotini 2018-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00077064/captopril-in-treating-patients-with-non-small-cell-lung-cancer-or-limited-stage-small-ce 2018-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02439346/phase-i-dose-escalation-and-expansion-of-oral-bay-1143269-in-combination-with-intravenou 2018-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01859338/soft-tissue-detection-on-mri-cone-beam-ct-and-fan-beam-ct-and-integration-of-functional 2018-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02491775/afatinib-genomic-landscape 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00265200/using-trap-to-evaluate-the-effect-of-zometa-on-bone-metastasis-due-to-lung-cancer 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01300299/stereotactic-radiation-and-chemotherapy-in-lung-cancer-stereo 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02554591/genomic-landscape-of-ceritinib 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00268151/oxaliplatin-in-combination-with-capecitabine-and-concurrent-radiation-therapy-in-non-sma 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00481624/using-iron-with-procrit-in-advanced-lung-cancer-patients-with-chemotherapy-induced-anemi 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01426620/standard-chemotherapy-with-blueberry-powder-in-non-small-cell-lung-cancer 2018-03-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02653612/intraoperative-imaging-of-pulmonary-adenocarcinoma 2018-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01752114/early-diagnosis-of-pulmonary-nodules 2018-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02590003/single-agent-versus-combination-chemotherapy-to-treat-high-risk-elderly-with-non-small-c 2018-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02512757/a-case-control-study-to-verify-diagnostic-performance-of-aminoindextm-technology 2018-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03076372/a-study-evaluating-mm-310-in-patients-with-solid-tumors 2018-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02342353/pacritinib-in-patients-with-endothelial-growth-factor-egfr-mutant-non-small-cell-lung-ca 2018-02-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01710293/intervention-protocol-for-automated-point-of-care-surveillance-of-outpatient-delays-in-c 2018-02-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00997334/erlotinib-therapy-and-subsequent-development-of-mechanisms-of-secondary-resistance-in-pa 2018-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01090830/safety-and-efficacy-of-belinostat-when-used-with-standard-of-care-chemotherapy-for-untre 2018-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00399789/a-phase-1-2-trial-of-perifosine-in-the-treatment-of-non-small-cell-lung-cancer 2018-02-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01924416/lung-cancer-information-study-lcis-r01 2018-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02122146/a-study-of-pf-06664178-in-patients-with-advanced-solid-tumors 2018-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00588263/anonymous-testing-of-pathology-specimens-for-brca-mutations-in-ashkenazi-jewish-individu 2018-02-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00738452/radiolabeled-monoclonal-antibody-therapy-in-treating-patients-with-stage-i-iiib-non-smal 2018-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02119650/ruxolitinib-in-combination-with-pemetrexed-cisplatin-in-non-small-cell-lung-cancer 2018-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00072631/erlotinib-tarceva-trademark-osi-774-in-treating-patients-with-advanced-non-small-cell-lu 2018-02-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02393209/docetaxel-with-or-without-tak-117-mln1117-in-participants-with-locally-advanced-or-metas 2018-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02755883/strides-for-life-i-increasing-physical-activity-in-stage-1-lung-cancer-patients 2018-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01860040/neoadjuvant-chemo-for-non-metastatic-non-small-cell-lung-cancer 2018-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02784158/an-expanded-access-study-of-brigatinib-for-patients-with-alk-positive-advanced-non-small 2018-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00681512/the-effect-of-berries-on-lung-cancer-tumors 2018-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01213004/evaluation-of-respiratory-motion-corrected-cone-beam-ct-in-radiation-treatment-of-thorac 2018-02-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003497/antineoplaston-therapy-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer 2018-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02594696/proactive-psychiatry-consultation-for-patients-with-cancer-and-severe-mental-illness 2018-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01335893/intraoperative-imaging-of-thoracic-malignancies-with-indocyanine-green 2018-02-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03087305/incidence-of-scln-metastasis-in-patients-referred-for-ebus-tbna 2018-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00553462/carboplatin-and-paclitaxel-albumin-stabilized-nanoparticle-formulation-followed-by-radia 2018-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003494/antineoplaston-therapy-in-treating-patients-with-recurrent-or-stage-iv-lung-cancer 2018-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01460134/a-study-of-cdx-1127-varlilumab-in-patients-with-select-solid-tumor-types-or-hematologic 2018-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00372515/high-dose-gefitinib-for-the-treatment-of-carcinomatous-meningitis-in-adult-patients-with 2018-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00455052/a-study-of-intravenous-xmt-1001-in-patients-with-advanced-solid-tumors 2018-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00138203/suberoylanilide-hydroxamic-acid-in-treating-patients-with-stage-iiib-stage-iv-or-recurre 2018-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00364351/efficacy-trial-comparing-zd6474-with-erlotinib-in-nsclc-after-failure-of-at-least-one-pr 2018-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00243074/s0509-azd2171-in-treating-patients-with-malignant-pleural-mesothelioma-that-cannot-be-re 2018-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00077922/anti-tac-fv-pe38-lmb-2-to-treat-chronic-lymphocytic-leukemia 2018-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02134015/study-of-patritumab-in-combination-with-erlotinib-in-subjects-with-locally-advanced-or-m 2018-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01486602/specialized-radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-iii-non-s 2018-01-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02934360/tr-ace-assay-clinical-specimen-study 2018-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01574222/a-vaccine-trial-for-patients-with-stage-iiib-iv-or-recurrent-non-small-cell-lung-cancer 2018-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01237678/a-study-of-imgn901-for-patients-with-advanced-solid-tumors-and-extensive-stage-small-cel 2018-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02018523/lenalidomide-maintenance-therapy-in-stage-iiib-iv-non-small-cell-lung-cancer 2018-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02014337/mifepristone-and-eribulin-in-patients-with-metastatic-triple-negative-breast-cancer-or-o 2018-01-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01815346/acupuncture-chemotherapy-induced-peripheral-neuropathy-cipn-irg 2018-01-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00777751/radiation-therapy-and-cardiac-enzymes 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00387660/irinotecan-and-carboplatin-in-treating-patients-with-metastatic-or-recurrent-small-cell 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00577707/erlotinib-and-chemotherapy-for-patients-with-stage-ib-iiia-nsclc-with-egfr-mutations-eco 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01676714/study-of-dovitinib-and-biomarkers-in-advanced-non-small-cell-lung-cancer-or-advanced-col 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00470548/abraxane-and-alimta-in-advanced-solid-tumors 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00036647/osi-774-tarceva-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-canc 2018-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02194049/cisplatin-etoposide-and-pi3k-inhibitor-bkm120-in-treating-patients-with-advanced-solid-t 2018-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01336842/study-of-cisplatin-and-pemetrexed-in-combination-with-panobinostat-in-solid-tumors 2018-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00807755/everolimus-carboplatin-and-etoposide-in-treating-patients-with-small-cell-lung-cancer-or 2018-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01261299/clinical-study-of-microdosing-carboplatin-in-lung-or-bladder-cancer 2018-01-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01419587/ketogenic-diet-with-chemoradiation-for-lung-cancer-ketolung 2018-01-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02705365/patient-navigation-for-lung-screening-at-mgh-community-health-centers 2018-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01012362/study-of-pazopanib-and-ixabepilone-in-patients-with-solid-tumors 2017-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00400803/carboplatin-and-gemcitabine-with-bevacizumab-every-2-weeks-for-stage-iiib-iv-non-small-c 2017-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00281827/carboplatin-gemcitabine-and-thalidomide-in-patients-undergoing-surgery-for-stage-ii-or-i 2017-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00365547/topotecan-and-bevacizumab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cel 2017-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02168036/study-of-biologic-materials-from-the-mediastinal-lymph-nodes-from-patients-with-lung-dis 2017-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00230126/osi-774-in-african-american-patients-with-advanced-and-previously-treated-non-small-cell 2017-12-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00023673/radiation-therapy-combined-with-paclitaxel-and-carboplatin-in-treating-patients-with-sta 2017-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00066222/cisplatin-etoposide-and-radiation-therapy-in-treating-patients-with-limited-stage-small 2017-12-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01797471/safety-of-lead-radiotherapy-plus-chemoradiation-in-patients-with-bulky-stage-iii-non-sma 2017-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00908960/enoxaparin-thromboprophylaxis-in-cancer-patients-with-elevated-tissue-factor-bearing-mic 2017-12-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00794547/phase-i-ii-calcitriol-in-lung-cancer 2017-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03097627/intravenous-indocyanine-green-for-localization-of-intra-thoracic-lesions 2017-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02172846/hypofractionated-proton-beam-radiation-therapy-paclitaxel-and-carboplatin-in-treating-pa 2017-12-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00093756/bortezomib-paclitaxel-carboplatin-and-radiation-therapy-for-non-small-cell-lung-cancer 2017-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00528645/azd0530-in-treating-patients-with-extensive-stage-small-cell-lung-cancer 2017-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01511081/stereotactic-body-radiotherapy-sbrt-versus-stereotactic-body-proton-therapy-sbpt 2017-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01342770/pioglitazone-hydrochloride-in-treating-patients-with-stage-ia-iiia-non-small-cell-lung-c 2017-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00362882/docetaxel-and-bortezomib-in-treating-patients-with-progressive-or-recurrent-non-small-ce 2017-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00783705/inositol-in-preventing-lung-cancer-in-current-or-former-smokers-with-bronchial-dysplasia 2017-12-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01228435/ipi-504-in-nsclc-patients-with-alk-translocations 2017-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00622674/bortezomib-and-cetuximab-in-treating-patients-with-advanced-solid-tumors 2017-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005023/vaccine-therapy-plus-sargramostim-in-treating-patients-with-stage-iii-or-stage-iv-cancer 2017-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00619021/bronchial-artery-infusion-of-gemcitabine-in-treating-patients-with-recurrent-or-progress 2017-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00703638/sorafenib-pemetrexed-and-cisplatin-in-treating-patients-with-advanced-solid-tumors 2017-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00356941/oxaliplatin-docetaxel-and-radiation-therapy-in-treating-patients-with-unresectable-stage 2017-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00620295/bortezomib-and-gemcitabine-in-treating-older-patients-with-advanced-solid-tumors 2017-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00526890/carboplatin-paclitaxel-selenomethionine-and-radiation-therapy-in-treating-patients-with 2017-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02476526/safety-of-low-dose-iv-contrast-ct-scanning-in-chronic-kidney-disease 2017-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01862081/a-dose-escalation-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-gdc-00 2017-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03352635/mechanisms-of-ethnic-racial-differences-in-lung-cancer-due-to-cigarette-smoking-clinical 2017-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02009631/a-study-to-evaluate-the-effects-of-veliparib-on-heart-rhythms-in-patients-with-solid-tum 2017-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01746810/ir-guided-ablation-irga-combined-with-stereotactic-ablative-radiation-sabr-for-large-lun 2017-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00619424/a-phase-i-study-of-pazopanib-with-either-erlotinib-or-pemetrexed-in-patients-with-advanc 2017-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00259935/a-study-to-determine-if-two-different-versions-of-topotecan-have-the-same-potency-in-pat 2017-11-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00666978/health-education-counseling-with-or-without-bupropion-in-helping-african-americans-stop 2017-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00866528/study-of-pazopanib-and-paclitaxel-in-advanced-non-small-cell-lung-cancer 2017-11-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02297087/next-generation-sequencing-of-small-cell-lung-cancer-to-identify-actionable-targets-for 2017-11-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00955773/a-study-of-the-gsk-mek-inhibitor-gsk1120212-and-everolimus-in-cancer-subjects 2017-11-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01154140/a-clinical-trial-testing-the-efficacy-of-crizotinib-versus-standard-chemotherapy-pemetre 2017-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02405910/ph2-nab-paclitaxel-with-gemcitabine-to-determine-efficacy-in-advanced-non-squamous-nsclc 2017-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02340715/advanced-mri-sequences-for-radiation-therapy-treatment-planning 2017-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01344824/carboplatin-pemetrexed-disodium-and-bevacizumab-for-patients-with-stage-iii-or-iv-non-sm 2017-10-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01387269/safety-and-efficacy-of-anamorelin-hcl-in-patients-with-non-small-cell-lung-cancer-cachex 2017-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01387282/safety-and-efficacy-of-anamorelin-hcl-in-patients-with-non-small-cell-lung-cancer-cachex 2017-10-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00374140/phase-ii-trial-of-rad001-everolimus-in-previously-treated-small-cell-lung-cancer 2017-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01966003/efficacy-and-safety-study-of-abp-215-compared-with-bevacizumab-in-patients-with-advanced 2017-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00932152/fulvestrant-and-anastrozole-as-consolidation-therapy-in-postmenopausal-women-with-advanc 2017-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00732563/fludeoxyglucose-f-18-in-detecting-lymph-node-metastasis-in-patients-with-stage-i-or-stag 2017-10-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00534209/vaccine-therapy-in-patients-with-stages-iiib-iv-non-small-cell-lung-cancer-who-have-fini 2017-10-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01687738/lung-cancer-surgery-decisions-against-life-saving-care-the-intervention 2017-10-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00946673/phase-i-vorinostat-concurrent-with-stereotactic-radiosurgery-srs-in-brain-metastases-fro 2017-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01995188/a-study-to-evaluate-the-safety-and-pharmacology-of-dnib0600a-in-participants-with-platin 2017-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02440906/evaluation-of-the-texas-wellness-incentives-and-navigation-win-project 2017-10-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02100007/me-344-given-in-combination-with-hycamtin-in-patients-with-solid-tumors 2017-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00309907/etanercept-in-treating-young-patients-with-idiopathic-pneumonia-syndrome-after-undergoin 2017-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003491/antineoplaston-therapy-in-treating-patients-with-stage-iv-lung-cancer 2017-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003495/antineoplaston-therapy-in-treating-patients-with-recurrent-or-stage-iv-lung-cancer 2017-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003496/antineoplaston-therapy-in-treating-patients-with-recurrent-or-extensive-stage-small-cell 2017-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01834651/a-phase-ii-study-of-cabozantinib-xl184-therapy-in-castrate-resistant-prostate-cancer-crp 2017-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01065818/early-prediction-of-pathology-response-of-chemoradiotherapy-with-flt-pet 2017-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01529112/a-study-comparing-the-combination-of-the-best-supportive-care-plus-e7080-versus-best-sup 2017-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03077230/pre-post-study-for-supporting-appropriate-implementation-of-lung-cancer-screening 2017-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01355965/autologous-redirected-rna-meso-cir-t-cells 2017-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01351415/a-study-of-bevacizumab-in-combination-with-standard-of-care-treatment-in-participants-wi 2017-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02695290/afatinib-in-egfr-nsclc-recurrent-or-stage-iv-patients-with-poor-performance-status-ecog 2017-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01727076/recombinant-interleukin-15-in-treating-patients-with-advanced-melanoma-kidney-cancer-non 2017-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01395914/anamorelin-hcl-in-the-treatment-of-non-small-cell-lung-cancer-cachexia-nsclc-c-an-extens 2017-09-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00086268/non-small-cell-lung-cancer-study-us75-z-pact 2017-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03184168/single-dose-study-of-14c-lorlatinib-pf-06463922-metabolism-in-healthy-male-volunteers 2017-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00881712/proton-therapy-with-chemotherapy-for-stage-iii-non-small-cell-lung-cancer-lu02 2017-09-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02538627/phase-1-combination-study-of-mm-151-with-mm-121-mm-141-or-trametinib 2017-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02121925/registry-measuring-the-impact-of-adding-rna-expression-testing-on-referral-decisions-in 2017-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02121899/registry-measuring-impact-of-rna-expression-testing-on-treatment-decisions-in-early-stag 2017-09-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01262560/manuka-honey-in-preventing-esophagitis-related-pain-in-patients-receiving-chemotherapy-a 2017-08-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01793246/registry-trial-to-determine-pcle-image-interpretation-criteria-and-preliminary-accuracy 2017-08-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01987232/phase-1b-2-study-of-carfilzomib-carboplatin-and-etoposide-in-patients-with-previously-un 2017-08-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02950792/mri-adaptive-replanning-using-viewray 2017-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02049151/tecemotide-following-concurrent-chemo-radiotherapy-for-non-small-cell-lung-cancer 2017-08-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02835599/registry-for-the-evolution-of-lung-cancer-therapy-implementation-and-outcomes-now 2017-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00310141/computer-assisted-counseling-in-helping-african-american-smokers-stop-smoking 2017-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00828139/s0802-topotecan-with-or-without-aflibercept-in-treating-patients-with-extensive-stage-sm 2017-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02715102/circulating-tumor-dna-in-patients-at-high-risk-for-lung-cancer 2017-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02015416/a-phase-1-trial-of-ny-eso-1-with-gla-se-in-patients-with-unresectable-or-metastatic-canc 2017-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01579929/combination-of-the-hedgehog-inhibitor-lde225-with-etoposide-and-cisplatin-in-the-first-l 2017-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00531284/phase-1b-2-study-of-carfilzomib-in-relapsed-solid-tumors-multiple-myeloma-or-lymphoma 2017-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02603367/comfort-caregiver-intervention-in-improving-communication-and-reducing-distress-in-careg 2017-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02425072/novottf-100a-therapy-for-refractory-cns-involved-small-cell-lung-cancer 2017-08-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00900328/study-of-tumor-samples-from-patients-with-lung-cancer 2017-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00253708/massage-therapy-in-treating-the-symptoms-of-patients-with-locally-advanced-or-metastatic 2017-08-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00410059/battle-program-erlotinib-in-previously-treated-subjects-with-advanced-nsclc 2017-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00102531/inhalation-slit-cisplatin-liposomal-for-the-treatment-of-osteosarcoma-metastatic-to-the 2017-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02080650/characterization-of-circulating-tumor-cells-captured-by-c-met-ctc-met 2017-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02639234/vigiltm-nivolumab-in-advanced-non-small-cell-lung-cancer 2017-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00791336/study-to-evaluate-using-nelfinavir-with-chemoradiation-for-non-small-cell-lung-cancer 2017-07-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01892046/safety-and-pharmacology-of-snx-5422-plus-carboplatin-and-paclitaxel-in-subjects-with-sol 2017-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00595218/patient-preference-survey-for-radiation-oncologists 2017-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01134146/radical-pleurectomy-decortication-pd-and-intensity-modulated-radiotherapy-imrt 2017-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00363428/lung-rehabilitation-in-treating-patients-with-chronic-obstructive-pulmonary-disease-who 2017-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00897650/protein-and-rna-expression-patterns-in-predicting-response-to-treatment-in-patients-with 2017-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01858389/a-study-of-dacomitinib-pf-00299804-in-patients-with-advanced-non-small-cell-lung-cancer 2017-07-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00856830/bendamustine-with-irinotecan-followed-by-etoposide-carboplatin-for-patients-with-extensi 2017-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00655850/lower-dose-chemotherapy-given-more-frequent-with-avastin-to-treat-advanced-non-squamous 2017-07-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00248495/pemetrexed-disodium-and-cisplatin-in-treating-patients-who-are-undergoing-surgery-for-st 2017-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00454324/study-of-abraxane-and-carboplatin-to-treat-small-cell-lung-cancer 2017-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02019199/magnetic-resonance-imaging-mri-in-motion 2017-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280735/ph-ii-adjuvant-carboplatin-docetaxel-in-curatively-resected-stage-i-iiia-nsclc 2017-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01328873/fob-in-hsct-and-leukemia-patients-with-acute-respiratory-symptoms-and-pulmonary-infiltra 2017-07-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01677780/an-extension-study-of-ro5045337-in-participants-participating-in-previous-roche-sponsore 2017-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01909752/combination-vaccine-immunotherapy-dribbles-for-patients-with-definitively-treated-stage 2017-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00487760/african-american-families-and-lung-cancer-study 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00341341/impact-of-lung-cancer-diagnosis-on-relatives-understanding-of-genetic-risk-and-receptivi 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00340847/construction-and-use-of-lung-tumor-microarray-for-the-analysis-of-gene-expression-in-lun 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01176500/a-pilot-open-label-study-of-18f-fluciclatide-pet-ct-imaging-in-the-evaluation-of-anti-an 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001893/study-of-tnfr-fc-enbrel-in-the-treatment-of-asthma 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00001702/evaluation-of-the-association-of-polymorphisms-in-the-innate-immune-system-with-the-risk 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00491335/hiv-infection-and-tobacco-use-among-injection-drug-users-in-baltimore-maryland-a-pilot-s 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01051934/a-phase-i-trial-of-ss1-dsfv-pe38-with-paclitaxel-carboplatin-and-bevacizumab-in-subjects 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02465892/pillars4life-trial 2017-07-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01936961/study-of-immunochemotherapy-hypofractionated-radiation-for-complete-response-in-solid-tu 2017-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01414595/study-of-tissue-samples-from-patients-with-non-small-cell-lung-cancer 2017-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00417040/collection-of-patient-reported-symptoms-and-performance-status-via-the-internet 2017-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01807546/oral-rigosertib-for-squamous-cell-carcinoma 2017-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01163253/a-long-term-study-to-evaluate-the-safety-and-tolerability-of-cp-690-550-for-patients-wit 2017-06-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280748/whole-brain-radiation-therapy-and-pemetrexed-in-treating-patients-with-brain-metastases 2017-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02495636/phase-2-study-of-mpdl3280a-combined-with-cdx-1401-in-ny-eso-1-iiib-iv-or-recurrent-non-s 2017-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01233687/amg-102-and-erlotinib-for-advanced-non-small-cell-lung-cancer 2017-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00958022/carboplatin-and-etoposide-plus-lbh589-for-small-cell-lung-cancer 2017-06-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01692951/serum-free-fatty-acid-metabolite-biomarkers-of-lung-cancer 2017-06-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280150/combination-chemotherapy-bev-rt-and-erlotinib-in-treating-patients-with-stage-iii-non-sm 2017-06-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01685060/ldk378-in-adult-patients-with-alk-activated-nsclc-previously-treated-with-chemotherapy-a 2017-06-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00129974/study-of-pemetrexed-and-gemcitabine-for-patients-with-a-new-diagnosis-of-extensive-stage 2017-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00178230/circulating-cytokines-as-predictors-of-radiation-induced-pulmonary-toxicity 2017-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00662311/vorinostat-paclitaxel-and-radiation-therapy-in-treating-patients-unable-to-tolerate-cisp 2017-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00519831/ph-ii-of-vinflunine-and-cetuximab-in-second-line-treatment-of-nsclc 2017-06-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01948141/nintedanib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-have-failed 2017-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00550537/proteomic-profiling-in-predicting-response-in-patients-receiving-erlotinib-for-stage-iii 2017-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01363947/safety-and-pharmacokinetics-of-escalating-doses-of-dnib0600a-in-participants-with-non-sm 2017-06-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00592007/study-evaluating-the-addition-of-fulvestrant-to-erlotinib-in-stage-iiib-iv-non-small-cel 2017-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02105012/study-to-assess-the-efficacy-and-safety-of-budesonide-pt008-in-adult-subjects-with-mild 2017-06-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01190527/using-fdg-pet-during-radiation-therapy-in-non-small-cell-lung-cancer 2017-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02345798/video-assisted-intervention-in-improving-recovery-in-patients-with-cancer-undergoing-lun 2017-06-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00043862/the-study-of-an-oral-drug-called-a-radiation-sensitizer-in-patients-with-newly-diagnosed 2017-05-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00376987/zinc-supplements-in-lowering-cadmium-levels-in-smokers 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00046111/a-bioequivalence-study-of-two-oral-formulations-of-topotecan-in-patients-with-advanced-s 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00899496/laboratory-assay-in-determining-cancer-resistance-in-patients-with-metastatic-cancer-and 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01336894/surgery-with-or-without-internal-radiation-therapy-compared-with-stereotactic-body-radia 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00310154/gefitinib-docetaxel-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00534001/bupropion-in-helping-adults-stop-smoking 2017-05-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00836992/quality-of-life-in-patients-undergoing-radiation-therapy-for-primary-lung-cancer-head-an 2017-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01360554/archer-1009-a-study-of-dacomitinib-pf-00299804-vs-erlotinib-in-the-treatment-of-advanced 2017-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01438307/phase-ii-study-of-cabazitaxel-xrp6258-in-advanced-non-small-cell-lung-cancer 2017-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00942825/triplet-combination-first-line-treatment-in-non-small-cell-lung-cancer-nsclc 2017-05-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01229150/randomized-phase-ii-study-of-azd6244-mitogen-activated-protein-kinase-inhibitor-mek-inhi 2017-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00728845/hydroxychloroquine-carboplatin-paclitaxel-and-bevacizumab-in-recurrent-advanced-non-smal 2017-05-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01940237/a-pilot-trial-of-interpersonal-psychotherapy-for-the-treatment-of-depression-in-patients 2017-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01663155/chest-imaging-breath-and-biomarkers-in-a-screening-trial 2017-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00801801/study-of-low-dose-chemotherapy-plus-sorafenib-as-initial-therapy-for-patients-with-advan 2017-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00691132/phenethyl-isothiocyanate-in-preventing-lung-cancer-in-smokers 2017-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02276560/cisplatin-and-nab-paclitaxel-for-n2-defined-nsclc 2017-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01783236/analgesic-efficacy-of-intravenous-acetaminophen-after-video-assisted-thoracic-surgery 2017-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00227539/positron-emission-tomography-in-predicting-response-in-patients-who-are-undergoing-treat 2017-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01017601/seneca-valley-virus-001-after-chemotherapy-in-treating-patients-with-extensive-stage-sma 2017-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01034514/4d-ct-based-ventilation-imaging-for-adaptive-functional-guidance-in-radiotherapy 2017-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00408499/erlotinib-and-cetuximab-in-treating-patients-with-advanced-solid-tumors-with-emphasis-on 2017-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00731952/phase-i-study-of-induction-therapy-with-velcade-and-vorinostat-in-patients-with-surgical 2017-05-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00300495/study-of-amiodarone-given-before-lung-surgery-to-prevent-atrial-fibrillation-after-lung 2017-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01471067/cord-blood-fucosylation-to-enhance-homing-and-engraftment-in-patients-with-hematologic-m 2017-04-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01493843/safety-and-efficacy-of-carboplatin-paclitaxel-and-carboplatin-paclitaxel-bevacizumab-wit 2017-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00408460/imatinib-mesylate-and-paclitaxel-in-treating-older-patients-with-stage-iiib-or-stage-iv 2017-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01141218/internet-based-clinical-information-and-blood-sample-collection-from-patients-with-non-s 2017-04-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00283244/ph-ii-gemcitabine-erlotinib-and-gemcitabine-with-erlotinib-elderly-patients-w-iiib-iv-ns 2017-04-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01999673/phase-3-study-of-bavituximab-plus-docetaxel-versus-docetaxel-alone-in-patients-with-late 2017-04-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00509444/cancer-prevention-and-treatment-among-african-american-older-adults-treatment-trial 2017-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00899028/identifying-biomarkers-for-lung-cancer-using-tissue-samples-from-patients-with-lung-canc 2017-04-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01160601/study-of-paclitaxel-carboplatin-with-or-without-bavituximab-in-previously-untreated-non 2017-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01138163/study-of-bavituximab-plus-docetaxel-in-patients-with-locally-advanced-or-metastatic-non 2017-04-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004095/irinotecan-plus-gemcitabine-in-treating-patients-with-unresectable-or-metastatic-solid-t 2017-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01672294/caregiver-outlook-an-intervention-to-improve-caregiving-in-serious-illness 2017-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01719861/phase-2a-desipramine-in-small-cell-lung-cancer-and-other-high-grade-neuroendocrine-tumor 2017-04-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00622193/dose-range-study-of-anamorelin-in-patients-with-non-small-cell-lung-cancer 2017-04-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01951690/phase-ii-study-of-vs-6063-in-patients-with-kras-mutant-non-small-cell-lung-cancer 2017-04-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00642759/carboplatin-abraxane-and-bevacizumab-in-previously-untreated-patients-with-advanced-non 2017-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00533884/neurocognitive-functioning-in-patients-with-newly-diagnosed-upper-aerodigestive-tract-ca 2017-04-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01992068/pilot-study-utilizing-manometry-to-assess-radiation-induced-changes-in-esophageal-functi 2017-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01726296/adherence-to-survivorship-care-guidelines-in-health-care-providers-for-non-small-cell-lu 2017-04-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01929720/cognitive-behavioral-intervention-for-worry-uncertainty-and-insomnia-for-cancer-survivor 2017-04-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00103116/vaccine-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-l 2017-04-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02087241/ph-ii-trial-of-carboplatin-and-pemetrexed-with-or-without-azd1775-for-untreated-lung-can 2017-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00499655/erlotinib-hydrochloride-with-or-without-celecoxib-in-treating-patients-with-stage-iiib-i 2017-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00863512/chemotherapy-or-observation-in-treating-patients-with-early-stage-non-small-cell-lung-ca 2017-03-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00612677/pemetrexed-oxaliplatin-in-patients-w-recurrent-nsclca-after-failure-to-platinum-based-ad 2017-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00226590/induction-gemcitabine-carboplatin-followed-by-paclitaxel-carboplatin-xrt-in-nsclc 2017-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00226577/pharmacogenomic-phase-ii-study-of-gemcitabine-and-pemetrexed-in-non-small-cell-lung-canc 2017-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00215930/the-made-it-clinical-trial-molecular-analyses-directed-individualized-therapy-for-advanc 2017-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00351039/phase-i-ii-trial-of-bevacizumab-pemetrexed-and-erlotinib-in-elderly-patients-with-non-sm 2017-03-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01302626/radiomics-a-study-of-outcome-in-lung-cancer 2017-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00454194/pemetrexed-disodium-with-or-without-sorafenib-as-second-line-therapy-in-treating-patient 2017-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00326599/gemcitabine-and-carboplatin-with-or-without-azd2171-as-first-line-therapy-in-treating-pa 2017-03-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01831726/dovitinib-for-patients-with-tumor-pathway-activations-inhibited-by-dovitinib 2017-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00520845/celecoxib-and-docetaxel-or-pemetrexed-in-treating-patients-with-advanced-recurrent-non-s 2017-03-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00963807/a-comparison-of-flt-to-fdg-pet-ct-in-the-early-assessment-of-chemotherapy-response-in-st 2017-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01357655/phase-2-dasatinib-combo-with-smoothened-smo-antagonist-bms-833923 2017-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01731704/neurocognitive-outcomes-in-patients-treated-with-radiotherapy-for-five-or-more-brain-met 2017-03-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct03077113/pilot-study-of-regional-lung-ventilation 2017-03-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02271139/expanded-access-study-of-alectinib-for-participants-with-anaplastic-lymphoma-kinase-alk 2017-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00109876/radiofrequency-ablation-in-treating-patients-with-stage-i-non-small-cell-lung-cancer 2017-03-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01390818/trial-of-mek-inhibitor-and-pi3k-mtor-inhibitor-in-subjects-with-locally-advanced-or-meta 2017-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01262820/pazopanib-in-stage-iiib-iv-nsclc-lung-cancer-after-progression-on-first-line-therapy-con 2017-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00227019/phase-2-trial-of-bevacizumab-in-combination-with-pemetrexed 2017-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00776100/radiation-therapy-or-observation-after-chemotherapy-in-treating-patients-with-stage-iv-n 2017-03-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01005797/study-of-panobinostat-in-combination-with-sorafenib-in-kidney-soft-tissue-or-lung-cancer 2017-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00874107/efficacy-safety-of-imprime-pgg-injection-with-bevacizumab-and-paclitaxel-carboplatin-in 2017-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00231465/phase-ii-study-of-docetaxel-zd1839-in-elderly-patients-with-non-small-cell-lung-cancer 2017-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00073008/a-study-of-oral-gw572016-in-advanced-or-metastatic-non-small-cell-lung-cancer 2017-02-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00906282/preoperative-pemetrexed-and-carboplatin-for-select-stage-ib-ii-and-iii-non-squamous-non 2017-02-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00444015/phase-i-dasatinib-erlotinib-in-recurrent-non-small-cell-lung-cancer-nsclc 2017-02-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00790400/efficacy-and-safety-of-rad001-in-patients-aged-18-and-over-with-angiomyolipoma-associate 2017-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003901/prognostic-study-of-metastases-in-patients-with-stage-i-stage-ii-or-stage-iii-non-small 2017-02-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00508144/single-agent-alimta-in-poor-performance-status-in-non-small-cell-lung-cancer 2017-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02262455/effects-of-stm-434-alone-or-in-combination-with-liposomal-doxorubicin-in-patients-with-o 2017-02-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00564733/fdg-labeled-pet-scan-in-planning-chemotherapy-in-treating-patients-with-stage-iiib-or-iv 2017-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00957424/acceptability-of-less-harmful-alternatives-to-cigarettes 2017-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02257476/extended-infusion-carfilzomib-on-a-weekly-schedule-in-patients-with-advanced-solid-tumor 2017-02-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00806819/lume-lung-2-bibf-1120-plus-pemetrexed-compared-to-placebo-plus-pemetrexed-in-2nd-line-no 2017-02-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02319889/feasibility-study-of-sbrt-plus-chemotherapy-for-non-small-cell-lung-carcinoma 2017-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00492206/study-of-cetuximab-with-radiation-followed-by-consolidation-chemotherapy-for-nsclc 2017-02-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01647711/a-study-of-intermittent-high-dose-afatinib-to-determine-the-maximal-tolerated-dose-and-a 2017-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01883986/supportive-care-for-patients-newly-diagnosed-with-lung-cancer 2017-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02568033/stereotactic-radiosurgery-and-systemic-dose-chemotherapy-for-locally-advanced-lung-cance 2017-01-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01026844/hydroxychloroquine-with-or-without-erlotinib-in-advanced-non-small-cell-lung-cancer-nscl 2017-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02372227/a-phase-1-dose-escalation-study-of-vs-5584-administered-in-combination-with-vs-6063-in-s 2017-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01870609/placebo-controlled-study-of-vs-6063-in-subjects-with-malignant-pleural-mesothelioma 2017-01-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02460120/evaluation-of-the-archimedestm-system-for-transparenchymal-nodule-access 2017-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01757158/cesium-131-seed-brachytherapy-plus-subtotal-resection-for-lung-cancer-patients 2017-01-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00798603/pemetrexed-carboplatin-and-bevacizumab-as-first-line-therapy-in-treating-older-patients 2017-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00571298/extrapleural-pneumonectomy-pleurectomy-decortication-ihoc-cisplatin-and-gemcitabine-with 2017-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00218179/assessing-the-link-between-smoke-carcinogen-biomarkers-and-lung-cancer-risk-1 2017-01-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003657/high-dose-ice-with-amifostine 2017-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00932451/an-investigational-drug-pf-02341066-is-being-studied-in-patients-with-advanced-non-small 2017-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00550654/conformal-radiation-therapy-in-treating-patients-with-metastatic-cancer-outside-the-brai 2017-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00322205/bio-behavioral-lung-cancer-prevention-program 2017-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02906423/results-from-a-health-system-wide-implementation-of-a-quality-of-life-questionnaire 2017-01-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00578006/internet-based-system-for-cancer-patients-to-self-report-toxicity 2017-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00158145/assessing-the-variability-over-time-of-tobacco-carcinogen-biomarkers-in-smokers-2 2017-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01173458/circulating-tumor-cells-ctcs-as-a-blood-based-tumor-marker-in-patients-with-small-cell-l 2017-01-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01383148/phase-iib-iii-of-tg4010-immunotherapy-in-patients-with-stage-iv-non-small-cell-lung-canc 2017-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00932893/an-investigational-drug-pf-02341066-is-being-studied-versus-standard-of-care-in-patients 2017-01-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01832857/phase-2-safety-tolerability-and-efficacy-study-of-cpi-613-in-cancer-patients 2016-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00098540/sorafenib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer 2016-12-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00401778/trial-of-rad001-in-patients-with-operable-non-small-cell-lung-cancer-nsclc 2016-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02059889/diffusion-weighted-mri-for-individualized-radiation-therapy-planning-of-lung-cancer 2016-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00305786/gemcitabine-and-oxaliplatin-as-second-line-therapy-in-treating-patients-with-stage-iii-o 2016-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01600053/revlimid-as-consolidation-treatment-chronic-lymphocytic-leukemia 2016-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00073723/trial-of-abi-007-administered-weekly-in-chemotherapy-naive-patients-with-advanced-non-sm 2016-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00503568/vaccine-therapy-in-treating-patients-with-stage-iii-stage-iv-or-relapsed-non-small-cell 2016-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00449020/carboplatin-irinotecan-and-radiation-therapy-followed-by-docetaxel-in-treating-patients 2016-12-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00062062/gefitinib-with-or-without-carboplatin-and-paclitaxel-in-treating-older-patients-with-unr 2016-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00921310/temsirolimus-and-pemetrexed-for-recurrent-or-refractory-non-small-cell-lung-cancer 2016-12-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00966277/dalteparin-for-primary-venous-thromboembolism-vte-prophylaxis-in-pancreatic-cancer-patie 2016-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01551082/outpatient-chest-tube-management-following-thoracic-resection-improves-patient-length-of 2016-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00352690/a-phase-ii-study-of-radiation-therapy-paclitaxel-poliglumex-and-carboplatin-in-stage-iii 2016-12-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00022646/pemetrexed-disodium-plus-gemcitabine-in-treating-patients-with-locally-advanced-or-metas 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00017186/gemcitabine-and-epirubicin-in-treating-patients-with-malignant-mesothelioma 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02639767/concurrent-pemetrexed-cisplatin-with-pleural-intensity-modulated-radiation-therapy-for-p 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00028925/combination-chemotherapy-with-or-without-filgrastim-in-treating-patients-with-previously 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00040885/docetaxel-with-or-without-infliximab-in-treating-weight-loss-loss-of-appetite-and-fatigu 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00041054/combination-chemotherapy-and-exisulind-in-treating-patients-with-extensive-stage-small-c 2016-12-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00565227/phase-i-study-of-vorinostat-in-combination-with-docetaxel-in-patients-with-advanced-and 2016-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00032032/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-non-small-cell 2016-12-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01649284/afatinib-expanded-access-program 2016-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02116712/the-tolerability-of-saracatinib-in-subjects-with-lymphangioleiomyomatosis-lam-slam-1 2016-11-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01294306/mk2206-and-erlotinib-hydrochloride-in-treating-patients-with-advanced-non-small-cell-lun 2016-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00874848/efficacy-safety-of-imprime-pgg-with-cetuximab-paclitaxel-carboplatin-therapy-in-pts-with 2016-11-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00442520/pharmacogenomic-study-in-patients-of-lung-colorectal-and-head-neck-cancers-receiving-che 2016-11-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00124280/study-investigating-the-effect-of-everolimus-monotherapy-in-patients-with-advanced-non-s 2016-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01886573/azacitidine-and-entinostat-in-treating-patients-with-newly-diagnosed-stage-ia-iiia-non-s 2016-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01679470/efficacy-study-of-aurolase-therapy-in-subjects-with-primary-and-or-metastatic-lung-tumor 2016-11-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01887886/a-study-of-onartuzumab-in-combination-with-erlotinib-in-patients-with-met-positive-stage 2016-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00974584/a-study-of-the-safety-and-pharmacology-of-pi3-kinase-inhibitor-gdc-0941-in-combination-w 2016-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01366131/study-evaluating-the-safety-and-efficacy-of-megf0444a-in-combination-with-carboplatin-pa 2016-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01456325/a-study-of-onartuzumab-metmab-in-combination-with-tarceva-erlotinib-in-participants-with 2016-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00975182/a-study-of-the-safety-and-pharmacology-of-gdc-0941-in-combination-with-erlotinib-in-pati 2016-11-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01047761/exercise-for-stable-myasthenia-gravis 2016-11-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01839955/erlotinib-hydrochloride-and-quinacrine-dihydrochloride-in-stage-iiib-iv-non-small-cell-l 2016-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01814553/adam-afatinib-diarrhea-assessment-and-management 2016-10-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00897442/collecting-tumor-samples-from-patients-with-gynecological-tumors 2016-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01328951/a-study-of-first-line-maintenance-erlotinib-versus-erlotinib-at-disease-progression-in-p 2016-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02083679/sym004-in-subjects-with-stage-iv-non-small-cell-lung-cancer 2016-10-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01861301/tivantinib-in-treating-patients-with-previously-treated-malignant-mesothelioma 2016-10-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00852462/lung-cancer-symptom-assessment-and-management-intervention 2016-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02267096/lombardi-comprehensive-cancer-center-legacy-pilot-study-to-reduce-adverse-smoking-outcom 2016-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00358397/one-time-injection-of-bacteria-to-treat-solid-tumors-that-have-not-responded-to-standard 2016-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00117962/pemetrexed-disodium-carboplatin-and-radiation-therapy-with-or-without-cetuximab-in-treat 2016-10-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01522820/vaccine-therapy-with-or-without-sirolimus-in-treating-patients-with-ny-eso-1-expressing 2016-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00839605/dexmedetomidine-and-hypoxic-pulmonary-vasoconstriction-in-thoracic-surgical-procedures-a 2016-10-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00404924/zd6474-zactimatm-phase-iii-study-in-egfr-failures 2016-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00312377/zactima-an-anti-egfr-anti-vegf-agent-combined-with-docetaxel-compared-to-docetaxel-in-no 2016-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01521325/a-single-dose-pilot-study-of-radiolabeled-amatuximab-morab-009-in-mesothelin-over-expres 2016-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00216203/pemetrexed-plus-cetuximab-in-patients-with-recurrent-non-small-cell-lung-cancer 2016-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01457417/a-study-of-dkn-01-in-multiple-myeloma-or-advanced-solid-tumors 2016-09-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02186236/detection-of-oncogenic-tumor-mutations-in-the-urine-and-blood-of-lung-and-colorectal-can 2016-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00850785/autologous-tumor-dribble-vaccine-in-patients-with-non-small-cell-lung-cancer 2016-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02033551/a-study-evaluating-veliparib-as-a-single-agent-or-in-combination-with-chemotherapy-in-su 2016-09-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01734915/detecting-egfr-t790m-mutations-from-circulating-tumor-cells 2016-09-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01496742/a-study-of-onartuzumab-metmab-in-combination-with-bevacizumab-avastin-plus-platinum-and 2016-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00310115/motivational-counseling-in-preventing-smoking-relapse-after-pregnancy-in-pregnant-women 2016-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00702572/carboplatin-paclitaxel-bevacizumab-and-vorinostat-for-patients-with-advanced-non-small-c 2016-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01723800/pi3k-inhibitor-bkm120-carboplatin-and-pemetrexed-disodium-in-treating-patients-with-stag 2016-09-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00035152/study-comparing-weekly-taxol-and-carboplatin-vs-standard-taxol-and-carboplatin-regimen-f 2016-09-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01770665/validation-of-the-mick-assay 2016-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00525148/lux-lung-2-phase-ii-single-arm-bibw-2992-afatinib-in-nsclc-with-egfr-activating-mutation 2016-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01179308/regional-anesthesia-and-lung-cancer-recurrence 2016-09-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01722903/detection-of-ctcs-in-patients-undergoing-surgery-for-stage-iv-colorectal-cancer 2016-09-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02233842/cognitive-testing-of-tobacco-use-measurement-items-for-administration-with-cancer-patien 2016-09-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02895503/yoga-in-improving-quality-of-life-in-patients-with-non-small-cell-lung-cancer-undergoing 2016-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00165503/pleurectomy-decortication-with-intraoperative-intrathoracic-intraperitoneal-heated-cispl 2016-09-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01451632/a-safety-study-of-mm-121-with-cetuximab-and-irinotecan-in-patients-with-advanced-cancers 2016-09-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00323869/phase-ii-bevacizumab-gemcitabine-and-carboplatin-in-newly-diagnosed-non-small-cell-lung 2016-09-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01519804/a-study-of-onartuzumab-metmab-versus-placebo-in-combination-with-paclitaxel-plus-platinu 2016-09-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02126527/auranofin-and-sirolimus-in-treating-patients-with-advanced-solid-tumors-or-recurrent-non 2016-08-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00047840/this-study-is-to-assess-the-efficacy-and-safety-of-zd6474-in-subjects-with-non-small-cel 2016-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00071188/zd6474-alone-or-in-combination-with-paclitaxel-and-carboplatin-in-subjects-with-previous 2016-08-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00059722/this-study-is-to-compare-the-efficacy-of-zd6474-and-zd1839-in-subjects-with-nsclc 2016-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01808677/registry-study-of-thoracic-reirradiation-for-non-small-cell-lung-cancer-nsclc-utilizing 2016-08-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00994123/a-study-of-mm-121-combination-therapy-in-patients-with-advanced-non-small-cell-lung-canc 2016-08-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00580320/safety-study-of-dacarbazine-and-bortezomib-in-melanoma-and-soft-tissue-sarcoma 2016-08-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00320255/a-phase-2-pilot-study-of-apixaban-for-the-prevention-of-thromboembolic-events-in-patient 2016-08-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01851096/safety-and-pharmacology-study-of-snx-5422-in-subjects-with-resistant-lung-adenocarcinoma 2016-08-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01045421/alisertib-in-adults-with-nonhematological-malignancies-followed-by-alisertib-in-lung-bre 2016-08-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00509041/dasatinib-in-treating-patients-with-previously-treated-malignant-mesothelioma 2016-08-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003726/lepirudin-in-treating-patients-with-recurrent-or-advanced-small-cell-lung-cancer 2016-08-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00827333/palliative-care-teaching-sessions-for-family-caregivers-of-patients-with-non-small-cell 2016-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01528137/talactoferrin-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cance 2016-08-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00740636/temozolomide-for-relapsed-sensitive-or-refractory-small-cell-lung-cancer 2016-08-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01559844/efficacy-of-sofosbuvir-with-ribavirin-administered-pre-transplant-in-preventing-hepatiti 2016-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00656136/bibw-2992-and-bsc-versus-placebo-and-bsc-in-non-small-cell-lung-cancer-patients-failing 2016-07-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00417248/cisplatin-etoposide-radiotherapy-followed-by-consolidation-sorafenib-for-inoperable-stag 2016-07-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01137162/clinical-and-pathologic-studies-of-patients-undergoing-treatment-with-egfr-inhibitors 2016-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00405951/safety-and-efficacy-of-obatoclax-mesylate-gx15-070ms-in-combination-with-docetaxel-for-t 2016-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00682981/a-phase-i-ii-study-of-carboplatin-and-etoposide-with-or-without-obatoclax-in-extensive-s 2016-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004139/gemcitabine-plus-docetaxel-or-irinotecan-in-treating-patients-with-stage-iiib-or-stage-i 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003387/carboplatin-paclitaxel-and-radiation-therapy-in-treating-patients-with-stage-iii-non-sma 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003299/cisplatin-plus-etoposide-with-or-without-paclitaxel-in-treating-patients-with-extensive 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00832715/utility-of-endobronchial-ultrasound-guided-needle-biopsy-in-early-stage-non-small-cell-l 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003666/irofulven-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003812/chemotherapy-plus-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-l 2016-07-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00033553/combination-chemotherapy-and-computer-planned-radiation-therapy-in-treating-patients-wit 2016-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00010218/karenitecin-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer 2016-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00033696/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-limited-stage-s 2016-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01700452/diagnostic-study-for-lung-cancer-detection-test 2016-07-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01325558/a-study-of-alt-836-in-combination-with-gemcitabine-for-locally-advanced-or-metastatic-so 2016-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01204476/cixutumumab-everolimus-and-octreotide-acetate-in-treating-patients-with-advanced-low-to 2016-07-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005972/combination-chemotherapy-in-treating-patients-with-recurrent-or-refractory-small-cell-lu 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004183/capecitabine-in-treating-patients-with-malignant-mesothelioma 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02451852/azd9291-us-expanded-access-program 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005646/paclitaxel-in-treating-patients-with-extensive-stage-small-cell-lung-cancer 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005059/carboplatin-and-paclitaxel-in-treating-older-patients-with-metastatic-or-recurrent-unres 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003565/docetaxel-in-treating-patients-with-solid-tumors 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003566/thoracoscopy-in-patients-with-stage-iiia-non-small-cell-lung-cancer 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00009789/radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-and-lung 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002624/video-assisted-surgery-followed-by-radiation-therapy-in-treating-patients-with-stage-i-n 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003831/lymph-node-removal-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-can 2016-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003317/combination-chemotherapy-with-or-without-radiation-therapy-in-treating-patients-with-sta 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003762/docetaxel-and-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cel 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004055/topotecan-paclitaxel-and-filgrastim-in-treating-patients-with-previously-untreated-exten 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003281/topotecan-and-paclitaxel-in-treating-patients-with-recurrent-or-refractory-small-cell-lu 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003674/standard-therapy-with-or-without-dalteparin-in-treating-patients-with-advanced-breast-lu 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02324881/pain-management-smartphone-application-for-patients-with-stage-iii-iv-head-and-neck-canc 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003600/epoetin-alfa-in-treating-anemia-in-patients-who-are-receiving-chemotherapy 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005610/study-of-aerosolized-sargramostim-in-treating-patients-with-melanoma-metastatic-to-the-l 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006349/donepezil-and-vitamin-e-to-prevent-side-effects-caused-by-radiation-therapy-to-the-head 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00008333/vinorelbine-in-treating-older-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-c 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00004138/positron-emission-tomography-for-detecting-non-small-cell-lung-cancer 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00033592/comparison-of-nicotine-inhaler-and-or-bupropion-in-helping-people-to-stop-smoking-and-pr 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006483/sargramostim-in-treating-patients-with-kidney-cancer-that-has-spread-to-the-lung 2016-07-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003724/conventional-or-video-assisted-surgery-in-treating-patients-with-lung-metastases 2016-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01515969/phase-1-erlotinib-and-dovitinib-tki258-in-advanced-non-small-cell-lung-cancer-nsclc 2016-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01182519/lung-inflammation-and-lung-metastases-from-breast-cancer 2016-07-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01888510/ct-in-diagnosing-patients-with-lung-cancer 2016-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006012/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-limited-stage-s 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003900/irinotecan-with-docetaxel-in-treating-patients-with-recurrent-or-metastatic-non-small-ce 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00227565/pemetrexed-disodium-and-carboplatin-in-treating-patients-with-extensive-stage-small-cell 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00124618/cetuximab-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00017121/inhaled-sargramostim-in-treating-patients-with-melanoma-metastatic-to-the-lung 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00077324/proteomic-profiling-in-diagnosing-non-small-cell-lung-cancer-in-patients-who-are-undergo 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00072527/cisplatin-and-irinotecan-followed-by-carboplatin-etoposide-and-radiation-therapy-in-trea 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00268489/pemetrexed-disodium-and-bevacizumab-in-treating-patients-with-stage-iii-or-stage-iv-non 2016-07-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00042770/standard-chest-tube-compared-with-a-small-catheter-in-treating-malignant-pleural-effusio 2016-07-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00005850/combination-chemotherapy-plus-fluoxetine-in-treating-patients-with-advanced-or-recurrent 2016-07-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01798485/a-phase-3-study-of-ganetespib-in-combination-with-docetaxel-versus-docetaxel-alone-in-pa 2016-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01182155/breath-analysis-for-evaluation-of-radiation-exposure-in-lung-cancer-patients-treated-wit 2016-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01172041/the-role-of-audiovisual-biofeedback-on-image-quality-during-4d-anatomic-and-functional-i 2016-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00053885/ptk787-zk-222584-in-treating-patients-with-unresectable-malignant-mesothelioma 2016-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00089310/sentinel-lymph-node-mapping-in-detecting-cancer-that-has-spread-to-lymph-nodes-in-patien 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003117/paclitaxel-with-or-without-carboplatin-in-treating-patients-with-advanced-non-small-cell 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00787267/phase-ii-study-of-dasatinib-in-previously-treated-patients-with-advanced-nsclc 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00984997/combined-modality-treatment-for-resectable-non-small-cell-superior-sulcus-tumors 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00077311/docetaxel-and-cisplatin-with-or-without-dimesna-in-treating-patients-with-stage-iiib-or 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00070486/carboplatin-and-gemcitabine-combined-with-celecoxib-and-or-zileuton-in-treating-patients 2016-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00003006/detection-of-early-metastases-in-patients-with-stage-i-non-small-cell-lung-cancer 2016-06-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00826449/dasatinib-and-erlotinib-in-non-small-cell-lung-cancer-nsclc 2016-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00686959/chemotherapy-and-radiation-in-treating-participants-with-stage-3-non-small-cell-lung-can 2016-06-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01788566/a-study-of-gemcitabine-cisplatin-chemotherapy-plus-necitumumab-in-the-first-line-treatme 2016-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01320059/study-of-18f-fluoro-peg6-ipqa 2016-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00948961/a-study-of-cdx-1401-in-patients-with-malignancies-known-to-express-ny-eso-1 2016-06-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02224053/drug-drug-interaction-study-with-azd9291-and-omeprazole-in-healthy-volunteers 2016-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02277457/personalized-adaptive-radiation-therapy-with-individualized-systemic-targeted-therapy-pa 2016-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00637728/treatment-of-cancer-anorexia-using-megestrol-acetate-concentrated-suspension-in-lung-or 2016-06-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01723306/phase-ii-pilot-study-of-2nd-generation-anti-cea-designer-t-cells-in-adenocarcinomas 2016-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02087176/a-placebo-controlled-study-comparing-azd1775-docetaxel-versus-placebo-docetaxel-to-treat 2016-06-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01155258/temsirolimus-and-vinorelbine-ditartrate-in-treating-patients-with-unresectable-or-metast 2016-06-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01666977/phase-1b-2-trial-of-amg386-with-pemetrexed-and-carboplatin-in-non-small-cell-lung-cancer 2016-06-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02783079/insomnia-interventions-in-cancer-survivors 2016-05-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00057746/brain-irradiation-in-treating-patients-with-limited-stage-small-cell-lung-cancer 2016-05-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00290537/phase-ii-study-of-zd6474-in-advanced-nsclc 2016-05-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01778920/pilot-and-feasibility-study-of-the-imaging-potential-of-ec17-intraoperative-folate-fluor 2016-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00651508/study-to-evaluate-kos-1584-in-patients-with-advanced-or-metastatic-stage-iiib-iv-non-sma 2016-05-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02351505/selinexor-in-treating-patients-with-relapsed-small-cell-lung-cancer 2016-05-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01291017/cyclin-dependent-kinase-cdk-4-6-inhibitor-pd0332991-in-advanced-non-small-cell-lung-canc 2016-05-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00250120/pharmacology-study-of-aerosolized-liposomal 2016-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01042288/carboplatin-pemetrexed-and-panitumumab-in-patients-with-advanced-non-squamous-k-ras-wild 2016-05-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01115790/a-phase-1-study-in-participants-with-advanced-cancer 2016-05-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00063258/tarceva-surgery-for-resectable-stage-iiia-n2-and-iiib-t4-n2-non-small-cell-lung-cancer 2016-05-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00555256/a-phase-i-study-of-sunitinib-and-rapamycin-in-advanced-non-small-cell-lung-cancer-nsclc 2016-05-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01076504/a-trial-of-amrubicin-and-carboplatin-with-pegfilgrastim-in-patients-with-extensive-stage 2016-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00692380/gated-intensity-modulated-radiation-therapy-and-concurrent-chemotherapy-for-inoperable-n 2016-05-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00362739/blood-collection-from-individuals-with-lung-disease-for-genetic-studies 2016-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01570855/chemotherapy-resistance-and-sensitivity-testing-in-lung-tumors 2016-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00732303/pemetrexed-and-radiation-for-poor-risk-stage-iii-non-small-cell-lung-cancer 2016-04-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02283320/a-study-of-bind-014-docetaxel-nanoparticles-for-injectable-suspension-as-second-line-the 2016-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00257608/a-study-comparing-bevacizumab-therapy-with-or-without-erlotinib-for-first-line-treatment 2016-04-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01792479/a-phase-2-study-to-determine-the-safety-and-efficacy-of-bind-014-docetaxel-nanoparticles 2016-04-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01117740/pleural-catheters-versus-thoracoscopic-pleurodesis 2016-04-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00508313/thermal-signature-of-patients-undergoing-radiation-therapy 2016-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00609804/sorafenib-and-erlotinib-or-sorafenib-alone-in-advanced-non-small-cell-lung-cancer-progre 2016-04-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00998192/a-study-of-reolysin-in-combination-with-paclitaxel-and-carboplatin-in-patients-with-squa 2016-03-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00365508/counseling-and-nicotine-replacement-therapy-in-helping-adult-smokers-quit-smoking 2016-03-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00784095/outlook-quality-of-life-intervention 2016-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00087048/topotecan-in-treating-patients-with-recurrent-extensive-stage-small-cell-lung-cancer 2016-03-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01082549/trial-of-gemcitabine-carboplatin-with-or-without-iniparib-sar240550-a-parp1-inhibitor-in 2016-03-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00216125/cisplatin-etoposide-radiotherapy-consolidation-docetaxel-in-advanced-stage-iii-non-small 2016-03-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01297491/safety-and-efficacy-of-bkm120-in-patients-with-metastatic-non-small-cell-lung-cancer 2016-03-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01993550/telephone-support-program-for-lung-cancer-patients-and-their-family-caregivers 2016-03-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00402896/malignant-pleural-effusion-with-zd6474 2016-03-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01522833/non-small-cell-lung-cancer-patients-treated-with-erlotinib-six-months-or-longer 2016-03-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01355484/phase-iii-study-of-the-effect-of-gtx-024-on-muscle-wasting-in-patients-with-non-small-ce 2016-03-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01433263/clinical-study-of-bym338-for-the-treatment-of-unintentional-weight-loss-in-patients-with 2016-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00398138/vaccine-therapy-and-gm-csf-in-treating-patients-with-acute-myeloid-leukemia-myelodysplas 2016-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01124864/a-study-of-auy922-in-non-small-cell-lung-cancer-patients-who-have-received-previous-two 2016-03-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01171924/a-phase-ib-expansion-study-investigating-the-safety-efficacy-and-pharmacokinetics-of-int 2016-03-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01760941/compassionate-same-day-evaluation-delivery-of-xrt-for-bony-metastasis-in-hospice-patient 2016-02-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00579930/cytogenetic-and-molecular-genetic-studies-in-bone-sarcomas 2016-02-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00587964/phase-ii-trial-of-stereotactic-radiosurgery-boost-following-surgical-resection-for-brain 2016-02-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00843219/motion-correction-of-positron-emission-tomography-pet-data-using-amplitude-gating 2016-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01565772/proton-radiation-therapy-with-cisplatin-and-etoposide-followed-by-surgery-in-stage-iii-n 2016-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01525446/proton-stereotactic-body-radiation-therapy-for-early-stage-non-small-cell-lung-cancer 2016-02-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01029925/dichloroacetate-dca-in-patients-with-previously-treated-metastatic-breast-or-non-small-c 2016-02-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00411671/battle-program-sorafenib-in-patients-with-nsclc 2016-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00367601/erlotinib-bevacizumab-for-ps-2-chemotherapy-nai-ve-non-small-cell-lung-cancer 2016-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01466946/understanding-symptom-recognition-and-treatment-decision-making-in-hispanic-latino-lung 2016-02-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00900302/ox-40-protein-expression-in-the-sentinel-lymph-nodes-of-patients-with-cancer 2016-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00533585/bay-43-9006-in-previously-untreated-patients-with-non-small-cell-lung-cancer-nsclc 2016-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00035516/a-phase-ii-study-of-epothilone-analog-bms-247550-in-patients-with-non-small-cell-lung-ca 2016-02-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01346839/effectiveness-of-electronic-health-record-based-interventions-for-improving-follow-up-in 2016-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01300533/a-study-of-bind-014-given-to-patients-with-advanced-or-metastatic-cancer 2016-02-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00280241/protocol-for-the-treatment-of-patients-with-previously-untreated-chronic-lymphocytic-leu 2016-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00579683/registry-for-patients-with-acquired-resistance-to-small-molecule-kinase-inhibitors-in-no 2016-02-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00352391/vanguard-study-for-head-and-neck-cancer-or-non-small-cell-lung-cancer-nsclc-patients 2016-02-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01027598/randomized-double-blind-trial-of-erlotinib-pazopanib-or-erlotinib-placebo-in-patients-wi 2016-01-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01823094/ctp-imaging-of-lung-cancer 2016-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01137968/imetelstat-as-maintenance-therapy-after-initial-induction-chemotherapy-in-non-small-cell 2016-01-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00130780/multimodality-treatment-for-patients-with-resectable-non-small-cell-lung-cancer-nsclc-be 2016-01-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00570401/dasatinib-in-treating-patients-with-advanced-lung-cancer-that-is-no-longer-responding-to 2016-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00588445/phase-ii-trial-to-correlate-radiographic-response-induced-by-gefitinib-with-mutations-in 2016-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01830426/circulating-tumor-cells-in-non-small-cell-lung-carcinoma 2016-01-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00096486/gefitinib-and-everolimus-in-treating-patients-with-stage-iiib-or-stage-iv-or-recurrent-n 2016-01-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01621295/assessing-the-patient-experience-in-cancer-care 2016-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00249964/combination-paclitaxel-carboplatin-and-temozolomide 2016-01-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00996060/use-of-hydralazine-and-valproic-acid-in-advanced-solid-tumor-malignancies 2016-01-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01533181/linsitinib-or-topotecan-hydrochloride-in-treating-patients-with-relapsed-small-cell-lung 2016-01-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00779389/comparison-of-biomarker-modulation-by-inhibition-of-egfr-and-or-src-family 2016-01-13 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01349647/immunization-with-a-pentavalent-vaccine-composed-of-klh-conjugates-of-gd2l-gd3l-globo-h 2016-01-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00807573/paclitaxel-bevacizumab-and-pemetrexed-in-patients-with-untreated-advanced-non-small-cell 2015-12-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00581815/spectroscopy-with-surface-coils-and-decoupling 2015-12-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00112294/study-of-taxane-carboplatin-cetuximab-as-first-line-treatment-for-patients-with-advanced 2015-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01109524/safety-study-of-cetuximab-in-combination-with-cisplatin-and-vinorelbine-to-treat-advance 2015-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00588328/the-use-of-breathing-synchronized-ct-and-pet-scans-in-radiation-therapy-treatment-planni 2015-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00510445/study-of-grn163l-with-paclitaxel-and-carboplatin-in-patients-with-advanced-or-metastatic 2015-12-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00890955/amrubicin-cyclophosphamide-in-advanced-solid-organ-malignancies 2015-12-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01263886/trial-of-ombrabulin-ave8062-in-combination-with-taxane-and-platinum-in-patients-with-non 2015-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00762034/a-study-of-pemetrexed-carboplatin-and-bevacizumab-in-participants-with-nonsquamous-non-s 2015-12-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00466232/phase-i-study-of-weekly-topotecan-in-combination-with-sorafenib-in-treatment-of-relapsed 2015-12-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00122135/a-culturally-sensitive-values-guided-aid-for-end-of-life-decision-making 2015-12-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01431378/pilot-study-of-model-based-iterative-reconstruction-using-64-slice 2015-12-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02190864/patient-defined-treatment-success-and-preferences-in-stage-iv-lung-cancer-patients 2015-12-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01172028/pemetrexed-disodium-and-docetaxel-in-treating-patients-with-advanced-solid-tumors 2015-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00141726/study-of-enbrel-etanercept-for-the-treatment-sub-acute-pulmonary-dysfunction-after-allog 2015-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00625456/safety-study-of-recombinant-vaccinia-virus-to-treat-refractory-solid-tumors 2015-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00298298/dnp-modified-autologous-tumor-cell-vaccine-for-resectable-non-small-cell-lung-cancer 2015-12-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00861627/phase-2-study-of-reolysin-in-combination-with-paclitaxel-and-carboplatin-for-non-small-c 2015-12-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01261507/reader-study-of-deltaviewtm-chest-radiograph-software 2015-12-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00876915/a-study-of-dalteparin-prophylaxis-in-high-risk-ambulatory-cancer-patients 2015-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00053846/buspirone-in-reducing-shortness-of-breath-in-patients-with-cancer 2015-11-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00409188/cancer-vaccine-study-for-unresectable-stage-iii-non-small-cell-lung-cancer-start 2015-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01044290/outlook-quality-of-life-intervention-study 2015-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00741039/prospective-trial-of-vaccine-responses-against-pneumococcus-and-influenza-in-adult-cance 2015-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00675597/docetaxel-taxotere-vinorelbine-and-bevacizumab-as-adjuvant-chemotherapy-for-patients-wit 2015-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00988169/erlotinib-and-at-101-in-advanced-non-small-cell-lung-cancer-nsclc-patients-with-epiderma 2015-11-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01626001/imaging-study-compare-4dct-image 2015-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01193868/ro4929097-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-have-recentl 2015-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00402766/cisplatin-pemetrexed-and-imatinib-mesylate-in-malignant-mesothelioma 2015-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01189435/erlotinib-re-challenge-for-recurrent-egfr-mutant-lung-cancer-in-patients-who-previously 2015-11-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00081302/cetuximab-paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-with-unresec 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00016315/gemcitabine-carboplatin-or-paclitaxel-plus-radiation-therapy-in-treating-patients-with-s 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01809730/pilot-study-cardiovascular-events-in-high-risk-orthopedic-surgical-patients 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01135849/b-receptor-signaling-in-cardiomyopathy 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00002550/chemotherapy-plus-radiation-therapy-with-or-without-surgery-in-treating-patients-with-st 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00059761/chemotherapy-combined-with-radiation-therapy-in-treating-patients-with-limited-stage-sma 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00046839/celecoxib-and-radiation-therapy-in-treating-patients-with-locally-advanced-non-small-cel 2015-11-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00161187/irradiated-donor-lymphocyte-infusion-in-treating-patients-with-relapsed-or-refractory-he 2015-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00823732/effects-of-palliative-care-on-quality-of-life-and-symptom-control-in-patients-with-stage 2015-11-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01348126/study-of-ganetespib-sta-9090-docetaxel-in-advanced-non-small-cell-lung-cancer 2015-11-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01411098/radiation-therapy-cisplatin-and-etoposide-in-treating-patients-with-non-small-cell-lung 2015-11-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00738881/pemetrexed-disodium-or-erlotinib-hydrochloride-as-second-line-therapy-in-treating-patien 2015-10-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00207116/an-exploratory-pharmacogenomic-study-of-monotherapy-erbitux-in-subjects-with-metastatic 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00965731/erlotinib-is-being-studied-with-or-without-an-investigational-drug-pf-02341066-in-patien 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00768131/a-study-to-determine-whether-egfr-status-by-fish-can-predict-results-in-non-small-cell-l 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00162318/a-phase-i-study-of-cetuximab-in-combination-with-gefitinib-in-patients-with-advanced-met 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00112346/study-of-gemcitabine-platinum-cetuximab-as-first-line-treatment-for-patients-with-advanc 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01121575/a-study-of-combined-c-met-inhibitor-and-pan-her-inhibitor-pf-02341066-and-pf-00299804-in 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00768755/evaluation-of-the-efficacy-of-the-combination-of-axitinib-with-pemetrexed-and-cisplatin 2015-10-28 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00450281/s0424-carcinogens-in-lung-tissue-from-smokers-closed-to-entry-as-of-7-15-07-and-non-smok 2015-10-26 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00905801/computed-tomography-ct-perfusion-imaging-of-lung-cancer 2015-10-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01100931/a-phase-i-ii-study-of-paclitaxel-carboplatin-and-ym155-survivin-suppressor-in-subjects-w 2015-10-19 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00103142/vaccine-therapy-in-treating-patients-with-liver-or-lung-metastases-from-colorectal-cance 2015-10-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00743938/a-comparison-between-bms-690514-and-erlotinib-in-patients-who-were-previously-treated-fo 2015-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00660816/pemetrexed-or-docetaxel-with-or-without-erlotinib-in-stage-iiib-or-stage-iv-non-small-ce 2015-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00850577/ph-ii-of-a-novel-anti-angiogenic-agent-in-combination-with-chemotherapy-for-the-treatmen 2015-10-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00897143/identifying-early-lung-cancer-cells-in-malignant-pleural-effusion-samples-from-patients 2015-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00684801/disease-management-program-or-usual-care-in-patients-with-stage-iii-or-stage-iv-lung-can 2015-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00633789/phase-ii-study-of-brivanib-bms-582664-to-treat-multiple-tumor-types 2015-10-09 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00062270/neoadjuvant-chemoradiotherapy-with-or-without-gefitinib-in-treating-patients-with-stage 2015-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00673738/cetuximab-plus-conformal-thoracic-radiotherapy-in-patients-pts-with-inoperable-or-unrese 2015-10-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00769067/a-randomized-trial-of-pf-00299804-taken-orally-versus-erlotinib-taken-orally-for-treatme 2015-10-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02134886/erlotinib-hydrochloride-in-treating-non-small-cell-lung-cancer-that-is-metastatic-or-can 2015-10-06 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00204880/aging-and-cancer-effects-ace-study 2015-10-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01090011/trial-of-bibw-2992-afatinib-cetuximab-in-non-small-cell-lung-cancer 2015-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00205413/surveillance-for-new-lung-primaries 2015-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01963715/a-phase-1-study-of-imgn289-in-adult-patients-with-egfr-positive-solid-tumors 2015-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00733252/optical-coherence-tomography-of-the-airway-for-lung-cancer-or-lung-disease 2015-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00104767/celecoxib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer 2015-10-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00627029/evaluation-of-programs-of-coordinated-care-and-disease-management 2015-10-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923481/a-broad-multi-histology-phase-ii-study-of-the-multi-kinase-inhibitor-r935788-fostamatini 2015-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00905086/psychosocial-adjustment-after-radiation-therapy-in-patients-with-cancer 2015-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00923949/pioglitazone-to-treat-adults-undergoing-surgery-for-non-small-cell-lung-cancer 2015-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00397384/erlotinib-hydrochloride-and-cetuximab-in-treating-patients-with-advanced-gastrointestina 2015-09-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01193881/ro4929097-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iv-or-recurrent-no 2015-09-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00585377/bevacizumab-avastin-erlotinib-as-first-line-therapy-for-stage-iiib-iv-or-recurrent-non-s 2015-09-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00973427/dna-chip-based-prognosis-of-lung-cancer 2015-09-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01212367/intrapleural-gene-transfer-for-pleural-mesothelioma 2015-09-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01851161/prone-patient-positioning-in-reducing-tumor-motion-and-improving-breathing-reproduction 2015-09-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00373425/a-study-of-erlotinib-tarceva-after-surgery-with-or-without-adjuvant-chemotherapy-in-non 2015-09-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02250378/stereotactic-radiosurgery-followed-by-wedge-resection-in-treating-patients-with-early-st 2015-09-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00368992/s0536-cetuximab-paclitaxel-carboplatin-and-bevacizumab-in-treating-patients-with-advance 2015-09-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01057212/trial-of-bevacizumab-and-ixabepilone-for-advanced-or-metastatic-non-small-cell-lung-canc 2015-09-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01184287/a-study-of-ranpirnase-onconase-to-pemetrexed-plus-carboplatin-in-patients-with-non-squam 2015-09-02 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00178256/pulsed-paclitaxel-and-daily-thoracic-radiotherapy-for-inoperable-stage-i-ii-or-unresecta 2015-08-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00704392/safety-study-of-xl647-and-xl147-administered-in-combination-daily-in-adults-with-solid-t 2015-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01130714/resistance-training-in-lung-cancer-patients-on-chemotherapy 2015-08-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00391586/erlotinib-and-standard-platinum-based-chemotherapy-for-newly-diagnosed-advanced-non-smal 2015-08-17 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02405247/tauras-t790-aura-screenfailure-soc-registry-study 2015-07-31 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00912366/assessment-of-video-assisted-thoracoscopic-surgery-vats-versus-open-surgery-for-patients 2015-07-27 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00748085/cryospray-ablation-tm-in-malignant-airway-disease-to-determine-safety-and-tissue-effect 2015-07-23 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00907179/pemetrexed-and-lbh589-in-patients-with-advanced-non-small-cell-lung-cancer 2015-07-22 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01937637/improving-management-of-breathlessness-in-patients-with-lung-cancer 2015-07-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00747916/safety-efficacy-and-side-effects-study-of-interventional-cryotherapy-in-the-pleural-spac 2015-07-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02388074/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphine-tcpp-for-detecti 2015-07-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01685346/biofeedback-training-in-patients-with-advanced-lung-cancer-a-pilot-study 2015-07-10 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00413075/study-of-oral-pxd101-in-patients-with-advanced-solid-tumors-or-lymphoma 2015-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00413322/study-of-pxd101-alone-and-in-combination-with-5-fluorouracil-5-fu-in-patients-with-advan 2015-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02368990/t790m-mutation-positive-2nd-line-standard-of-care-registry 2015-07-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00063154/safety-and-effect-of-pertuzumab-in-patients-with-advanced-non-small-cell-lung-cancer-whi 2015-07-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01011075/study-of-gleevec-and-weekly-paclitaxel-in-patients-aged-70-or-older-with-advanced-non-sm 2015-07-03 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00431873/a-phase-ii-study-of-mgcd0103-mg-0103-in-patients-with-refractory-chronic-lymphocytic-leu 2015-07-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01817686/study-of-default-options-in-advance-directives 2015-06-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01482741/understanding-patient-perspectives-on-the-risks-of-ionizing-radiation-used-for-medical-i 2015-06-25 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00327288/safety-study-of-imexon-plus-docetaxel-in-lung-breast-or-prostate-cancer-patients 2015-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00697060/a-safety-and-efficacy-trial-of-amplimexon-plus-taxotere-in-metastatic-non-small-cell-lun 2015-06-24 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01843192/powered-echelon-device-in-vats-surgery 2015-06-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01415089/tailored-web-based-intervention-for-cancer-patients-and-family-caregivers 2015-06-16 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00581113/neural-stem-cell-preserving-brain-radiation-therapy-stereotactic-radiosurgery-in-patient 2015-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01487499/bronchoscopic-intratumoral-chemotherapy-for-small-cell-lung-cancer-sclc 2015-06-11 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00378404/phase-i-trial-of-docetaxel-and-low-dose-fractionated-radiation-in-the-treatment-of-metas 2015-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00621049/carboplatin-docetaxel-bevacizumab-and-erlotinib-versus-chemotherapy-alone-in-resected-ns 2015-06-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01222572/stereotactic-boost-for-locally-advanced-non-small-cell-lung-cancer 2015-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00746759/airway-epithelium-gene-expression-aegis-ide 2015-06-04 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01038752/evaluation-of-non-cytotoxic-suramin-as-a-chemosensitizer-in-non-small-cell-lung-cancer 2015-05-21 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01562015/a-study-of-ganetespib-in-subjects-with-alk-positive-non-small-cell-lung-cancer-nsclc 2015-05-20 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00765570/study-of-advanced-bulky-malignancies-with-spatially-fractioned-radiation-therapy 2015-05-18 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00892710/trial-of-poor-performance-status-patients-topps 2015-05-15 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00638625/correlation-of-x-ray-and-pathology-with-needle-biopsy-of-lung-tumors 2015-05-14 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01024946/everolimus-rad001-for-the-treatment-of-malignant-pleural-mesothelioma-with-merlin-nf2-lo 2015-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00238615/phase-ii-docetaxel-carboplatin-xrt-surgical-resection-in-stage-iii-nsclc 2015-05-12 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct01598597/an-observational-pilot-study-evaluating-the-feasibility-of-conducting-genome-wide-associ 2015-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00676507/phase-iii-lucanixtm-vaccine-therapy-in-advanced-non-small-cell-lung-cancer-nsclc-followi 2015-05-08 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00743379/dose-escalation-study-of-th-302-in-combination-with-a-gemcitabine-or-b-docetaxel-or-c-pe 2015-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00316186/first-line-treatment-of-subjects-with-extensive-disease-small-cell-lung-cancer-with-week 2015-05-07 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006382/lung-screening-study 2015-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00521144/obatoclax-mesylate-and-topotecan-hydrochloride-in-treating-patients-with-relapsed-or-ref 2015-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00470054/dasatinib-in-treating-patients-with-relapsed-small-cell-lung-cancer 2015-05-05 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00041028/ef5-in-assessing-tumor-response-to-anticancer-therapy-in-patients-with-stage-i-stage-ii 2015-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct02132403/pm-01-imprime-pgg-with-bth1704-and-gemcitabine-for-advanced-pancreatic-cancer 2015-05-01 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00006981/immunotoxin-therapy-in-treating-patients-with-advanced-cancer 2015-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00716456/cetuximab-in-patients-with-lung-adenocarcinoma-receiving-erlotinib-that-have-developed-a 2015-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00066651/immunotoxin-therapy-in-treating-patients-with-advanced-solid-tumors 2015-04-30 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00019201/fluorescent-light-bronchoscopy-plus-white-light-bronchoscopy-for-early-detection-of-lung 2015-04-29 weekly 0.8 https://lungcancerclinicaltrials.org/trials/nct00019825/decitabine-in-treating-patients-with-unresectable-lung-or-esophageal-cancer-or-malignant 2015-04-29 weekly 0.8